A0_Samples	A17_Age	A18_Sex	A1_OS	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A3_T	A4_N	A5_M	A6_Stage	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	additional_studies	additional_studies.additional_study.disease_code	additional_studies.additional_study.project_code	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	anatomic_neoplasm_subdivision_other	bcr_patient_barcode	bcr_patient_uuid	day_of_form_completion	days_to_birth	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	diagnosis	dlco_predictive_percent	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	eastern_cancer_oncology_group	egfr_mutation_identified	egfr_mutation_performed	egfr_mutation_result	eml4_alk_translocation_identified	eml4_alk_translocation_method	eml4_alk_translocation_performed	eml4_alk_translocation_result	ethnicity	follow_ups.follow_up.additional_pharmaceutical_therapy	follow_ups.follow_up.additional_radiation_therapy	follow_ups.follow_up.additional_surgery_locoregional_procedure	follow_ups.follow_up.additional_surgery_metastatic_procedure	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_additional_surgery_locoregional_procedure	follow_ups.follow_up.days_to_additional_surgery_metastatic_procedure	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.eastern_cancer_oncology_group	follow_ups.follow_up.followup_case_report_form_submission_reason	follow_ups.follow_up.followup_treatment_success	follow_ups.follow_up.karnofsky_performance_score	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_neoplasm_event_types.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_event_after_initial_treatment	follow_ups.follow_up.performance_status_scale_timing	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.primary_therapy_outcome_success	follow_ups.follow_up.progression_determined_by_list.progression_determined_by	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	gender	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	karnofsky_performance_score	kras_gene_analysis_performed	kras_mutation_found	kras_mutation_result	location_in_lung_parenchyma	month_of_form_completion	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.locoregional_procedure.additional_surgery_locoregional_procedure	new_tumor_events.new_tumor_event.locoregional_procedure.days_to_additional_surgery_locoregional_procedure	new_tumor_events.new_tumor_event.metastatic_procedure.additional_surgery_metastatic_procedure	new_tumor_events.new_tumor_event.metastatic_procedure.days_to_additional_surgery_metastatic_procedure	new_tumor_events.new_tumor_event.new_neoplasm_event_types.new_neoplasm_event_type	new_tumor_events.new_tumor_event.progression_determined_by_list.progression_determined_by	new_tumor_events.new_tumor_event_after_initial_treatment	number_pack_years_smoked	other_dx	patient_id	performance_status_scale_timing	person_neoplasm_cancer_status	post_bronchodilator_fev1_fvc_percent	post_bronchodilator_fev1_percent	postoperative_rx_tx	pre_bronchodilator_fev1_fvc_percent	pre_bronchodilator_fev1_percent	primary_therapy_outcome_success	pulmonary_function_test_performed	race_list.race	radiation_therapy	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	residual_tumor	stage_event.ann_arbor.b_symptoms	stage_event.ann_arbor.extranodal_involvement	stage_event.clinical_stage	stage_event.gleason_grading.gleason_score	stage_event.gleason_grading.primary_pattern	stage_event.gleason_grading.secondary_pattern	stage_event.gleason_grading.tertiary_pattern	stage_event.igcccg_stage	stage_event.masaoka_stage	stage_event.pathologic_stage	stage_event.psa.days_to_psa	stage_event.psa.psa_value	stage_event.serum_markers	stage_event.system_version	stage_event.tnm_categories.clinical_categories.clinical_M	stage_event.tnm_categories.clinical_categories.clinical_N	stage_event.tnm_categories.clinical_categories.clinical_T	stage_event.tnm_categories.pathologic_categories.pathologic_M	stage_event.tnm_categories.pathologic_categories.pathologic_N	stage_event.tnm_categories.pathologic_categories.pathologic_T	stopped_smoking_year	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tobacco_smoking_history	tumor_tissue_site	vital_status	year_of_form_completion	year_of_initial_pathologic_diagnosis	year_of_tobacco_smoking_onset
TCGA-J2-8192	65	FEMALE	739	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N1	MX	Stage IIA	1	482.0		Locoregional Recurrence	TUMOR FREE				65	L-Upper	Not Applicable	TCGA-J2-8192	369f14c4-2191-4962-a309-3e23ddc4e5fc	6	-23892	Not Applicable	0	154	Not Available	Lung Adenocarcinoma	112	TCGA-J2-8192-D32572;TCGA-J2-8192-D32574;TCGA-J2-8192-D55392	5FA2C5DE-EEB3-450E-8D40-F0B739F6106D;5751CCC2-7B5B-4703-8405-CF1E474220FB;A136AC0B-F93F-4B43-AE17-770DADF20159	Not Available;Not Available;Not Available	6;6;16	Not Available;Not Available;Not Available	105;105;641	cisplatin;pemetrexed;Erlotinib	Not Available;Not Available;Not Available	6;6;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2014	Not Available	Not Available	YES	Exon 19 Deletion	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	NO	TCGA-J2-8192-F55390	EFDC3166-C726-484E-8EB1-5A436DF66A0A	18	Not Available	Not Available	Not Applicable	739	482	Not Evaluated	Scheduled Follow-up Submission	Unknown	Not Evaluated	NO	2	Locoregional Recurrence	YES	Not Available	Unknown	YES	Progressive Disease	Biopsy with Histologic Confirmation	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Prior Malignancy	8192	Not Available	TUMOR FREE	100	89	YES	97	77	Unknown	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a	Not Available	YES	NO	J2	1	Lung	Alive	2012	2011	Not Available
TCGA-91-8499	76	FEMALE	36	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	36			Unknown				76	L-Lower	Not Applicable	TCGA-91-8499	54480f58-7e63-4aed-a116-c2c2252e8364	29	-27853	Not Applicable	0	36	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-8499-F37976	A3296482-B65D-46DC-8306-36D9A0CE0CAB	7	Not Applicable	Not Applicable	Not Applicable	36	Not Applicable	Not Available	Scheduled Follow-up Submission	Unknown	Unknown	YES	12	Not Available	NO	Not Available	Unknown	NO	Unknown	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Unknown	NO	Not Available	Not Available	Unknown	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	90	No	8499	Not Available	Unknown	49	Not Available	NO	Not Available	Not Available	Unknown	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	YES	NO	91	2	Lung	Alive	2012	2011	1945
TCGA-53-7624	40	FEMALE	1043	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M1	Stage IV	1	400.0		Distant Metastasis	WITH TUMOR				40	R-Upper	Not Applicable	TCGA-53-7624	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	13	-14794	1043	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-53-7624-D39727;TCGA-53-7624-D39729;TCGA-53-7624-D39730;TCGA-53-7624-D39731;TCGA-53-7624-D39732;TCGA-53-7624-D39735;TCGA-53-7624-D39736;TCGA-53-7624-D39737;TCGA-53-7624-D39738;TCGA-53-7624-D39739	CABE6493-EEA3-4417-991E-E2D8BAA5D0F4;28681B5B-2CCC-41DB-B342-A1BB56EE7432;03D35A9D-2F9E-4DD6-BEF9-4EAE9D35C1DB;F6AB7F08-1341-440F-90F1-54F3E9CF0C7F;588CEFB2-2FCB-4A28-893B-35DDF6E44FB9;9628B2FD-EDBE-415B-A139-7EC10C28CF7E;5CDA082A-CFF9-4E2A-9C47-299425450EF8;87E2D964-3168-438C-9CB9-1F81D70122AE;0F25327C-C54D-4542-A956-47AFFD9D63B5;EAC0A9FD-301B-48F7-AFD2-499DFE2F0418	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	31;31;31;31;31;31;31;31;31;31	966;922;980;861;782;186;186;490;490;490	924;880;980;803;726;66;66;339;339;339	Irinotecan;Erlotinib;Abraxane;Docetaxel;Gemcitabine;Cisplatin;Vinorelbine;Carboplatinum;Bevacizumab;Pemetrexed	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	1;1;1;1;1;1;1;1;1;1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013;2013;2013;2013;2013	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	HISPANIC OR LATINO	YES	YES	Not Available	YES	TCGA-53-7624-F39722	9661057B-3EF1-4814-AE67-408068F09148	31	Not Available	593	1043	Not Available	400	Not Available	Scheduled Follow-up Submission	Progressive Disease	0	NO	1	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Biopsy with Histologic Confirmation	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	7624	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-53-7624-R39726	78FACC85-69B0-4EEE-9713-CBF425E45FE0	Not Available	31	624	613	Radiographic Progressive Disease	1	10	30	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	Not Available	NO	YES	53	2	Lung	Dead	2011	2008	1986
TCGA-55-6986	74	FEMALE	3261	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T2	N0	M0	Stage IB	0	3261			TUMOR FREE				74	R-Lower	Not Applicable	TCGA-55-6986	028e99e9-5b9a-4954-bb6e-6d4709a3cea8	26	Not Available	Not Applicable	0	2151	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-55-6986-F45606	D147F3D1-27F0-467E-9212-AE14BCF08700	17	Not Applicable	Not Applicable	Not Applicable	3261	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	7	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6986	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	55	1	Lung	Alive	2011	2004	Not Available
TCGA-38-4632	42	MALE	1357	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M1	Stage IV	1	680.0			WITH TUMOR				42	L-Upper	Not Applicable	TCGA-38-4632	875333ab-9048-462d-aaa2-693ad127e3cc	13	-15418	1357	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-38-4632-D4840;TCGA-38-4632-D4844;TCGA-38-4632-D13822;TCGA-38-4632-D13824	77d7b5e2-ec9e-44d8-a8bb-fc29c602ae6a;54475225-34f4-4948-996f-e97089cd5a04;d1a79d21-2ed8-415a-aea3-af762a661683;e8d4b552-6c8f-4cfb-93cd-267605c6a506	Not Available;Not Available;Not Available;Not Available	13;13;14;14	802;1169;802;1169	679;1136;679;1127	gemcitabine;Carboplatin;Paclitaxel;CPT-11	Not Available;Not Available;Not Available;Not Available	12;12;7;7	6;2;6;2	Not Available;Not Available;Not Available;Not Available	mg;mg;Not Available;Not Available	RECURRENCE;PALLIATIVE;RECURRENCE;PALLIATIVE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	LCCC 9831;3;LCCC 9831;3	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2010;2010;2011;2011	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;YES	NO;YES	NO;NO	NO;NO	TCGA-38-4632-F4839;TCGA-38-4632-F4842	ecb636f6-dc7d-48c5-9a00-02aec73f03b1;1fb434a3-8648-499c-8e36-97c1ea94dad2	13;13	Not Available;Not Available	Not Available;Not Available	1357;1357	Not Available;Not Available	680;925	Not Available;Not Available	Not Available;Not Available	Stable Disease;Progressive Disease	Not Available;Not Available	Not Available;Not Available	12;12	Not Available;Not Available	YES;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Dead;Dead	2010;2010	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	No	4632	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	BLACK OR AFRICAN AMERICAN	Not Available	Distant Recurrence;Distant site	TCGA-38-4632-R4843;TCGA-38-4632-R40104	5dd66aad-2ab7-4f32-9a98-b640c47d392f;E3818E10-E37C-4DCF-881F-A1B668E6A6B7	3;Not Available	13;12	955;70	955;35	Not Available;Complete Response	12;2	10;22	2500;5800	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	PALLIATIVE;Not Available	Not Available;Not Available	cGy;cGy	2010;2013	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T2	1991	NO	YES	38	4	Lung	Dead	2010	1998	Not Available
TCGA-78-7146	71	FEMALE	173	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N2	M0	Stage IIIA	0	173			Not Available				71	L-Lower	Not Applicable	TCGA-78-7146	ff9def3d-17e5-4ef6-b74e-933f11ed6f00	28	-26272	173	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-78-7146-F16969	89a4cee2-d516-4b0e-8664-c1a31a242e71	28	Not Available	Not Available	173	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	No	7146	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1998	NO	YES	78	4	Lung	Dead	2011	1999	1988
TCGA-NJ-A4YG	65	MALE	2261	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	2261			TUMOR FREE				65	L-Upper	Not Applicable	TCGA-NJ-A4YG	7FD03220-531E-4EF8-BECA-E9703E8C0AE1	26	-23812	Not Applicable	0	1726	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-NJ-A4YG-F50865;TCGA-NJ-A4YG-F70643	C3CF3C86-3DA7-477A-A2DE-B89D114EE5BC;BF940C94-BC39-49DE-A9DF-843E7ED62019	1;27	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	1904;2261	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	11;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2013;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8255/3	C34.1	YES	Not Evaluated	Not Available	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	104	No	A4YG	Not Evaluated	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Not Applicable	NO	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2007	NO	YES	NJ	4	Lung	Alive	2013	2008	1955
TCGA-86-8279	46	MALE	949	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N1	M0	Stage IIA	0	949			TUMOR FREE				46	R-Upper	Not Applicable	TCGA-86-8279	2923e404-38f2-437a-b57e-23401fbe0273	6	-17032	Not Applicable	0	21	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8279-D41676;TCGA-86-8279-D41677	9F2065E1-C62F-4D2A-92CB-B1DB2F7963E2;233E4E3A-65B3-467B-B214-C52773DD2094	Not Available;Not Available	25;25	119;119	28;28	Etoposide;Cisplatin	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-86-8279-F41673;TCGA-86-8279-F59731	56E63750-3C49-4C3E-8586-0497C56C4A45;2203355D-451D-42E6-A83A-A8D2CC685DC5	25;20	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	482;949	Not Applicable;Not Applicable	1;1	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	90;90	NO;NO	3;5	Not Available;Not Available	NO;NO	Pre-Adjuvant Therapy;Preoperative	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	YES;YES	Alive;Alive	2013;2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	NO	Not Available	Not Available	Peripheral Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	8279	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	Not Available	Complete Remission/Response	NO	WHITE	YES	Primary Tumor Field	TCGA-86-8279-R41678	8C483E9F-5DD2-4828-91A6-F81F0A420544	Not Available	25	208	139	Complete Response	3	33	66	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	YES	NO	86	1	Lung	Alive	2012	2011	Not Available
TCGA-50-6591	63	FEMALE	119	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M1	Stage IV	1				WITH TUMOR				63	L-Lower	Not Applicable	TCGA-50-6591	9b132e4f-7e35-4cc5-8711-43ad62b906d0	25	-23067	119	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-50-6591-F43833	911B7995-6444-4317-A9F1-A366B72E0186	4	Not Applicable	Not Applicable	119	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	6	Not Available	NO	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6591	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	Not Available	NO	YES	50	1	Lung	Dead	2011	2007	Not Available
TCGA-50-5939	85	MALE	460	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N0	M0	Stage IB	0	460			TUMOR FREE				85	R-Upper	Not Applicable	TCGA-50-5939	12b79b4f-c28c-418e-a1e7-e622f33fdcc2	2	-31236	460	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-50-5939-F32124	2105f694-4ccf-4c6e-8eba-917a55c789e3	17	Not Applicable	Not Applicable	460	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	Not Available	5	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Dead	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	No	5939	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1968	NO	YES	50	3	Lung	Dead	2011	2008	Not Available
TCGA-62-8402	73	FEMALE	1498	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N2	M0	Stage IIIA	1	772.0		Locoregional Recurrence	WITH TUMOR				73	R-Upper	Not Applicable	TCGA-62-8402	433a32d0-93d1-4897-8e36-beb1ec1d998e	4	-26934	Not Applicable	0	1445	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	YES	Exon 19 Deletion	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	YES	Not Available	NO	TCGA-62-8402-F52547	08295B1A-EE42-42DD-9431-741E62382F2E	4	Not Available	Not Available	1498	Not Available	772	0	Scheduled Follow-up Submission	Progressive Disease	100	NO	12	Distant Metastasis	YES	Preoperative	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	100	NO	Not Available	Not Available	Peripheral Lung	7	YES	YES	772	NO	Not Available	NO	Not Available	Locoregional Recurrence;Distant Metastasis	Convincing Imaging	YES	Not Available	No	8402	Preoperative	WITH TUMOR	Not Available	Not Available	Unknown	80	134	Complete Remission/Response	YES	WHITE	YES	Regional site	TCGA-62-8402-R33812	181E46B6-E825-45DA-A720-020A04CA720F	Not Available	19	73	28	Complete Response	7	25	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	62	1	Lung	Alive	2012	2008	Not Available
TCGA-49-4506	68	FEMALE	999	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	692.0		Locoregional Recurrence	Discrepancy				68	L-Upper	Not Applicable	TCGA-49-4506	b61abdfd-b7a0-4e1a-b570-d1eaecad3a9e	3	-25132	999	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	Not Available	TCGA-49-4506-F58841	8288A530-E15A-453B-A072-A3824044F22E	25	Not Available	Not Available	999	Not Available	692	2	Scheduled Follow-up Submission	Progressive Disease	70	NO	4	Locoregional Recurrence	YES	Post-Adjuvant Therapy	Discrepancy	YES	Complete Remission/Response	Convincing Imaging	YES	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	100	No	4506	Pre-Adjuvant Therapy	Discrepancy	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	49	2	Lung	Dead	2011	1997	Not Available
TCGA-91-6847	62	FEMALE	842	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	1	772.0		Distant Metastasis	Not Available				62	R-Lower	Not Applicable	TCGA-91-6847	97831d28-ab41-4c18-bfc2-c4c6bc757d13	19	-22862	Not Applicable	0	842	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	NO	TCGA-91-6847-F32637	FB5F10C7-9572-4BC0-B5F4-245D88F78D07	5	Not Available	Not Available	Not Applicable	842	772	Unknown	Scheduled Follow-up Submission	Stable Disease	Unknown	YES	6	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Convincing Imaging	YES	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6847	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site;Distant site	TCGA-91-6847-R32638;TCGA-91-6847-R32640	8EF10C9E-D1AB-4797-A3E8-9204A1446CC0;C84D7330-6ED5-4C67-A689-182C0A994A88	Not Available;Not Available	5;5	781;842	772;842	Stable Disease;Unknown	6;6	Not Available;1	40;14.5	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2012;2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	1967	NO	YES	91	3	Lung	Alive	2011	2002	Not Available
TCGA-97-8547	78	FEMALE	657	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N2	MX	Stage IIIA	0	657			TUMOR FREE				78	R-Lower	Not Applicable	TCGA-97-8547	ac0d7a82-82cb-4aec-b859-e37375f3de8b	27	-28801	Not Applicable	0	148	Not Available	Lung Adenocarcinoma	87	TCGA-97-8547-D35445;TCGA-97-8547-D35446;TCGA-97-8547-D35447	46926057-7C1B-4651-913D-B4C08C699594;8EDFE56A-3EB6-47A8-A4BA-2255FF3A3418;393D56D3-0031-4F0A-9E38-F16B66B602D5	Not Available;Not Available;Not Available	27;27;27	111;111;Not Available	47;47;124	Taxol;Carboplatin;TARCEVA	Complete Response;Complete Response;Not Applicable	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Evaluated	Not Available	YES	Exon 19 Deletion	Not Available	Not Available	NO	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	TCGA-97-8547-F49559	C213E7BE-D60E-412A-BD5D-8BCFC8749CA7	3	Not Applicable	Not Applicable	Not Applicable	657	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	10	Not Available	NO	Not Evaluated	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8550/3	C34.3	YES	Not Available	YES	NO	Not Available	Unknown	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8547	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	136	Complete Remission/Response	YES	Not Evaluated	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T2a	Not Available	YES	NO	97	1	Lung	Alive	2012	2012	Not Available
TCGA-97-7546	76	FEMALE	1285	Lung Acinar Adenocarcinoma	Lung	Alive	T1	N0	MX	Stage IA	1	1255.0		New Primary Tumor	TUMOR FREE				76	L-Upper	Not Applicable	TCGA-97-7546	1d90c9f3-5025-4867-a2f0-e455b6a254fa	17	-27913	Not Applicable	0	964	Not Available	Lung Adenocarcinoma	60	TCGA-97-7546-D32027	BFAB42A6-E8C6-4F2C-AAE1-8C7D88AB5CFD	Not Available	15	Not Available	1255	Tarceva	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	Not Available	Not Available	TCGA-97-7546-F31995	14A442B8-34A0-48DF-A9B0-6768DA7DE62F	15	Not Available	Not Available	Not Applicable	1285	1255	Not Available	Additional New Tumor Event	Not Evaluated	Not Available	NO	5	New Primary Tumor	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Convincing Imaging	YES	Alive	2012	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	7546	Not Available	TUMOR FREE	96	84	Not Available	100	85	Not Available	YES	WHITE	Not Available	Primary Tumor Field	TCGA-97-7546-R32026	85B50FCD-5DA2-4D3E-9A31-E2F14A14CEFB	1	15	1255	1255	Not Available	5	Not Available	Not Available	NO	OTHER	Direct to the Spot	ADJUVANT	Not Available	Not Available	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	1983	NO	YES	97	3	Lung	Alive	2011	2008	1963
TCGA-73-4659	66	MALE	711	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	1	35.0			WITH TUMOR				66	R-Upper	Not Applicable	TCGA-73-4659	cd0dc947-b708-464e-beb7-954c9d4583e7	3	-24253	711	0	711	Not Available	Lung Adenocarcinoma	Not Available	TCGA-73-4659-D12858;TCGA-73-4659-D12862;TCGA-73-4659-D12421;TCGA-73-4659-D12823;TCGA-73-4659-D12430;TCGA-73-4659-D12827;TCGA-73-4659-D12854;TCGA-73-4659-D12830	e1e21cb8-57eb-41c0-bc61-810f106edb69;0d2c7085-2781-4e8e-8b42-63ec7e58b646;98e093a8-64cb-4848-a1c5-0cb8c8b550f9;9025783d-e657-4c73-a5f6-e9ee2e60a789;a14661c5-aff8-4e99-af96-b96b3dafcf52;cd7e24d6-b03d-4d4d-aa1d-1f3263695c72;4a12034c-0bf9-4eb9-a160-0cf1abb40e59;8cfd7bb0-b951-48a1-bb37-5452ea0cbf5a	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3	609;657;298;452;406;494;581;581	602;624;257;410;312;473;546;539	Taxol;CYC-116/Cyclocel;Alimta;Vinorelbine;Erlotonib;Docetoxel/Taxotere;Cisplatin;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12	2;3;3;2;5;4;2;2	50mg/m2 = 100mg;720 mg;500;25mg/m2 = 50;150;25mg/m2 = 50mg;75mg/m2 - 150mg;100mg/m2	mg/m2;mg;mg/m2;mg/m2;mg;g/m2;mg/m2;mg/m2	PROGRESSION;OTHER, SPECIFY IN NOTES;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Protocol;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	7;8;3;3;4;4;6;5	IV;PO;IV;IV;PO;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Aurora Kinase Inhibitor - Protocol therapy;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	200;15120;3000;300;9000;150;300;Not Available	mg;mg;mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;YES;NO	YES;NO;YES	NO;NO;Not Available	Not Available;Not Available;NO	TCGA-73-4659-F12416;TCGA-73-4659-F42016;TCGA-73-4659-F42024	f2d5e4ac-03fa-459f-b244-372e45af7556;29AE1152-27C6-4EC5-BF73-5E60331EB46D;A3EC6F64-BB1F-4BDF-A2C0-1C928B6342DB	3;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	711;711;711	711;Not Available;Not Available	35;47;316	Not Available;Not Available;Not Available	Not Available;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease;Progressive Disease	0;0;0	Not Available;NO;NO	12;4;4	Not Available;Locoregional Recurrence;Distant Metastasis	YES;YES;YES	Other;Other;Other	WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;NO;NO	Not Available;Progressive Disease;Progressive Disease	Not Available;Convincing Imaging;Convincing Imaging	NO;NO;NO	Dead;Dead;Dead	2010;2013;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	90	NO	Not Available	Not Available	Central Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	No	4659	Other	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site;Regional site	TCGA-73-4659-R12417;TCGA-73-4659-R12419	1982ff3d-adc9-4ee5-a1db-ac538d6ccbdb;a399e767-7839-4e48-bcc9-7df3fd55366c	1;2	3;3	337;529	337;516	Not Available;Not Available	12;12	1;10	2200;3000	NO;NO	OTHER;EXTERNAL BEAM	Gamma Knife;Not Applicable	PROGRESSION;PALLIATIVE	Not Available;Not Available	cGy;cGy	2010;2010	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1986	NO	YES	73	3	Lung	Dead	2011	2006	1974
TCGA-55-A48Y	69	MALE	630	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N0	M0	Stage IIA	0	630			TUMOR FREE				69	L-Lower	Not Applicable	TCGA-55-A48Y	12C07138-E3FA-418A-89E3-628DA12BC99E	21	-25384	Not Applicable	0	42	Not Available	Lung Adenocarcinoma	42	TCGA-55-A48Y-D59059;TCGA-55-A48Y-D59060	47E0007B-5A41-4E22-8E2B-2483E168CA99;A497B509-E9BB-4278-851A-F25CB653F363	Not Available;Not Available	30;30	163;163	91;91	Carboplatin;Alimta	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-A48Y-F59057	D3AB8E13-5211-4F85-B576-F476B974C2D1	30	Not Applicable	Not Applicable	Not Applicable	630	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	4	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	50	No	A48Y	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	38	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	YES	NO	55	2	Lung	Alive	2013	2012	1962
TCGA-50-5049	70	MALE	3094	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IA	1	1568.0		Locoregional Recurrence	TUMOR FREE				70	R-Upper	Not Applicable	TCGA-50-5049	9944f46f-9fa8-4e2c-a806-776bec7f8803	25	-25577	Not Applicable	0	1485	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;NO	NO;YES	Not Available;NO	NO;Not Available	TCGA-50-5049-F32017;TCGA-50-5049-F70448	79588753-1945-43ea-8245-803ff0d345a2;90D123CB-CB20-432C-B1EB-DE4AC04FBEB9	15;16	1520;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	2146;3094	1568;2544	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	NO;NO	5;2	Locoregional Recurrence;Locoregional Recurrence	YES;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Progressive Disease;Progressive Disease	Biopsy with Histologic Confirmation;Convincing Imaging;Convincing Imaging	YES;YES	Alive;Alive	2012;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5049	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Primary Tumor Field;Local Recurrence;Local Recurrence	TCGA-50-5049-R32018;TCGA-50-5049-R40451;TCGA-50-5049-R70449	f905863f-864f-47e2-b71c-97e4751409f6;5A078CE3-58C7-4D83-90B5-53A805868ACD;6A997CE9-D4FE-4BB9-BB53-165C43494E55	01;Not Available;Not Available	15;20;16	0;1572;2544	0;1572;2544	Not Available;Partial Response;Unknown	5;2;2	Not Available;4;Not Available	10;12;Not Available	NO;NO;NO	IMPLANTS;External;External	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Gy;Not Available	2012;2013;2015	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	50	Not Available	Lung	Alive	2011	2006	Not Available
TCGA-44-3396	74	FEMALE	1130	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N2	M0	Stage IIIA	0	1130			TUMOR FREE				74	Discrepancy	Not Available	TCGA-44-3396	3bd6badb-27ff-4d8d-b206-4d28dc264862	18	-27073	Not Applicable	0	311	Not Available	Lung Adenocarcinoma	48	TCGA-44-3396-D5017;TCGA-44-3396-D5019	cb7c2370-e79f-4706-9c22-02b0152ffc04;d9d59d53-accc-4e89-bc4c-c13fde7550f1	Not Available;Not Available	22;22	192;192	129;129	Alimta;Carboplatin	Not Available;Not Available	10;10	4;4	850;600	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3400;2100	mg;mg	Not Available;Not Available	2010;2010	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-44-3396-F5016;TCGA-44-3396-F39080	5e3024c8-c8ce-42c6-bfec-8fbe87e3146a;65BCFB65-301A-471C-9683-5088DE18ED24	22;11	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	411;1130	Not Applicable;Not Applicable	1;Not Available	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;80	Not Available;NO	10;1	Not Available;Not Available	NO;NO	Adjuvant therapy;Other	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2010;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	3396	Other	TUMOR FREE	Not Available	Not Available	Not Available	98	89	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	YES	NO	44	2	Lung	Alive	2010	2009	1959
TCGA-05-4405	74	FEMALE	610	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	610			TUMOR FREE				74	R-Lower	Not Applicable	TCGA-05-4405	f587c9ab-2949-4410-80d6-a050865d48aa	22	-27241	Not Applicable	0	610	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4405-F36494	83F914FE-F0D0-4B75-9F4B-DD17F59C62A0	31	Not Applicable	Not Applicable	Not Applicable	610	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	NO	Not Applicable	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	65	Yes	4405	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1994	NO	YES	05	4	Lung	Alive	2010	2006	1951
TCGA-78-8662	53	FEMALE	3361	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	3044.0		Locoregional Recurrence	Unknown				53	R-Upper	Not Applicable	TCGA-78-8662	16e64a1e-08b0-4c27-8c69-fa64551f8ca4	23	-19563	3361	0	Not Available	Not Available	Lung Adenocarcinoma	76																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Evaluated																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	Unknown	YES	3044	NO	Not Available	Not Available	Not Available	Locoregional Recurrence	Biopsy with Histologic Confirmation	YES	45	No	8662	Preoperative	Unknown	Not Available	Not Available	NO	64	96	Complete Remission/Response	YES	Not Evaluated	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	78	2	Lung	Dead	2012	2000	1964
TCGA-50-8460	74	MALE	829	Lung Papillary Adenocarcinoma	Lung	Alive	T1a	N0	M0	Stage IA	0	829			Unknown				74	R-Upper	Not Applicable	TCGA-50-8460	497cc506-03fe-4ffa-860b-5a12adb1bc7d	18	-27270	Not Applicable	0	105	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-50-8460-F69335	D2F418F0-13A0-45DB-B9B4-F1D07DFA9D55	5	Not Applicable	Not Applicable	Not Applicable	829	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	1	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	YES	Alive	2015	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8460	Not Available	Unknown	Not Available	Not Available	NO	Not Available	Not Available	Unknown	NO	WHITE	YES	Primary Tumor Field	TCGA-50-8460-R42675	1EB8F1A2-25A0-4301-B2A6-731A17BE04FB	Not Available	26	49	49	Complete Response	4	Not Available	Not Available	NO	Internal	Not Applicable	Not Available	Not Available	Not Available	2013	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	50	Unknown	Lung	Alive	2012	2012	Not Available
TCGA-55-8087	59	FEMALE	462	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	462			TUMOR FREE				59	R-Upper	Not Applicable	TCGA-55-8087	e254aaeb-012c-4d92-8a03-cce1f6a2bcd6	15	-21655	Not Applicable	0	21	Not Available	Lung Adenocarcinoma	142																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8087-F47822	7E1BBF1B-2639-4442-A633-A2B9D0B088C9	28	Not Applicable	Not Applicable	Not Applicable	462	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8087	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	126	Complete Remission/Response	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	55	1	Lung	Alive	2012	2011	Not Available
TCGA-MP-A4TA	75	FEMALE	950	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	1	725.0		Distant Metastasis	WITH TUMOR				75	R-Upper	Not Applicable	TCGA-MP-A4TA	98EE294A-46ED-4572-BDD4-A932C3498A25	2	-27513	950	0	Not Available	Not Available	Lung Adenocarcinoma	46																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Peripheral Lung	4	YES	YES	725	Not Available	Not Available	NO	Not Available	Distant Metastasis	Biopsy with Histologic Confirmation	YES	55	Yes, History of Prior Malignancy	A4TA	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	74	NO	Not Available	65	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2006	NO	YES	MP	4	Lung	Dead	2013	2006	1951
TCGA-55-7815	76	MALE	773	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	1	466.0		Locoregional Recurrence	TUMOR FREE				76	R-Lower	Not Applicable	TCGA-55-7815	dd46c83e-6551-485b-b935-f3beed891244	9	-28119	Not Applicable	0	54	Not Available	Lung Adenocarcinoma	59	TCGA-55-7815-D61496;TCGA-55-7815-D61499	ACA058EE-8C58-4DBD-99EB-8E97EE4F6CC6;A6E48EE4-3A3F-49A9-8FEF-18D08A8F7BE4	Not Available;Not Available	30;30	585;Not Available	493;706	Chemo, NOS;Chemo, NOS	Clinical Progressive Disease;Not Applicable	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES;YES	NO;YES	NO;NO	Not Available;NO	TCGA-55-7815-F61495;TCGA-55-7815-F61497	65349788-E32F-44C4-B26D-8C918338BD6E;6453FCE4-3AA4-4688-B362-E357741C142B	30;30	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	773;773	466;592	Unknown;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event	Progressive Disease;Progressive Disease	Unknown;Not Available	NO;NO	6;6	Locoregional Recurrence;Distant Metastasis	YES;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Convincing Imaging;Not Available	NO;NO	Alive;Alive	2014;2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7815	Not Available	TUMOR FREE	Not Available	76	Not Available	Not Available	72	Not Available	YES	Not Available	Not Available	Distant Recurrence	TCGA-55-7815-R61498	3CE21127-ECB2-4DF3-97FC-5630023BAE41	Not Available	30	616	616	Radiographic Progressive Disease	6	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	55	1	Lung	Alive	2012	2011	Not Available
TCGA-55-8096	67	FEMALE	719	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N0	MX	Stage IB	1	566.0		Distant Metastasis	WITH TUMOR				67	L-Upper	Not Applicable	TCGA-55-8096	36470b30-a3b3-4d28-851b-918a7ff88011	17	-24684	Not Applicable	0	47	Not Available	Lung Adenocarcinoma	Not Available																								2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	NO	TCGA-55-8096-F59097	8C87E2A2-73CA-4684-8F57-4E60B151A5F2	30	Not Available	Not Available	719	Not Available	566	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	4	Distant Metastasis	YES	Not Evaluated	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	70	NO	Not Available	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	104	No	8096	Preoperative	WITH TUMOR	Not Available	Not Available	Unknown	77	55	Unknown	YES	WHITE	Unknown	Distant Recurrence;Distant Recurrence	TCGA-55-8096-R59099;TCGA-55-8096-R59100	CBA362C5-DDE4-49C3-8870-7282E45CEE6D;3F231937-362D-43AA-8744-F5FA20BA913D	Not Available;Not Available	30;30	600;679	579;641	Radiographic Progressive Disease;Radiographic Progressive Disease	4;4	14;Not Available	3500;Not Available	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2014;2014	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	1959
TCGA-NJ-A55R	67	MALE	603	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	603			TUMOR FREE				67	L-Upper	Not Applicable	TCGA-NJ-A55R	7C7D777B-BF00-4C24-97FC-922580D5605F	27	-24738	Not Applicable	0	603	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-NJ-A55R-F50899;TCGA-NJ-A55R-F70652	02EB453B-5913-4F97-A3A3-6E67ECC7568E;2000A52F-31B2-4A1B-ACB6-36A88942F0E0	1;27	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	603;603	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;YES	11;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2013;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8230/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Unknown	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	5	No	A55R	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Stable Disease	NO	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	1986	Not Available	Not Available	NJ	3	Lung	Alive	2013	2011	Not Available
TCGA-91-7771	62	MALE	492	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	MX	Stage IIB	0	492			Not Available				62	R-Upper	Not Applicable	TCGA-91-7771	c0fdb152-25d2-404b-bec7-a43ece381f5b	24	-22926	Not Applicable	0	31	Not Available	Lung Adenocarcinoma	Not Available	TCGA-91-7771-D37917;TCGA-91-7771-D37919	494CE129-C26D-4374-B915-382105753D85;7D947262-1775-4C0C-981A-AAF1E6E7D92E	Not Available;Not Available	6;6	156;156	77;77	Cisplatin;Pemetrexed	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-7771-F37916	5CE9E189-97C2-4431-8689-FBACCA998B25	6	Not Applicable	Not Applicable	Not Applicable	492	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	12	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	75	Yes	7771	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	2011	YES	NO	91	4	Lung	Alive	2012	2011	Not Available
TCGA-69-7760	73	MALE	202	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T3	N0	M0	Stage IIB	0	202			Not Available				73	R-Lower	Not Applicable	TCGA-69-7760	8981f0c9-7155-4c96-bf77-7d40fe404323	24	-26777	Not Applicable	0	154	Not Available	Lung Adenocarcinoma	125	TCGA-69-7760-D20981;TCGA-69-7760-D21152	94bb8b11-881e-449b-8206-95458a4e6762;5fa9b68b-32b6-4df9-a9a8-01cc626473d6	Not Available;Not Available	25;2	110;110	47;47	Carboplatin;pemetrexed disodium	Not Available;Not Available	1;2	4;4	588.6;905	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-7760-F29247	58e0fa1d-b060-47b2-808b-631e2c8d3b82	13	Not Applicable	Not Applicable	Not Applicable	202	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Not Available	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7760	Not Available	Not Available	Not Available	Not Available	Not Available	91	83	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	69	1	Lung	Alive	2012	2011	Not Available
TCGA-44-5644	51	FEMALE	863	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0		Stage IB	0	863			TUMOR FREE				51	R-Lower	Not Applicable	TCGA-44-5644	1fc81cd4-fa89-4135-8c3c-027ffae82b05	12	-18644	Not Applicable	0	498	Not Available	Lung Adenocarcinoma	61																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;Not Available	TCGA-44-5644-F17419;TCGA-44-5644-F38817	002c588c-531f-435b-98a5-bcd8255fb0c1;A4C3F323-E35C-4654-9855-2092454AAB32	12;26	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	498;863	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	10;12	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	17.5	No	5644	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	103	59	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	Not Available	N0	T2a	Not Available	YES	NO	44	2	Lung	Alive	2011	2010	1975
TCGA-69-7973	42	FEMALE	230	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N0	M0	Stage IB	0	230			TUMOR FREE				42	R-Middle	Not Applicable	TCGA-69-7973	dc9eaaa0-0bfd-46d0-994f-310826879da4	2	-15355	Not Applicable	0	230	Not Available	Lung Adenocarcinoma	Not Available	TCGA-69-7973-D30332;TCGA-69-7973-D30341;TCGA-69-7973-D30344;TCGA-69-7973-D30346	2B5DC03D-AFEF-4C32-BB62-02A37D57897F;8C513402-CD6E-424D-9844-E3390F02D0C3;D947DBDE-9875-4B03-AE2A-F2B3AE12CCD8;8C538EDD-BE6D-4A7E-8936-5487EB1589D3	Not Available;Not Available;Not Available;Not Available	9;9;9;9	63;63;132;132	63;63;91;91	Cisplatin;Taxotere;Cisplatin;Pemetrexed	Unknown;Unknown;Complete Response;Complete Response	4;4;4;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	1	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-69-7973-F30347	3A3CBBC0-50FA-42BB-88C1-99E0CF4F765C	9	Not Applicable	Not Applicable	Not Applicable	230	Not Applicable	1	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	Not Available	4	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	7973	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	2011	NO	YES	69	4	Lung	Alive	2012	2011	Not Available
TCGA-44-6145	62	FEMALE	595	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	595			TUMOR FREE				62	R-Upper	Not Applicable	TCGA-44-6145	6144d666-8f77-4efe-95f1-f9e5c4e5e056	31	-22745	Not Applicable	0	103	Not Available	Lung Adenocarcinoma	73																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-44-6145-F28687;TCGA-44-6145-F38802	32fc1b78-c824-434f-b655-22498b49fb64;0C442DE0-4653-41AC-B01C-344325306F22	28;24	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	328;595	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	2;12	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	NO	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	75	No	6145	Preoperative	TUMOR FREE	91	90	Not Available	77	71	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1999	YES	NO	44	4	Lung	Alive	2011	2011	1963
TCGA-64-1676	58	MALE	1728	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	1728			TUMOR FREE				58	R-Lower	Not Applicable	TCGA-64-1676	fb6b289c-aaf9-4d8e-b6e0-5d35bce1b6e1	15	-21428	Not Applicable	0	1728	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-64-1676-F4366	d70bd353-950d-4da4-b04a-934497c1974a	15	Not Applicable	Not Applicable	Not Applicable	1728	Not Applicable	Not Available	Not Available	Complete Remission/Response	Not Available	Not Available	11	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2010	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	No	1676	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	NO	YES	64	2	Lung	Alive	2010	2005	Not Available
TCGA-97-7553	58	FEMALE	1870	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T1	N0	MX	Stage IA	0	1870			TUMOR FREE				58	L-Lower	Not Applicable	TCGA-97-7553	37c8d73a-45ae-40fc-ba9a-721b755c1160	17	-21518	Not Applicable	0	1332	Not Available	Lung Adenocarcinoma	64																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-7553-F31865	BA07C466-8C62-4560-BB7C-07344BAF0FA8	14	Not Applicable	Not Applicable	Not Applicable	1870	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Not Available	Not Evaluated	NO	5	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	7553	Not Available	TUMOR FREE	70	99	Not Available	70	99	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	Not Available	NO	YES	97	2	Lung	Alive	2011	2007	1967
TCGA-55-8511	73	FEMALE	552	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	1	460.0			TUMOR FREE				73	R-Upper	Not Applicable	TCGA-55-8511	1f1df7ea-00b9-4432-86de-da773d1451e5	11	-26986	Not Applicable	0	9	Not Available	Lung Adenocarcinoma	31																								2	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Unknown	Unknown	NO	NO	TCGA-55-8511-F66028	E2BDF53C-410E-4BF9-910E-C89C1F94487E	1	Not Available	Not Available	Not Applicable	552	460	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Not Available	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	70	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	58	Yes, History of Prior Malignancy	8511	Preoperative	TUMOR FREE	Not Available	Not Available	NO	82	53	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	55	2	Lung	Alive	2013	2012	1953
TCGA-MP-A4TF	58	FEMALE	336	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2b	N0	M0	Stage IIA	1	195.0		Distant Metastasis	WITH TUMOR				58	R-Upper	Not Applicable	TCGA-MP-A4TF	86DAC334-F30E-438E-810A-8E45F69DBB7E	2	-21387	336	0	Not Available	Not Available	Lung Adenocarcinoma	77	TCGA-MP-A4TF-D41409;TCGA-MP-A4TF-D41410	DB475CAC-B2D9-461C-A714-D5BBD7B9CF48;51556339-4419-45EF-B7B5-597FECF9A3D5	Not Available;Not Available	18;18	151;133	48;48	Navelbine;Cisplatin	Partial Response;Partial Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Peripheral Lung	4	NO	YES	195	Not Available	Not Available	YES	202	Distant Metastasis	Biopsy with Histologic Confirmation;Convincing Imaging	YES	40	No	A4TF	Not Evaluated	WITH TUMOR	Not Available	108	YES	Not Available	109	Partial Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	2010	NO	YES	MP	4	Lung	Dead	2013	2010	1970
TCGA-55-8204	87	FEMALE	515	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	515			TUMOR FREE				87	L-Upper	Not Applicable	TCGA-55-8204	75589307-f141-4d0d-b35d-adbbc77b3dec	8	-31818	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	101																								Unknown	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8204-F47802	A13C7C7D-9375-4938-BE6F-E877CD27ADBD	28	Not Applicable	Not Applicable	Not Applicable	515	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Unknown	Unknown	Not Available	Not Available	Unknown	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Prior Malignancy	8204	Unknown	TUMOR FREE	Not Available	Not Available	Unknown	88	85	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	55	3	Lung	Alive	2012	2011	Not Available
TCGA-55-8616	58	FEMALE	48	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	48			TUMOR FREE				58	R-Upper	Not Applicable	TCGA-55-8616	fe714ac0-f874-426a-924b-a2980232b5f7	28	-21225	Not Applicable	0	48	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8616	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Not Applicable	Not Available	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1999	YES	NO	55	4	Lung	Alive	2012	2012	Not Available
TCGA-86-8281	75	MALE	0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	NX	M0	Stage IA	0	0			TUMOR FREE				75	R-Lower	Not Applicable	TCGA-86-8281	5d7ec32a-049f-4997-9882-1b3ac157e02d	30	-27409	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8281-F57953	017E9B68-F25D-49A5-B8E0-DB66626379F3	21	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	YES	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	100	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	No	8281	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	1985	YES	NO	86	3	Lung	Alive	2012	2011	1955
TCGA-55-7574	64	FEMALE	995	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N0	M0	Stage IB	1	478.0		Distant Metastasis	WITH TUMOR				64	R-Upper	Not Applicable	TCGA-55-7574	a7911bdc-13f1-434a-bfa3-f8ba55d15846	11	-23703	Not Applicable	0	95	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-7574-D20394;TCGA-55-7574-D20393;TCGA-55-7574-D64281;TCGA-55-7574-D64282	50bc6792-9c2d-4274-950b-9916578c4a38;fac718aa-4cd8-4b69-a353-5c3619f96f9a;4FE5B8E6-4EEE-41ED-986D-BD7841309AFC;855D0B62-EF5B-4164-B03B-74957166BF47	Not Available;Not Available;Not Available;Not Available	11;11;28;28	184;184;631;631	130;130;478;478	Carboplatin;Docetaxel;Topotecan;Avastin	Not Available;Not Available;Partial Response;Partial Response	1;1;8;8	5;5;Not Available;Not Available	160;30;Not Available;Not Available	mg;mg;Not Available;Not Available	ADJUVANT;ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;Not Available;Not Available	IV;IV;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;NO;NO	2012;2012;2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	NO	NO	TCGA-55-7574-F64279	5044B8DF-923E-4D53-9106-5A864756F25C	28	Not Available	Not Available	995	Not Available	478	3	Scheduled Follow-up Submission	Progressive Disease	50	NO	8	Distant Metastasis	YES	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Convincing Imaging	YES	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	No	7574	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Distant Recurrence	TCGA-55-7574-R20395;TCGA-55-7574-R64280	17dcc733-d220-4557-aa17-6c2fe68d4dd6;9DB59113-7988-4908-A908-B0A73E2F7D33	1;Not Available	11;28	162;487	123;487	Not Available;Stable Disease	1;8	Not Available;Not Available	3800;Not Available	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	cGy;Not Available	2012;2014	R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	2011	YES	NO	55	4	Lung	Alive	2012	2011	1971
TCGA-L9-A743	56	MALE	664	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N1	M0	Stage IIA	0	664			TUMOR FREE				56	L-Upper	Not Applicable	TCGA-L9-A743	A5F2576A-D628-47DE-A5DF-76A4F3105DCC	14	-20780	Not Applicable	0	312	Not Available	Lung Adenocarcinoma	45	TCGA-L9-A743-D58553;TCGA-L9-A743-D58554	88D31EDF-D154-4FAF-B5A3-0BABE6D20D73;BD488F92-7CB9-4C9E-B60D-9F199C561475	Not Available;Not Available	14;14	193;193	120;120	TAXOTERE;CISPLATIN	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-L9-A743-F66554	F0B1840B-09D9-4DEB-978E-CEAB73FADEC9	20	Not Applicable	Not Applicable	Not Applicable	664	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Preoperative	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Central Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40.5	Yes, History of Prior Malignancy	A743	Preoperative	TUMOR FREE	81	78	YES	85	88	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	YES	NO	L9	2	Lung	Alive	2014	2013	1986
TCGA-73-4670	69	FEMALE	131	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M1	Stage IV	0	131			WITH TUMOR				69	L-Upper	Not Applicable	TCGA-73-4670	1b354837-4925-4480-ac32-6b44d0957314	6	-25526	Not Applicable	0	14	Not Available	Lung Adenocarcinoma	Not Available	TCGA-73-4670-D12984;TCGA-73-4670-D12987;TCGA-73-4670-D12986;TCGA-73-4670-D12988	fce5249c-69e4-43b1-ba19-7261731a8a90;06e09d14-17d7-4d81-a98c-780ac3ff2162;2aaeb964-d8d0-4811-85a8-5b26948bf157;634e1395-f22a-4b7b-80d6-9f2d2929ccd1	Not Available;Not Available;Not Available;Not Available	15;15;15;15	110;110;110;54	33;33;54;33	carboplatin;Avastin;alimta;taxol	Not Available;Not Available;Not Available;Not Available	6;6;6;6	4;4;4;1	538;930;680;308	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	2152;3720;2720;308	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-73-4670-F12983	9f66a7c0-c40c-412d-ab8c-b6bac0bfe58d	15	Not Applicable	Not Applicable	Not Applicable	131	Not Applicable	2	Not Available	Not Available	50	Not Available	6	Not Available	NO	Adjuvant therapy	Not Available	YES	Stable Disease	Not Available	NO	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Discrepancy	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	4670	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	2009	NO	YES	73	4	Lung	Alive	2011	2010	1979
TCGA-50-5066	72	MALE	1442	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	1	477.0		Distant Metastasis	Not Available				72	R-Upper	Not Applicable	TCGA-50-5066	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	2	-26385	Not Applicable	0	297	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5066-D32029;TCGA-50-5066-D32030;TCGA-50-5066-D32031	5be0e05b-35a4-4283-90e3-38874324ed7a;ad7d0412-3694-4490-8268-f0191cbe615c;1ac70461-ad8a-48f2-b045-ce88d310315b	Not Available;Not Available;Not Available	15;15;15	567;567;567	508;508;508	Carboplatin;Taxol;Avastin	Stable Disease;Stable Disease;Stable Disease	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	YES	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	YES;Not Available	NO;Not Available	NO;Not Available	YES;Not Available	TCGA-50-5066-F32028;TCGA-50-5066-F70450	e8fd3201-f957-4c6e-9942-c2fc7699fcd8;AB6C6622-1AE5-480A-A3DB-CB949ED02E15	15;16	Not Available;Not Applicable	598;Not Applicable	Not Applicable;Not Applicable	944;1442	477;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Complete Remission/Response	Not Available;Not Available	NO;NO	5;2	Distant Metastasis;Not Available	YES;NO	Not Available;Not Available	WITH TUMOR;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2015	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5066	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	50	1	Lung	Alive	2011	2009	Not Available
TCGA-75-5126	Not Available	FEMALE		Lung Papillary Adenocarcinoma	Lung		T3	N2	M0	Stage IIIA	1				WITH TUMOR				Not Available	L-Upper	Not Applicable	TCGA-75-5126	93766482-2f20-4c8f-bbd8-bdd203c37d5a	31	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	NO	Not Available	TCGA-75-5126-F11746	8ee06ba1-ac92-4ac5-9748-27ba9607d9e7	4	Not Available	Not Available	Not Applicable	Not Available	Not Available	1	Not Available	Progressive Disease	Not Available	Not Available	4	Not Available	YES	Adjuvant therapy	WITH TUMOR	NO	Partial Remission/Response	Not Available	NO	Alive	2011	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	5126	Other	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	2007	NO	YES	75	4	Lung	Alive	2011	2007	Not Available
TCGA-64-5779	61	MALE	864	Lung Acinar Adenocarcinoma	Lung	Alive	T2	N2	M0	Stage IIIA	1	795.0		Distant Metastasis	TUMOR FREE				61	L-Lower	Not Applicable	TCGA-64-5779	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	2	-22305	Not Applicable	0	507	Not Available	Lung Adenocarcinoma	100	TCGA-64-5779-D11375;TCGA-64-5779-D11376;TCGA-64-5779-D31475;TCGA-64-5779-D31476	c0d60743-bdf0-436e-9702-4e8ce35c248d;621a2148-00ec-4c00-a0bc-980442ab9522;d2824bc2-e94d-4926-9b6b-0600e519bb80;b55016e7-e7a7-430d-93e0-377e6fb2fb50	Not Available;Not Available;Not Available;Not Available	2;2;3;3	157;157;157;157	94;94;94;94	Cisplatin;Pemetrexed;Cisplatin;Pemetrexed	Not Available;Not Available;Complete Response;Complete Response	5;5;5;5	04;04;Not Available;Not Available	75;500;Not Available;Not Available	mg/m2;mg/m2;Not Available;Not Available	ADJUVANT;ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	01;01;Not Available;Not Available	IV;IV;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;YES;YES	2011;2011;2012;2012	0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;NO	Not Available;YES	Not Available;Not Available	Not Available;YES	TCGA-64-5779-F11373;TCGA-64-5779-F31473	04f76938-5fba-43c0-98dc-09975c964e2b;e630e4b1-4907-4640-a3cf-9909d6695755	2;3	Not Applicable;Not Available	Not Applicable;797	Not Applicable;Not Applicable	507;864	Not Applicable;795	0;0	Not Available;Additional New Tumor Event	Stable Disease;Unknown	Not Available;Unknown	Not Available;Not Available	5;5	Not Available;Distant Metastasis	NO;YES	Post-Adjuvant Therapy;Post-Adjuvant Therapy	Not Available;Unknown	YES;YES	Stable Disease;Discrepancy	Not Available;Not Available	YES;YES	Alive;Alive	2011;2012	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	5779	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	94	100	Not Available	YES	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field;Distant site	TCGA-64-5779-R11374;TCGA-64-5779-R31474;TCGA-64-5779-R31477	0eb7ccdf-6dff-4dd1-802d-f035caf16d3a;92e10658-9cdc-4b28-a801-c37c70128b36;2e1ad728-abff-4e0d-9a8b-01a72cad7afc	01;01;02	2;17;17	241;241;864	Not Available;201;852	Not Available;Not Available;Not Available	5;4;4	28;28;09	Not Available;5040;2700	NO;NO;NO	EXTERNAL BEAM;EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;ADJUVANT;RECURRENCE	Not Available;Not Available;Not Available	cGy;cGy;cGy	2011;2012;2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	2009	NO	YES	64	4	Lung	Alive	2011	2009	1969
TCGA-55-6543	60	FEMALE	435	Lung Bronchioloalveolar Carcinoma Mucinous	Lung	Alive	T1b	N0	MX	Stage IA	0	435			TUMOR FREE				60	R-Upper	Not Applicable	TCGA-55-6543	e68219b0-a9c2-49df-8f0d-db5ea97fd2dc	3	Not Available	Not Applicable	0	2	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-55-6543-F46659	328EC06C-F892-4324-A3ED-FB2A283BCC0B	13	Not Applicable	Not Applicable	Not Applicable	435	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	8	Not Available	NO	Unknown	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.1	8253/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	No	6543	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	2004	NO	YES	55	4	Lung	Alive	2010	2010	Not Available
TCGA-55-A48Z	60	FEMALE	651	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1a	N3	MX	Stage IIIB	1	536.0		Distant Metastasis	WITH TUMOR				60	R-Upper	Not Applicable	TCGA-55-A48Z	16D3C1C1-CF3A-44B6-B564-8AE5464B243D	21	-22056	Not Applicable	0	29	Not Available	Lung Adenocarcinoma	110	TCGA-55-A48Z-D59069;TCGA-55-A48Z-D59070	AFA50190-D879-4A5D-A4A9-F1A7F1E161AA;1B807520-A86F-4B84-8830-F8DDCC3231BE	Not Available;Not Available	30;30	202;202	58;58	Cisplatin;Alimta	Stable Disease;Stable Disease	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	2	Not Available	YES	Other	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	NO	TCGA-55-A48Z-F59061	D7D0B518-0721-4E90-96F0-BBDE43C09282	30	Not Available	Not Available	Not Applicable	651	536	Unknown	Scheduled Follow-up Submission	Not Applicable	Unknown	NO	4	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Stable Disease	Convincing Imaging	YES	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	70	YES	NO	Not Available	Central Lung	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	A48Z	Preoperative	WITH TUMOR	Not Available	Not Available	Unknown	85	87	Unknown	YES	WHITE	Unknown	Primary Tumor Field;Distant Recurrence	TCGA-55-A48Z-R59063;TCGA-55-A48Z-R59068	5402A6C5-9B30-41B2-84A2-CA7417D81721;E95BD641-FE8E-4767-B875-0517421D30B7	Not Available;Not Available	30;30	195;567	154;539	Stable Disease;Radiographic Progressive Disease	4;4	Not Available;Not Available	5040;Not Available	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2014;2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N3	T1a	2012	YES	NO	55	4	Lung	Alive	2013	2012	1972
TCGA-86-8278	63	FEMALE	944	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N1	M0	Stage IIB	1	29.0			TUMOR FREE				63	L-Lower	Not Applicable	TCGA-86-8278	a816e355-be6f-4d16-b051-b6d86ed8cded	6	-23117	Not Applicable	0	23	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8278-D41670;TCGA-86-8278-D41671;TCGA-86-8278-D41672	964E5BFB-3A3B-47C8-A346-6F5BDACA4D99;9ACDE909-44BF-475C-AAFC-8C721F24CFD9;8C3C7ABD-D1E8-4672-965B-91AF4B8F03CE	Not Available;Not Available;Not Available	25;25;25	156;156;Not Available	29;29;178	Etoposide;Cisplatin;Gefitinib	Stable Disease;Stable Disease;Not Applicable	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES;Not Available	NO;Not Available	NO;Not Available	NO;Not Available	TCGA-86-8278-F41668;TCGA-86-8278-F59732	AC1B771F-E726-4EE8-99BB-16A15628DF26;7676E1AE-1FFF-4CF0-B2AF-D97D745A06F7	25;20	Not Available;Not Applicable	Not Available;Not Applicable	Not Applicable;Not Applicable	476;944	29;Not Applicable	1;1	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	90;90	NO;NO	3;5	Not Available;Not Available	YES;NO	Preoperative;Preoperative	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.30	8480/3	C34.3	YES	80	NO	Not Available	Not Available	Peripheral Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8278	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Complete Remission/Response	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	YES	NO	86	1	Lung	Alive	2012	2011	Not Available
TCGA-L4-A4E5	48	FEMALE	578	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage I	0	578			TUMOR FREE				48	L-Upper	Not Applicable	TCGA-L4-A4E5	32A7B827-C3F9-4607-AE63-DAE8CAA2BC97	5	-17680	Not Applicable	0	213	Not Available	Lung Adenocarcinoma	93																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-L4-A4E5-F49031	DC4F62D9-03A2-4A06-A9B0-89FCCD37B4FB	25	Not Applicable	Not Applicable	Not Applicable	578	Not Applicable	1	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	9	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Central Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	33	No	A4E5	Preoperative	TUMOR FREE	94	82	NO	94	82	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2012	NO	YES	L4	4	Lung	Alive	2012	2012	1979
TCGA-49-4505	61	FEMALE	428	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	417.0		Distant Metastasis	WITH TUMOR				61	R-Lower	Not Applicable	TCGA-49-4505	088edf89-d2b5-40c7-b066-df3bd383f7ea	3	-22628	428	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Unknown	Unknown	Unknown	Not Available	TCGA-49-4505-F58844	7535318E-69AD-45DE-A08C-DB0184BC487D	25	Not Available	Not Available	428	Not Available	417	1	Scheduled Follow-up Submission	Unknown	80	NO	4	Distant Metastasis;New Primary Tumor	YES	Preoperative	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	74	No	4505	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	1986	NO	YES	49	4	Lung	Dead	2011	1996	1949
TCGA-69-7980	70	FEMALE	411	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage I	0	411			TUMOR FREE				70	R-Upper	Not Applicable	TCGA-69-7980	aee86a89-0377-4080-b16c-408bfbe78687	9	-25583	Not Applicable	0	43	Not Available	Lung Adenocarcinoma	71																								Not Available	Not Available	YES	Other	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	NO;Not Available	Not Available;Not Available	TCGA-69-7980-F39916;TCGA-69-7980-F57659	B9570D2D-FF75-4067-8D99-C36BCD332AC0;B3F0B9EB-890D-418B-9A53-A3F0240BB33D	11;19	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	411;362	Not Applicable;Not Applicable	Not Evaluated;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Not Applicable	Not Evaluated;Not Available	NO;NO	2;3	Not Available;Not Available	NO;NO	Not Evaluated;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8550/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80	No	7980	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	86	92	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	2001	YES	NO	69	4	Lung	Alive	2012	2011	Not Available
TCGA-55-7725	68	FEMALE	442	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	442			TUMOR FREE				68	R-Lower	Not Applicable	TCGA-55-7725	9fcdccae-676e-4071-93c3-23d2d3ab0c00	8	-24848	Not Applicable	0	39	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7725-F46647	6AC6EF5E-2614-45DD-8C0B-9F1053CF037A	13	Not Applicable	Not Applicable	Not Applicable	442	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	8	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	90	NO	Not Available	Not Available	Central Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	16	Yes	7725	Preoperative	TUMOR FREE	88	64	Not Available	89	61	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	1994	YES	NO	55	3	Lung	Alive	2012	2011	1963
TCGA-78-7162	75	MALE	3169	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1	N0	M0	Stage IA	1	2218.0			Not Available				75	L-Upper	Not Applicable	TCGA-78-7162	16cd58db-d52c-403e-9e9c-6da2e99f6bad	3	-27593	3169	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO;YES	YES;NO	NO;NO	NO;NO	TCGA-78-7162-F17125;TCGA-78-7162-F17127	19df3a15-5642-4b23-ab3b-d6fbc2d17193;125d989e-fe36-43e7-b9f2-515970b19506	3;3	Not Available;Not Available	Not Available;Not Available	3169;3169	Not Available;Not Available	2218;2740	Not Available;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	10;10	Not Available;Not Available	YES;YES	Not Available;Not Available	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;Not Available	NO;NO	Dead;Dead	2011;2011	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	No	7162	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-78-7162-R17154	25072ff0-dbfb-45ab-9bfc-f640a5b12e6a	1	4	Not Available	Not Available	Not Available	10	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	Not Available	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	78	2	Lung	Dead	2011	1991	1940
TCGA-80-5608	Not Available	FEMALE	2832	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	2832			TUMOR FREE				Not Available	R-Upper	Not Applicable	TCGA-80-5608	5c06d97f-2aaa-43de-b085-09d7829356ba	15	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-80-5608-F15870;TCGA-80-5608-F72033	242c20b9-5323-4ed7-91f3-3620555f7814;D9A05844-EA6C-4BE0-A6B9-C557069ACD65	15;2	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;2832	Not Applicable;Not Applicable	Not Available;Unknown	Not Available;Scheduled Follow-up Submission	Not Available;Not Available	Not Available;Unknown	Not Available;NO	8;4	Not Available;Not Available	NO;NO	Not Available;Unknown	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	26	No	5608	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	80	2	Lung	Alive	2011	Not Available	1972
TCGA-78-7159	60	FEMALE	1974	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1	NX	M0	Stage IA	0	1974			Not Available				60	L-Upper	Not Applicable	TCGA-78-7159	4d153600-81f9-44fb-b485-6355ec306d6a	27	-22261	Not Applicable	0	1221	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-78-7159-F16828;TCGA-78-7159-F46103	9d4d1342-5a7d-40a6-a7e8-c2c343ef1bcd;437BB295-ED73-4457-A339-512A3547FDFB	27;4	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1221;1974	Not Available;Not Available	Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Not Available	Not Available;NO	9;8	Not Available;Not Available	Not Available;Unknown	Not Available;Unknown	Not Available;Unknown	NO;NO	Not Available;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	21	No	7159	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	2007	NO	YES	78	4	Lung	Alive	2011	2008	1965
TCGA-MP-A4TI	72	MALE	429	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N1	M0	Stage IIA	1	84.0		Locoregional Recurrence	WITH TUMOR				72	R-Lower	Not Applicable	TCGA-MP-A4TI	F327DEA0-2D30-482F-809C-76A148A749B7	2	-26565	429	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	YES	YES	G12C	Unknown	4	YES	YES	84	Unknown	Not Available	Unknown	Not Available	Locoregional Recurrence;Distant Metastasis	Convincing Imaging	YES	35	No	A4TI	Not Evaluated	WITH TUMOR	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	1990	NO	YES	MP	3	Lung	Dead	2013	2010	1955
TCGA-78-7542	56	MALE	321	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	0	321			Not Available				56	R-Upper	Not Applicable	TCGA-78-7542	e64f76e4-f748-4d9e-ba71-53e2818a7920	13	-20763	321	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-78-7542-F20456	d15aada7-429d-413c-855e-e49c5ab30779	13	Not Available	Not Available	321	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	No	7542	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	78	2	Lung	Dead	2012	1993	1952
TCGA-91-6836	52	FEMALE	417	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	0	417			TUMOR FREE				52	R-Upper	Not Applicable	TCGA-91-6836	0b31dbdf-0623-48e4-a0ec-017650dceda7	20	-19216	Not Applicable	0	11	Not Available	Lung Adenocarcinoma	97																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-6836-F32646	5fc630d3-b549-4447-ba28-c379c0b08fa4	5	Not Applicable	Not Applicable	Not Applicable	417	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	6	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	Yes	6836	Not Available	TUMOR FREE	101	109	Not Available	Not Available	108	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	Not Available	NO	YES	91	2	Lung	Alive	2011	2010	1973
TCGA-78-7537	72	MALE	1622	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N0	M0	Stage IB	0	1622			Not Available				72	R-Upper	Not Applicable	TCGA-78-7537	67a2bc21-7c87-4678-997d-a434de672436	13	-26610	1622	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-78-7537-F20455	6c5bda4d-e611-4338-b11b-ff753eac94d6	13	Not Available	Not Available	1622	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	Dead	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	7537	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1984	YES	NO	78	3	Lung	Dead	2012	2002	1944
TCGA-97-7941	72	FEMALE	484	Lung Acinar Adenocarcinoma	Lung	Alive	T1b	N0	MX	Stage IA	0	484			TUMOR FREE				72	L-Upper	Not Applicable	TCGA-97-7941	b266cbf5-80de-4473-b16f-08c502d365ca	13	-26298	Not Applicable	0	22	Not Available	Lung Adenocarcinoma	57																								0	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-7941-F33765	BB66B454-B72A-45B2-9CF6-FDF7E2D2CE4D	13	Not Applicable	Not Applicable	Not Applicable	484	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Not Available	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Available	YES	YES	G12A	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	22.5	No	7941	Preoperative	TUMOR FREE	81	98	Not Available	94	97	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	1985	YES	NO	97	3	Lung	Alive	2012	2011	1960
TCGA-MP-A4TJ	62	FEMALE	339	Lung Signet Ring Adenocarcinoma	Lung	Dead	T1	N0	M0	Stage IA	0	339			Unknown				62	R-Upper	Not Applicable	TCGA-MP-A4TJ	8F52CCCD-5709-4753-9670-31A573EE27AB	2	-22875	339	0	Not Available	Not Available	Lung Adenocarcinoma	29																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Unknown																													FEMALE	Lung Signet Ring Adenocarcinoma	No	C34.1	8490/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Central Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	A4TJ	Not Evaluated	Unknown	30.1	36	NO	29.7	27	Complete Remission/Response	YES	Unknown	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	MP	2	Lung	Dead	2013	2006	Not Available
TCGA-78-8660	69	MALE	321	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	242.0		Distant Metastasis	WITH TUMOR				69	R-Lower	Not Applicable	TCGA-78-8660	781f40c9-c099-4c96-8269-ebe2a449c93d	23	-25422	321	0	Not Available	Not Available	Lung Adenocarcinoma	87																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Evaluated																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	NO	YES	242	Not Available	Not Available	YES	260	Distant Metastasis	Biopsy with Histologic Confirmation	YES	11	Yes, History of Prior Malignancy	8660	Preoperative	WITH TUMOR	Not Available	Not Available	NO	72	108	Unknown	YES	Not Evaluated	YES	Primary Tumor Field	TCGA-78-8660-R36074	4B964C80-FF7E-42DD-93F3-6AA45D3B94EA	Not Available	23	97	Not Available	Radiographic Progressive Disease	10	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	2005	NO	YES	78	4	Lung	Dead	2012	2005	1954
TCGA-49-AARQ	41	FEMALE	6732	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage I	0	6732			TUMOR FREE				41	R-Upper	Not Applicable	TCGA-49-AARQ	9A2A226E-9605-4214-9320-469305E664E6	19	-15065	Not Applicable	0	6443	Not Available	Lung Adenocarcinoma	99.9																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-49-AARQ-F72093	60C40E3D-7A62-4E0D-9272-99ED242A7606	10	Not Applicable	Not Applicable	Not Applicable	6732	Not Applicable	1	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	4	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	60	No	AARQ	Preoperative	TUMOR FREE	56.8	56.1	NO	83.2	82.2	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	2007	NO	YES	49	4	Lung	Alive	2014	1996	Not Available
TCGA-05-4415	57	MALE	91	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T4	N2	M0	Stage IIIB	1	60.0			WITH TUMOR				57	L-Lower	Not Applicable	TCGA-05-4415	d15b7b29-c5c5-41d8-b83b-7cc12fe92820	22	-20880	91	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	Not Available	TCGA-05-4415-F36499	415D000D-5528-4214-A231-C7F0A9AA1535	31	Not Available	Not Available	91	Not Available	60	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Not Available	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Dead	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	29	No	4415	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T4	2007	NO	YES	05	4	Lung	Dead	2010	2008	1997
TCGA-86-A4JF	56	MALE	737	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N0	M0	Stage IIB	1	436.0		Distant Metastasis	TUMOR FREE				56	R-Upper	Not Applicable	TCGA-86-A4JF	E01E4FB3-236A-4D16-9073-555876B688E9	14	-20491	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-A4JF-D52793;TCGA-86-A4JF-D52796	85E463A3-A1DE-4C8E-8C0F-9BD9AB0377D8;F06AAA11-F3BF-4A51-BA60-963FDE4D8CB8	Not Available;Not Available	6;6	171;536	31;444	Not Available;Not Available	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;Not Available	Unknown;Not Available	Not Available;Not Available	NO;Not Available	TCGA-86-A4JF-F51505;TCGA-86-A4JF-F70857	D96618EB-06F6-47F9-8C4C-D1E3264691D1;C9326E9D-3C7D-45BF-A0F0-3FD9F0CF2214	6;10	Not Available;Not Applicable	Not Available;Not Applicable	Not Applicable;737	536;Not Available	436;Not Applicable	2;4	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	70;20	NO;NO	12;3	Distant Metastasis;Not Available	YES;NO	Post-Adjuvant Therapy;Post-Adjuvant Therapy	WITH TUMOR;WITH TUMOR	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Dead	2013;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	NO	Not Available	Not Available	Central Lung	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A4JF	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	2012	YES	NO	86	4	Lung	Alive	2013	2012	Not Available
TCGA-86-7701	66	MALE	947	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M1	Stage IV	1	424.0		Distant Metastasis	TUMOR FREE				66	R-Upper	Not Applicable	TCGA-86-7701	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	18	-24209	Not Applicable	0	11	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-7701-D36483;TCGA-86-7701-D36484;TCGA-86-7701-D58402;TCGA-86-7701-D58403;TCGA-86-7701-D58404;TCGA-86-7701-D58405;TCGA-86-7701-D58407;TCGA-86-7701-D58408	EC1417C7-2349-4F98-939F-E7E643F30F87;24A17B71-0E0B-4803-A21C-02BCB336024D;08D438DF-4B04-42CE-92EB-6AAC1EF6952E;7741F434-FD67-473C-B872-5A2B21734ED8;444CAEFF-EDEE-460D-9C88-C49C232A90DB;D7831CC1-B080-4F51-A2C1-3A32B60AA83F;8C75D7CE-9FC9-4BFF-B261-DD159CFED86F;DC37E270-9E05-421E-A7F4-8B20DF86DC92	Not Available;Not Available;Tyrosine kinase inhibitor;Not Available;Not Available;Not Available;Not Available;Not Available	31;31;9;9;9;9;9;9	207;207;601;601;601;Not Available;Not Available;Not Available	27;27;454;454;454;706;936;936	Etoposide;Cisplatin;Not Available;Docetaxel;Zoledronic acid;Zoledronic acid;Gemcitabine;Docetaxel	Complete Response;Complete Response;Stable Disease;Stable Disease;Stable Disease;Not Applicable;Not Applicable;Not Applicable	10;10;4;4;4;4;4;4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Ancillary;Ancillary;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;YES;NO;NO;NO;NO;NO	2012;2012;2014;2014;2014;2014;2014;2014	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES;YES	NO;YES	Not Available;Not Available	NO;NO	TCGA-86-7701-F36476;TCGA-86-7701-F58406	277C6CF8-C341-45A1-AC77-78CA122BDD86;212F60F8-9A3F-4256-BC3A-C5150373B1E7	31;9	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	474;947	424;900	0;2	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Progressive Disease	100;80	NO;NO	10;4	Distant Metastasis;Distant Metastasis	YES;YES	Post-Adjuvant Therapy;Post-Adjuvant Therapy	WITH TUMOR;WITH TUMOR	YES;YES	Complete Remission/Response;Complete Remission/Response	Convincing Imaging;Not Available	NO;NO	Alive;Alive	2012;2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	Not Available	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7701	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Distant Recurrence	TCGA-86-7701-R58409	248F5702-58CA-4E1B-BC44-BCAC81B476C1	Not Available	9	929	917	Radiographic Progressive Disease	4	13	29	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	Not Available	YES	NO	86	1	Lung	Alive	2012	2011	Not Available
TCGA-44-3918	60	FEMALE	1036	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	1	511.0		Locoregional Recurrence	TUMOR FREE		FPPP	TCGA	60	L-Upper	Not Applicable	TCGA-44-3918	6e3b6b72-142d-4b8d-a462-28a205796e41	7	-22236	Not Applicable	0	197	197	Lung Adenocarcinoma	76	TCGA-44-3918-D20986;TCGA-44-3918-D20985	16f14090-dd3a-4b0c-91c7-998cee0e8d40;4cc469d8-02e3-4ef9-88d3-cd70b4fbc386	Not Available;Not Available	25;25	648;648	543;543	Carboplatin;Alimta	Not Available;Not Available	1;1	6;6	500;930	mg;mg	RECURRENCE;RECURRENCE	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3380;5660	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;YES;YES	NO;YES;YES	NO;NO;NO	NO;Not Available;Not Available	TCGA-44-3918-F5231;TCGA-44-3918-F21270;TCGA-44-3918-F38999	439f02a5-f262-430e-8cda-1308ad6cbb3d;02d8cb32-463a-4a11-bdf6-defceba7c69b;2C352F95-6915-4088-A9C0-D97582F74B5C	8;8;10	Not Applicable;Not Available;Not Available	Not Applicable;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	197;715;1036	Not Applicable;511;511	Not Available;0;Not Available	Not Available;Additional New Tumor Event;Scheduled Follow-up Submission	Complete Remission/Response;Stable Disease;Stable Disease	Not Available;Not Available;90	Not Available;Not Available;NO	10;2;1	Not Available;Not Available;Locoregional Recurrence	NO;YES;YES	Not Available;Other;Other	TUMOR FREE;WITH TUMOR;WITH TUMOR	NO;Not Available;NO	Complete Remission/Response;Not Available;Complete Remission/Response	Not Available;Not Available;Biopsy with Histologic Confirmation;Convincing Imaging	NO;Not Available;NO	Alive;Alive;Alive	2010;2012;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	3918	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	103	104	Not Available	YES	WHITE	Not Available	Local Recurrence	TCGA-44-3918-R21268	2b4b3df7-bfff-4e7e-b5be-3cad8f87f82d	1	8	697	686	Not Available	2	10	3000	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	cGy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1994	YES	NO	44	3	Lung	Alive	2010	2010	1974
TCGA-50-6597	79	FEMALE	1268	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	0	1268			TUMOR FREE				79	R-Lower	Not Applicable	TCGA-50-6597	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	26	-29195	Not Applicable	0	1015	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-50-6597-F44134	FC850BDD-7D70-423E-97AE-7FE982CCC259	13	Not Applicable	Not Applicable	1268	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	TUMOR FREE	NO	Partial Remission/Response	Not Available	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	YES	NO	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6597	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	50	1	Lung	Alive	2011	2007	Not Available
TCGA-NJ-A4YI	87	FEMALE	4	Lung Papillary Adenocarcinoma	Lung	Dead	T2	N2	M0	Stage IIIA	0	4			Unknown				87	R-Upper	Not Applicable	TCGA-NJ-A4YI	2C03141E-A0BD-4E8D-91E4-9744D139CCCE	24	-31867	4	0	Not Available	Not Available	Lung Adenocarcinoma	52																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	TCGA-NJ-A4YI-F50887	5768A19F-C788-44AE-9925-B7C2D4F5236D	1	Not Applicable	Not Applicable	4	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	11	Not Available	NO	Not Available	Unknown	NO	Unknown	Not Available	NO	Dead	2013	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	No	A4YI	Not Evaluated	Unknown	Not Available	94	NO	Not Available	89	Not Applicable	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1976	NO	YES	NJ	3	Lung	Dead	2013	2009	1936
TCGA-86-8280	54	FEMALE	701	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T2b	N0	M0	Stage IIA	0	701			TUMOR FREE				54	L-Lower	Not Applicable	TCGA-86-8280	d8faa3a7-6b3f-4e69-8c88-184e41055bd7	30	-19977	Not Applicable	0	16	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8280-D66080;TCGA-86-8280-D66081	7B11F24A-04FA-472B-A420-D8E1764C3600;2895FB6B-3FC1-4DFD-B743-1CB915268336	Not Available;Not Available	2;2	129;129	16;16	Cisplatin;Etoposide	Complete Response;Complete Response	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8280-F66079	F949DB0E-42F2-40F9-B663-70562177DC57	2	Not Applicable	Not Applicable	Not Applicable	701	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	10	Not Available	NO	Other	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8280	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	YES	NO	86	1	Lung	Alive	2012	2011	Not Available
TCGA-44-2666	43	MALE	97	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1				WITH TUMOR		FPPP	TCGA	43	R-Upper	Not Applicable	TCGA-44-2666	e16ca88f-488b-40f0-9169-e5a62482a2ff	8	-15970	97	0	97	97	Lung Adenocarcinoma	66																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-44-2666-F5304	3f3411e8-5a55-4b73-b4e9-42c1e7bfdf7d	12	Not Applicable	Not Applicable	97	97	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	NO	Not Available	WITH TUMOR	NO	Not Available	Not Available	NO	Dead	2010	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	2666	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	86	87	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	44	2	Lung	Dead	2010	2009	1979
TCGA-78-7154	72	MALE	593	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N2	M0	Stage IIIA	0	593			Not Available				72	L-Upper	Not Applicable	TCGA-78-7154	d288b69f-1e79-4429-8646-9994b7c54f8f	27	-26481	593	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-78-7154-F16951	9a2d2bfa-8f97-4a0f-9f2c-95bdea60e9c7	28	Not Available	Not Available	593	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	112.5	No	7154	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	1993	NO	YES	78	4	Lung	Dead	2011	2003	1948
TCGA-55-A491	81	FEMALE	626	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	626			TUMOR FREE				81	L-Lower	Not Applicable	TCGA-55-A491	A250A369-E536-4A18-B7AF-2911133D7BDC	21	-29593	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	68																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-A491-F60134	83201851-01DF-44E5-AB4C-DCB1F355360C	29	Not Applicable	Not Applicable	Not Applicable	626	Not Applicable	2	Scheduled Follow-up Submission	Complete Remission/Response	80	NO	5	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	45	Yes, History of Prior Malignancy	A491	Not Available	TUMOR FREE	73	68	Unknown	72	64	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	1982	YES	NO	55	3	Lung	Alive	2013	2012	1952
TCGA-05-4390	58	FEMALE	1126	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	1	395.0			TUMOR FREE				58	R-Upper	Not Applicable	TCGA-05-4390	b8475929-2d9d-4909-bd62-59684a140bd7	22	-21430	Not Applicable	0	1126	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-4390-D36457;TCGA-05-4390-D36458	1C563458-F78C-43FA-9FD0-9F31F386B0D7;E9C5A69B-2C5F-40D1-9CE9-46F808524536	Not Available;Not Available	5;5	92;92	61;61	Cisplatin;Vinorelbine	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	Not Available	TCGA-05-4390-F36456	732D9E3F-5FEB-41B6-BE2A-142253ED6110	31	Not Available	Not Available	Not Applicable	1126	395	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	YES	Not Available	TUMOR FREE	YES	Progressive Disease	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	No	4390	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1996	NO	YES	05	4	Lung	Alive	2010	2005	1966
TCGA-05-4382	68	MALE	607	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	1	334.0		Distant Metastasis	TUMOR FREE				68	L-Upper	Not Applicable	TCGA-05-4382	3434b91a-c05f-460f-a078-7b1bb6e7085d	22	-24868	Not Applicable	0	607	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	Not Available	TCGA-05-4382-F36329	A8CCFEBD-82AA-41E1-85E0-75E97DEA2051	29	Not Available	Not Available	Not Applicable	607	334	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Distant Metastasis	YES	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	YES	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	62	Yes	4382	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Distant Recurrence	TCGA-05-4382-R36336	6AE3BFBC-DEA0-46D9-A3B6-1EF2CE28AA24	Not Available	29	393	365	Complete Response	10	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	05	4	Lung	Alive	2010	2009	Not Available
TCGA-55-8206	56	MALE	888	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	888			TUMOR FREE				56	R-Upper	Not Applicable	TCGA-55-8206	a214a959-3b21-4f25-a615-383cda7afdff	15	-20690	Not Applicable	0	46	Not Available	Lung Adenocarcinoma	98																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8206-F65698	E1AC477E-3512-4DF7-979A-AB575A80690D	26	Not Applicable	Not Applicable	Not Applicable	888	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8206	Not Available	TUMOR FREE	Not Available	Not Available	NO	104	84	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	55	1	Lung	Alive	2012	2012	Not Available
TCGA-55-7576	54	MALE	670	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	670			TUMOR FREE				54	R-Upper	Not Applicable	TCGA-55-7576	055e9a43-3c00-4110-a303-e4407676bec0	11	-19917	Not Applicable	0	40	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-7576-D45604;TCGA-55-7576-D45605	081CF755-293A-4A75-8F90-BC270CBB0C58;12803CED-7A32-4FB2-B0BB-7351A5C61BA7	Not Available;Not Available	17;17	168;168	104;104	Alimta;Cisplatin	Complete Response;Complete Response	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7576-F45603	062163B2-5EE5-4AC5-A2C1-AF02D4B0CD90	17	Not Applicable	Not Applicable	Not Applicable	670	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	7	Not Available	NO	Unknown	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7576	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	1972
TCGA-55-8506	62	FEMALE	11	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	MX	Stage IIB	0	11			Unknown				62	R-Upper	Not Applicable	TCGA-55-8506	3ed05070-6633-4de5-9f72-090f93aa2e4d	28	-22850	Not Applicable	0	11	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	Unknown	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8506	Not Evaluated	Unknown	Not Available	Not Available	Unknown	Not Available	Not Available	Not Applicable	Not Available	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	YES	NO	55	2	Lung	Alive	2012	2012	1972
TCGA-50-5930	47	MALE	282	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N2	M0	Stage IIIA	1	177.0		Distant Metastasis	WITH TUMOR				47	Discrepancy	Not Available	TCGA-50-5930	368e23f0-e573-4547-bf5a-14080baf737b	29	-17238	282	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5930-D32066	1a5b7d4d-a7ea-4064-b672-a951d639b77e	Not Available	16	146	85	Taxotere	Clinical Progressive Disease	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	NO	TCGA-50-5930-F32064	51c0573d-cbd9-4d7a-a72a-1e71ab3ae05a	16	Not Available	Not Available	282	Not Available	177	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Convincing Imaging	YES	Dead	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5930	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-50-5930-R32065	873291ff-f54a-44c0-9f9b-ff040cd9518a	Not Available	16	177	177	Not Available	5	Not Available	2520	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	50	Not Available	Lung	Dead	2011	2001	Not Available
TCGA-05-4403	76	MALE	578	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	578			Not Available				76	R-Upper	Not Applicable	TCGA-05-4403	ce15f31f-2bad-4485-96fa-495bfa262e66	22	-27881	Not Applicable	0	578	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4403	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1975	NO	YES	05	3	Lung	Alive	2010	2006	Not Available
TCGA-55-7911	70	FEMALE	537	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	1	515.0		New Primary Tumor	TUMOR FREE				70	R-Middle	Not Applicable	TCGA-55-7911	1f0a5312-0590-4230-9da9-fd0cfe693586	10	-25746	Not Applicable	0	21	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	NO	TCGA-55-7911-F48785	6C67B112-4633-4A5E-8731-C18F764ADB3E	20	Not Available	Not Available	Not Applicable	537	515	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	9	New Primary Tumor	YES	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	NO	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	96	No	7911	Not Available	TUMOR FREE	Not Available	86	Not Available	Not Available	64	Not Available	YES	WHITE	Not Available	Primary Tumor Field	TCGA-55-7911-R48786	D8885BBE-DB76-4E6B-BE99-41D87580699B	Not Available	20	536	524	Complete Response	9	5	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	1981	YES	NO	55	3	Lung	Alive	2012	2011	1959
TCGA-78-7143	62	FEMALE	4961	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Dead	T2	N0	M0	Stage IB	1	1500.0			Discrepancy				62	L-Upper	Not Applicable	TCGA-78-7143	54254f5a-50e8-4150-a9b7-56a0470d2a56	23	-22673	4961	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO;NO	NO;NO	NO;YES	NO;NO	TCGA-78-7143-F16669;TCGA-78-7143-F16667	b280d071-c071-4b1f-8df7-1eb99db3a117;6bba4fc0-b389-42ae-b498-67aeae1e3b46	23;23	Not Available;1577	Not Available;Not Available	4961;4961	Not Available;Not Available	4608;1500	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;Not Available	9;9	Not Available;Not Available	YES;YES	Not Available;Not Available	Discrepancy;Discrepancy	Not Available;NO	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Dead;Dead	2011;2011	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Central Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7143	Preoperative	Discrepancy	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	78	1	Lung	Dead	2011	1992	Not Available
TCGA-62-A46P	65	MALE	594	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N0	M0	Stage IB	1	267.0		Distant Metastasis	TUMOR FREE				65	L-Upper	Not Applicable	TCGA-62-A46P	0C59FF96-5E4A-4664-A0B1-D057B4725483	29	-23993	594	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	100	NO	Not Available	Not Available	Central Lung	10	YES	NO	267	Not Available	Not Available	YES	267	Distant Metastasis	Convincing Imaging	YES	40	No	A46P	Preoperative	TUMOR FREE	Not Available	Not Available	NO	66	78	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	62	4	Lung	Dead	2012	2006	Not Available
TCGA-95-8494	67	MALE	84	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N1	M0	Stage IIA	0	84			Unknown				67	R-Middle	Not Applicable	TCGA-95-8494	6ee9caec-65ac-46db-9426-ffaa31967ae2	30	-24773	Not Applicable	0	71	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-95-8494-F58476	5A2D5D46-74F5-48C7-8E7E-751B9C1F0BF3	10	Not Available	Not Available	Not Applicable	84	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	4	Not Available	Unknown	Not Available	Not Available	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	NO	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8494	Not Available	Unknown	Not Available	Not Available	NO	Not Available	Not Available	Unknown	NO	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	YES	NO	95	5	Lung	Alive	2012	2012	Not Available
TCGA-35-5375	61	MALE	264	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N2	M0	Stage IIIA	0	264			TUMOR FREE				61	L-Upper	Not Applicable	TCGA-35-5375	5d2a9a4f-678d-4089-a8c5-81a5cb696629	20	-22628	Not Applicable	0	264	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-35-5375-F68920	8B27426D-4A36-4ED5-82E4-1622898D6E17	24	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	Not Available	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	35	No	5375	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	2006	NO	YES	35	4	Lung	Alive	2011	2010	1971
TCGA-78-7163	60	MALE	7248	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	7248			TUMOR FREE				60	R-Lower	Not Applicable	TCGA-78-7163	5abd6651-69be-42f8-bdc0-308e68136d31	26	-22002	Not Applicable	0	6812	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-78-7163-F16824;TCGA-78-7163-F46140	18ffcd96-26be-4690-8195-11c72cba0f56;6E88BDD8-0163-4A50-AA1F-6E3E77AB3A5D	27;4	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	6812;7248	Not Applicable;Not Available	Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Unknown	Not Available;Not Available	Not Available;NO	9;8	Not Available;Not Available	NO;Unknown	Not Available;Not Available	TUMOR FREE;Unknown	NO;NO	Not Available;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	41	No	7163	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1991	NO	YES	78	4	Lung	Alive	2011	1992	1950
TCGA-05-4417	51	FEMALE	455	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	455			TUMOR FREE				51	R-Upper	Not Applicable	TCGA-05-4417	a244a99a-d7cc-4fb1-bc76-b66886481621	22	-18780	Not Applicable	0	455	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4417-F36502	9B56A013-ECA5-4BE4-BC40-1E4BCAAE0501	31	Not Applicable	Not Applicable	Not Applicable	455	Not Applicable	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	NO	Partial Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	56	No	4417	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2008	NO	YES	05	4	Lung	Alive	2010	2008	1971
TCGA-91-6828	70	MALE	323	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	323			Not Available				70	L-Lower	Not Applicable	TCGA-91-6828	9536e32d-2707-48d2-a36d-08c521665bb9	15	-25870	Not Applicable	0	38	Not Available	Lung Adenocarcinoma	71																								2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-6828-F21014	182ca854-9147-4d4e-b2aa-7b899e591214	8	Not Applicable	Not Applicable	Not Applicable	323	Not Applicable	2	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	5	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6828	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	81	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	1993	YES	NO	91	3	Lung	Alive	2011	2011	Not Available
TCGA-44-A47A	78	FEMALE	466	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	1	397.0		Distant Metastasis	TUMOR FREE				78	R-Upper	Not Applicable	TCGA-44-A47A	7B9479FF-23D6-4689-91F0-02EFC94300F9	27	-28782	Not Applicable	0	202	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO;NO	NO;YES	NO;NO	NO;NO	TCGA-44-A47A-F46608;TCGA-44-A47A-F46609	F1D65C08-A2C8-432A-B4A0-AB16EC44BC2B;77A73903-5DE5-4FE9-96D7-AC3D0CCB31B6	12;12	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	466;466	400;397	Not Evaluated;Not Evaluated	Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Not Applicable	Not Evaluated;Not Evaluated	NO;NO	8;8	Locoregional Recurrence;Distant Metastasis	YES;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Biopsy with Histologic Confirmation;Convincing Imaging;Convincing Imaging	NO;NO	Alive;Alive	2013;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	80	No	A47A	Preoperative	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	NO	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	2010	YES	NO	44	4	Lung	Alive	2012	2012	1970
TCGA-L9-A443	63	FEMALE	193	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1a	N0	MX	Stage IA	0	193			Not Available				63	L-Lower	Not Applicable	TCGA-L9-A443	3B89AC82-63F6-41B9-A03D-34B9FFC1550D	26	-23062	Not Applicable	0	116	Not Available	Lung Adenocarcinoma	61																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-L9-A443-F46410	398C8700-07A7-4896-9EE8-F4E5D8693E79	7	Not Applicable	Not Applicable	193	Not Available	Not Applicable	Unknown	Scheduled Follow-up Submission	Unknown	Not Available	NO	8	Not Available	NO	Unknown	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	90	Yes, History of Prior Malignancy	A443	Preoperative	Not Available	74	69	NO	Not Available	Not Available	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	2005	YES	NO	L9	4	Lung	Alive	2012	2012	1960
TCGA-86-A4D0	48	MALE	116	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2b	N0	M0	Stage IIA	0	116			TUMOR FREE				48	R-Upper	Not Applicable	TCGA-86-A4D0	528A0FCE-0719-4B19-A69D-3F18681696C5	6	-17607	Not Applicable	0	30	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-A4D0-D52966;TCGA-86-A4D0-D52968	6BF8E543-7F35-4B18-83AE-963B50ADA0CD;781B2224-221B-4BDA-9872-513C7BF06A99	Not Available;Not Available	9;9	80;80	76;76	Etoposide;Cisplatin	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-A4D0-F52852	7EA60B7C-46CC-46A0-90F7-88199CDE946A	6	Not Applicable	Not Applicable	116	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	12	Not Available	NO	Not Evaluated	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A4D0	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	YES	NO	86	2	Lung	Alive	2012	2012	1983
TCGA-44-A479	73	FEMALE	486	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	1	437.0		New Primary Tumor	TUMOR FREE				73	R-Upper	Not Applicable	TCGA-44-A479	851867CB-9AD0-4FDF-AC75-9BB0427AD440	28	-27024	Not Applicable	0	256	Not Available	Lung Adenocarcinoma	60																								0	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;NO	Not Available;NO	Not Available;YES	Not Available;NO	TCGA-44-A479-F41312;TCGA-44-A479-F45874	7FF14E7B-72D0-4EEB-9483-855DE51FB0D5;DD21BCBF-913D-49C3-A321-E156FEF9D73C	14;12	Not Applicable;437	Not Applicable;Not Available	Not Applicable;Not Applicable	392;486	Not Applicable;437	Not Available;Not Evaluated	Scheduled Follow-up Submission;Additional New Tumor Event	Complete Remission/Response;Complete Remission/Response	Not Available;Not Evaluated	NO;NO	3;8	Not Available;New Primary Tumor	NO;YES	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	A479	Preoperative	TUMOR FREE	Not Available	Not Available	NO	115	102	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	2002	YES	NO	44	4	Lung	Alive	2012	2012	1962
TCGA-97-A4LX	81	MALE	614	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N0	M0	Stage IB	0	614			Unknown				81	Other (please specify)	Lingula	TCGA-97-A4LX	E2B0D873-4942-4483-9A88-D5C6338D0382	7	-29915	Not Applicable	0	272	Not Available	Lung Adenocarcinoma	61																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-A4LX-F57384	81B37883-9051-4643-B671-9899F7A40B07	10	Not Applicable	Not Applicable	Not Applicable	614	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	3	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Evaluated	YES	YES	G12A	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	120	Yes, History of Synchronous/Bilateral Malignancy	A4LX	Preoperative	Unknown	96	90	NO	91	91	Complete Remission/Response	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1985	YES	NO	97	3	Lung	Alive	2013	2012	1945
TCGA-49-4486	72	MALE	2318	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	1	2045.0		Distant Metastasis	WITH TUMOR				72	R-Lower	Not Applicable	TCGA-49-4486	61c655ec-52b5-453f-a6cc-b2aba445b027	3	-26415	2318	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-49-4486-F58843	67E6E0FC-CA40-4FBA-B179-4F85F0E039F6	25	Not Available	Not Available	2318	Not Available	2045	2	Scheduled Follow-up Submission	Progressive Disease	60	NO	4	Distant Metastasis	YES	Other	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	17.5	No	4486	Other	WITH TUMOR	69	96	Not Available	77	108	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1967	NO	YES	49	3	Lung	Dead	2011	1992	1932
TCGA-50-5932	75	MALE	1235	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	1090.0		Locoregional Recurrence	WITH TUMOR				75	R-Upper	Not Applicable	TCGA-50-5932	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	2	-27454	1235	0	1091	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	NO	TCGA-50-5932-F32080	aa578f39-0f94-41df-ad90-1a68f7a7fb43	16	Not Available	Not Available	1235	Not Available	1090	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Locoregional Recurrence	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Biopsy with Histologic Confirmation;Convincing Imaging	NO	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	5932	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	50	Not Available	Lung	Dead	2011	2001	Not Available
TCGA-86-8073	58	MALE	740	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T2a	N0	M0	Stage IB	0	740			TUMOR FREE				58	L-Upper	Not Applicable	TCGA-86-8073	cd902d08-215e-4bd0-88e4-4fd01ab43cbf	13	-21214	Not Applicable	0	13	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8073-F66082	FD02835A-886E-4E52-B3D1-53DCF8D4BB81	2	Not Applicable	Not Applicable	Not Applicable	740	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	10	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8250/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	40	No	8073	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	86	2	Lung	Alive	2012	2011	1970
TCGA-NJ-A55O	56	FEMALE	13	Mucinous (Colloid) Carcinoma	Lung	Alive	T1b	N1	M0	Stage IIA	0	13			TUMOR FREE				56	R-Upper	Not Applicable	TCGA-NJ-A55O	8AB8C4BA-311E-41D0-85EA-A0245ACA1BDD	27	-20628	Not Applicable	0	13	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-NJ-A55O-F50898	FFE4E344-2FBF-47D2-A1D5-8C91E9F635EC	1	Not Applicable	Not Applicable	Not Applicable	13	Not Applicable	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	YES	11	Not Available	NO	Not Available	Not Available	NO	Stable Disease	Not Available	NO	Alive	2013	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	No	A55O	Not Evaluated	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Stable Disease	NO	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	2000	Not Available	Not Available	NJ	4	Lung	Alive	2013	2011	Not Available
TCGA-55-A494	61	FEMALE	481	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	481			TUMOR FREE				61	R-Lower	Not Applicable	TCGA-55-A494	ADBABA9C-5EFC-4130-82F6-8055EAB13795	21	-22540	Not Applicable	0	5	Not Available	Lung Adenocarcinoma	76																								1	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-A494-F59038	C756AD9D-B853-4622-A840-F6365F418A50	30	Not Applicable	Not Applicable	Not Applicable	481	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	4	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	80	YES	YES	G12D	Peripheral Lung	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	7	No	A494	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	95	77	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	1980	YES	NO	55	3	Lung	Alive	2013	2012	1967
TCGA-69-7765	56	MALE	165	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T4	N0	MX		0	165			Not Available				56	R-Upper	Not Applicable	TCGA-69-7765	bcf2e591-9dae-440f-bd03-5f27c57db741	27	-20625	Not Applicable	0	129	Not Available	Lung Adenocarcinoma	45	TCGA-69-7765-D21012;TCGA-69-7765-D29489	dd4077d4-121a-4548-b9cb-131aee81484b;5e1b818b-56f7-4340-91eb-d490e7bc91a2	Not Available;Not Available	27;20	Not Available;Not Available	93;93	Carboplatin;Pemetrexed	Not Available;Not Available	1;3	4;4	6;500	AUC;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NO	Other	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-7765-F29244	79cba3a7-8b66-4cac-a18e-ebc14740d0d0	13	Not Applicable	Not Applicable	Not Applicable	165	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	Not Available	YES	Not Available	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7765	Not Available	Not Available	Not Available	Not Available	Not Available	86	84	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T4	2011	YES	NO	69	4	Lung	Alive	2012	2011	1981
TCGA-86-8672	59	MALE	19	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N0	M0	Stage IIB	0	19			TUMOR FREE				59	R-Upper	Not Applicable	TCGA-86-8672	c0e263eb-1a83-4dc8-8abe-3dd2a59bae1b	31	-21682	Not Applicable	0	15	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8672-F46401	892123F6-665F-4DAC-96FE-4E45BD22A9D6	7	Not Applicable	Not Applicable	19	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Unknown	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	Unknown	NO	Complete Remission/Response	Not Available	NO	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Unknown	NO	Not Available	Not Available	Central Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	8672	Unknown	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	86	1	Lung	Alive	2012	2012	Not Available
TCGA-49-4488	74	FEMALE	869	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	MX	Stage IA	1	634.0			Not Available				74	L-Lower	Not Applicable	TCGA-49-4488	d721bfe0-90e3-415e-b9f3-1a270efa5fbb	9	-27332	869	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	Not Available	TCGA-49-4488-F14699	0e28bc4e-7453-4d8a-a604-dafc492ada64	9	Not Available	690	869	Not Available	634	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	8	Not Available	YES	Not Available	Not Available	NO	Not Available	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4488	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-49-4488-R14700	f8812bf8-fe15-4311-889d-637f25592e9f	2	9	717	703	Not Available	8	Not Available	3000	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	1964	NO	YES	49	3	Lung	Dead	2011	1992	Not Available
TCGA-55-7903	64	MALE	567	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	567			TUMOR FREE				64	R-Lower	Not Applicable	TCGA-55-7903	77c4dbb2-eceb-4e0d-bcde-63dc817d5f35	10	-23509	Not Applicable	0	19	Not Available	Lung Adenocarcinoma	83																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7903-F47840	A3E1AF4A-8377-4442-A98B-0F3218B1E228	29	Not Applicable	Not Applicable	Not Applicable	567	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	7903	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	63	66	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	Not Available
TCGA-MP-A4T2	71	MALE	1136	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	1	575.0		Distant Metastasis	WITH TUMOR				71	L-Lower	Not Applicable	TCGA-MP-A4T2	E379CF55-68EF-4FBC-AF3E-0A5040C27F0F	2	-26010	1136	0	Not Available	Not Available	Lung Adenocarcinoma	46																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	NO	TCGA-MP-A4T2-F41327	BF1208FF-001B-4A2D-A75A-3E8E0B826A8B	14	Not Available	Not Available	1136	Not Available	1110	Not Evaluated	Additional New Tumor Event	Progressive Disease	Not Evaluated	NO	3	Locoregional Recurrence;Distant Metastasis	YES	Not Evaluated	WITH TUMOR	NO	Complete Remission/Response	Biopsy with Histologic Confirmation	NO	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	NO	NO	575	Not Available	Not Available	YES	575	Distant Metastasis	Biopsy with Histologic Confirmation	YES	75	No	A4T2	Not Evaluated	WITH TUMOR	Not Available	51	NO	Not Available	31	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2001	NO	YES	MP	4	Lung	Dead	2013	2003	1951
TCGA-49-4487	72	FEMALE	855	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	1	697.0			WITH TUMOR				72	L-Upper	Not Applicable	TCGA-49-4487	bd4e9a9f-17f3-4d33-92fc-fcc45dd0e7b4	9	-26583	855	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	YES	YES	YES	TCGA-49-4487-F14693	c1cdbc66-08a8-47a7-906e-949c08e2bbfc	9	697	712	855	Not Available	697	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	8	Not Available	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Not Available	YES	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	4487	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-49-4487-R14697	3b6918b1-000b-4ce2-bf5e-797ed368d94b	2	9	741	725	Not Available	8	Not Available	3600	NO	OTHER	Whole Brain	RECURRENCE	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	49	4	Lung	Dead	2011	1992	Not Available
TCGA-99-8033	74	FEMALE	656	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	TX	NX	M1	Stage IV	1				WITH TUMOR				74	R-Upper	Not Applicable	TCGA-99-8033	9582b436-145b-4f84-8f7f-8b39b8254cc1	18	-27342	Not Applicable	0	170	Not Available	Lung Adenocarcinoma	Not Available	TCGA-99-8033-D32956;TCGA-99-8033-D32958;TCGA-99-8033-D32959	AAAFB521-2D55-4F3A-A369-95F7C05964EB;05A9596F-9551-49BF-8D1F-F899C9375EFC;987496D9-FF47-4ADB-B105-C8AF22F185E4	Not Available;Not Available;Not Available	18;18;18	Not Available;78;Not Available	78;78;107	Carboplatin;Alimta;Taxol	Not Applicable;Unknown;Not Applicable	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	1	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-99-8033-F58623	D7BC0D18-7B7D-4404-86A3-C62CB2474F57	30	Not Applicable	Not Applicable	656	Not Available	Not Applicable	2	Scheduled Follow-up Submission	Not Applicable	Unknown	NO	3	Not Available	NO	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Not Available	YES	Dead	2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	YES	NO	Not Available	Peripheral Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8033	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Unknown	NO	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	NX	TX	Not Available	YES	NO	99	1	Lung	Alive	2012	2011	Not Available
TCGA-50-5068	59	FEMALE	1499	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	MX	Stage IIB	1	686.0		Distant Metastasis	WITH TUMOR				59	R-Lower	Not Applicable	TCGA-50-5068	591c068f-bbb1-4df2-9abb-d1a2e4a58372	2	-21728	1499	0	1499	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5068-D32058	416e251e-06ba-4e59-b9b0-22db5fac92e1	Not Available	16	140	99	Taxol	Clinical Progressive Disease	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	YES	NO	TCGA-50-5068-F32057	271667fa-b39c-433f-a7d7-f65d87b30992	16	686	Not Available	1499	Not Available	686	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Biopsy with Histologic Confirmation;Convincing Imaging	NO	Dead	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5068	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2	Not Available	NO	YES	50	Not Available	Lung	Dead	2011	2003	Not Available
TCGA-55-6978	81	MALE	176	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2b	N0	MX	Stage IIA	1	42.0			WITH TUMOR				81	R-Middle	Not Applicable	TCGA-55-6978	5134c56f-8286-4ec8-8348-237cee7dad5e	27	Not Available	176	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	NO	TCGA-55-6978-F45607	503F8882-F797-4D4A-86CC-4FD93814BA3C	17	Not Available	Not Available	176	Not Available	42	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	7	Not Available	YES	Not Evaluated	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	6978	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-55-6978-R45613	4BF13E15-8053-43E3-8D6E-D647C58C72E3	Not Available	17	95	60	Radiographic Progressive Disease	7	11	3200	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	Not Available	NO	YES	55	1	Lung	Dead	2011	2010	Not Available
TCGA-91-A4BC	59	MALE	44	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N0	MX	Stage IIA	0	44			Unknown				59	R-Upper	Not Applicable	TCGA-91-A4BC	EA0B9461-0D4D-4ADE-A255-1B03DD85E30E	5	-21565	Not Applicable	0	44	Not Available	Lung Adenocarcinoma	44																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-A4BC-F45192	5A4ACA69-D8C5-4169-9815-150180962775	10	Not Available	Not Available	Not Applicable	44	Not Available	Not Evaluated	Scheduled Follow-up Submission	Unknown	Not Evaluated	YES	7	Not Available	Unknown	Not Evaluated	Unknown	Unknown	Unknown	Not Available	Unknown	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	30	Yes, History of Synchronous/Bilateral Malignancy	A4BC	Not Evaluated	Unknown	Not Available	69	Unknown	Not Available	Not Available	Unknown	YES	WHITE	Unknown																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	2001	YES	NO	91	4	Lung	Alive	2013	2012	1976
TCGA-49-4490	45	FEMALE	385	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N2	M0	Stage IIIA	1				Not Available				45	L-Upper	Not Applicable	TCGA-49-4490	6c3655ca-8ae7-4ad7-b3e4-0c3ec293fba7	9	-16634	385	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-49-4490-D14704	c7e179cb-df02-47c2-b3b6-a4877f84b06c	Not Available	9	163	79	Cisplatin	Not Available	8	2	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-49-4490-F14703	b7af674f-dfd7-41ca-b313-fbe7cf636256	9	Not Applicable	Not Applicable	385	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	8	Not Available	NO	Not Available	WITH TUMOR	YES	Not Available	Not Available	YES	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	No	4490	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-49-4490-R14708	ba1585c0-b517-4b45-af9b-c6bbbf8cb070	1	9	253	240	Not Available	8	Not Available	3000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	Not Available	NO	YES	49	3	Lung	Dead	2011	1993	Not Available
TCGA-86-7955	62	MALE	1072	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	1	820.0		Locoregional Recurrence	TUMOR FREE				62	R-Lower	Not Applicable	TCGA-86-7955	0d0d83d9-d558-4d38-977b-6f1b2471beda	14	-22772	Not Applicable	0	14	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-7955-D41098;TCGA-86-7955-D41099;TCGA-86-7955-D63518;TCGA-86-7955-D63519	7C0A1FDD-293F-4DF9-AC3D-67AB0630FF20;6E123B02-3E4D-4660-9400-A5BDA061292D;B33DF174-A60F-4916-97D6-315FF1B3CBF3;4F1FAE32-57AF-472B-8BCD-8E1EAB496CDC	Not Available;Not Available;Not Available;Not Available	12;12;12;12	274;274;922;922	27;27;823;823	Vepesid;Cisplatin;Gemcitabine;Cisplatin	Complete Response;Complete Response;Complete Response;Complete Response	3;3;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2014;2014	1	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;YES	Not Available;YES	Not Available;NO	Not Available;Not Available	TCGA-86-7955-F41096;TCGA-86-7955-F63517	BE3BF32A-D5A9-43DA-BE40-6F8B888E0949;F2DA8AAE-377B-4F5E-8640-51294564B4D4	12;12	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	508;1072	Not Applicable;820	1;0	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	90;100	NO;NO	3;8	Not Available;Locoregional Recurrence	NO;YES	Preoperative;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	YES;YES	Alive;Alive	2013;2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	90	NO	Not Available	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7955	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-86-7955-R41101;TCGA-86-7955-R63520	AA293A6B-ED04-439A-8F4C-E01F9D5B679E;29EF3999-EA2A-4E8E-A0AF-09FF97FDCE95	Not Available;Not Available	12;12	190;1057	114;1027	Complete Response;Complete Response	3;8	31;18	62;36	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2014	RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	86	1	Lung	Alive	2012	2011	Not Available
TCGA-05-4430	59	FEMALE	761	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	761			TUMOR FREE				59	L-Lower	Not Applicable	TCGA-05-4430	3a23cdb5-2327-45ac-b0b5-d4afe038c757	22	-21884	Not Applicable	0	761	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4430-F36427	A35C227E-F4EF-4535-9765-FD2DAD9B0C06	30	Not Applicable	Not Applicable	Not Applicable	761	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	Unknown	Not Applicable	Not Available	Unknown	Alive	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80	No	4430	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	05	4	Lung	Alive	2010	2008	Not Available
TCGA-44-3398	77	FEMALE	1163	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	1163			TUMOR FREE				77	R-Lower	Not Applicable	TCGA-44-3398	ffb0c0b7-165e-4439-b3e6-62431f40b7fe	11	-28392	Not Applicable	0	253	Not Available	Lung Adenocarcinoma	60																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-44-3398-F5292;TCGA-44-3398-F38762	b338b0a9-78f2-44d5-a19c-5beca343abd0;9EF69CF2-2F1A-43EA-AACA-49F8E51CC52C	11;21	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	253;1163	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	10;12	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2010;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	No	3398	Not Available	TUMOR FREE	89	96	Not Available	84	87	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	2009	YES	NO	44	4	Lung	Alive	2010	2009	1959
TCGA-49-4507	73	FEMALE	268	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N1	M0	Stage IIIA	1	158.0			WITH TUMOR				73	Discrepancy	Not Available	TCGA-49-4507	50b2c647-aecd-4c81-af22-0d8116593552	2	-26851	268	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-49-4507-D7010;TCGA-49-4507-D13868;TCGA-49-4507-D17259	5d1cdc10-8244-4d21-b7fd-b69dfe9548dc;96cdd9a1-d9ad-4861-88e3-d65b2d13f956;7c8c9fcb-3b5f-42fe-9f31-c8319cde0fc7	Not Available;Not Available;Not Available	2;18;6	110;110;Not Available	47;47;174	Taxol;Carboplatin;Gemcitabine	Not Available;Not Available;Not Available	2;7;10	4;4;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	1;1;2	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;4 cycles;Not Available	g/m2;g/m2;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	NO	TCGA-49-4507-F7007	33c2605a-97c1-495f-ac44-17fff4c8ebd6	2	Not Available	Not Available	268	Not Available	158	1	Not Available	Progressive Disease	Not Available	Not Available	2	Not Available	YES	Preoperative	WITH TUMOR	YES	Progressive Disease	Not Available	YES	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.0	8140/3	C34.0	YES	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	78	No	4507	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-49-4507-R7009	becb6cbe-b49e-49ae-ae68-ac7e19de8c3b	1	2	95	46	Not Available	2	34	1620	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	1991	NO	YES	49	4	Lung	Dead	2011	1997	Not Available
TCGA-97-A4M5	83	MALE	634	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1b	N0	M0	Stage IA	0	634			Unknown				83	R-Upper	Not Applicable	TCGA-97-A4M5	5FE77D4A-A8A5-4C90-8FF2-9C3BBBB309EF	7	-30665	Not Applicable	0	132	Not Available	Lung Adenocarcinoma	51																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-A4M5-F57443	45F6F53F-E17E-47FD-A616-202C86D48D1F	12	Not Applicable	Not Applicable	Not Applicable	634	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	3	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Evaluated	YES	YES	G12C	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	6	No	A4M5	Not Evaluated	Unknown	84	94	NO	85	98	Complete Remission/Response	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	1982	YES	NO	97	3	Lung	Alive	2013	2012	1952
TCGA-49-6745	82	MALE	522	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N2	M0	Stage IIIA	0	522			TUMOR FREE				82	L-Upper	Not Applicable	TCGA-49-6745	9c7875ad-ab71-4d48-b2e3-e4c7a46393e9	11	-30133	Not Applicable	0	156	Not Available	Lung Adenocarcinoma	Not Available	TCGA-49-6745-D16687	8a687c99-eae5-4635-80db-1d8acc5bcff1	Not Available	23	156	64	Not Available	Not Available	9	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-49-6745-F15015	47cc0678-9e26-4402-8fcf-1e549c6cf16d	11	Not Applicable	Not Applicable	Not Applicable	522	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	8	Not Available	NO	Not Available	TUMOR FREE	YES	Not Available	Not Available	NO	Alive	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8260/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	Yes	6745	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2a	Not Available	NO	YES	49	4	Lung	Alive	2011	2011	Not Available
TCGA-86-8674	50	MALE	806	Lung Papillary Adenocarcinoma	Lung	Alive	T2a	N1	M0	Stage IIA	1	334.0		Locoregional Recurrence	TUMOR FREE				50	R-Middle	Not Applicable	TCGA-86-8674	0a1eea76-e19a-4547-9b24-abf7051cc4db	30	-18479	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8674-D42028;TCGA-86-8674-D42029	55CE92CA-ED7F-460F-BCDD-25F915DE1A54;34F415AA-90DB-4E2C-9F08-160D35EAA160	Not Available;Not Available	9;9	81;81	57;57	Vinblastine;Cisplatin	Clinical Progressive Disease;Clinical Progressive Disease	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Unknown	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	NO;Not Available	NO;Not Available	NO;Not Available	Not Available;Not Available	TCGA-86-8674-F42027;TCGA-86-8674-F59096	5B567A02-6171-4C9E-ACB9-E6DBF6EEA647;6757DE70-2A11-4D3A-8663-03DCF4FC2E57	9;30	Not Available;Not Applicable	Not Available;Not Applicable	Not Applicable;Not Applicable	405;806	334;Not Applicable	Not Evaluated;Not Evaluated	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Complete Remission/Response	Not Evaluated;Not Evaluated	NO;NO	4;4	Locoregional Recurrence;Not Available	YES;NO	Not Evaluated;Not Evaluated	WITH TUMOR;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	MALE	Lung Papillary Adenocarcinoma	No	C34.2	8260/3	C34.2	YES	Unknown	Unknown	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	37.5	No	8674	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	2012	YES	NO	86	4	Lung	Alive	2012	2012	1982
TCGA-05-4384	66	MALE	426	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N2	M0	Stage IIIA	1	183.0		Distant Metastasis	Not Available				66	R-Lower	Not Applicable	TCGA-05-4384	9a50e7e4-831d-489f-87d2-979e987561cc	22	-24411	Not Applicable	0	426	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-4384-D36331;TCGA-05-4384-D36332;TCGA-05-4384-D36333;TCGA-05-4384-D36334	281E8624-371D-4473-BA5E-E41E0C21D551;19860FED-A03B-407A-9081-F0CD43C3BD54;8009725B-0627-43CB-B0EB-37B12CCB3848;5B01A1B0-5946-4ECC-A816-E6DC557CF563	Not Available;Not Available;Not Available;Not Available	5;5;5;5	153;153;426;426	61;61;395;245	Cisplatin;Vinorelbine;Cisplatin;Zoledronic acid	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	Not Available	TCGA-05-4384-F36330	F4555A19-ABBE-4673-9871-083B5C01710A	29	Not Available	Not Available	Not Applicable	426	183	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Not Available	YES	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	Yes	4384	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Distant Recurrence	TCGA-05-4384-R36335	E131951D-3ADE-4C06-9406-088B151B75A3	Not Available	29	214	183	Radiographic Progressive Disease	10	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1987	NO	YES	05	3	Lung	Alive	2010	2009	1963
TCGA-69-7979	71	FEMALE	408	Lung Acinar Adenocarcinoma	Lung	Alive	T2a	N0	MX	Stage IB	0	408			Not Available				71	R-Upper	Not Applicable	TCGA-69-7979	a5bd7d50-9c14-49e6-89cf-6bf440c42309	9	-26180	Not Applicable	0	89	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-69-7979-F39913;TCGA-69-7979-F40026	F557D080-A35A-4FC9-A673-5055389DCCF4;E05A8EC6-B473-4218-A7AF-9E5D2027CA4C	11;19	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	89;408	Not Applicable;Not Available	Not Evaluated;Not Available	Scheduled Follow-up Submission;Not Available	Stable Disease;Unknown	Unknown;Not Available	NO;Not Available	2;3	Not Available;Not Available	NO;Unknown	Not Evaluated;Not Available	TUMOR FREE;Not Available	NO;Not Available	Stable Disease;Not Available	Not Available;Not Available	NO;Not Available	Alive;Alive	2013;2014	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	28	No	7979	Not Available	Not Available	71	64	Not Available	70	59	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	NO	YES	69	2	Lung	Alive	2012	2011	1955
TCGA-78-7147	67	FEMALE	586	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	578.0			WITH TUMOR				67	R-Upper	Not Applicable	TCGA-78-7147	e7d30bc2-42e8-49c5-a5b3-9f58411b007a	28	-24809	586	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	NO	NO	TCGA-78-7147-F16971	a52cbdf4-8abe-4493-9575-72d42251aea8	28	Not Available	Not Available	586	Not Available	578	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	9	Not Available	YES	Not Available	WITH TUMOR	NO	Not Available	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	7147	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	78	2	Lung	Dead	2011	2001	1950
TCGA-93-7347	76	FEMALE	683	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1a	N0	MX	Stage IA	0	683			TUMOR FREE				76	R-Upper	Not Applicable	TCGA-93-7347	ef03654a-dcf1-41ff-a67e-4f3fbf9ba807	30	-27949	Not Applicable	0	297	Not Available	Lung Adenocarcinoma	70																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-93-7347-F29886;TCGA-93-7347-F43155	3cb5e775-0ae6-4d83-8d2a-049f1eb2b119;1AA9F067-47F9-4CB2-837D-E9907C167259	30;14	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	297;683	Not Applicable;Not Applicable	0;Not Evaluated	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Not Applicable	100;Not Evaluated	Not Available;NO	3;5	Not Available;Not Available	NO;NO	Other;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Central Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	No	7347	Not Available	TUMOR FREE	61	84	Not Available	62	84	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	1967	YES	NO	93	3	Lung	Alive	2012	2011	1952
TCGA-49-4514	79	FEMALE	1700	Lung Papillary Adenocarcinoma	Lung	Alive	T1	N0	M0	Stage IA	0	1700			TUMOR FREE				79	L-Upper	Not Applicable	TCGA-49-4514	b87a5d92-4c09-48fe-bb08-b3c89a7c892e	9	-28908	Not Applicable	0	1314	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-49-4514-F14817	8e78115f-ef3f-4e4f-b8e4-16fdf02e5002	10	Not Applicable	Not Applicable	Not Applicable	1700	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	8	Not Available	NO	Not Available	Not Available	NO	Complete Remission/Response	Not Available	NO	Alive	2011	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	65	No	4514	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	49	3	Lung	Alive	2011	2007	Not Available
TCGA-49-6742	70	MALE	488	Mucinous (Colloid) Carcinoma	Lung	Dead	T2a	N1	M0	Stage IIA	1	214.0		Distant Metastasis	TUMOR FREE				70	L-Upper	Not Applicable	TCGA-49-6742	21fb46f9-4bbb-441c-af19-a687e9138344	9	-25839	Not Applicable	0	Discrepancy	Not Available	Lung Adenocarcinoma	Not Available	TCGA-49-6742-D14744;TCGA-49-6742-D16680;TCGA-49-6742-D16679;TCGA-49-6742-D17830	3b0101a9-80a8-4824-a268-205c46c9ac31;f59fb2c2-a314-4463-af34-81a5299331fc;e4f03b6f-8150-4976-8b9a-1783d3aaaf2e;23b5df36-e5bf-4b57-a0db-04bc5b0c0c9c	Not Available;Not Available;Not Available;Not Available	9;23;23;26	184;184;184;396	31;31;31;335	Alimta;Pemetrexed;Cisplatin;MDX-1106 clinical trial	Not Available;Not Available;Not Available;Not Available	8;9;9;10	3;3;3;1	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;mg/m2;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES;YES	NO;NO	NO;NO	YES;YES	TCGA-49-6742-F14741;TCGA-49-6742-F70579	e6565afe-c87f-4fa9-94e1-29b1e25d0ab8;E22C1C68-2566-426D-AEB5-065CFD61A1C2	9;25	Not Available;Not Available	214;214	Not Applicable;488	445;Not Available	214;214	Not Available;3	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Progressive Disease	Not Available;40	Not Available;NO	8;2	Not Available;Distant Metastasis	YES;YES	Not Available;Post-Adjuvant Therapy	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	Alive;Dead	2011;2015	MALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Yes	6742	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	NO	YES	49	3	Lung	Alive	2011	2010	Not Available
TCGA-MN-A4N1	60	MALE	827	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N1	M0	Stage IIA	0	827			Unknown				60	R-Upper	Not Applicable	TCGA-MN-A4N1	75A0BB0B-6528-4FB8-A9E6-254905D21DF4	4	-21939	Not Applicable	0	285	Not Available	Lung Adenocarcinoma	55																								0	Not Available	YES	Not Available	Not Available	IHC	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-MN-A4N1-F56662	0BAC11C6-A02B-49D5-A830-26313F1AC0F6	17	Not Applicable	Not Applicable	Not Applicable	827	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	2	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	NO	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Prior Malignancy	A4N1	Preoperative	Unknown	Not Available	Not Available	NO	74	117	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	NO	YES	MN	2	Lung	Alive	2012	2011	1967
TCGA-J2-A4AD	61	FEMALE	550	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1a	N0	MX	Stage IA	1	524.0		Locoregional Recurrence	TUMOR FREE				61	L-Upper	Not Applicable	TCGA-J2-A4AD	096BD95F-9900-4DB2-B1C4-103902C3B31F	27	-22414	Not Applicable	0	287	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	TCGA-J2-A4AD-F55524	7AD20CAA-27DA-470D-838D-F1A687F16E39	8	Not Available	Not Available	550	Not Available	524	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	1	Locoregional Recurrence;Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Unknown	Convincing Imaging	NO	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Unknown	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	120	No	A4AD	Unknown	TUMOR FREE	Not Available	Not Available	NO	Not Available	1.95	Unknown	YES	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	Not Available	YES	NO	J2	2	Lung	Alive	2012	2012	1970
TCGA-78-7160	61	MALE	697	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T4	N2	M1	Stage IV	0	697			Not Available				61	R-Lower	Not Applicable	TCGA-78-7160	c1a01e8c-1f7e-4e24-bfad-90b73f88e992	29	-22385	Not Applicable	0	678	Not Available	Lung Adenocarcinoma	Not Available	TCGA-78-7160-D17521	dfe0d27b-fd72-4141-82d3-f56f096e7434	Not Available	14	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	Not Available	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-78-7160-F16984;TCGA-78-7160-F46139	c5a03168-cea3-45ad-bf3f-9a0c42ce2888;5F952AAA-E4D6-4C77-9D38-71754880C0B6	29;4	Not Available;Not Available	Not Available;Not Available	Not Applicable;697	678;Not Available	Not Available;Not Available	Not Available;Not Evaluated	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Not Available	Not Available;NO	9;8	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;Unknown	YES;YES	Not Available;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Dead	2011;2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	43.8	No	7160	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T4	1998	NO	YES	78	4	Lung	Alive	2011	2008	1963
TCGA-05-4397	65	MALE	731	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N1	M0	Stage IIB	0	731			Not Available				65	R-Middle	Not Applicable	TCGA-05-4397	6dfd47d2-831a-4386-9051-f78199a16bb5	22	-23833	731	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	45	No	4397	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	05	2	Lung	Dead	2010	2006	Not Available
TCGA-91-8497	75	FEMALE	434	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1a	N0	MX	Stage IA	0	434			Unknown				75	R-Upper	Not Applicable	TCGA-91-8497	4ad63dac-76a7-4527-abce-d7a0184e8739	20	-27632	Not Applicable	0	174	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-8497-F58334	4D8EEDE1-07CE-42E8-89C1-747366728090	7	Not Applicable	Not Applicable	434	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	4	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8497	Not Evaluated	Unknown	Not Available	Not Available	NO	Not Available	Not Available	Unknown	NO	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	Not Available	YES	NO	91	1	Lung	Alive	2012	2012	Not Available
TCGA-55-7283	76	FEMALE	609	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T3	N2	MX	Stage IIIA	1				WITH TUMOR				76	R-Upper	Not Applicable	TCGA-55-7283	ccfdad76-cc45-447f-bed8-ede8f6a8844d	6	-27946	Not Applicable	0	35	Not Available	Lung Adenocarcinoma	64	TCGA-55-7283-D46989;TCGA-55-7283-D46990	E0804552-E06E-4FA2-A637-AFD1546794D4;1B14B0D0-2927-4B35-9310-FE9EC2E5726C	Not Available;Not Available	21;21	386;386	83;83	Carboplatin;Alimta	Partial Response;Partial Response	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7283-F46988	CD19EF4F-EC9B-43BD-8940-11F6F54CB88D	21	Not Applicable	Not Applicable	Not Applicable	609	Not Applicable	Unknown	Scheduled Follow-up Submission	Partial Remission/Response	Unknown	NO	8	Not Available	NO	Unknown	WITH TUMOR	YES	Partial Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES	100	NO	Not Available	Not Available	Central Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	No	7283	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	105	82	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T3	1961	YES	NO	55	3	Lung	Alive	2011	2011	1950
TCGA-05-4244	70	MALE	0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N2	M1	Stage IV	0	0			TUMOR FREE				70	R-Lower	Not Applicable	TCGA-05-4244	34040b83-7e8a-4264-a551-b16621843e28	22	-25752	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	38	No	4244	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T2	Not Available	NO	YES	05	4	Lung	Alive	2010	2009	Not Available
TCGA-91-6848	59	MALE	224	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N2	MX	Stage IIIA	0	224			Not Available				59	L-Upper	Not Applicable	TCGA-91-6848	0232d299-4cdf-4fd7-9a5e-8d13c208b40c	19	-21829	Not Applicable	0	127	Not Available	Lung Adenocarcinoma	Not Available	TCGA-91-6848-D32644;TCGA-91-6848-D33330	84DFEC23-536C-4115-8F5A-A423FC91FAE2;C0CD8924-B559-41B3-B3A3-53EFB06231E5	Not Available;Not Available	5;28	154;154	91;91	Cisplatin;Docetaxel	Complete Response;Complete Response	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-6848-F32641	DA1E6F28-C0EE-4F97-B849-62A0E36951AB	5	Not Applicable	Not Applicable	Not Applicable	224	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	YES	6	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6848	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T2	2007	NO	YES	91	4	Lung	Alive	2011	2009	Not Available
TCGA-MP-A4TD	71	MALE	307	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	1	226.0		Locoregional Recurrence	Unknown				71	L-Lower	Not Applicable	TCGA-MP-A4TD	383D1253-349F-43B3-BEBD-9F1D1CF14B3D	8	-25983	307	0	Not Available	Not Available	Lung Adenocarcinoma	61	TCGA-MP-A4TD-D41400;TCGA-MP-A4TD-D41401	151B0D62-C2EE-442B-8FC7-DDCE9131ABBD;429B9434-707A-41B3-A4B6-07DA60A412A3	Not Available;Not Available	18;18	165;165	75;75	Cisplatin;Gemcitabine	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Unknown																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Peripheral Lung	5	YES	Unknown	226	NO	Not Available	Not Available	Not Available	Locoregional Recurrence	Convincing Imaging	YES	20	Yes, History of Prior Malignancy	A4TD	Post-Adjuvant Therapy	Unknown	Not Available	92	YES	Not Available	93	Complete Remission/Response	YES	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1990	NO	YES	MP	3	Lung	Dead	2013	2008	Not Available
TCGA-55-8620	60	MALE	375	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1a	N1	M1b	Stage IV	1				WITH TUMOR				60	L-Upper	Not Applicable	TCGA-55-8620	5510ad32-62fd-4adc-964a-ae4e997c2f4b	11	-22091	Not Applicable	0	66	Not Available	Lung Adenocarcinoma	64																								2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8620-F59081	B7AB11B2-6770-4031-B6CC-3416F978BF1A	30	Not Applicable	Not Applicable	375	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	4	Not Available	NO	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	YES	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	70	NO	Not Available	Not Available	Central Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	154	No	8620	Preoperative	WITH TUMOR	Not Available	Not Available	NO	73	76	Progressive Disease	YES	WHITE	YES	Distant site	TCGA-55-8620-R59083	265BD0A0-A402-44D1-A79C-9846E6AFF684	Not Available	30	161	132	Radiographic Progressive Disease	4	18	3600	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1b	N1	T1a	2012	YES	NO	55	4	Lung	Alive	2013	2012	1965
TCGA-97-7547	67	FEMALE	1965	Lung Papillary Adenocarcinoma	Lung	Alive	T2	N0	MX	Stage IB	1	775.0			TUMOR FREE				67	R-Upper	Not Applicable	TCGA-97-7547	6092bd5c-e97c-4a77-a4ad-c87623b17507	17	-24737	Not Applicable	0	1435	Not Available	Lung Adenocarcinoma	94	TCGA-97-7547-D19222;TCGA-97-7547-D19232;TCGA-97-7547-D19224;TCGA-97-7547-D19225;TCGA-97-7547-D19221	01e4dd25-611e-44b1-a8fa-6907e2e5f41c;1744a5f8-ceb6-4df7-9801-ffe6d2e7dfc0;d1fd8e0b-6c15-4718-a3f0-e4c15eba9dfa;6da633dd-18f1-40bd-a370-cdbee368a8b2;1dee112c-3291-47a9-b009-eb9c1d669e75	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	124;866;75;110;89	96;824;47;103;33	Vinorelbine;Alimta;Cisplatin;Cisplatin;Vinorelbine	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	1;4;1;1;1	20;788;75;40;39	mg;mg;mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1;1	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	20;3152;75;40;39	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES;YES	NO;NO	YES;YES	NO;Not Available	TCGA-97-7547-F19227;TCGA-97-7547-F37177	7559a14a-9161-4170-8e6c-cd8040be78ad;A5BE7986-A826-4AF1-99F0-EEE9CAF9B02B	6;29	776;1894	Not Available;Not Available	Not Applicable;Not Applicable	1965;1965	775;1147	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	Not Available;Not Available	Not Available;NO	12;11	Not Available;Locoregional Recurrence	YES;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Not Available;Progressive Disease	Not Available;Biopsy with Histologic Confirmation	NO;NO	Alive;Alive	2011;2012	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	7547	Not Available	TUMOR FREE	83	101	Not Available	82	106	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	1986	NO	YES	97	3	Lung	Alive	2011	2007	Not Available
TCGA-44-6777	85	FEMALE	987	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	NX	MX	Stage IB	0	987			TUMOR FREE				85	L-Upper	Not Applicable	TCGA-44-6777	349e6f38-2c67-4a69-a777-b9173a2a27cf	30	-31234	987	0	Not Available	Not Available	Lung Adenocarcinoma	178																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-44-6777-F15694	d62760e3-307f-4aad-a7b8-1ab9f020e3f7	30	Not Applicable	Not Applicable	987	Not Available	Not Applicable	3	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	8	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response	Not Available	YES	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	64	No	6777	Preoperative	TUMOR FREE	77	71	Not Available	68	62	Not Available	YES	WHITE	Not Available	Primary Tumor Field	TCGA-44-6777-R15693	b19b3be9-6f5a-4ada-b550-8e5fde588838	1	30	356	306	Not Available	8	37	7400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	2006	NO	YES	44	4	Lung	Dead	2011	2006	1942
TCGA-38-4629	68	MALE	864	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N0	M0	Stage IIB	1	379.0			WITH TUMOR				68	R-Upper	Not Applicable	TCGA-38-4629	127bf818-f7e5-46b5-a9de-39f6d96b8b83	13	-25104	864	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-38-4629-F4887	5ece2db2-89aa-48dc-92be-f4df4bbbef10	14	Not Available	Not Available	864	Not Available	379	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Not Available	NO	Dead	2010	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	100	Yes	4629	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	2003	NO	YES	38	4	Lung	Dead	2010	2003	Not Available
TCGA-55-8097	60	FEMALE	476	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	476			TUMOR FREE				60	R-Upper	Not Applicable	TCGA-55-8097	afe83af5-af22-49c0-88b4-f1d0dfcbe238	15	-22260	Not Applicable	0	15	Not Available	Lung Adenocarcinoma	74																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8097-F47821	CD4B0E92-54B8-474F-AAD7-FB4A9C9CE4E3	28	Not Applicable	Not Applicable	Not Applicable	476	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Unknown	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	35	No	8097	Not Available	TUMOR FREE	Not Available	87	Unknown	Not Available	79	Complete Remission/Response	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	2008	YES	NO	55	4	Lung	Alive	2012	2012	1973
TCGA-97-8179	72	MALE	435	Lung Acinar Adenocarcinoma	Lung	Alive	T1a	N0	M0	Stage IA	0	435			TUMOR FREE				72	R-Upper	Not Applicable	TCGA-97-8179	11c2e619-8aeb-4f86-b03b-78f9a8099263	13	-26305	Not Applicable	0	15	Not Available	Lung Adenocarcinoma	73																								0	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-8179-F44247	0FB47890-87D5-4A74-80DE-3F0F16E906DB	19	Not Applicable	Not Applicable	Not Applicable	435	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	6	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	60	No	8179	Preoperative	TUMOR FREE	91	95	NO	86	90	Complete Remission/Response	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	1988	YES	NO	97	3	Lung	Alive	2012	2012	1958
TCGA-78-8648	58	FEMALE	1209	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N0	M0	Stage IIB	1	720.0		Locoregional Recurrence	Unknown				58	R-Upper	Not Applicable	TCGA-78-8648	5ace9608-d38a-42f2-a877-ec7c9d211808	23	-21443	1209	0	Not Available	Not Available	Lung Adenocarcinoma	69																								2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Evaluated																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	Unknown	Unknown	720	Unknown	Not Available	Not Available	Not Available	Locoregional Recurrence	Biopsy with Histologic Confirmation	YES	45	No	8648	Preoperative	Unknown	Not Available	Not Available	NO	83	70	Unknown	YES	Not Evaluated	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	NO	YES	78	2	Lung	Dead	2012	2002	1971
TCGA-75-5125	Not Available	MALE	2027	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	1752.0			TUMOR FREE				Not Available	R-Upper	Not Applicable	TCGA-75-5125	205759a6-6391-491b-9857-0080c3a5871e	31	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;NO	Not Available;YES	Not Available;NO	Not Available;Not Available	TCGA-75-5125-F11748;TCGA-75-5125-F72028	406f25c2-f2f7-4aa9-9016-034a5798f561;6219D889-CA6E-4935-8D96-082E561B630B	31;2	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;2027	Not Available;Not Available	Not Applicable;1752	Not Available;Unknown	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Progressive Disease	Not Available;Not Evaluated	Not Available;NO	3;4	Not Available;Not Available	NO;YES	Adjuvant therapy;Not Available	TUMOR FREE;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Dead	2011;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	5125	Other	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	1987	NO	YES	75	3	Lung	Alive	2011	Not Available	Not Available
TCGA-95-7944	71	MALE	377	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	377			TUMOR FREE				71	L-Lower	Not Applicable	TCGA-95-7944	abab925c-bef3-4072-b9c4-40f808744593	21	-26003	Not Applicable	0	21	Not Available	Lung Adenocarcinoma	60																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-95-7944-F29525;TCGA-95-7944-F40938	747C761B-CB03-4D90-A93D-6C327834296D;9B9307F4-5CE2-402C-9634-04C7816FDE90	21;7	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	21;377	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	3;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;TUMOR FREE	NO;NO	Not Available;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	7944	Not Available	TUMOR FREE	Not Available	87	Not Available	Not Available	86	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	95	2	Lung	Alive	2012	2011	1961
TCGA-44-6147	67	FEMALE	845	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	NX	M0	Stage IA	0	845			TUMOR FREE		FPPP	TCGA	67	R-Upper	Not Applicable	TCGA-44-6147	889aec8e-14ba-48d9-8fe1-f2416e82b333	5	-24631	Not Applicable	0	236	Not Available	Lung Adenocarcinoma	68																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;NO	Not Available;NO	Not Available;NO	NO;Not Available	TCGA-44-6147-F20460;TCGA-44-6147-F38947	7717ec1a-6c2f-486f-a3f4-3a5d0ddb4e2d;286EBBD3-255A-40BB-AC90-973B1E9D0203	13;4	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	441;845	Not Applicable;Not Applicable	2;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;80	Not Available;NO	1;1	Not Available;Not Available	NO;NO	Other;Other	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	6147	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	105	97	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1b	1980	YES	NO	44	3	Lung	Alive	2011	2010	1976
TCGA-55-7727	70	MALE	119	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N2	MX	Stage IIIA	0	119			TUMOR FREE				70	L-Upper	Not Applicable	TCGA-55-7727	ba49117e-dab6-4e7d-bc44-f11dcafa1318	8	-25929	Not Applicable	0	34	Not Available	Lung Adenocarcinoma	86																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7727-F66030	DF6E56D7-6870-4C45-8AC3-8D2CECB26497	1	Not Applicable	Not Applicable	Not Applicable	119	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	YES	10	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7727	Not Available	TUMOR FREE	48	73	Not Available	49	74	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T1a	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	Not Available
TCGA-95-7039	54	FEMALE	1272	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	MX	Stage IIB	1	1258.0		Locoregional Recurrence	TUMOR FREE				54	R-Upper	Not Applicable	TCGA-95-7039	ae702159-5b6a-41dd-868c-7540f9e1131c	Not Available	-19981	Not Applicable	0	34	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available;NO	Not Available;Not Available;NO	Not Available;Not Available;NO	Not Available;Not Available;Not Available	TCGA-95-7039-F15635;TCGA-95-7039-F40734;TCGA-95-7039-F67192	1a1c33a9-1df7-4697-9cac-7d942e1bf067;4C4658AB-3BB7-4D82-B7DF-5CA813F3F854;7EAB8F50-92B9-438E-B11F-A8EF2BCB7807	Not Available;15;31	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	34;34;1272	Not Available;Not Available;1258	1;Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Additional New Tumor Event	Complete Remission/Response;Complete Remission/Response;Progressive Disease	Not Available;Not Available;Not Evaluated	Not Available;YES;NO	8;3;10	Not Available;Not Available;Locoregional Recurrence	Not Available;Unknown;YES	Preoperative;Not Available;Not Available	Not Available;Not Available;WITH TUMOR	NO;NO;NO	Complete Remission/Response;Not Available;Complete Remission/Response	Not Available;Not Available;Biopsy with Histologic Confirmation;Convincing Imaging;Positive Biomarker(s)	NO;NO;NO	Alive;Alive;Alive	2011;2013;2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	34	No	7039	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	YES	NO	95	2	Lung	Alive	2011	2011	Not Available
TCGA-55-6975	61	MALE	118	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N1	M0	Stage IIB	1				WITH TUMOR				61	L-Lower	Not Applicable	TCGA-55-6975	a046888c-f153-4f35-a1b6-23dd1691a91a	27	Not Available	118	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-6975-F45635	2CC60EBB-2FF5-41FE-8FCF-9C419EDDE7D9	17	Not Applicable	Not Applicable	118	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	7	Not Available	NO	Not Evaluated	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Dead	2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6975	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	2004	NO	YES	55	4	Lung	Dead	2011	2004	Not Available
TCGA-05-4433	82	MALE	730	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	730			TUMOR FREE				82	L-Lower	Not Applicable	TCGA-05-4433	aea68827-dc0f-484d-a00d-06deeaa4b3ce	22	-30194	Not Applicable	0	730	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4433-F36530	B10301B6-0587-4CEE-84C4-26BEC5D40614	1	Not Applicable	Not Applicable	Not Applicable	730	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	TUMOR FREE	Unknown	Not Applicable	Not Available	Unknown	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	No	4433	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1948	NO	YES	05	3	Lung	Alive	2010	2008	1946
TCGA-05-4427	65	FEMALE	791	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N1	M0	Stage IIB	0	791			TUMOR FREE				65	L-Upper	Not Applicable	TCGA-05-4427	78a24c56-576c-4245-bb42-6603b3d19897	22	-23893	Not Applicable	0	791	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-4427-D36565;TCGA-05-4427-D36566	8809622A-D398-4D9D-95B7-92480AD0CA12;2978B988-DC8D-449A-83CC-6C4831AA0FE2	Not Available;Not Available	5;5	122;122	61;61	Cisplatin;Vinorelbine	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4427-F36564	C0280C41-DC59-4741-8314-055BD0B90DC2	2	Not Applicable	Not Applicable	Not Applicable	791	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Yes	4427	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	2008	NO	YES	05	4	Lung	Alive	2010	2008	1993
TCGA-86-7711	70	MALE	1046	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N1	M0	Stage IIA	1				TUMOR FREE				70	R-Lower	Not Applicable	TCGA-86-7711	9c894668-88f5-4308-a1c0-6b8acc6aaaec	2	-25719	Not Applicable	0	27	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-7711-D36470;TCGA-86-7711-D36471	5969CF61-8D1A-4E11-8018-EA0CC6004B7B;88D02F6F-8FB9-47F9-8722-B3078EA28D7B	Not Available;Not Available	31;31	181;181	37;37	Cisplatin;Etoposide	Complete Response;Complete Response	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-86-7711-F36464;TCGA-86-7711-F41203	A9C3D370-F629-4A00-A8EF-8DA24B519C43;1D299B3D-1130-4A71-9E9C-B523833689E9	31;13	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;1046	630;Not Available	Not Applicable;Not Applicable	0;Not Evaluated	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	100;Not Evaluated	NO;NO	10;3	Not Available;Not Available	NO;NO	Post-Adjuvant Therapy;Not Evaluated	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	Alive;Dead	2012;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	80	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	7711	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	YES	NO	86	2	Lung	Alive	2011	2011	1960
TCGA-69-7761	84	MALE	186	Lung Acinar Adenocarcinoma	Lung	Alive	T2a	N0	MX	Stage IB	0	186			TUMOR FREE				84	L-Lower	Not Applicable	TCGA-69-7761	77828a90-8e2a-4664-b674-d837e6e34fe4	13	-31041	Not Applicable	0	186	Not Available	Lung Adenocarcinoma	80	TCGA-69-7761-D29256;TCGA-69-7761-D29253	15c9dc00-5f02-401f-96c4-e5098a9d7f91;827ec9b8-ee79-4f14-8cb1-001249e90c74	Not Available;Not Available	13;13	147;147	84;84	Alimta;Carboplatin	Not Available;Not Available	3;3	4;4	1000/100;625/500	mg/mL;mg/mL	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	1	Not Available	YES	Other	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-7761-F29252	86590873-3f3a-4004-8f1e-1c36818eb6fd	13	Not Applicable	Not Applicable	Not Applicable	186	Not Applicable	1	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3	Not Available	NO	Adjuvant therapy	TUMOR FREE	YES	Not Available	Not Available	NO	Alive	2012	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	7761	Other	TUMOR FREE	Not Available	Not Available	Not Available	91	98	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	1975	NO	YES	69	3	Lung	Alive	2012	2011	1955
TCGA-44-2661	69	FEMALE	1159	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	1159			TUMOR FREE				69	L-Upper	Not Applicable	TCGA-44-2661	f3501466-cf32-4866-b5fb-e94dd32341bc	8	-25313	Not Applicable	0	103	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-44-2661-F5051;TCGA-44-2661-F12810;TCGA-44-2661-F41293	7ac97c53-3160-4567-ba1e-bac4b06376cd;2463a46b-1698-45e4-b11c-5f691e0f69f3;B711FC80-F8AA-4F4C-AF2A-C9AA98016533	8;8;14	Not Applicable;Not Available;Not Applicable	Not Applicable;Not Available;Not Applicable	Not Applicable;Not Applicable;Not Applicable	446;741;1159	Not Applicable;Not Available;Not Applicable	1;Not Available;Not Available	Not Available;Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Not Available	Not Available;Not Available;NO	10;6;3	Not Available;Not Available;Not Available	NO;Not Available;NO	Pre-Adjuvant Therapy;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Not Available	NO;NO;NO	Alive;Alive;Alive	2010;2011;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	2661	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	YES	NO	44	1	Lung	Alive	2010	2009	Not Available
TCGA-55-6981	53	FEMALE	1379	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N2	M0	Stage IIIA	0	1379			TUMOR FREE				53	L-Upper	Not Applicable	TCGA-55-6981	0a45f302-5748-48f3-9dc9-66c01843a68e	27	-19497	1379	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-6981-D56245	C7F9FCD5-F2FB-4097-9417-19F1B5F1855B	Not Available	30	Not Available	25	Chemo, NOS	Complete Response	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-6981-F56243	1E30CFED-13C2-4A05-B32F-1A96D4DE789B	30	Not Applicable	Not Applicable	1379	Not Available	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	1	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	YES	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6981	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-55-6981-R56244	524B09AA-4C5A-48CA-B8B5-92CC0C233997	Not Available	30	114	65	Complete Response	1	34	6120	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T1	Not Available	NO	YES	55	3	Lung	Dead	2011	2005	Not Available
TCGA-MP-A4TH	70	FEMALE	741	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	741			TUMOR FREE				70	L-Lower	Not Applicable	TCGA-MP-A4TH	7A111B4F-46E9-4E34-8024-0B9FDC5CBCD8	8	-25759	Not Applicable	0	142	Not Available	Lung Adenocarcinoma	73																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-MP-A4TH-F54545;TCGA-MP-A4TH-F69949	9659993E-D9ED-42F9-8410-F35E8CF2D676;0F71006D-E390-47A0-BCC2-C902FE43812E	19;22	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	446;741	Not Applicable;Not Applicable	Not Evaluated;Not Evaluated	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Evaluated;Not Evaluated	NO;NO	12;1	Not Available;Not Available	NO;NO	Not Available;Not Evaluated	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	No	A4TH	Not Available	TUMOR FREE	117	115	NO	110	115	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	1982	YES	NO	MP	3	Lung	Alive	2013	2012	1962
TCGA-55-8299	61	FEMALE	469	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1b	N0	MX	Stage IA	1	274.0		Distant Metastasis	TUMOR FREE				61	R-Upper	Not Applicable	TCGA-55-8299	2cd8ea73-cb3f-4b17-9b97-fa12eb03b85b	8	-22626	Not Applicable	0	216	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	NO	TCGA-55-8299-F57915	A9C89030-2543-4E48-87D9-5FA314877305	28	Not Available	Not Available	469	Not Available	274	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	3	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Unknown	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	No	8299	Not Available	TUMOR FREE	Not Available	Not Available	NO	75	74	Complete Remission/Response	YES	WHITE	NO	Distant Recurrence	TCGA-55-8299-R57916	A2DBBFEE-391A-4404-BA88-F6BBCBEF60A9	Not Available	28	320	304	Radiographic Progressive Disease	3	13	3250	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	2012	YES	NO	55	4	Lung	Alive	2012	2012	1971
TCGA-L4-A4E6	67	MALE	435	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	435			TUMOR FREE				67	R-Upper	Not Applicable	TCGA-L4-A4E6	26A92E1B-08D8-45CD-AF0C-EAF2514808A2	5	-24631	Not Applicable	0	76	Not Available	Lung Adenocarcinoma	98																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-L4-A4E6-F51277	4A1DF958-C4FC-4CEB-B14F-05210285715F	14	Not Applicable	Not Applicable	Not Applicable	435	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	11	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Peripheral Lung	12	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	No	A4E6	Not Evaluated	TUMOR FREE	82	85	NO	84	69	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1984	NO	YES	L4	3	Lung	Alive	2012	2012	1954
TCGA-44-A47F	74	MALE	337	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N1	M0	Stage IIB	0	337			TUMOR FREE				74	L-Upper	Not Applicable	TCGA-44-A47F	F61D599A-43BD-4743-9568-678317E75955	23	-27122	Not Applicable	0	246	Not Available	Lung Adenocarcinoma	Not Available	TCGA-44-A47F-D36953;TCGA-44-A47F-D36954	73D0B0CD-088C-4220-9ED5-280121CCD432;2F7AD0AB-78F2-4B48-8180-C42A2ECE1D3A	Not Available;Not Available	20;20	185;185	122;122	Alimta;Cisplatin	Complete Response;Complete Response	11;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-44-A47F-F41750	298CEB49-6D86-40DA-9DF6-5C65A0FC938A	27	Not Applicable	Not Applicable	Not Applicable	337	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	90	NO	3	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	Yes, History of Prior Malignancy	A47F	Preoperative	TUMOR FREE	127	84	YES	122	81	Complete Remission/Response	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2b	1987	YES	NO	44	3	Lung	Alive	2012	2012	1955
TCGA-55-7913	61	FEMALE	561	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1b	N0	MX	Stage IA	1	480.0		Distant Metastasis	TUMOR FREE				61	L-Lower	Not Applicable	TCGA-55-7913	c9c533ee-e154-4a56-bce9-b5af37574b2f	17	-22326	Not Applicable	0	62	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	NO	TCGA-55-7913-F57911	6CBD65CC-277E-43D4-BE2E-641C6AB8FF29	28	Not Available	Not Available	561	Not Available	480	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	3	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	90	YES	NO	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	7913	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	Not Available	BLACK OR AFRICAN AMERICAN	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	1971
TCGA-38-4628	65	FEMALE	1492	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	1083.0			WITH TUMOR				65	R-Upper	Not Applicable	TCGA-38-4628	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	9	-24057	1492	0	Not Available	Not Available	Lung Adenocarcinoma	72	TCGA-38-4628-D4678;TCGA-38-4628-D13831	0c5ddee7-c7b0-44a1-97d7-c6eb11c9b514;357b5e2f-bb1b-41f7-8c7c-4ea6dd8a2fd3	Not Available;Not Available	9;14	1238;1238	1147;1147	Carboplatin;Taxol	Not Available;Not Available	12;7	4;4	Not Available;Not Available	Not Available;Not Available	RECURRENCE;RECURRENCE	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2011	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	YES	TCGA-38-4628-F4676	cca64327-9837-4503-abfd-9e6ab40ff8dc	9	Not Available	1118	1492	Not Available	1083	Not Available	Not Available	Stable Disease	Not Available	Not Available	12	Not Available	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Not Available	NO	Dead	2010	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Central Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4628	Not Available	WITH TUMOR	78	85	Not Available	74	86	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	38	1	Lung	Dead	2010	2002	Not Available
TCGA-67-6215	52	FEMALE	174	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	174			TUMOR FREE				52	R-Lower	Not Applicable	TCGA-67-6215	dbd5b0de-94c9-45dd-afb3-6820a7ecaca2	2	-19310	Not Applicable	0	162	Not Available	Lung Adenocarcinoma	Not Available	TCGA-67-6215-D13739;TCGA-67-6215-D13760	f689f65f-4ee1-458b-a0a3-0830819796fc;7199c0c9-6baf-4418-a719-d2c648677db4	Not Available;Not Available	11;12	148;148	85;85	CISPLATIN;ALIMTA	Not Available;Not Available	7;7	4;4	135;900	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2011;2011	2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-67-6215-F13585	98f5011f-0421-4bb4-a740-a06c2e8d8794	6	Not Applicable	Not Applicable	Not Applicable	174	Not Applicable	2	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	7	Not Available	NO	Adjuvant therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6215	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	67	1	Lung	Alive	2011	2010	Not Available
TCGA-NJ-A7XG	49	MALE	617	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T4	N1	M0	Stage IIIA	1				WITH TUMOR				49	L-Upper	Not Applicable	TCGA-NJ-A7XG	01E9888D-B5B9-48F1-8BA6-8A89AF108A04	22	-18127	Not Applicable	0	295	Not Available	Lung Adenocarcinoma	Not Available	TCGA-NJ-A7XG-D71392;TCGA-NJ-A7XG-D71393;TCGA-NJ-A7XG-D71463	722B8970-EEDA-4CD9-B2C5-9FE8E763C119;4006A0DF-514F-45D2-8CFA-20E163DF66DE;3340775B-1C82-4EB8-9F90-84B465A9C799	Not Available;Not Available;Not Available	25;25;25	100;128;128	30;100;30	Cisplatin;carboplatin;Pemetrexed	Stable Disease;Stable Disease;Stable Disease	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	YES	Other	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-NJ-A7XG-F71390	79C34A2C-8467-47E1-BC78-F4652344C551	25	Not Applicable	Not Applicable	Not Applicable	617	Not Applicable	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	3	Not Available	NO	Not Available	WITH TUMOR	YES	Stable Disease	Not Available	NO	Alive	2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A7XG	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Stable Disease	NO	BLACK OR AFRICAN AMERICAN	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T4	Not Available	Not Available	Not Available	NJ	3	Lung	Alive	2014	2013	Not Available
TCGA-67-3772	82	FEMALE	573	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	573			TUMOR FREE				82	R-Upper	Not Applicable	TCGA-67-3772	673493f6-975c-49e8-934c-001e9a0fff90	3	-29989	Not Applicable	0	573	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	3772	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	67	1	Lung	Alive	2011	2009	Not Available
TCGA-S2-AA1A	68	FEMALE	513	Lung Bronchioloalveolar Carcinoma Mucinous	Lung	Alive	T1b	N0	M0	Stage IA	0	513			TUMOR FREE				68	R-Upper	Not Applicable	TCGA-S2-AA1A	31458638-E19C-43E5-AB13-9C64B3B3681D	22	-24903	Not Applicable	0	121	Not Available	Lung Adenocarcinoma	65																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-S2-AA1A-F67520	90F720D7-868B-4102-9B73-0824B7500158	7	Not Applicable	Not Applicable	Not Applicable	513	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	11	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.1	8253/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	95	No	AA1A	Not Available	TUMOR FREE	83	2.16	NO	79	2.01	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	1995	YES	NO	S2	3	Lung	Alive	2014	2013	1957
TCGA-49-6767	46	FEMALE	677	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	MX	Stage IIB	0	677			TUMOR FREE				46	R-Middle	Not Applicable	TCGA-49-6767	6bffe800-ec2b-4638-9333-97fe85dcd91c	10	-17108	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-49-6767-F58822	DC7C7640-FF2D-4F4E-8220-4EFFAD635D0E	24	Not Available	Not Available	Not Applicable	677	Not Available	Unknown	Scheduled Follow-up Submission	Unknown	Unknown	NO	4	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Not Available	Unknown	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	6767	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	NO	YES	49	2	Lung	Alive	2011	2010	Not Available
TCGA-55-6980	56	MALE	2109	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T1	N0	M0	Stage IA	0	2109			TUMOR FREE				56	R-Lower	Not Applicable	TCGA-55-6980	2f0710f4-827b-45b2-9b7e-c27385b481a7	27	Not Available	Not Applicable	0	67	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-55-6980-F46642	280D1471-7D87-47DB-AAD2-6281B990E361	13	Not Applicable	Not Applicable	Not Applicable	2109	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6980	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	55	1	Lung	Alive	2011	2006	Not Available
TCGA-44-6144	58	MALE	723	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	1	399.0		Locoregional Recurrence	TUMOR FREE				58	R-Upper	Not Applicable	TCGA-44-6144	22302e92-fdfa-462a-9249-efdaa26ee5ed	7	-21283	Not Applicable	0	9	9	Lung Adenocarcinoma	82																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;YES	Not Available;NO	Not Available;NO	Not Available;NO	TCGA-44-6144-F28683;TCGA-44-6144-F39034	4731cc65-66df-442b-ba6c-c440bd44e8b0;7EED8AFF-FF01-4647-B239-80D021B2BD52	28;9	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	407;723	399;399	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	Not Available;70	Not Available;NO	2;1	Not Available;Locoregional Recurrence;Distant Metastasis	YES;YES	Not Available;Other	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Biopsy with Histologic Confirmation;Convincing Imaging	NO;NO	Alive;Alive	2012;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	67.5	No	6144	Preoperative	TUMOR FREE	97	77	Not Available	87	63	Not Available	YES	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	44	2	Lung	Alive	2011	2011	1968
TCGA-44-5645	61	FEMALE	852	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	NX		Stage IA	0	852			TUMOR FREE		FPPP	TCGA	61	L-Upper	Not Applicable	TCGA-44-5645	ddeacccf-0953-4952-8a4e-c2617f2e7bcc	13	-22471	Not Applicable	0	208	Not Available	Lung Adenocarcinoma	82																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;Not Available	TCGA-44-5645-F14601;TCGA-44-5645-F38800	9d996467-3fd5-408f-9225-258a86d0bd01;241EC925-44CC-4331-B9AF-BF5E912AF547	4;24	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	383;852	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	8;12	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	No	5645	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	90	100	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	Not Available	NX	T1	1973	YES	NO	44	3	Lung	Alive	2011	2010	1963
TCGA-MP-A4T7	75	FEMALE	167	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M1	Stage IV	0	167			Unknown				75	R-Lower	Not Applicable	TCGA-MP-A4T7	47062AD2-BA82-45C8-A871-BDEA84F0C405	2	-27603	167	0	Not Available	Not Available	Lung Adenocarcinoma	57																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Unknown																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	50	No	A4T7	Not Evaluated	Unknown	Not Available	91	NO	Not Available	87	Unknown	YES	Unknown	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	2004	NO	YES	MP	4	Lung	Dead	2013	2005	1954
TCGA-62-A46V	78	FEMALE	2199	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	2199			TUMOR FREE				78	L-Lower	Not Applicable	TCGA-62-A46V	F809E21D-5F2E-4F3B-A1AA-D6B8D463552A	30	-28495	Not Applicable	0	1631	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-62-A46V-F51440	58E3C427-7F74-4CC2-9847-DF0700AF43D5	19	Not Applicable	Not Applicable	Not Applicable	2199	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	90	NO	11	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	90	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A46V	Preoperative	TUMOR FREE	Not Available	Not Available	NO	51	100	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	62	3	Lung	Alive	2012	2007	Not Available
TCGA-44-6774	56	FEMALE	658	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N2	M0	Stage IIIA	0	658			Not Available				56	L-Lower	Not Applicable	TCGA-44-6774	33c71ead-4c2a-476d-85ef-885dbbfc2cbd	24	-20462	Not Applicable	0	166	Not Available	Lung Adenocarcinoma	101	TCGA-44-6774-D30170;TCGA-44-6774-D30176;TCGA-44-6774-D30173	0AF8AD7E-12CE-4B54-A0AD-E385FCB7BFDF;43806307-3701-4257-911D-EA7D9340D5DE;DB768637-FE0C-46B2-8620-1FA1BE5C429A	Not Available;Not Available;Not Available	3;3;3	154;154;112	91;133;91	Alimta;Carboplatin;Cisplatin	Not Available;Not Available;Not Available	4;4;4	4;2;2	1000;525-560;150	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	4000;1085;300	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;Not Available	TCGA-44-6774-F30164;TCGA-44-6774-F39646	E1541BC7-F0F2-4081-85B4-DE781B1C27EC;F8E892DC-9234-421F-94F8-256BFAAE6DF6	3;28	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	361;658	Not Applicable;Not Applicable	1;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	4;1	Not Available;Not Available	NO;NO	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	YES;YES	Alive;Alive	2012;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	6774	Other	Not Available	Not Available	Not Available	Not Available	84	96	Not Available	YES	WHITE	Not Available	Primary Tumor Field	TCGA-44-6774-R30167	F2186547-7A4A-4F49-9913-F70E94CF7A3E	1	3	228	193	Not Available	4	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T1	Not Available	YES	NO	44	2	Lung	Alive	2011	2011	1971
TCGA-55-8621	75	FEMALE	515	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	515			TUMOR FREE				75	L-Lower	Not Applicable	TCGA-55-8621	8d535aa6-6d59-4965-b5ed-17217d8f5930	11	-27485	Not Applicable	0	106	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8621-F48791	E4B4EB9A-0821-4025-BE16-EFAD0D846418	20	Not Applicable	Not Applicable	Not Applicable	515	Not Applicable	1	Scheduled Follow-up Submission	Complete Remission/Response	90	NO	9	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	Yes, History of Prior Malignancy	8621	Not Available	TUMOR FREE	112	105	NO	110	105	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	2010	YES	NO	55	4	Lung	Alive	2013	2012	1980
TCGA-05-4396	76	MALE	303	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T4	N1	M0	Stage IIIB	0	303			Not Available				76	R-Lower	Not Applicable	TCGA-05-4396	9f81c602-8afa-4588-b0b6-6e5a1a128d5a	22	-28094	303	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	19	Yes	4396	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T4	1984	NO	YES	05	3	Lung	Dead	2010	2006	1947
TCGA-55-7573	72	FEMALE	487	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	487			TUMOR FREE				72	R-Upper	Not Applicable	TCGA-55-7573	8e41153b-9faf-45c3-8397-8a428ef5c0d5	11	-26302	Not Applicable	0	4	Not Available	Lung Adenocarcinoma	51																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7573-F46657	483D103F-ADB6-45F2-991D-ED029568C19C	13	Not Applicable	Not Applicable	Not Applicable	487	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	8	Not Available	NO	Unknown	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	NO	Not Available	Not Available	Central Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	7573	Preoperative	TUMOR FREE	119	134	Not Available	115	130	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	1983	YES	NO	55	3	Lung	Alive	2012	2011	Not Available
TCGA-49-AARR	68	MALE	4992	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	MX	Stage IA	1	1099.0		New Primary Tumor	TUMOR FREE				68	L-Upper	Not Applicable	TCGA-49-AARR	9B93A7C5-F9B4-4461-8078-0201A725C9CF	19	-24942	Not Applicable	0	4630	Not Available	Lung Adenocarcinoma	103.5																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	Not Available	TCGA-49-AARR-F70574	A41DDC21-E254-43A4-BBC7-FE6D974EB739	25	Not Available	Not Available	Not Applicable	4992	4812	1	Scheduled Follow-up Submission	Stable Disease	80	NO	2	Locoregional Recurrence	YES	Preoperative	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Alive	2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	Not Available	Not Available	Not Available	Not Available	6	NO	NO	1099	Not Available	Not Available	Not Available	1099	New Primary Tumor	Biopsy with Histologic Confirmation;Convincing Imaging	YES	Not Available	No	AARR	Preoperative	TUMOR FREE	76.3	78.8	NO	77.8	80.3	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	1987	NO	YES	49	3	Lung	Alive	2014	2001	Not Available
TCGA-97-A4M3	69	FEMALE	540	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1b	N0	M0	Stage IA	1	54.0		New Primary Tumor	Unknown				69	R-Upper	Not Applicable	TCGA-97-A4M3	575752F8-2788-43CD-AFDE-F0F600F39D18	7	-25384	Not Applicable	0	237	Not Available	Lung Adenocarcinoma	106																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	TCGA-97-A4M3-F57436	F59A23A0-77D8-4C10-B37D-67549803202E	11	Not Available	Not Available	Not Applicable	540	54	1	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	3	New Primary Tumor	YES	Other	TUMOR FREE	NO	Complete Remission/Response	Biopsy with Histologic Confirmation	NO	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Evaluated	YES	NO	Not Available	Unknown	3	NO	NO	54	Not Available	Not Available	Not Available	Not Available	New Primary Tumor	Biopsy with Histologic Confirmation	YES	37.5	Yes, History of Prior Malignancy	A4M3	Preoperative	Unknown	69	73	NO	61	61	Complete Remission/Response	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	1984	YES	NO	97	3	Lung	Alive	2013	2012	1959
TCGA-49-AARO	39	FEMALE	3759	Lung Papillary Adenocarcinoma	Lung	Alive	T1a	N0	MX	Stage IA	1	1144.0		Locoregional Recurrence	WITH TUMOR				39	L-Upper	Not Applicable	TCGA-49-AARO	5202458B-C38A-47C0-A0BA-5F1A59A762A0	19	-14527	Not Applicable	0	3755	Not Available	Lung Adenocarcinoma	103.3																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	Not Available	TCGA-49-AARO-F70571	FC43C360-D46F-4775-B16A-C5739011E368	25	Not Available	Not Available	Not Applicable	3759	3521	3	Scheduled Follow-up Submission	Stable Disease	40	NO	2	Locoregional Recurrence	YES	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Convincing Imaging	YES	Alive	2015	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	90	Not Available	Not Available	Not Available	Not Available	6	NO	NO	1144	YES	3664	Not Available	Not Available	Locoregional Recurrence	Convincing Imaging	YES	Not Available	No	AARO	Preoperative	WITH TUMOR	84.4	83.9	NO	83.6	83.0	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	Not Available	NO	YES	49	2	Lung	Alive	2014	2003	Not Available
TCGA-91-6830	65	FEMALE	60	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N1	MX	Stage IIA	1	18.0		Distant Metastasis	WITH TUMOR				65	L-Upper	Not Applicable	TCGA-91-6830	5a2f8140-8f90-4e94-b703-5fa5aa96be7b	19	-23922	Not Applicable	0	1	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	YES	TCGA-91-6830-F32595	557AFAED-4E1C-41AA-BFA7-0BEFFDF7227D	4	Not Available	18	Not Applicable	60	18	Unknown	Scheduled Follow-up Submission	Unknown	Unknown	YES	6	Distant Metastasis	YES	Not Available	Unknown	NO	Unknown	Biopsy with Histologic Confirmation	NO	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	No	6830	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-91-6830-R32598	C7C5B07C-450D-4B29-8A87-B339547AAF1D	Not Available	4	60	60	Unknown	6	1	2000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1	2002	NO	YES	91	4	Lung	Alive	2011	2002	1990
TCGA-38-6178	70	FEMALE	448	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N2		Stage IIIA	1				WITH TUMOR				70	L-Upper	Not Applicable	TCGA-38-6178	edf80622-aea2-4b50-bb69-691d6708aa83	14	-25593	Not Applicable	0	158	Not Available	Lung Adenocarcinoma	Not Available	TCGA-38-6178-D22083;TCGA-38-6178-D22081	5ad35ad6-ca82-4ca6-9db3-cd262b61c75f;7068c8ff-4abb-437c-961f-cffe77e553b7	Not Available;Not Available	23;23	98;98	57;57	Carboplatin;Taxol	Not Available;Not Available	2;2	3;3	6;175	AUC;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	YES	Exon 19 Deletion	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-38-6178-F22078	e24c953c-286d-4f97-a3ac-9c2723bd1f76	23	Not Applicable	Not Applicable	Not Applicable	448	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	2	Not Available	NO	Not Available	WITH TUMOR	YES	Stable Disease	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	NO	Not Available	Central Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	6178	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	N2	T2b	Not Available	YES	NO	38	1	Lung	Alive	2011	2010	Not Available
TCGA-55-8091	74	MALE	600	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	0	600			TUMOR FREE				74	R-Lower	Not Applicable	TCGA-55-8091	d12b6930-9ae4-4fe7-ad69-d183135c91ab	15	-27385	Not Applicable	0	43	Not Available	Lung Adenocarcinoma	65																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8091-F47820	B40ED298-8EB6-4147-BE8D-F6338BF3163B	28	Not Applicable	Not Applicable	Not Applicable	600	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Unknown	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Prior Malignancy	8091	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	79	82	Complete Remission/Response	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	1985	YES	NO	55	3	Lung	Alive	2012	2011	Not Available
TCGA-55-8507	53	MALE	418	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	418			TUMOR FREE				53	R-Upper	Not Applicable	TCGA-55-8507	d63c028b-b6d3-49ce-b63e-261eed3b86df	28	-19390	Not Applicable	0	8	Not Available	Lung Adenocarcinoma	Not Available																								3	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8507-F48792	46ECC264-1E48-4AA2-BE86-30B8AB909150	20	Not Applicable	Not Applicable	Not Applicable	418	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	9	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	40	Unknown	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	120	No	8507	Other	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	Not Available	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	Not Available	YES	NO	55	2	Lung	Alive	2012	2012	1972
TCGA-75-7030	Not Available	MALE		Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung		T3	N0	M0	Stage IIB	0				TUMOR FREE				Not Available	R-Lower	Not Applicable	TCGA-75-7030	df576520-a6b6-4c9b-8d06-3f59cc5342fd	16	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-75-7030-D18798;TCGA-75-7030-D18797	0c13d354-be1b-4d41-a8d4-1579f902bf38;e83f6d9d-f80b-46df-948c-10ad8c4706a2	Not Available;Not Available	17;17	Not Available;Not Available	Not Available;Not Available	Cisplatin;Vinorelbine Tartrate	Not Available;Not Available	11;11	4;4	92;46	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	YES;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	736;552	mg;mg	Not Available;Not Available	2011;2011	0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	NO	NO	TCGA-75-7030-F15878	63eba997-c2ac-44fa-8c2b-d620644e2410	16	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	0	Not Available	Complete Remission/Response	Not Available	Not Available	8	Not Available	NO	Post-Adjuvant Therapy	Not Available	YES	Complete Remission/Response	Not Available	NO	Alive	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7030	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	NO	YES	75	1	Lung	Alive	2011	2007	Not Available
TCGA-86-A456	78	FEMALE	896	Lung Papillary Adenocarcinoma	Lung	Alive	T1a	N0	M0	Stage IA	0	896			TUMOR FREE				78	L-Upper	Not Applicable	TCGA-86-A456	8E2ACA86-7CBA-4631-9F25-4D14219DBC6D	6	-28533	Not Applicable	0	10	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-86-A456-F46034;TCGA-86-A456-F67789	7603E36B-91F1-4DD6-9E6D-EFE55834CFAB;A4D461D5-A81D-4CE9-81D9-68E74863A0A0	29;11	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	405;896	Not Applicable;Not Applicable	1;Not Evaluated	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	90;80	NO;NO	7;11	Not Available;Not Available	NO;NO	Post-Adjuvant Therapy;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	Unknown;Unknown	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	Unknown	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	A456	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	ASIAN	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	2009	YES	NO	86	4	Lung	Alive	2012	2012	1974
TCGA-55-A492	70	FEMALE	596	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	596			TUMOR FREE				70	R-Upper	Not Applicable	TCGA-55-A492	39AB7174-5707-498D-9959-523680E04198	21	-25719	Not Applicable	0	1	Not Available	Lung Adenocarcinoma	52																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-A492-F60135	98B54E54-A0F9-4C7A-A526-F632A36A972D	29	Not Applicable	Not Applicable	Not Applicable	596	Not Applicable	2	Scheduled Follow-up Submission	Complete Remission/Response	80	NO	5	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	35	Yes, History of Prior Malignancy	A492	Not Available	TUMOR FREE	Not Available	92	Unknown	Not Available	95	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	1995	YES	NO	55	3	Lung	Alive	2013	2012	1962
TCGA-64-1678	70	FEMALE	1189	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N0	M0		0	1189			TUMOR FREE				70	R-Middle	Not Applicable	TCGA-64-1678	f77cf4d3-9829-4fd3-95a1-b29aed9e94b8	15	-25931	Not Applicable	0	1189	Not Available	Lung Adenocarcinoma	Not Available	TCGA-64-1678-D4374;TCGA-64-1678-D4372	8e66e3b4-e400-4d79-b659-1633ac4dc232;52f1e822-e632-41d3-8878-da3dcc2611d1	Not Available;Not Available	15;15	132;132	69;69	Carboplatin;Paclitaxel	Not Available;Not Available	11;11	4;4	6;200	AUC;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-64-1678-F4371	5b51f40d-c1d0-43fe-8136-48ede23d4525	15	Not Applicable	Not Applicable	Not Applicable	1189	Not Applicable	Not Available	Not Available	Complete Remission/Response	Not Available	Not Available	11	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2010	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	1678	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	1990	NO	YES	64	3	Lung	Alive	2010	2006	1970
TCGA-62-8399	62	MALE	2696	Lung Papillary Adenocarcinoma	Lung	Alive	T2	N2	M0	Stage IIIA	0	2696			TUMOR FREE				62	L-Upper	Not Applicable	TCGA-62-8399	62380447-3b94-4e7c-823a-72dd7b4ccf3a	4	-22952	Not Applicable	0	2093	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-62-8399-F52545	147B5527-FA29-41B2-92BD-C0882730DDC1	4	Not Applicable	Not Applicable	Not Applicable	2696	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	12	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8255/3	C34.1	YES	100	NO	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	70	No	8399	Preoperative	TUMOR FREE	Not Available	Not Available	NO	48	32	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	62	4	Lung	Alive	2012	2006	Not Available
TCGA-55-6985	58	FEMALE	1233	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	0	1233			TUMOR FREE				58	L-Upper	Not Applicable	TCGA-55-6985	e5cb0c86-8fe2-4cfc-b32b-e8ec3839ffc4	26	-21381	Not Applicable	0	1233	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-55-6985-F37056	F432F92C-4BB0-437C-A742-B9E6B4BD8E55	22	Not Applicable	Not Applicable	Not Applicable	1233	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	YES	2	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	6985	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	2004	NO	YES	55	4	Lung	Alive	2011	2004	Not Available
TCGA-44-8120	58	MALE	260	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	260			TUMOR FREE				58	R-Upper	Not Applicable	TCGA-44-8120	83e38dbd-edab-47f2-b19f-6ea38fc6bece	31	-21188	Not Applicable	0	169	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-44-8120-F36757	9CE462FD-8E7F-483D-BB93-B5B2CDFCA189	13	Not Applicable	Not Applicable	Not Applicable	260	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Unknown	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	No	8120	Preoperative	TUMOR FREE	100	101	NO	98	97	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	44	5	Lung	Alive	2012	2011	1981
TCGA-50-5935	86	FEMALE	653	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	0	653			Not Available				86	L-Upper	Not Applicable	TCGA-50-5935	100430c8-1446-45c8-af36-b6dbb3ddd0c1	2	-31610	653	0	653	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Other	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	NO	Not Available	TCGA-50-5935-F32108	1e2da076-3f69-4de4-af22-9f3dfc1ce1f3	17	Not Applicable	Not Applicable	653	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	YES	Dead	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	YES	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	5935	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-50-5935-R32109	5aa7172f-ba04-4f8f-8dcc-82cb5f544459	1	17	0	0	Not Available	5	Not Available	100	NO	IMPLANTS	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	50	Not Available	Lung	Dead	2011	2006	Not Available
TCGA-50-5044	72	FEMALE	624	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T4	N1	M0	Stage IIIB	1	483.0		Distant Metastasis	WITH TUMOR				72	R-Lower	Not Applicable	TCGA-50-5044	fa0c7392-d485-41ac-bf7e-244a528209ae	25	-26567	624	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	NO	NO	TCGA-50-5044-F31976	699a5471-d724-47d8-9a63-e846f461acd2	14	Not Available	Not Available	624	Not Available	483	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Convincing Imaging	YES	Dead	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5044	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-50-5044-R40427	B8DB558B-F9D7-4576-AA04-5B5F98E27BFE	Not Available	19	500	491	Unknown	2	7	14.7	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T4	Not Available	NO	YES	50	Not Available	Lung	Dead	2011	2002	Not Available
TCGA-55-8085	64	MALE	904	Lung Papillary Adenocarcinoma	Lung	Alive	T1b	N0	M0	Stage IA	0	904			TUMOR FREE				64	L-Lower	Not Applicable	TCGA-55-8085	5fd0f07b-8bb9-4378-bd26-28a26057e8fe	15	-23596	Not Applicable	0	33	Not Available	Lung Adenocarcinoma	51																								1	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8085-F65697	CA62DF16-FCE4-47BE-8B87-6AC56FCECE60	26	Not Applicable	Not Applicable	Not Applicable	904	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Papillary Adenocarcinoma	No	C34.3	8260/3	C34.3	YES	Not Available	Unknown	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8085	Not Available	TUMOR FREE	46	45	Unknown	39	35	Complete Remission/Response	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	Not Available
TCGA-L9-A444	60	FEMALE	307	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	307			Not Available				60	R-Upper	Not Applicable	TCGA-L9-A444	4A1D30E8-E93A-41ED-8E54-08EAFF6556A7	26	-22202	Not Applicable	0	6	Not Available	Lung Adenocarcinoma	57																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-L9-A444-F46270	B1C53C2B-9FB6-4024-888D-0192BE820066	5	Not Applicable	Not Applicable	Not Applicable	307	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Central Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	10	Yes, History of Prior Malignancy	A444	Preoperative	Not Available	62	54	NO	58	49	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	Not Available	YES	NO	L9	2	Lung	Alive	2012	2012	1972
TCGA-55-8615	67	MALE	446	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N2	MX	Stage IIIA	1	224.0		Distant Metastasis	TUMOR FREE				67	R-Middle	Not Applicable	TCGA-55-8615	06fe7f3e-4edd-4150-981c-93787ea19b39	11	-24786	Not Applicable	0	15	Not Available	Lung Adenocarcinoma	83	TCGA-55-8615-D56256;TCGA-55-8615-D56257;TCGA-55-8615-D56258;TCGA-55-8615-D56259	C3E3F94E-7959-47E7-941B-5092013166FF;BCB6362E-FD58-49FE-82E2-ACD98A53F2D7;E08B7831-B7A9-4EC0-9D20-39B36957E6C1;2B2ABC4D-DB6C-4DBC-9DD8-519DEE12F63C	Not Available;Not Available;Not Available;Not Available	30;30;30;30	Not Available;Not Available;324;416	89;89;234;234	Carboplatin;Taxol;Carboplatin;Alimta	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	1;1;1;1	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	YES	YES	NO	NO	TCGA-55-8615-F56254	A2AF20F3-F8C6-4A5A-9E03-9E9583D59194	30	Not Available	Not Available	Not Applicable	446	224	Unknown	Scheduled Follow-up Submission	Progressive Disease	Unknown	NO	1	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Complete Remission/Response	Convincing Imaging	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	67	No	8615	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	88	Complete Remission/Response	YES	WHITE	NO	Distant Recurrence	TCGA-55-8615-R56255	D1E015AB-A6F7-4308-8187-F60F9195E63B	Not Available	30	446	426	Radiographic Progressive Disease	1	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T3	Not Available	YES	NO	55	2	Lung	Alive	2013	2012	1966
TCGA-97-A4M0	60	FEMALE	652	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N0	M0	Stage IB	0	652			Unknown				60	R-Upper	Not Applicable	TCGA-97-A4M0	DD63D0FD-E24B-40A5-88C5-7D3D4106631E	7	-22206	Not Applicable	0	216	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-A4M0-F57385	551C91CF-3AEC-44DA-BF0F-DAB40F977E32	10	Not Applicable	Not Applicable	Not Applicable	652	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	3	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Evaluated	YES	YES	G12C	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	34	No	A4M0	Preoperative	Unknown	Not Available	Not Available	NO	90	97	Complete Remission/Response	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	2004	YES	NO	97	4	Lung	Alive	2013	2012	1970
TCGA-95-7562	71	MALE	87	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N1	M0	Stage IIA	0	87			TUMOR FREE				71	R-Lower	Not Applicable	TCGA-95-7562	193201a3-1447-47b1-bdf1-11ae0eb3b2f3	13	-26000	87	0	Not Available	Not Available	Lung Adenocarcinoma	57	TCGA-95-7562-D33261;TCGA-95-7562-D33262	1CB62B54-E04A-4A35-A0C0-5362A3F24D93;4F33410C-01F5-4F0E-A0A8-A416520BE0F7	Not Available;Not Available	26;26	81;81	60;60	CISPLATIN;ALIMTA	Unknown;Unknown	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2012;2012	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-95-7562-F32832	CCBA82F1-C522-4EF5-B5BB-A1F58E29ED89	13	Not Applicable	Not Applicable	87	Not Available	Not Applicable	1	Scheduled Follow-up Submission	Not Evaluated	Not Available	NO	6	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Not Evaluated	Not Available	NO	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	10	Yes, History of Prior Malignancy	7562	Post-Adjuvant Therapy	TUMOR FREE	72	90	YES	76	80	Not Evaluated	YES	BLACK OR AFRICAN AMERICAN	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	1983	YES	NO	95	3	Lung	Dead	2012	2011	1973
TCGA-38-4626	57	FEMALE	3674	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N0	M0		1	2518.0		New Primary Tumor	TUMOR FREE				57	L-Upper	Not Applicable	TCGA-38-4626	2079155a-d91d-4246-a038-01934a580f32	7	-20903	Not Applicable	0	2595	Not Available	Lung Adenocarcinoma	57																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;NO	Not Available;NO	Not Available;NO	Not Available;Not Available	TCGA-38-4626-F4507;TCGA-38-4626-F33409	f7d53f3d-25b9-43f5-9d12-f4c38dd72816;11F9E5D4-D903-4AC9-A6CC-3CB66E89CD21	8;26	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	2595;3674	Not Applicable;2518	Not Available;Not Available	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	12;7	Not Available;New Primary Tumor	NO;YES	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2010;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	4626	Not Available	TUMOR FREE	68	85	Not Available	71	85	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	NO	YES	38	2	Lung	Alive	2010	2003	1962
TCGA-67-6216	57	FEMALE	141	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	141			TUMOR FREE				57	R-Middle	Not Applicable	TCGA-67-6216	ccecce70-dd54-4c5b-bf9f-ca87d290cb00	3	-20967	Not Applicable	0	141	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-67-6216-F13587	106303e5-cdb6-4df7-9e15-6f4d77d4dd50	6	Not Applicable	Not Applicable	Not Applicable	141	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	7	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	NO	Not Available	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6216	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	67	1	Lung	Alive	2011	2010	Not Available
TCGA-75-6203	Not Available	FEMALE		Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung		T2	N2	M0	Stage IIIA	0				TUMOR FREE				Not Available	L-Lower	Not Applicable	TCGA-75-6203	a8d6694c-a213-4544-ac0b-63bce16d8f4e	15	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-75-6203-D15865;TCGA-75-6203-D15864;TCGA-75-6203-D15863	a50cc582-dab3-4a3c-b8e7-b5cf188baf9a;51cbf34c-bb80-4826-8d78-451bc17e2701;ebfe876c-5580-4fbe-9edb-8749e6f6a5bd	Not Available;Not Available;Not Available	17;15;15	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Cisplatin;Navelbine	Not Available;Not Available;Not Available	8;8;8	Not Available;04;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;1	Not Available;IV;IV	YES;NO;NO	Not Available;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-75-6203-F15862	54091978-b5ea-4fa4-b94e-a707f5389de7	15	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Complete Remission/Response	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	YES	Complete Remission/Response	Not Available	NO	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6203	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	75	1	Lung	Alive	2011	2008	Not Available
TCGA-67-3773	84	FEMALE	427	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	427			TUMOR FREE				84	L-Lower	Not Applicable	TCGA-67-3773	009be09b-f9f6-43b7-8f45-4a648f8123ce	21	-30706	Not Applicable	0	427	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	3773	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	67	3	Lung	Alive	2011	2009	Not Available
TCGA-78-7161	69	FEMALE	291	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T3	N0	M0	Stage IIB	1	162.0		Locoregional Recurrence	WITH TUMOR				69	L-Upper	Not Applicable	TCGA-78-7161	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	27	-25294	Not Applicable	0	215	Not Available	Lung Adenocarcinoma	Not Available	TCGA-78-7161-D18780;TCGA-78-7161-D18781	0303cacf-83d5-48d3-970a-5ba7b72c1bc6;d8438615-27ba-430d-b895-ba73933869c4	Not Available;Not Available	25;25	132;132	40;40	Cisplatin;Vinorelbine	Not Available;Not Available	11;11	4;4	80;40	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	600;450	mg;mg	Not Available;Not Available	2011;2011	1	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO;Unknown	NO;Unknown	NO;NO	NO;Not Available	TCGA-78-7161-F18779;TCGA-78-7161-F46153	943f77cc-64c8-471a-9f85-66e8393a2463;864BF99A-DB82-4628-9D33-4CC4606FDFB6	25;23	Not Available;Not Available	Not Available;Not Available	Not Applicable;291	215;Not Available	162;162	Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Progressive Disease	Not Available;Not Available	Not Available;NO	11;8	Not Available;Locoregional Recurrence	YES;YES	Not Available;Unknown	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	Not Available;Biopsy with Histologic Confirmation	NO;NO	Alive;Dead	2011;2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	27.8	No	7161	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	1998	NO	YES	78	4	Lung	Alive	2011	2011	1961
TCGA-NJ-A4YQ	69	FEMALE	1432	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	1432			TUMOR FREE				69	L-Upper	Not Applicable	TCGA-NJ-A4YQ	52DF074F-A402-4B78-9472-F8EB268EFDED	27	-25427	Not Applicable	0	886	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-NJ-A4YQ-F50895;TCGA-NJ-A4YQ-F70646	D75D2FE9-18DE-4D15-B47A-208D923F3550;C88AC622-0782-4420-B5C0-FEFFABE44A85	1;27	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	886;1432	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	11;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2013;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Unknown	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	A4YQ	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Stable Disease	NO	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	2011	Not Available	Not Available	NJ	4	Lung	Alive	2013	2011	Not Available
TCGA-50-5072	74	MALE	250	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	1	213.0		Distant Metastasis	WITH TUMOR				74	L-Upper	Not Applicable	TCGA-50-5072	1575148b-0f63-44ee-86fd-93ae1a02be0b	26	-27036	Not Applicable	0	246	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5072-D16665;TCGA-50-5072-D16677;TCGA-50-5072-D32061;TCGA-50-5072-D32062	4adceb9e-78a8-4ce3-b347-89e14fa7ad72;74b1d95f-22cc-40ec-9b91-d894a1520042;84dcbd76-6ce7-47f8-beba-5421a69c3189;26e785c9-d595-4ed7-a15b-7a0d73b47e07	Not Available;Not Available;Not Available;Not Available	22;23;16;16	68;68;182;182	22;22;121;121	Cisplatin;TAXOTERE;Carboplatin;Taxol	Not Available;Not Available;Clinical Progressive Disease;Clinical Progressive Disease	9;9;5;5	3;3;Not Available;Not Available	4;4;Not Available;Not Available	mg/m2;mg/m2;Not Available;Not Available	OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;Not Available;Not Available	neoadjuvant;neoadjuvant;Not Applicable;Not Applicable	1;Not Available;Not Available;Not Available	IV;IV;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	225;225;Not Available;Not Available	mg/m2;mg/m2;Not Available;Not Available	Not Available;Not Available;NO;NO	2011;2011;2012;2012	Not Available	Not Available	YES	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	NO	TCGA-50-5072-F32059	cf66baf1-832b-4912-8b40-7be0f47acbbc	16	Not Available	Not Available	250	Not Available	213	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Convincing Imaging	YES	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Yes	C34.1	8140/3	C34.1	YES	Not Available	YES	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	No	5072	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Primary Tumor Field	TCGA-50-5072-R32060	1637644b-0d29-4cc1-8ddd-bd095e729cdb	Not Available	16	182	152	Not Available	5	29	5800	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1974	NO	YES	50	3	Lung	Alive	2011	2009	Not Available
TCGA-50-5931	75	FEMALE	434	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	425.0		Distant Metastasis	TUMOR FREE				75	L-Upper	Not Applicable	TCGA-50-5931	12ccd581-a921-41bc-bcee-4e9be54532cc	2	-27733	434	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	NO	TCGA-50-5931-F32067	6abc6f4d-700c-429a-8a96-cab76c1bd8ae	16	Not Available	Not Available	434	Not Available	425	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Convincing Imaging	NO	Dead	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	5931	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	50	4	Lung	Dead	2011	2001	Not Available
TCGA-49-AARN	56	FEMALE	1135	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	MX	Stage IA	0	1135			Unknown				56	R-Lower	Not Applicable	TCGA-49-AARN	98EF41FA-3015-445A-BBDC-984361C911F7	19	-20605	1135	0	Not Available	Not Available	Lung Adenocarcinoma	110.6																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	90	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Yes, History of Synchronous/Bilateral Malignancy	AARN	Preoperative	Unknown	85.9	101.1	NO	80.2	94.4	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	Not Available	NO	YES	49	5	Lung	Dead	2014	2000	Not Available
TCGA-64-1681	61	FEMALE	1167	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	1	439.0			Not Available				61	R-Upper	Not Applicable	TCGA-64-1681	c583fdd1-8cd2-4c15-a23e-0644261f65da	21	-22525	1167	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-64-1681-D20366	27af4417-3bc7-4992-9965-9f4b6c1f6434	Not Available	21	Not Available	481	Tarceva	Not Available	12	Not Available	150	mg	RECURRENCE	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	YES	Exon 19 Deletion	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	NO	Not Available	TCGA-64-1681-F20365	2dd45a93-1ce5-4d03-902f-6cec7a998472	21	Not Available	Not Available	1167	Not Available	439	Not Available	Additional New Tumor Event	Not Available	Not Available	Not Available	12	Not Available	YES	Not Available	Not Available	NO	Not Available	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	0	YES	NO	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	1681	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-64-1681-R20367	99c88968-d1fb-474c-bf43-99a06c4386ac	1	21	Not Available	711	Not Available	12	Not Available	3000	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1988	NO	YES	64	3	Lung	Dead	2011	2008	1968
TCGA-99-7458	74	FEMALE	747	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T4	N0	M0	Stage IIIA	1				TUMOR FREE				74	R-Lower	Not Applicable	TCGA-99-7458	96d93e23-bb0d-46a8-9685-5ed0d6b83059	6	-27359	Not Applicable	0	251	Not Available	Lung Adenocarcinoma	Not Available	TCGA-99-7458-D20337	c261c20d-0ded-4038-a815-f22775bf86a6	Not Available	9	323	53	Tarceva (Erlotinib)	Not Available	1	Not Available	150	mg/day	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	1	Not Available	YES	Not Available	Not Available	RT-PCR	YES	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-99-7458-F20338;TCGA-99-7458-F40777	6b1fe365-99fc-4a3b-8dcd-7bb0f50b1369;F3957B1D-CF6F-4A0B-8F7B-E040D49F7CC4	9;17	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	392;747	Not Applicable;Not Applicable	1;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Stable Disease	90;Unknown	Not Available;NO	1;4	Not Available;Not Available	NO;NO	Post-Adjuvant Therapy;Not Evaluated	TUMOR FREE;WITH TUMOR	YES;YES	Not Available;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	90	YES	YES	G12A	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	52	No	7458	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	2010	NO	YES	99	4	Lung	Alive	2012	2010	1958
TCGA-35-4122	69	MALE	225	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	225			TUMOR FREE				69	L-Upper	Not Applicable	TCGA-35-4122	44adf4cb-2829-4153-80fd-a8b7ee0e654a	20	-25491	Not Applicable	0	225	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-35-4122-F68915	38E92345-0056-4825-BE80-B4E43166B1D2	23	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	12	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	Unknown	Not Available	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	45	No	4122	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2010	NO	YES	35	4	Lung	Alive	2010	2010	1965
TCGA-55-7728	64	FEMALE	704	Mucinous (Colloid) Carcinoma	Lung	Alive	T2a	N0	MX	Stage IB	0	704			TUMOR FREE				64	L-Upper	Not Applicable	TCGA-55-7728	db769d5c-a794-448d-9130-38a82d051c95	8	-23505	Not Applicable	0	24	Not Available	Lung Adenocarcinoma	64																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7728-F47841	CCDF4AD4-BA17-413E-8B00-5016A4E94A75	29	Not Applicable	Not Applicable	Not Applicable	704	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	7728	Not Available	TUMOR FREE	Not Available	74	Not Available	Not Available	67	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	1996	YES	NO	55	4	Lung	Alive	2012	2011	1980
TCGA-44-7672	52	FEMALE	719	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	719			TUMOR FREE				52	L-Upper	Not Applicable	TCGA-44-7672	4036c6fc-c82e-47bb-a384-6f299dc30b52	10	-19200	Not Applicable	0	418	Not Available	Lung Adenocarcinoma	82																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-44-7672-F20374;TCGA-44-7672-F39074	80e34e50-79ea-44cf-9fc7-6a93b7e88cf0;1624E3CC-EAF9-4542-BB4C-CE2D8256625D	10;10	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	418;719	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	1;1	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	7672	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	90	105	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	44	2	Lung	Alive	2012	2010	1980
TCGA-44-7662	61	MALE	218	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	218			TUMOR FREE				61	L-Upper	Not Applicable	TCGA-44-7662	ab9e6815-4d13-44db-93e5-553eb4f5bc95	21	-22543	Not Applicable	0	50	Not Available	Lung Adenocarcinoma	57																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-44-7662-F34016	58426E9F-D0BD-4163-9767-80A6768F6B3F	25	Not Applicable	Not Applicable	Not Applicable	218	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	7	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	7662	Not Available	TUMOR FREE	66	68	Not Available	68	60	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	44	2	Lung	Alive	2011	2011	1961
TCGA-86-7714	61	FEMALE	625	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1b	N2	M0	Stage IIIA	1				WITH TUMOR				61	R-Lower	Not Applicable	TCGA-86-7714	532c1852-76dd-489f-9380-36766d6e3c34	12	-22619	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-7714-F53595	8A9C1B25-5034-43BB-BB4A-187D9735D9FB	12	Not Applicable	Not Applicable	625	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Progressive Disease	0	NO	12	Not Available	NO	Post-Adjuvant Therapy	WITH TUMOR	NO	Stable Disease	Not Available	NO	Dead	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	100	NO	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	43	No	7714	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T1b	Not Available	YES	NO	86	2	Lung	Alive	2011	2011	1968
TCGA-97-7552	70	MALE	1932	Lung Bronchioloalveolar Carcinoma Mucinous	Lung	Alive	T2	N0	MX	Stage IB	1	798.0		New Primary Tumor	TUMOR FREE				70	L-Lower	Not Applicable	TCGA-97-7552	1b110eb4-a01d-4c50-ba18-77da4dedd549	17	-25578	Not Applicable	0	1476	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;NO	NO;NO	Not Available;Not Available	Not Available;Not Available	TCGA-97-7552-F18844;TCGA-97-7552-F37174	3e54d908-6857-428c-9f5c-f1832e592ace;85ED4CFE-DA99-429B-91F9-D17B739AD495	28;29	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1932;1932	798;798	Not Available;Not Available	Additional New Tumor Event;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	11;11	Not Available;New Primary Tumor	YES;YES	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Not Available;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2011;2012	MALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.3	8253/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	7552	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	82	81	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	1985	NO	YES	97	3	Lung	Alive	2011	2007	Not Available
TCGA-44-5643	53	MALE	1013	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N2	M0	Stage IIIA	1				TUMOR FREE				53	R-Lower	Not Applicable	TCGA-44-5643	27fceec1-3298-4cdd-a4e6-8f5cf34604f0	13	-19426	Not Applicable	0	106	Not Available	Lung Adenocarcinoma	75	TCGA-44-5643-D12952;TCGA-44-5643-D12950;TCGA-44-5643-D12954	2b6a8199-4f87-4880-b81d-ac2b704b0451;9fedb69f-cc66-4f2f-b9f0-71e1dd2d695b;21d67e97-9cd3-4de6-8df9-83f9a1330403	Not Available;Not Available;Not Available	14;14;14	208;Not Available;208	131;223;131	Carboplatin;Tarceva;Taxol	Not Available;Not Available;Not Available	6;6;6	8;132;8	205-300;150;185-190	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;PO;IV	NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2035;19800;1505	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;Not Available	TCGA-44-5643-F12927;TCGA-44-5643-F39742	0dd73d87-f8f5-42fe-85e8-a7552e3c8915;AC910C02-04DD-4779-8BE1-E41E05FE1AD3	14;25	Not Available;Not Applicable	Not Available;Not Applicable	Not Applicable;Not Applicable	417;1013	Not Available;Not Applicable	Not Available;1	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	6;2	Not Available;Not Available	Not Available;NO	Not Available;Other	WITH TUMOR;TUMOR FREE	YES;Not Available	Not Available;Not Available	Not Available;Not Available	YES;Not Available	Alive;Alive	2011;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	5643	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	92	66	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-44-5643-R12947	973a5961-8dc0-4467-863b-01a26eba6b3a	1	14	168	129	Not Available	6	25	60	NO	OTHER	IMRT	ADJUVANT	Not Available	cGy	2011	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2b	Not Available	YES	NO	44	2	Lung	Alive	2011	2010	Not Available
TCGA-75-7025	Not Available	MALE	3305	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	1	1481.0		Locoregional Recurrence	TUMOR FREE				Not Available	L-Lower	Not Applicable	TCGA-75-7025	681b1176-9676-44d3-892c-1d5dba1ce25b	11	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;YES	Not Available;NO	Not Available;YES	Not Available;YES	TCGA-75-7025-F15874;TCGA-75-7025-F72041	68cda392-87e8-466a-9dc5-e7f00f2cb0ba;3D210D11-BA20-4227-95D6-9E77D7C10C7D	11;2	Not Applicable;1481	Not Applicable;2092	Not Applicable;Not Applicable	Not Available;3305	Not Applicable;1481	Not Available;Unknown	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Unknown	Not Available;NO	8;4	Not Available;Locoregional Recurrence;Distant Metastasis	NO;YES	Not Available;Unknown	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7025	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1986	NO	YES	75	3	Lung	Alive	2011	Not Available	1967
TCGA-78-8655	77	FEMALE	2360	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1	N0	M0	Stage IA	0	2360			Unknown				77	L-Lower	Not Applicable	TCGA-78-8655	a905d275-9283-4fa6-bbbf-46019bd1bcb7	23	-28379	Not Applicable	0	2360	Not Available	Lung Adenocarcinoma	93																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	TCGA-78-8655-F46154	36A22148-00C4-4964-A2D4-6D5680C6D49F	28	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	YES	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	10	No	8655	Preoperative	Unknown	Not Available	Not Available	NO	70	128	Complete Remission/Response	YES	Not Evaluated	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2001	NO	YES	78	4	Lung	Alive	2012	2003	1981
TCGA-97-7937	65	MALE	564	Lung Micropapillary Adenocarcinoma	Lung	Alive	T2a	N0	MX	Stage IB	0	564			Not Available				65	L-Upper	Not Applicable	TCGA-97-7937	fcfe0b53-dfc1-42fa-9efc-2b2ff259297e	13	-23919	Not Applicable	0	181	Not Available	Lung Adenocarcinoma	89																								0	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	NO	Not Available	TCGA-97-7937-F33767	483E201C-601E-4BEC-9BD0-EF8AFFBA9552	12	Not Applicable	Not Applicable	Not Applicable	564	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	NO	9	Not Available	NO	Not Available	TUMOR FREE	NO	Stable Disease	Not Available	NO	Alive	2012	MALE	Lung Micropapillary Adenocarcinoma	No	C34.1	8507/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	35	No	7937	Preoperative	Not Available	Not Available	Not Available	Not Available	77	120	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	1994	YES	NO	97	3	Lung	Alive	2012	2011	Not Available
TCGA-64-1679	58	FEMALE	2488	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N2	M0	Stage IIIA	0	2488			TUMOR FREE				58	R-Upper	Not Applicable	TCGA-64-1679	81a0b2ff-a3d3-41bb-9ce6-765e6ae894af	21	-21310	Not Applicable	0	1686	Not Available	Lung Adenocarcinoma	Not Available	TCGA-64-1679-D20370;TCGA-64-1679-D20371	a1d5051d-3893-4e77-b34c-88e599bda776;42c98e6b-93c1-4647-8b65-82716be9d850	Not Available;Not Available	21;21	139;139	55;55	Cisplatin;Gemcitabine	Not Available;Not Available	12;12	4;4	75;1000	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2011;2011	0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-64-1679-F20369;TCGA-64-1679-F66261	8a815a0c-b766-4a8e-9b29-7eeb682a688e;B39531A0-0DD8-4B57-A36C-29DBE8F73F24	21;7	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	1686;2488	Not Applicable;Not Applicable	0;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Unknown	Not Available;NO	12;10	Not Available;Not Available	NO;NO	Post-Adjuvant Therapy;Unknown	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	1679	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T1	Not Available	NO	YES	64	2	Lung	Alive	2011	2007	Not Available
TCGA-86-A4P8	59	FEMALE	805	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N2	MX	Stage IIIA	0	805			Unknown				59	R-Lower	Not Applicable	TCGA-86-A4P8	646910EE-5F5D-40AC-A21A-75790F89430A	7	-21738	Not Applicable	0	39	Not Available	Lung Adenocarcinoma	85	TCGA-86-A4P8-D48293;TCGA-86-A4P8-D48295	C22B8623-E5C2-4F22-8CCD-7859A4802584;054E5CD2-940A-4364-A458-39387314D2AE	Not Available;Not Available	11;11	106;106	43;43	Cisplatin;Alimta	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Unknown	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-86-A4P8-F48289;TCGA-86-A4P8-F65331	34D83F16-C390-4C4F-882D-B34483F55C29;F8D137C4-C479-4576-A4AB-6F01C2973E15	11;22	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	431;805	Not Applicable;Not Applicable	0;0	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Unknown;Unknown	NO;NO	9;9	Not Available;Not Available	NO;NO	Post-Adjuvant Therapy;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	YES;YES	Unknown;Complete Remission/Response	Not Available;Not Available	YES;YES	Alive;Alive	2013;2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Unknown	NO	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	A4P8	Unknown	Unknown	78	89	Unknown	74	84	Complete Remission/Response	YES	WHITE	Unknown	Primary Tumor Field	TCGA-86-A4P8-R48298	09736DC5-00BA-4D11-9400-13848477B168	Not Available	11	186	145	Complete Response	9	28	50.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T1b	Not Available	YES	NO	86	1	Lung	Alive	2013	2012	Not Available
TCGA-55-8205	76	FEMALE	599	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N0	M0	Stage IIA	1	495.0		Distant Metastasis	TUMOR FREE				76	R-Lower	Not Applicable	TCGA-55-8205	95fa64b0-91e1-4427-b81a-53c47a053563	17	-28063	Not Applicable	0	33	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-8205-D59042;TCGA-55-8205-D59043;TCGA-55-8205-D59044	0EC2801F-BAED-4EC4-973E-BE336BDA8894;E6B41481-C1F8-465D-8757-E2F2F2B0A4DB;DA27B801-8C82-4033-87DD-101B032FF22E	Not Available;Not Available;Not Available	30;30;30	154;154;Not Available	93;93;488	Carboplatin;Alimta;Tarceva	Complete Response;Complete Response;Not Applicable	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	0	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	YES	Not Available	NO	TCGA-55-8205-F59040	324D6FE4-9E52-45A9-82EB-03C088BC06E3	30	Not Available	Not Available	Not Applicable	599	495	Unknown	Scheduled Follow-up Submission	Progressive Disease	Unknown	NO	4	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Convincing Imaging	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	100	YES	NO	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	Yes, History of Prior Malignancy	8205	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	73	42	Unknown	YES	WHITE	Unknown	Distant Recurrence	TCGA-55-8205-R59041	78705F45-C5A7-452B-9548-2FA5A83DD7C9	Not Available	30	525	508	Radiographic Progressive Disease	4	14	3500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	2012	YES	NO	55	4	Lung	Alive	2012	2012	1951
TCGA-44-2668	51	MALE	761	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	433.0			TUMOR FREE		FPPP	TCGA	51	R-Upper	Not Applicable	TCGA-44-2668	bab43415-d413-40be-a4c0-2c40a52afe6a	22	-18856	Not Applicable	0	246	Not Available	Lung Adenocarcinoma	53																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;YES	Not Available;YES	Not Available;NO	TCGA-44-2668-F5041;TCGA-44-2668-F18688	5510cceb-3418-48f7-870a-01d65ebd2f55;878f1377-c807-4832-887e-3dcc134fdbae	22;22	Not Applicable;453	Not Applicable;Not Available	Not Applicable;761	246;Not Available	Not Applicable;433	0;Not Available	Not Available;Additional New Tumor Event	Complete Remission/Response;Progressive Disease	Not Available;Not Available	Not Available;Not Available	10;11	Not Available;Not Available	NO;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	NO;Not Available	Complete Remission/Response;Not Available	Not Available;Not Available	NO;Not Available	Alive;Dead	2010;2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	No	2668	Other	TUMOR FREE	Not Available	Not Available	Not Available	104	82	Not Available	YES	WHITE	Not Available	Distant Recurrence;Distant Recurrence;Distant Recurrence;Distant Recurrence	TCGA-44-2668-R18707;TCGA-44-2668-R18708;TCGA-44-2668-R18690;TCGA-44-2668-R18706	0b7f3a19-ed59-4ad2-bb47-860f1d7c29ed;ba5b2712-d4ea-49ef-afe9-e835ad30d748;023f6abf-6688-4f41-8699-acaf19e4dff2;b807d917-e8d2-44fb-b1a4-9fe135310bc3	2;2;1;2	22;22;22;22	587;587;488;589	586;587;468;586	Not Available;Not Available;Not Available;Not Available	11;11;11;11	2;1;14;3	1800;1800;3500;2100	NO;NO;NO;NO	OTHER;OTHER;EXTERNAL BEAM;OTHER	Cyberknife;Cyberknife;Not Applicable;Cyberknife	PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE	Not Available;Not Available;Not Available;Not Available	cGy;cGy;cGy;cGy	2011;2011;2011;2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2009	YES	NO	44	4	Lung	Alive	2010	2009	1979
TCGA-NJ-A4YP	52	MALE	50	Lung Papillary Adenocarcinoma	Lung	Alive	T2a	N0	M0	Stage IB	0	50			TUMOR FREE				52	R-Lower	Not Applicable	TCGA-NJ-A4YP	42259AA6-C9F5-4309-A956-DBF930312F44	27	-19106	Not Applicable	0	50	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-NJ-A4YP-F50888	5B07D5AE-C22E-4DED-8460-EA2FE846A2B4	1	Not Applicable	Not Applicable	Not Applicable	50	Not Applicable	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	YES	11	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2013	MALE	Lung Papillary Adenocarcinoma	No	C34.3	8255/3	C34.3	YES	Unknown	NO	Not Available	Not Available	Unknown	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	60	No	A4YP	Unknown	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Stable Disease	NO	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	Not Available	Not Available	NJ	5	Lung	Alive	2013	2011	Not Available
TCGA-49-4494	77	MALE	1081	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N2	M0	Stage IIIA	0	1081			WITH TUMOR				77	L-Upper	Not Applicable	TCGA-49-4494	c6d78e27-e510-4f57-abae-19efa6105a8d	3	-28387	1081	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-49-4494-F58840	7264A47D-2B6F-445A-94E5-514CA2BE320F	25	Not Available	Not Available	1081	Not Available	Not Available	1	Scheduled Follow-up Submission	Unknown	90	NO	4	Not Available	Unknown	Preoperative	Unknown	Unknown	Complete Remission/Response	Not Available	Unknown	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	4494	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	1955	NO	YES	49	3	Lung	Dead	2011	1995	1930
TCGA-49-AAR9	61	MALE	260	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N0	MX	Stage IIB	0	260			WITH TUMOR				61	Other (please specify)	ALL 3 LOBES OF RT LUNG	TCGA-49-AAR9	47B749E6-E060-4AA1-8F29-976E489BA789	18	-22510	260	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	80	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	AAR9	Preoperative	WITH TUMOR	Not Available	Not Available	NO	Not Available	Not Available	Progressive Disease	NO	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	NO	YES	49	2	Lung	Dead	2014	1999	Not Available
TCGA-38-4625	66	FEMALE	2973	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	2973			Not Available				66	R-Upper	Not Applicable	TCGA-38-4625	0ea4920f-f4c8-4590-84b3-eb419824e144	7	-24241	Not Applicable	0	2973	Not Available	Lung Adenocarcinoma	68																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-38-4625-F4505;TCGA-38-4625-F33407	3ba4cc67-5bc8-4ad5-a486-601d63f9f7c7;F9656835-E4F0-4DCD-8208-0E49AF248244	8;26	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	2973;2973	Not Available;Not Available	Not Available;Not Available	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;YES	12;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Available;Not Available	NO;Not Available	Alive;Alive	2010;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	4625	Not Available	Not Available	66	66	Not Available	68	64	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	NO	YES	38	2	Lung	Alive	2010	2002	1952
TCGA-44-7661	69	FEMALE	557	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N0	M0	Stage IB	1	335.0		Locoregional Recurrence	TUMOR FREE				69	R-Lower	Not Applicable	TCGA-44-7661	cbfef004-b437-4d51-9d88-a2db50aa6481	17	-25483	Not Applicable	0	153	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	YES	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	YES;YES	YES;YES	NO;NO	Not Available;NO	TCGA-44-7661-F33227;TCGA-44-7661-F39321	11a48e0b-2787-45f8-8a4d-920b7298072f;6C7C6AA4-9911-4736-9167-EAB29F024AEB	25;17	Not Available;Not Available	Not Available;Not Available	Not Applicable;557	366;Not Available	335;335	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	6;1	Locoregional Recurrence;Locoregional Recurrence	YES;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Convincing Imaging;Convincing Imaging	NO;NO	Alive;Dead	2012;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	22	Yes	7661	Preoperative	TUMOR FREE	95	81	Not Available	92	68	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1976	YES	NO	44	3	Lung	Alive	2012	2011	1961
TCGA-55-7726	72	FEMALE	652	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	652			TUMOR FREE				72	L-Lower	Not Applicable	TCGA-55-7726	923b37e4-fcf7-46a0-8cb2-9139711fec7b	8	-26451	Not Applicable	0	39	Not Available	Lung Adenocarcinoma	72																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7726-F47844	3F1E5E80-6F83-41FA-8999-94F152C1EDCB	29	Not Applicable	Not Applicable	Not Applicable	652	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	Yes	7726	Not Available	TUMOR FREE	59	61	Not Available	55	49	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	1979	YES	NO	55	3	Lung	Alive	2012	2011	1955
TCGA-75-6205	Not Available	FEMALE		Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung		T2a	N0	M0	Stage IB	1				TUMOR FREE				Not Available	L-Upper	Not Applicable	TCGA-75-6205	9a63f744-4ed4-4b4d-aac6-f9bda66aa563	21	Not Available	Not Available	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	NO	NO	TCGA-75-6205-F15083	c118a061-f9b0-4470-ba1e-07a472245a8f	21	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	YES	Adjuvant therapy	WITH TUMOR	NO	Complete Remission/Response	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6205	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	NO	YES	75	1	Lung	Dead	2011	2006	Not Available
TCGA-55-6972	72	MALE	1632	Lung Papillary Adenocarcinoma	Lung	Dead	T2	N0	M0	Stage IB	0	1632			TUMOR FREE				72	R-Upper	Not Applicable	TCGA-55-6972	c4d1e105-28b7-48df-abef-fbe09782fdb2	27	-26625	Not Applicable	0	1475	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-6972-F56187	6284B038-E7CE-476E-881E-8376A9D912BD	29	Not Applicable	Not Applicable	1632	Not Available	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	1	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Dead	2014	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6972	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	55	2	Lung	Alive	2011	2005	Not Available
TCGA-86-8359	52	MALE	444	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N2	M0	Stage IIIA	0	444			TUMOR FREE				52	L-Lower	Not Applicable	TCGA-86-8359	7e7f089c-25f7-4e14-aed5-d741047b9e42	17	-19088	Not Applicable	0	26	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8359-F43296	5A4B847F-5627-4BA7-86C0-99956A979DE4	16	Not Available	Not Available	444	Not Available	Not Available	4	Scheduled Follow-up Submission	Unknown	20	NO	5	Not Available	Unknown	Post-Adjuvant Therapy	Unknown	Unknown	Unknown	Not Available	Unknown	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	80	Unknown	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	36	No	8359	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	Not Available	YES	NO	86	2	Lung	Alive	2012	2012	1982
TCGA-50-6673	84	FEMALE	22	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage I	0	22			Not Available				84	R-Upper	Not Applicable	TCGA-50-6673	ab8d7f84-dd71-42c7-9471-4db967a9c89c	9	-30689	22	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-50-6673-F44135	48C0BF4B-CE63-4AF9-AFE7-8EC001B9BBED	13	Not Applicable	Not Applicable	22	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	6	Not Available	NO	Not Available	Unknown	NO	Unknown	Not Available	YES	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6673	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-50-6673-R67043	14FB9A30-F935-4AFB-A869-099A1866D8E7	Not Available	29	0	0	Radiographic Progressive Disease	10	50	.508	NO	Internal	Not Applicable	Not Available	Not Available	mCi	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	50	1	Lung	Dead	2012	2004	Not Available
TCGA-44-3917	33	FEMALE	1183	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	1183			TUMOR FREE		FPPP	TCGA	33	R-Upper	Not Applicable	TCGA-44-3917	7099597a-b208-45b5-b9e0-11ab40d5e497	8	-12179	Not Applicable	0	392	Not Available	Lung Adenocarcinoma	83																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-44-3917-F5229;TCGA-44-3917-F38799	e67f8c0a-a881-475e-80c7-42f9756190a8;0886A555-3179-409D-BF92-241BDEE939BF	18;24	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	392;1183	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;100	Not Available;NO	10;12	Not Available;Not Available	NO;NO	Not Available;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	NO;NO	Not Available;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2010;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	16	No	3917	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	87	106	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	44	2	Lung	Alive	2010	2009	1993
TCGA-95-7567	61	MALE	568	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2b	N1	M0	Stage IIB	0	568			TUMOR FREE				61	R-Upper	Not Applicable	TCGA-95-7567	3bc7026f-73f2-418b-bd62-f4768582b790	31	-22437	Not Applicable	0	163	Not Available	Lung Adenocarcinoma	Not Available	TCGA-95-7567-D21124;TCGA-95-7567-D21202	277b806f-ce51-4dee-b155-04b7617289b8;524d0bef-d243-4ebc-9d01-e82ca5387c26	Not Available;Not Available	31;6	149;149	79;89	Cisplatin;DOCETAXEL	Not Available;Not Available	1;2	4;4	155;155	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	620;620	mg;mg	Not Available;Not Available	2012;2012	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-95-7567-F21122;TCGA-95-7567-F40935	cce538be-9b1a-4b55-a8d1-868d7561b6ab;7DD28F10-5810-4B3C-B625-E93F8CEE21C5	31;6	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	163;568	Not Applicable;Not Applicable	1;0	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;100	Not Available;NO	1;3	Not Available;Not Available	NO;NO	Post-Adjuvant Therapy;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	YES;YES	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7567	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2b	2011	YES	NO	95	4	Lung	Alive	2012	2011	1970
TCGA-97-8176	63	MALE	468	Lung Acinar Adenocarcinoma	Lung	Dead	T3	N1	M0	Stage IIIA	1	39.0		Distant Metastasis	TUMOR FREE				63	R-Lower	Not Applicable	TCGA-97-8176	12c27db5-db2f-48dc-a2ca-9557b951f43e	5	-23170	Not Applicable	0	252	Not Available	Lung Adenocarcinoma	61	TCGA-97-8176-D35660;TCGA-97-8176-D35661;TCGA-97-8176-D35662;TCGA-97-8176-D49551;TCGA-97-8176-D49550	3CDB750D-9A1C-4C74-B647-D988440014AE;C2AF0586-F52E-443A-9120-934B54628579;49597D40-3617-493C-8061-8DCCB9871B6B;51434296-C639-41F5-82B1-E61B82E05160;6B643397-9B35-4517-A6EC-013C81A73723	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;3;3	161;417;417;417;417	77;77;77;77;77	CARBOplatin;ALIMTA;B12;Neulasta;Xgeva	Partial Response;Partial Response;Partial Response;Unknown;Unknown	10;10;10;10;10	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Ancillary;Ancillary;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2013;2013	0	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-8176-F49542	F462990E-8C16-40DE-BCD8-D98F16F60DA6	11	Not Applicable	Not Applicable	468	Not Available	Not Applicable	Unknown	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Not Available	NO	Unknown	Unknown	YES	Stable Disease	Not Available	YES	Dead	2013	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES	Not Available	YES	YES	G12S	Not Available	10	YES	YES	39	Not Available	Not Available	YES	171	Distant Metastasis	Biopsy with Histologic Confirmation	YES	40	No	8176	Preoperative	TUMOR FREE	68	104	YES	67	100	Unknown	YES	WHITE	YES	Distant Recurrence;Distant Recurrence;Distant Recurrence	TCGA-97-8176-R35601;TCGA-97-8176-R35659;TCGA-97-8176-R49544	B10D270F-44DE-43D1-A82E-FB7D967C274B;411DC29A-8C31-4E66-8FF5-0A8675FA8495;B9986975-6FF6-4AC9-B988-2EA72265F180	Not Available;Not Available;Not Available	5;5;11	105;105;64	91;91;51	Partial Response;Partial Response;Partial Response	10;10;3	5;10;5	1500;3000;3000	NO;NO;NO	External;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2012;2012;2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	2011	YES	NO	97	4	Lung	Alive	2012	2012	1971
TCGA-64-1677	77	FEMALE	628	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	1	360.0			Not Available				77	R-Lower	Not Applicable	TCGA-64-1677	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	18	-28482	628	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-64-1677-D8693;TCGA-64-1677-D8696;TCGA-64-1677-D8692	654eaa9e-2e91-4ef6-9e36-02a237406432;8a35805b-e7b8-4f10-8aae-d78f856a372e;a4d38c0d-dd9a-4143-ae98-9be774d485c5	Not Available;Not Available;Not Available	18;18;18	121;Not Available;121	51;Not Available;51	Gemcitabine;Not Available;Carboplatin	Not Available;Not Available;Not Available	2;2;2	4;2;4	1600;Not Available;425	mg;Not Available;mg	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;Not Available;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	NO	NO	TCGA-64-1677-F8691	52f57fe8-b728-4758-942d-efc01c5cbf0e	18	Not Available	Not Available	628	Not Available	360	Not Available	Not Available	Not Available	0	Not Available	2	Not Available	YES	Not Available	Not Available	YES	Not Available	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	0	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	Yes	1677	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-64-1677-R8694	45477fba-0eb8-4966-8c18-d8e9b539d9fc	2	18	448	417	Not Available	2	31	Not Available	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	64	2	Lung	Dead	2011	2005	1955
TCGA-50-5942	67	FEMALE	1847	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	1	1378.0		Locoregional Recurrence	Not Available				67	R-Upper	Not Applicable	TCGA-50-5942	75dd635e-8e0c-4c0b-b21c-20f77770218d	26	-24781	Not Applicable	0	136	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;NO	Not Available;YES	Not Available;Not Available	Not Available;Not Available	TCGA-50-5942-F32133;TCGA-50-5942-F70452	266b3dcd-9cf6-4c25-adb5-da7f91e8ce40;709DA356-FD1C-424F-9DD2-8B1AFBB6A742	17;16	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	883;1847	Not Applicable;1378	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Unknown	Not Available;Not Available	NO;NO	5;2	Not Available;Locoregional Recurrence	NO;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	NO;NO	Stable Disease;Stable Disease	Not Available;Convincing Imaging	YES;YES	Alive;Alive	2012;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	5942	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Primary Tumor Field;Local Recurrence	TCGA-50-5942-R32134;TCGA-50-5942-R70453	b1859915-5ae6-41cf-a335-c12501ca2e70;D7ED9FE9-30E7-4159-B185-18F1303BF56F	1;Not Available	17;16	53;1641	53;1641	Not Available;Radiographic Progressive Disease	5;2	Not Available;Not Available	Not Available;Not Available	NO;NO	IMPLANTS;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2015	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2009	NO	YES	50	4	Lung	Alive	2011	2009	Not Available
TCGA-38-4627	64	FEMALE	1147	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1b	N1	M0	Stage IIA	0	1147			Not Available				64	R-Upper	Not Applicable	TCGA-38-4627	d717fa33-3c91-4ced-89c6-79ff5542f04c	7	-23510	1147	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-38-4627-F4508	f15fda3c-b93a-4ae2-95d3-c372aed5ea42	8	Not Available	Not Available	1147	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	NO	Complete Remission/Response	Not Available	NO	Dead	2010	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4627	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	Not Available	NO	YES	38	4	Lung	Dead	2010	2003	Not Available
TCGA-86-8055	79	MALE	124	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N1	M0	Stage IIA	0	124			TUMOR FREE				79	L-Upper	Not Applicable	TCGA-86-8055	34d8e84e-c3e1-417d-8b9b-8563d9fa0f8e	9	-29124	Not Applicable	0	10	Not Available	Lung Adenocarcinoma	Not Available																								2	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	NO	Not Available	TCGA-86-8055-F40636	BA1E1408-283C-44C3-BA03-E0144E835EC2	26	Not Applicable	Not Applicable	124	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	2	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	60	No	8055	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	YES	NO	86	2	Lung	Alive	2012	2011	1955
TCGA-55-A4DF	88	MALE	440	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1b	N0	MX	Stage IA	1	440.0		Distant Metastasis	TUMOR FREE				88	R-Lower	Not Applicable	TCGA-55-A4DF	362000E4-CF7C-48FC-93CC-8F5994B442EA	25	-32432	Not Applicable	0	47	Not Available	Lung Adenocarcinoma	82																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	NO	TCGA-55-A4DF-F59072	B4A1C81E-113A-41E4-8C10-FEFA43BCB273	30	Not Available	Not Available	440	Not Available	440	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	4	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	60	Yes, History of Synchronous/Bilateral Malignancy	A4DF	Not Available	TUMOR FREE	Not Available	58	NO	Not Available	47	Complete Remission/Response	YES	WHITE	NO	Distant Recurrence	TCGA-55-A4DF-R59073	64AB51F5-F53A-403A-8BA3-694141F508E7	Not Available	30	440	440	Radiographic Progressive Disease	4	Not Available	3500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	1984	YES	NO	55	3	Lung	Alive	2013	2012	Not Available
TCGA-44-2664	66	FEMALE	1251	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	1	813.0		Distant Metastasis	TUMOR FREE				66	R-Lower	Not Applicable	TCGA-44-2664	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	11	-24468	Not Applicable	0	383	Not Available	Lung Adenocarcinoma	74																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available;NO;NO	Not Available;Not Available;YES;YES	Not Available;Not Available;Not Available;NO	Not Available;Not Available;NO;Not Available	TCGA-44-2664-F5296;TCGA-44-2664-F15047;TCGA-44-2664-F34041;TCGA-44-2664-F34138	e3f6c051-1883-4b1f-a604-a42023d0ad34;5c9c31da-1f23-44ba-8545-85922236296c;E5416B4E-48B4-4B0B-A3CE-7F1741A14DA0;D19E4687-3387-4057-BA51-2A86D4AE43AA	11;11;30;30	Not Applicable;Not Applicable;Not Available;Not Available	Not Applicable;Not Applicable;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	383;683;1251;1251	Not Applicable;Not Applicable;813;832	Not Available;Not Available;2;2	Not Available;Scheduled Follow-up Submission;Additional New Tumor Event;Additional New Tumor Event	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;NO;NO	10;8;7;7	Not Available;Not Available;Distant Metastasis;Locoregional Recurrence	NO;NO;YES;YES	Not Available;Not Available;Other;Other	TUMOR FREE;TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Convincing Imaging;Convincing Imaging	NO;NO;NO;NO	Alive;Alive;Alive;Alive	2010;2011;2012;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	23	No	2664	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	109	113	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	YES	NO	44	2	Lung	Alive	2010	2009	1964
TCGA-44-A47B	79	MALE	287	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	287			TUMOR FREE				79	R-Upper	Not Applicable	TCGA-44-A47B	967D6548-5A84-4B7E-BC3F-2E522859FCE6	20	-28869	Not Applicable	0	105	Not Available	Lung Adenocarcinoma	73																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-44-A47B-F41746	F1FE3CC6-00FC-40B7-AD09-0F7D71224725	27	Not Applicable	Not Applicable	Not Applicable	287	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	3	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4.5	No	A47B	Preoperative	TUMOR FREE	102	96	NO	98	96	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1965	YES	NO	44	3	Lung	Alive	2012	2012	1956
TCGA-62-A46R	54	FEMALE	1725	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N0	M0	Stage IB	0	1725			TUMOR FREE				54	L-Lower	Not Applicable	TCGA-62-A46R	C497F8C7-2FB5-44D9-BC7C-69CFD0B51B54	29	-20063	1725	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	100	NO	Not Available	Not Available	Central Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	25	No	A46R	Preoperative	TUMOR FREE	Not Available	Not Available	NO	73	74	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	62	4	Lung	Dead	2012	2006	Not Available
TCGA-71-8520	60	FEMALE	210	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	179.0		Locoregional Recurrence	TUMOR FREE				60	L-Upper	Not Applicable	TCGA-71-8520	37884d39-64e8-4242-b6bd-4c0a1daa21cd	15	-21921	Not Applicable	0	3	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	Not Available	TCGA-71-8520-F70925	31390530-007C-4160-9E08-4A980480B334	10	Not Available	Not Available	210	Not Available	179	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	3	Locoregional Recurrence	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Not Available	YES	Dead	2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	40	YES	NO	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8520	Preoperative	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	NO	ASIAN	NO	Regional site	TCGA-71-8520-R70926	E036E361-397E-4FDB-A92D-039E27A04A17	Not Available	10	80	51	Radiographic Progressive Disease	3	22	44	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	71	1	Lung	Alive	2013	2011	Not Available
TCGA-80-5611	Not Available	MALE	2595	Lung Solid Pattern Predominant Adenocarcinoma	Lung	Alive	T2	N0	M0	Stage IB	0	2595			TUMOR FREE				Not Available	L-Upper	Not Applicable	TCGA-80-5611	e51f717f-72e8-400e-9f35-fc5dc32fdf71	26	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-80-5611-F15076;TCGA-80-5611-F72034	468f2750-4845-4353-9dbb-ff8f8555652f;340EF9A3-C0D0-4638-94D8-14FCAD26AEA2	26;2	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;2595	Not Applicable;Not Applicable	0;Unknown	Not Available;Scheduled Follow-up Submission	Not Available;Not Available	Not Available;Unknown	Not Available;NO	7;4	Not Available;Not Available	NO;NO	Not Available;Unknown	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	MALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.1	8230/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	Yes	5611	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2008	NO	YES	80	4	Lung	Alive	2011	Not Available	Not Available
TCGA-05-4250	79	FEMALE	121	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N1	M0	Stage IIIA	0	121			Not Available				79	R-Lower	Not Applicable	TCGA-05-4250	f98ecd8a-b878-4f53-b911-20cd8e17281c	22	-29068	121	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	47	No	4250	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	Not Available	NO	YES	05	4	Lung	Dead	2010	2007	Not Available
TCGA-78-7158	59	FEMALE	179	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T4	N2	M0	Stage IIIB	1	132.0			WITH TUMOR				59	L-Lower	Not Applicable	TCGA-78-7158	501c987e-d1eb-48a9-89eb-72a5062c90b4	15	-21742	179	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-78-7158-D16167;TCGA-78-7158-D16978	b9fc15d3-ee12-436e-8bd1-d57382720f61;b2454d2f-cb59-470a-b300-029134f6bb34	Not Available;Not Available	15;29	103;103	54;54	Carboplatin;Paclitaxel	Not Available;Not Available	9;9	3;3	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1220;620	mg;mg	Not Available;Not Available	2011;2011	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	NO	NO	TCGA-78-7158-F16166	cd749669-0955-4e60-80d4-d02a208e1f64	15	Not Available	Not Available	179	Not Available	132	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	9	Not Available	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	14	No	7158	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T4	2005	NO	YES	78	4	Lung	Dead	2011	2007	1963
TCGA-53-7813	51	FEMALE	424	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T4	N0	M0	Stage IIIB	0	424			TUMOR FREE				51	R-Upper	Not Applicable	TCGA-53-7813	42d208bd-cd77-4bfb-ad53-9fc072a87393	14	-18875	Not Applicable	0	418	Not Available	Lung Adenocarcinoma	88	TCGA-53-7813-D41063;TCGA-53-7813-D41065;TCGA-53-7813-D41069;TCGA-53-7813-D41072	C5ECD05C-F0BC-43C9-9F9B-747BF40673B6;CE53D275-2F09-480B-B9DD-7A65EC848C45;81C8185C-C45B-44F1-A49B-4F668D595E8F;B98BBB32-9B61-4BA9-8A39-D94A205614DC	Not Available;Not Available;Not Available;Not Available	11;11;11;11	40;40;146;146	40;40;62;62	Cisplatin;docetaxel;carboplatin;Taxol	Unknown;Unknown;Stable Disease;Stable Disease	3;3;3;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-53-7813-F39281	F1618090-79FF-4125-8030-11B958CA39B2	31	Not Available	Not Available	Not Applicable	424	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	1	Not Available	Unknown	Not Available	Not Available	YES	Progressive Disease	Not Available	NO	Alive	2013	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	35	No	7813	Pre-Adjuvant Therapy	TUMOR FREE	69	91	Not Available	67	90	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	2008	NO	YES	53	4	Lung	Alive	2012	2008	1973
TCGA-55-6970	67	FEMALE	464	Lung Papillary Adenocarcinoma	Lung	Dead	T2	N2	MX	Stage IIIA	1	457.0		Locoregional Recurrence	WITH TUMOR				67	R-Upper	Not Applicable	TCGA-55-6970	7cce924f-12a1-4895-9866-5d4b1869dde6	26	-24773	464	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-6970-D57906;TCGA-55-6970-D57907;TCGA-55-6970-D57908	E7D92A5F-612A-448A-B26A-B4E6D018D887;E03F99C9-6200-45D2-AFA8-A1289F63B270;E5FF3DC9-209A-481E-BF51-DB84716FF0C4	Not Available;Not Available;Not Available	28;28;28	117;117;183	89;89;162	Cisplatin;VP-16;Taxotere	Stable Disease;Stable Disease;Stable Disease	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	NO	Not Available	TCGA-55-6970-F57904	CBF3A7D1-584C-4CCD-B4DE-B8AB2DABFD79	28	Not Available	Not Available	464	Not Available	457	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	3	Locoregional Recurrence	YES	Not Available	WITH TUMOR	YES	Stable Disease	Convincing Imaging	YES	Dead	2014	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6970	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-55-6970-R57905	0C87F58B-FCCD-4262-A4D8-840B320508BA	Not Available	28	124	90	Stable Disease	3	Not Available	5940	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T2	Not Available	NO	YES	55	4	Lung	Dead	2011	2004	Not Available
TCGA-73-A9RS	41	MALE	340	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N0	M0	Stage IIB	1	107.0		Locoregional Recurrence	WITH TUMOR				41	R-Upper	Not Applicable	TCGA-73-A9RS	2A394996-809F-459F-A647-D209921CCBD2	17	-15162	Not Applicable	0	305	Not Available	Lung Adenocarcinoma	Not Available	TCGA-73-A9RS-D60824;TCGA-73-A9RS-D60826;TCGA-73-A9RS-D60827;TCGA-73-A9RS-D60828;TCGA-73-A9RS-D60829;TCGA-73-A9RS-D60830	F9D3AD0B-B57B-4BC4-BE99-581990D65A30;0462262C-D185-4D68-B111-FE7D35239FFC;F252506A-D42C-4B51-8A33-83867E2282B5;91902CAB-804C-475D-855B-44440709C0BE;F29AAA5F-2DEF-42E3-AAB4-39BC2259681E;BC782E72-1B7C-451F-A7DD-FF17F0EA035A	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17;17	186;186;186;242;284;Not Available	130;130;130;200;242;284	carboplatin;paclitaxel;bevacizumab;pemetrexed;docetaxel;gemcitabine	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Not Applicable	6;6;6;6;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;YES;NO;NO;NO	2014;2014;2014;2014;2014;2014	1	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-73-A9RS-F64487	3D9025D6-1190-49DC-986A-FC52C19BBA9B	3	Not Applicable	Not Applicable	340	Not Available	Not Applicable	1	Scheduled Follow-up Submission	Progressive Disease	80	NO	9	Not Available	NO	Preoperative	WITH TUMOR	NO	Progressive Disease	Not Available	YES	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8480/3	C34.1	YES	80	YES	NO	Not Available	Peripheral Lung	6	YES	NO	107	NO	Not Available	Not Available	Not Available	Locoregional Recurrence	Convincing Imaging	YES	11	No	A9RS	Preoperative	WITH TUMOR	81.9	60.2	NO	81.5	59.6	Progressive Disease	YES	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-73-A9RS-R60823	F991F8D3-049C-4842-AAFE-A155907BCBBB	Not Available	17	53	53	Radiographic Progressive Disease	6	1	12	NO	Internal	Not Applicable	Not Available	Not Available	Gy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	NO	YES	73	2	Lung	Alive	2014	2013	1990
TCGA-69-7764	75	MALE	414	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1b	N0	M0	Stage IA	0	414			Not Available				75	R-Upper	Not Applicable	TCGA-69-7764	243c6fd6-5516-46e5-bcef-292d93d7b7d3	26	-27693	Not Applicable	0	414	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-7764-F20992	7523c29c-28ca-4dcc-8407-7545d04f3af4	26	Not Applicable	Not Applicable	Not Applicable	414	Not Applicable	0	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	1	Not Available	NO	Other	TUMOR FREE	NO	Not Available	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	7764	Other	Not Available	Not Available	Not Available	Not Available	94	106	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	1991	NO	YES	69	3	Lung	Alive	2012	2010	1977
TCGA-55-8094	51	MALE	541	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N0	M1b	Stage IV	1				WITH TUMOR				51	L-Upper	Not Applicable	TCGA-55-8094	69584d55-18f7-4786-b3cc-cd528500be44	8	-18903	Not Applicable	0	4	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8094-F66029	AE9F74E2-023B-42DA-8C1F-9C7A9F3C253B	1	Not Applicable	Not Applicable	Not Applicable	541	Not Applicable	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	WITH TUMOR	YES	Progressive Disease	Not Available	YES	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	70	No	8094	Not Available	WITH TUMOR	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	Not Available	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1b	N0	T2b	2011	YES	NO	55	4	Lung	Alive	2012	2012	1976
TCGA-95-A4VN	62	FEMALE	553	Lung Solid Pattern Predominant Adenocarcinoma	Lung	Alive	T2a	N1	M0	Stage IIA	0	553			TUMOR FREE				62	R-Lower	Not Applicable	TCGA-95-A4VN	389F78A3-FA0B-406C-9434-AA0298341A8C	22	-22927	Not Applicable	0	142	Not Available	Lung Adenocarcinoma	50																								Not Available	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-95-A4VN-F58501	878D540E-C5BA-45D0-BC56-66F85D659549	11	Not Applicable	Not Applicable	Not Applicable	553	Not Applicable	1	Scheduled Follow-up Submission	Stable Disease	Not Evaluated	NO	4	Not Available	NO	Pre-Adjuvant Therapy	TUMOR FREE	NO	Stable Disease	Not Available	NO	Alive	2014	FEMALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	42	Yes, History of Prior Malignancy	A4VN	Not Available	TUMOR FREE	65	67	NO	60	58	Stable Disease	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	2007	YES	NO	95	4	Lung	Alive	2013	2012	1965
TCGA-69-8254	85	MALE	409	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2b				0	409			TUMOR FREE				85	R-Lower	Not Applicable	TCGA-69-8254	f0c94f68-bfd9-45cb-b4fd-8bb1ae4e9a2b	4	-31134	Not Applicable	0	77	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Other	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-8254-F41950	F1B78CC3-B120-4814-91CD-93C4CD359BEA	5	Not Applicable	Not Applicable	Not Applicable	409	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	4	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	80	NO	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	8254	Other	TUMOR FREE	Not Available	Not Available	NO	Not Available	62	Complete Remission/Response	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	T2b	1989	YES	NO	69	3	Lung	Alive	2012	2012	Not Available
TCGA-49-AAR3	69	MALE	1893	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N1	MX	Stage IIB	1	1893.0		Locoregional Recurrence	Discrepancy				69	R-Upper	Not Applicable	TCGA-49-AAR3	5813997A-D7DC-4F7C-8D4B-E979832168A9	18	-25469	Not Applicable	0	1893	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-49-AAR3-F70567	9B56C5FC-1A78-41F4-8707-440A0C3F8FFF	25	Not Applicable	Not Applicable	Not Applicable	1893	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	2	Not Available	NO	Post-Adjuvant Therapy	Discrepancy	YES	Complete Remission/Response	Not Available	NO	Alive	2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	Not Available	Not Available	Not Available	Not Available	6	NO	NO	1893	NO	Not Available	Not Available	Not Available	Locoregional Recurrence	Convincing Imaging	YES	Not Available	No	AAR3	Preoperative	Discrepancy	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	NO	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2	Not Available	NO	YES	49	Unknown	Lung	Alive	2014	2008	Not Available
TCGA-49-4510	51	FEMALE	896	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	502.0		Distant Metastasis	WITH TUMOR				51	L-Upper	Not Applicable	TCGA-49-4510	f77b6930-a1ce-446e-a15d-c018cbbecfee	3	-18762	896	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	NO	TCGA-49-4510-F58842	7F6D5AAD-0EEC-452F-9AEC-D99D92CD3A3E	25	Not Available	Not Available	896	Not Available	502	1	Scheduled Follow-up Submission	Stable Disease	80	NO	4	Distant Metastasis	YES	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	Convincing Imaging	YES	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	55.5	No	4510	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	49	2	Lung	Dead	2011	2001	Not Available
TCGA-55-7281	70	FEMALE	872	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	1	339.0		Distant Metastasis	TUMOR FREE				70	R-Middle	Not Applicable	TCGA-55-7281	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	6	-25870	Not Applicable	0	18	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-7281-D47811;TCGA-55-7281-D47814;TCGA-55-7281-D47815;TCGA-55-7281-D47816;TCGA-55-7281-D47817;TCGA-55-7281-D47818	F65BFFAD-A23B-4066-829C-5D92F15865DE;B212E1D8-57BE-4365-BFBA-1EA76A701912;DC5037B4-AFDE-459F-8830-340492F0AA06;638427FC-0F5A-4F6A-8E41-E90771270BA7;5046F93F-1D01-4A67-9B87-ED115A6C742A;F582DDC9-3FBE-4AC6-870A-530C86640E54	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28	474;579;579;Not Available;Not Available;Not Available	424;508;508;712;712;712	Carboplatin;Carboplatin;Alimta;Carboplatin;Taxol;Avastin	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Partial Response;Partial Response;Partial Response	8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	NO	NO	TCGA-55-7281-F47807	0804D88A-04B2-4C56-9A68-68D39DDB1617	28	Not Available	Not Available	Not Applicable	872	339	Not Evaluated	Scheduled Follow-up Submission	Partial Remission/Response	Not Evaluated	NO	8	Distant Metastasis	YES	Not Evaluated	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	7281	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site;Distant site	TCGA-55-7281-R47808;TCGA-55-7281-R47810	F3791E9B-5039-47A4-8E77-A47AF6CD8BE4;722364F3-700A-4E78-8A04-C6D4C2353780	Not Available;Not Available	28;28	370;647	339;634	Radiographic Progressive Disease;Radiographic Progressive Disease	8;8	Not Available;10	Not Available;03000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;cGy	2013;2013	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	55	4	Lung	Alive	2011	2011	Not Available
TCGA-69-7763	69	MALE	690	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1b	N0	M0	Stage IA	0	690			Not Available				69	R-Middle	Not Applicable	TCGA-69-7763	1b31cdb3-1837-49d6-a857-1830f8800299	25	-25316	Not Applicable	0	690	Not Available	Lung Adenocarcinoma	72																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-7763-F20990	742bb503-45e8-406d-8578-66299cd22dfb	26	Not Applicable	Not Applicable	Not Applicable	690	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	1	Not Available	NO	Not Available	Not Available	NO	Not Available	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8550/3	C34.2	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7.5	No	7763	Other	Not Available	Not Available	Not Available	Not Available	93	89	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	2004	NO	YES	69	4	Lung	Alive	2012	2010	1959
TCGA-78-7148	71	MALE	626	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N1	M0	Stage IIB	1	182.0			Not Available				71	L-Upper	Not Applicable	TCGA-78-7148	e8060c45-451d-4779-9584-f284db47e63e	4	-25990	626	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	NO	YES	TCGA-78-7148-F17170	208bf3ac-10c9-4d63-ad87-332ddb82517d	4	Not Available	182	626	Not Available	182	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	10	Not Available	YES	Not Available	Not Available	NO	Not Available	Not Available	NO	Dead	2011	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	57	No	7148	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	78	2	Lung	Dead	2011	2001	1944
TCGA-97-A4M7	74	MALE	629	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1b	N0	M0	Stage IA	0	629			TUMOR FREE				74	R-Middle	Not Applicable	TCGA-97-A4M7	C6B680E3-D96E-4FC7-8053-77454B7A14FA	7	-27062	Not Applicable	0	271	Not Available	Lung Adenocarcinoma	99																								0	Not Available	YES	L858R	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-A4M7-F57383	FF856855-D4FF-4537-86B6-C69C98F1AA5C	10	Not Applicable	Not Applicable	Not Applicable	629	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	3	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES	Not Evaluated	YES	NO	Not Available	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	Yes, History of Synchronous/Bilateral Malignancy	A4M7	Preoperative	TUMOR FREE	82	101	NO	74	91	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	1978	YES	NO	97	3	Lung	Alive	2013	2012	1958
TCGA-86-8668	61	FEMALE	423	Lung Bronchioloalveolar Carcinoma Mucinous	Lung	Alive	T1b	N0	M0	Stage IA	0	423			TUMOR FREE				61	L-Lower	Not Applicable	TCGA-86-8668	f2d8b332-2f03-46e5-a9d5-f163972e5fa7	30	-22383	Not Applicable	0	45	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8668-F66084	1631B6D9-406C-4FFC-BC60-4B3233895638	2	Not Applicable	Not Applicable	Not Applicable	423	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	10	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.3	8253/3	C34.3	YES	100	NO	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	8668	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	86	1	Lung	Alive	2012	2012	Not Available
TCGA-49-AAQV	63	FEMALE	677	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1	N1	MX	Stage II	1	509.0		Distant Metastasis	TUMOR FREE				63	L-Lower	Not Applicable	TCGA-49-AAQV	96DFA373-4597-49A5-942E-D9B4DC5D28FC	13	-23370	677	0	Not Available	Not Available	Lung Adenocarcinoma	95.5																								1	Not Available	YES	Exon 19 Deletion	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	90	Not Available	Not Available	Not Available	Not Available	6	NO	YES	509	Not Available	Not Available	YES	536	Distant Metastasis	Biopsy with Histologic Confirmation;Convincing Imaging	YES	Not Available	No	AAQV	Preoperative	TUMOR FREE	77.29	81.7	NO	78.80	83.3	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1	Not Available	NO	YES	49	1	Lung	Dead	2014	2012	Not Available
TCGA-71-6725	48	FEMALE	256	Lung Papillary Adenocarcinoma	Lung	Alive	T2	N0	M0	Stage IB	1	164.0		Locoregional Recurrence	TUMOR FREE				48	R-Upper	Not Applicable	TCGA-71-6725	4b7cd595-e7f9-45a8-b736-a8c7c42d9539	9	-17793	Not Applicable	0	61	Not Available	Lung Adenocarcinoma	Not Available	TCGA-71-6725-D70932;TCGA-71-6725-D70933	C96AEDBF-65F7-4278-9841-02DE35F2FBD4;58FFFDD4-06DF-4156-903D-ECAA85C8D3B5	Not Available;Not Available	10;10	127;127	107;107	Cisplatin;Etoposide	Clinical Progressive Disease;Clinical Progressive Disease	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2015;2015	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	Not Available	TCGA-71-6725-F70928	91E9D55E-8826-486C-8511-B70EB38747D7	10	Not Available	Not Available	Not Applicable	256	164	2	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	3	Locoregional Recurrence	YES	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Not Available	NO	Alive	2015	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	60	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6725	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available	Primary Tumor Field	TCGA-71-6725-R70931	F21BE49A-8969-4E71-BF16-E5FFB34417E3	Not Available	10	204	159	Radiographic Progressive Disease	3	35	70	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	71	2	Lung	Alive	2011	2011	Not Available
TCGA-55-7570	60	MALE	824	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	824			TUMOR FREE				60	R-Upper	Not Applicable	TCGA-55-7570	ff07ea4b-4e50-410d-99d6-96a351dad7b1	11	-22218	Not Applicable	0	6	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7570-F56185	A3150ABF-460E-41B1-8D92-F9298F52C36B	29	Not Applicable	Not Applicable	Not Applicable	824	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	1	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7570	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	1971
TCGA-05-4402	57	FEMALE	244	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	NX	M1	Stage IV	0	244			TUMOR FREE				57	R-Lower	Not Applicable	TCGA-05-4402	722d6818-f1cb-49f4-b68a-fd0a31304681	22	-20819	244	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-4402-D36467;TCGA-05-4402-D36468;TCGA-05-4402-D36469	C22C6B31-7A7B-4961-B95D-137666A2C3FF;BA9F9930-88F2-4DA0-982D-BEDBEA793B76;8CEA61DA-614E-4CE9-8202-877E85ECC83F	Not Available;Not Available;Not Available	5;5;5	91;91;122	30;30;122	Carboplatin;Vinorelbine;Erlotinib	Complete Response;Complete Response;Complete Response	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4402-F36466	DFAF4F5D-D945-4D17-8F16-6BFB6E538D7A	31	Not Applicable	Not Applicable	244	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Dead	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	4402	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	NX	T2	Not Available	NO	YES	05	1	Lung	Dead	2010	2007	Not Available
TCGA-67-4679	69	MALE	448	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	M0		0	448			TUMOR FREE				69	R-Lower	Not Applicable	TCGA-67-4679	3e635902-5310-4406-8b4d-a238ce382639	21	-25202	Not Applicable	0	448	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4679	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	67	4	Lung	Alive	2011	2009	Not Available
TCGA-05-4422	68	MALE	365	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	365			Not Available				68	L-Lower	Not Applicable	TCGA-05-4422	44dec838-b653-42a7-a58b-a1fd232cd68c	22	-24837	Not Applicable	0	365	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	147	No	4422	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	05	4	Lung	Alive	2010	2008	Not Available
TCGA-55-7227	77	MALE	952	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N1	MX	Stage IIIA	1	255.0		Locoregional Recurrence	TUMOR FREE				77	R-Lower	Not Applicable	TCGA-55-7227	4e7b2af4-b158-41a7-be22-bea227a759e6	6	-28458	Not Applicable	0	53	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-7227-D65705;TCGA-55-7227-D65706;TCGA-55-7227-D65707	5BC0FDF2-9109-4D86-A20D-1322832BE50E;2D4D2D9E-CEB1-4321-A97C-750CB79A547B;DEF1B875-0578-458E-9F26-D60CAAD1BB9B	Not Available;Not Available;Not Available	26;26;26	409;409;876	289;289;442	Carboplatin;Pemetrexed;Pemetrexed	Stable Disease;Stable Disease;Clinical Progressive Disease	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	Not Available	TCGA-55-7227-F65704	3B44DFC4-EC36-4F1D-837D-6297BF49D8AF	26	Not Available	Not Available	952	Not Available	255	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	9	Locoregional Recurrence	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7227	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T3	1993	YES	NO	55	3	Lung	Alive	2011	2011	1953
TCGA-55-1594	68	MALE	1178	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N2	M0	Stage IIIA	0	1178			TUMOR FREE				68	R-Lower	Not Applicable	TCGA-55-1594	6d72de06-232a-4983-a06c-eba6d82cb3f1	14	-25008	Not Applicable	0	1178	1178	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	1594	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	55	2	Lung	Alive	2010	2005	1965
TCGA-49-AAR4	51	MALE	879	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	MX	Stage IIIA	0	879			WITH TUMOR				51	L-Upper	Not Applicable	TCGA-49-AAR4	765AD5A5-134B-4680-A6D4-1DD113DC47CC	18	-18939	879	0	Not Available	Not Available	Lung Adenocarcinoma	109.4	TCGA-49-AAR4-D65009;TCGA-49-AAR4-D65010	4477C3EF-3A88-4C2F-955E-149887AC8C8F;AB97458F-B092-494A-BCEE-2FD308ED618A	Not Available;Not Available	17;17	61;61	57;57	TAXOL;CARBOPLATIN	Partial Response;Partial Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	35	No	AAR4	Preoperative	WITH TUMOR	79.0	97.5	YES	81.2	100.2	Stable Disease	YES	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-49-AAR4-R65008	3013A2ED-A16A-4023-9E1D-FFE753568235	Not Available	17	153	118	Complete Response	9	Not Available	4,500 cGy	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T2	Not Available	NO	YES	49	2	Lung	Dead	2014	2006	Not Available
TCGA-62-A46Y	70	FEMALE	414	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N2	M0	Stage IIIA	1	314.0		Distant Metastasis	WITH TUMOR				70	R-Lower	Not Applicable	TCGA-62-A46Y	562A562B-CA03-44AC-B282-B51B457D8DAE	30	-25905	414	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-62-A46Y-D36365;TCGA-62-A46Y-D40578	55FA6477-77DE-4CB4-9BDF-8AC7045569AA;06D3010F-39E9-4C9D-96D8-EAE50C4C705B	Not Available;Not Available	30;25	256;256	74;74	Cisplatin;Navelbine	Complete Response;Complete Response	10;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2013	Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	90	NO	Not Available	Not Available	Peripheral Lung	10	YES	NO	314	Not Available	Not Available	NO	Not Available	Distant Metastasis	Biopsy with Histologic Confirmation;Convincing Imaging	YES	Not Available	No	A46Y	Preoperative	WITH TUMOR	Not Available	Not Available	YES	84	88	Complete Remission/Response	YES	WHITE	YES	Regional site	TCGA-62-A46Y-R36366	7364E4A0-C21C-485D-B4FF-5335F2218905	Not Available	31	256	227	Complete Response	10	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	62	1	Lung	Dead	2012	2008	Not Available
TCGA-86-8054	61	MALE	1148	Lung Acinar Adenocarcinoma	Lung	Alive	T2b	N1	M0	Stage IIB	0	1148			TUMOR FREE				61	R-Upper	Not Applicable	TCGA-86-8054	0fe909ea-d52c-4b71-816f-57f62d4a5744	2	-22584	Not Applicable	0	19	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8054-D41093;TCGA-86-8054-D41094	AB80A551-9E5E-4095-8852-00599B1C8859;7BBDF359-8AE5-4BBC-9539-38B87210A586	Not Available;Not Available	12;12	136;136	65;65	Paclitaxel;Cisplatin	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-86-8054-F41092;TCGA-86-8054-F65792	8F4BDD45-6498-4773-B290-73CAA6C38692;8E595367-4502-4FF5-B1BC-6AE74B441506	12;30	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	745;1148	Not Applicable;Not Applicable	2;2	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	80;80	NO;NO	3;9	Not Available;Not Available	NO;NO	Preoperative;Preoperative	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Central Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	9	No	8054	Not Evaluated	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2b	Not Available	YES	NO	86	2	Lung	Alive	2012	2011	1994
TCGA-62-A46S	73	MALE	1653	Lung Papillary Adenocarcinoma	Lung	Dead	T2	N0	M0	Stage IB	1	527.0		Locoregional Recurrence	WITH TUMOR				73	L-Upper	Not Applicable	TCGA-62-A46S	E00A60D7-4253-443D-A187-680AD0931349	29	-26825	1653	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-62-A46S-D36326;TCGA-62-A46S-D40574	A78743CC-2953-4ECE-A4AE-0C60106B1A3C;C9C16A96-C581-4DB9-B7F3-5B6ACCC39DFC	Not Available;Not Available	31;25	198;198	78;78	Tarceva;Placebo	Unknown;Unknown	10;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Targeted Molecular therapy;Targeted Molecular therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2012;2013	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	100	NO	Not Available	Not Available	Peripheral Lung	10	YES	NO	527	NO	Not Available	NO	Not Available	Locoregional Recurrence;Distant Metastasis	Convincing Imaging	YES	40	No	A46S	Preoperative	WITH TUMOR	Not Available	Not Available	YES	66	72	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	62	4	Lung	Dead	2012	2007	Not Available
TCGA-97-8177	59	FEMALE	499	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N0	M0	Stage IB	0	499			TUMOR FREE				59	L-Lower	Not Applicable	TCGA-97-8177	09078761-1c14-4d01-8e15-535c19a9b0f9	13	-21648	Not Applicable	0	147	Not Available	Lung Adenocarcinoma	97	TCGA-97-8177-D32866;TCGA-97-8177-D32868;TCGA-97-8177-D44245	E1EB8A22-561A-4E54-9A4A-AE4C3AB3056A;AA1A57A5-C0DC-4888-A6D2-E6C632A31929;46424E43-2394-4493-8F96-9A71AF33D4F8	Not Available;Not Available;Not Available	14;14;19	Not Available;Not Available;Not Available	93;93;205	Alimta;CARBOplatin;Tarceva	Not Available;Not Available;Not Available	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2013	0	Not Available	YES	L858R	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-8177-F44243	76A1E7C1-9C2C-4E07-A5AA-389AA2168572	19	Not Applicable	Not Applicable	Not Applicable	499	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	6	Not Available	NO	Not Evaluated	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	YES	NO	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8177	Preoperative	TUMOR FREE	82	109	YES	80	106	Not Evaluated	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	97	1	Lung	Alive	2012	2012	Not Available
TCGA-05-5425	68	MALE	882	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2b	N1	M0	Stage IIB	1	486.0			TUMOR FREE				68	R-Upper	Not Applicable	TCGA-05-5425	9b4eeecb-6aff-435b-a244-ec362af92b7f	22	-25020	Not Applicable	0	90	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-5425-D36415;TCGA-05-5425-D36417;TCGA-05-5425-D36418;TCGA-05-5425-D36419	B19108E0-0562-45A5-A84F-1EB6D1A472B0;5BEC112E-BA69-4195-810A-A41A10693781;188127D6-E1B8-4C4D-907E-3CEEF9D3C816;48588402-EA64-4934-989B-E4FAB2CEC262	Not Available;Not Available;Not Available;Not Available	5;5;5;5	761;761;669;Not Available	700;700;608;792	Paclitaxel;Carboplatin;Gefitinib;Erlotinib	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Not Applicable	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Immunotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	Not Available	TCGA-05-5425-F36403	714FDB72-0FF1-4CF6-A6F1-ED54B3FF03DD	30	Not Available	Not Available	Not Applicable	882	486	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Not Available	YES	Not Available	WITH TUMOR	YES	Not Applicable	Not Available	YES	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.9	8255/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	5425	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Distant Recurrence	TCGA-05-5425-R36420	8C6DAC9A-FA50-4180-91E8-608C5A264A09	Not Available	30	547	516	Radiographic Progressive Disease	10	Not Available	40	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2b	1985	NO	YES	05	3	Lung	Alive	2011	2009	1965
TCGA-49-6744	64	FEMALE	1683	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N1	MX	Stage IIA	0	1683			TUMOR FREE				64	L-Upper	Not Applicable	TCGA-49-6744	15340dd3-84ae-49fb-989a-eb212f3e73da	10	-23484	Not Applicable	0	890	Not Available	Lung Adenocarcinoma	Not Available	TCGA-49-6744-D16686	9954442a-123d-4dc2-a41d-966d898e3090	Not Available	23	108	16	Not Available	Not Available	9	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;NO	Not Available;NO	Not Available;Not Available	Not Available;Not Available	TCGA-49-6744-F14923;TCGA-49-6744-F70580	1841d2d6-26a6-417f-b575-0af2e3d8ca1a;64733B43-3503-4D09-8FA4-D6BACF138AF4	10;25	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	890;1683	Not Applicable;Not Applicable	Not Available;1	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;90	Not Available;NO	8;2	Not Available;Not Available	NO;NO	Not Available;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	YES	YES	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	6744	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a	Not Available	NO	YES	49	4	Lung	Alive	2011	2010	Not Available
TCGA-44-6778	59	MALE	1864	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	MX	Stage IA	0	1864			TUMOR FREE				59	Discrepancy	Not Available	TCGA-44-6778	5d5cc436-6e57-4d23-a164-7f5153c2e666	31	-21725	Not Applicable	0	1110	Not Available	Lung Adenocarcinoma	53																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-44-6778-F15765;TCGA-44-6778-F39376	cdcf76b6-e93b-4d22-8d67-6a137b04617f;E7E66030-97D0-480D-853E-39F85ED1F874	31;21	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	1110;1864	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	8;1	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	No	6778	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	90	74	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	2004	NO	YES	44	4	Lung	Alive	2011	2007	1974
TCGA-75-6206	Not Available	MALE	2590	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	2590			TUMOR FREE				Not Available	R-Upper	Not Applicable	TCGA-75-6206	c4c1469d-752f-42b6-8686-714ad4a8ac97	21	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-75-6206-F15085;TCGA-75-6206-F72036	9fa30583-7256-4ed8-93ac-9cf0f6a928c0;DBEE9981-7853-4690-9B0B-62CBF6625199	21;2	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;2590	Not Applicable;Not Applicable	0;Not Evaluated	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Evaluated	Not Available;NO	7;4	Not Available;Not Available	NO;NO	Adjuvant therapy;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	6206	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1962	NO	YES	75	3	Lung	Alive	2011	Not Available	Not Available
TCGA-80-5607	Not Available	FEMALE		Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung		T2	N1	M0	Stage IIB	1				WITH TUMOR				Not Available	L-Upper	Not Applicable	TCGA-80-5607	645903b5-ba37-48a1-985b-a019b8db3236	12	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	NO	NO	TCGA-80-5607-F15867	f401b266-27b0-450f-a213-254caa5e63c9	15	Not Available	Not Available	Not Applicable	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	8	Not Available	YES	Not Available	WITH TUMOR	NO	Not Available	Not Available	NO	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	Yes	5607	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	1985	NO	YES	80	3	Lung	Alive	2011	2007	1965
TCGA-NJ-A4YF	50	FEMALE	2161	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1	N0	M0	Stage IA	0	2161			Unknown				50	R-Upper	Not Applicable	TCGA-NJ-A4YF	595FC3AD-F603-421B-B130-52F1F617050B	25	-18584	Not Applicable	0	1720	Not Available	Lung Adenocarcinoma	77.5																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-NJ-A4YF-F50858	635C2793-F06E-4540-80A4-D9F2C1D72DFB	1	Not Applicable	Not Applicable	Not Applicable	2161	Not Applicable	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	11	Not Available	NO	Not Available	TUMOR FREE	NO	Stable Disease	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	No	A4YF	Not Evaluated	Unknown	95.1	83.9	Unknown	96	80.7	Not Applicable	YES	BLACK OR AFRICAN AMERICAN	Unknown																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	NJ	3	Lung	Alive	2013	2007	Not Available
TCGA-78-7220	53	FEMALE	807	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N2	M0	Stage IIIA	1	531.0			WITH TUMOR				53	L-Upper	Not Applicable	TCGA-78-7220	fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb	8	-19480	807	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	YES	NO	NO	TCGA-78-7220-F19298	6125a3be-8022-43a7-8d60-00e74d6061c3	8	Not Available	Not Available	807	Not Available	531	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	12	Not Available	YES	Not Available	WITH TUMOR	NO	Not Available	Not Available	YES	Dead	2011	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	35	No	7220	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Distant site	TCGA-78-7220-R19299;TCGA-78-7220-R19300	cea1849b-13c0-4d25-a6c7-aeae07d41d0b;d5d23e28-c8be-4193-8bf5-c8587e92133e	1;2	8;8	96;740	60;734	Not Available;Not Available	12;12	25;5	5000;2000	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;RECURRENCE	Not Available;Not Available	cGy;cGy	2011;2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	78	2	Lung	Dead	2011	2000	1965
TCGA-50-6595	74	FEMALE	189	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	1	182.0		Distant Metastasis	WITH TUMOR				74	R-Upper	Not Applicable	TCGA-50-6595	82476d2d-e403-4f6b-8dd6-cc84e3329478	25	-27197	189	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-6595-D44132	5CE76459-2545-4AE1-BFB7-D99A28C8576B	Not Available	13	162	123	Carboplatin	Clinical Progressive Disease	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	Not Available	YES	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	YES	TCGA-50-6595-F44127	AEA27241-AF39-4C5C-ADA3-91E25F21073D	13	Not Available	187	189	Not Available	182	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	6	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Biopsy with Histologic Confirmation	YES	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6595	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Primary Tumor Field	TCGA-50-6595-R44128	DF7FD391-A020-46D8-8EA6-A937605E3002	Not Available	13	161	123	Radiographic Progressive Disease	6	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1979	NO	YES	50	3	Lung	Dead	2011	2009	Not Available
TCGA-78-7167	77	MALE	2681	Lung Papillary Adenocarcinoma	Lung	Dead	T2	N0	M1	Stage IV	1	726.0			WITH TUMOR				77	Not Available	Not Applicable	TCGA-78-7167	fe3eeeb6-0db4-46d7-a020-55604d474c12	4	-28295	2681	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	NO	NO	TCGA-78-7167-F17172	c8c4cb37-14b3-47ab-83a8-795fe5195bcb	4	Not Available	Not Available	2681	Not Available	726	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	10	Not Available	YES	Not Available	WITH TUMOR	NO	Not Available	Not Available	NO	Dead	2011	MALE	Lung Papillary Adenocarcinoma	No	C34.9	8260/3	C34.9	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	64	No	7167	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	Not Available	NO	YES	78	2	Lung	Dead	2011	2002	1937
TCGA-95-7948	42	FEMALE	476	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N0	M0	Stage IB	0	476			TUMOR FREE				42	R-Lower	Not Applicable	TCGA-95-7948	a52e99d6-a61a-439d-b0b1-ca7a0eabcb04	22	-15363	Not Applicable	0	133	Not Available	Lung Adenocarcinoma	87																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-95-7948-F29540;TCGA-95-7948-F40945	DE1F1595-55A3-445C-A427-26050FE637FA;BDEC4035-069A-4823-947C-D9277CAF627E	22;7	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	133;476	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	3;3	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Not Available;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	.15	Yes	7948	Not Available	TUMOR FREE	Not Available	79	Not Available	Not Available	72	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1995	YES	NO	95	3	Lung	Alive	2012	2011	1993
TCGA-75-6207	Not Available	MALE		Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung		T2	N2	M0	Stage IIIA	0				Not Available				Not Available	R-Upper	Not Applicable	TCGA-75-6207	58babefe-7e81-4594-ba29-50d1de92a5ab	21	Not Available	Not Available	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	Not Available	Not Available	TCGA-75-6207-F15092	53c4832a-9167-41ab-8172-0713906b893e	21	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	NO	Complete Remission/Response	Not Available	NO	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	No	6207	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1972	NO	YES	75	3	Lung	Dead	2011	2007	Not Available
TCGA-05-4389	70	MALE	1369	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1	N0	M0	Stage IA	0	1369			TUMOR FREE				70	R-Upper	Not Applicable	TCGA-05-4389	a3de401d-91fe-49a2-bb07-81c1a06506e6	22	-25660	Not Applicable	0	1369	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4389-F36455	A2734A4F-5C1D-4D7B-B01D-01305FF9E917	31	Not Applicable	Not Applicable	Not Applicable	1369	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	NO	Not Applicable	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	43	No	4389	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	05	3	Lung	Alive	2010	2005	Not Available
TCGA-05-5429	60	MALE	275	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N2	M0	Stage IIIA	0	275			TUMOR FREE				60	L-Upper	Not Applicable	TCGA-05-5429	63bd2175-4b7c-44c9-aef3-9efc8f79837b	22	-22066	Not Applicable	0	30	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	TCGA-05-5429-F36396	6271312D-642D-4C7C-AF77-B70D79E7B2CC	30	Not Available	Not Available	275	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	10	Not Available	Unknown	Not Available	Unknown	Unknown	Not Applicable	Not Available	Unknown	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5429	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	Not Available	NO	YES	05	1	Lung	Alive	2011	2010	Not Available
TCGA-55-7907	77	MALE	343	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N1	MX	Stage IIA	1	294.0		Distant Metastasis	TUMOR FREE				77	L-Upper	Not Applicable	TCGA-55-7907	bf755bc2-b7aa-4c3c-8b3c-58b089b5cab6	10	-28201	Not Applicable	0	16	Not Available	Lung Adenocarcinoma	75																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	NO	TCGA-55-7907-F60132	6ECFF27E-F203-441F-A6A5-2608A1B7989E	29	Not Available	Not Available	343	Not Available	294	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	5	Distant Metastasis	YES	Not Evaluated	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80	No	7907	Not Available	TUMOR FREE	80	87	Not Available	75	76	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a	1994	YES	NO	55	3	Lung	Alive	2012	2011	1954
TCGA-67-3776	57	FEMALE	61	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N1	M0	Stage IIB	0	61			TUMOR FREE				57	R-Lower	Not Applicable	TCGA-67-3776	102fba48-b23a-46d4-8371-71c11c1a6654	21	-20940	Not Applicable	0	61	579	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	3776	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	YES	NO	67	3	Lung	Alive	2011	2009	Not Available
TCGA-73-4677	74	MALE	38	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N0	M0		0	38			WITH TUMOR				74	R-Upper	Not Applicable	TCGA-73-4677	03c3409a-9d16-41d0-9e26-f9fc2547a4c8	7	-27381	38	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-73-4677-F12744	579419ee-f9cb-451a-9a14-ad2ecfa0376b	1	Not Applicable	Not Applicable	38	Not Available	Not Applicable	1	Not Available	Not Available	80	Not Available	6	Not Available	NO	Adjuvant therapy	Not Available	NO	Stable Disease	Not Available	NO	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4677	Other	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1985	NO	YES	73	3	Lung	Dead	2011	2010	Not Available
TCGA-97-8172	75	FEMALE	545	Lung Acinar Adenocarcinoma	Lung	Alive	T2a	N0	M0	Stage IB	0	545			TUMOR FREE				75	R-Upper	Not Applicable	TCGA-97-8172	cbf1f718-6bb7-4daf-b9d6-fb294281decb	13	-27416	Not Applicable	0	182	Not Available	Lung Adenocarcinoma	64.98																								1	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-8172-F44230	52560AC4-46A3-4DEC-8DD6-A80E5C3A6658	19	Not Applicable	Not Applicable	Not Applicable	545	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	6	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Available	YES	YES	G12V	Unknown	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	Yes, History of Prior Malignancy	8172	Preoperative	TUMOR FREE	105.10	107.25	NO	93.27	104.64	Complete Remission/Response	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1981	YES	NO	97	3	Lung	Alive	2012	2011	1961
TCGA-75-5147	Not Available	FEMALE	1333	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	1333			TUMOR FREE				Not Available	R-Upper	Not Applicable	TCGA-75-5147	d2824e6d-3784-45c2-9b0f-52b17356b5da	6	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-75-5147-F11742;TCGA-75-5147-F72031	370b3d05-3d9b-4c7f-bcee-7def6e2322cf;71D9C3BB-5ECC-4FC4-BABB-C3A94B378051	7;2	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;1333	Not Applicable;Not Applicable	Not Available;Not Evaluated	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Evaluated	Not Available;NO	4;4	Not Available;Not Available	NO;NO	Adjuvant therapy;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8252/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5147	Other	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	75	1	Lung	Alive	2011	Not Available	Not Available
TCGA-50-5045	57	FEMALE	2174	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0		1	1433.0		Locoregional Recurrence	WITH TUMOR				57	R-Lower	Not Applicable	TCGA-50-5045	9ee20c0d-a1c3-47f3-abda-131b3f190f52	30	-20961	2174	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	NO	Not Available	TCGA-50-5045-F32015	403e16e6-4db0-4a0c-866e-00b26e1fad62	15	Not Available	Not Available	2174	Not Available	1433	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Locoregional Recurrence	YES	Not Available	WITH TUMOR	Not Available	Progressive Disease	Biopsy with Histologic Confirmation	YES	Dead	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5045	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-50-5045-R32016	86ec2fc8-2b21-48d4-9c2c-d70695750424	Not Available	15	Not Available	63	Not Available	5	Not Available	Not Available	Not Available	OTHER	Radioactive vicryl Mesh	ADJUVANT	Not Available	Not Available	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	50	Not Available	Lung	Dead	2011	2004	Not Available
TCGA-44-A4SU	67	FEMALE	409	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1a	N0	MX	Stage IA	1	260.0		Locoregional Recurrence	TUMOR FREE				67	R-Lower	Not Applicable	TCGA-44-A4SU	BF34664D-423D-4257-99D4-797F7D366455	29	-24820	Not Applicable	0	76	Not Available	Lung Adenocarcinoma	74																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	Not Available	TCGA-44-A4SU-F49438	D0EC82D0-E3BC-4820-AD56-81831A4CF3EC	3	Not Available	Not Available	409	Not Available	260	3	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	10	Locoregional Recurrence	YES	Other	WITH TUMOR	NO	Complete Remission/Response	Biopsy with Histologic Confirmation;Convincing Imaging	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	50	No	A4SU	Preoperative	TUMOR FREE	100	95	NO	100	88	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	2011	YES	NO	44	4	Lung	Alive	2013	2012	1961
TCGA-55-8301	58	MALE	534	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	1	238.0		Locoregional Recurrence	TUMOR FREE				58	R-Lower	Not Applicable	TCGA-55-8301	b36b7567-30d3-4d0c-84c4-b203986e0fdb	3	-21535	Not Applicable	0	44	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-8301-D56263;TCGA-55-8301-D56264	81EAC4EA-9876-4E67-B2D2-230762F91928;D6B06699-89FF-4995-95D5-D7B9B1095651	Not Available;Not Available	30;30	Not Available;Not Available	261;261	Carboplatin;Taxol	Partial Response;Partial Response	1;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	NO	NO	TCGA-55-8301-F56261	F961BE96-B9C1-48C0-9CC2-B368B6495583	30	Not Available	Not Available	Not Applicable	534	238	Unknown	Scheduled Follow-up Submission	Partial Remission/Response	Unknown	NO	1	Locoregional Recurrence	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Unknown	Not Available	Not Available	Not Available	Unknown	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	100	No	8301	Unknown	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	Not Available	WHITE	NO	Regional site	TCGA-55-8301-R56262	F51AFBFF-1D27-42D6-A936-C1FFA21A4A43	Not Available	30	309	257	Partial Response	1	30	6660	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	55	2	Lung	Alive	2012	2012	1962
TCGA-55-1596	55	MALE	2065	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N1	M0	Stage IIB	0	2065			TUMOR FREE				55	R-Upper	Not Applicable	TCGA-55-1596	199386c2-bb53-4fad-a1b6-59ab216a4a50	13	-20381	Not Applicable	0	1375	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-1596-D40545;TCGA-55-1596-D40546	D3AC7328-D4A7-4F72-86F7-07379246F800;5871BBDC-FC66-413D-8DE6-E44CB7DACA4D	Not Available;Not Available	22;22	Not Available;Not Available	34;34	Carboplatin;Taxol	Complete Response;Complete Response	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-1596-F40544	123C8E70-9662-45C2-80BF-E22343435AD4	22	Not Applicable	Not Applicable	Not Applicable	2065	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	2	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	1596	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	55	2	Lung	Alive	2010	2004	1979
TCGA-55-A4DG	71	MALE	608	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	608			TUMOR FREE				71	R-Upper	Not Applicable	TCGA-55-A4DG	3E34C7D9-90FA-41E2-BA6B-4BBC332ADC4E	25	-26044	Not Applicable	0	162	Not Available	Lung Adenocarcinoma	61																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-A4DG-F59047	E7DACEFC-7054-4CF2-9F0F-80A0AC65AB66	30	Not Applicable	Not Applicable	Not Applicable	608	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	4	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	100	No	A4DG	Not Available	TUMOR FREE	Not Available	Not Available	NO	73	Not Available	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	2012	YES	NO	55	4	Lung	Alive	2013	2012	Not Available
TCGA-49-AARE	51	FEMALE	1229	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	MX	Stage IA	1	388.0		Locoregional Recurrence	WITH TUMOR				51	R-Upper	Not Applicable	TCGA-49-AARE	CD9E70E4-8622-4A07-8646-63F8275C1737	19	-18893	1229	0	Not Available	Not Available	Lung Adenocarcinoma	107.2																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	Not Available	Not Available	Not Available	Not Available	6	YES	YES	388	YES	392	Not Available	Not Available	Locoregional Recurrence	Biopsy with Histologic Confirmation;Convincing Imaging	YES	15	No	AARE	Other	WITH TUMOR	55.2	41.7	NO	81	61.2	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	1995	NO	YES	49	4	Lung	Dead	2014	1999	1980
TCGA-50-6592	71	FEMALE	777	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1				WITH TUMOR				71	L-Lower	Not Applicable	TCGA-50-6592	09918b81-4696-4cba-a45a-5fe7407c2337	25	-26191	777	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-50-6592-F43835	BCFF54CF-3536-4F06-99D9-8C54307CBEFF	4	Not Applicable	Not Applicable	777	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	6	Not Available	NO	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	YES	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6592	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-50-6592-R43837	D910E461-431F-4861-97AF-9701837BFDE4	Not Available	4	39	39	Radiographic Progressive Disease	6	Not Available	Not Available	NO	Internal	Not Applicable	Not Available	Not Available	Not Available	2013	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	50	4	Lung	Dead	2011	2007	Not Available
TCGA-J2-A4AG	66	FEMALE	988	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	988			TUMOR FREE				66	L-Upper	Not Applicable	TCGA-J2-A4AG	E21E2AF3-DC71-41FA-94BA-7A7929F47D90	27	-24224	Not Applicable	0	238	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-J2-A4AG-F55526;TCGA-J2-A4AG-F70848	E18C8E1A-90F4-4EBC-AD9D-7B4C8E64F099;BDE8905E-3F01-45AE-BDB2-150D1F22DE83	8;10	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	500;988	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	1;3	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2014;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	25	No	A4AG	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	NO	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	1981	YES	NO	J2	3	Lung	Alive	2012	2012	1956
TCGA-67-3771	77	FEMALE	610	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	610			TUMOR FREE				77	L-Upper	Not Applicable	TCGA-67-3771	0df573ee-28f0-4244-b434-09e6ca59fbf0	21	-28406	Not Applicable	0	610	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Central Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	3771	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	YES	NO	67	4	Lung	Alive	2011	2009	Not Available
TCGA-73-4662	65	FEMALE	2515	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	1	21.0			TUMOR FREE				65	L-Upper	Not Applicable	TCGA-73-4662	294ff941-aea1-4588-9a0e-e9f5393e2bb6	6	-23762	Not Applicable	0	912	Not Available	Lung Adenocarcinoma	116																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;Not Available	YES;Not Available	YES;Not Available	NO;Not Available	TCGA-73-4662-F8554;TCGA-73-4662-F71029	7772d756-649c-41b9-85f1-b38aa3c4cdea;FFBDD995-8D42-4D31-AB72-91A28CBECA08	6;18	36;Not Applicable	Not Available;Not Applicable	Not Applicable;Not Applicable	912;2515	21;Not Applicable	0;Not Evaluated	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	100;Not Evaluated	Not Available;NO	1;3	Not Available;Not Available	YES;NO	Adjuvant therapy;Not Evaluated	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	No	4662	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	115	111	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1972	NO	YES	73	3	Lung	Alive	2011	2007	1955
TCGA-05-5420	67	MALE	457	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N2	M0	Stage IIIA	1	245.0			TUMOR FREE				67	L-Upper	Not Applicable	TCGA-05-5420	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	22	-24472	Not Applicable	0	31	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	Not Available	TCGA-05-5420-F36422	5E6ACDEB-BC35-4B1C-BF79-F54891E7274D	30	Not Available	Not Available	Not Applicable	457	245	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Not Available	YES	Not Available	WITH TUMOR	Unknown	Progressive Disease	Not Available	Unknown	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	Yes	5420	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	2001	NO	YES	05	4	Lung	Alive	2011	2008	1961
TCGA-86-8056	63	FEMALE	139	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T4	N0	M0	Stage IIIA	0	139			TUMOR FREE				63	Other (please specify)	Right upper, lower	TCGA-86-8056	472337c2-a2fc-403a-8c17-69511193128b	9	-23369	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8056-F57951	38936117-0356-4D10-A167-483740FE2A8B	28	Not Available	Not Available	Not Applicable	139	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	3	Not Available	Unknown	Not Available	Unknown	Unknown	Unknown	Not Available	Unknown	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	100	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	36	No	8056	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	1975	YES	NO	86	3	Lung	Alive	2012	2011	1963
TCGA-J2-A4AE	77	FEMALE	1079	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	1079			TUMOR FREE				77	L-Upper	Not Applicable	TCGA-J2-A4AE	E5F956DD-F49F-435C-83C3-5B1B0A2050ED	27	-28163	Not Applicable	0	282	Not Available	Lung Adenocarcinoma	89																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-J2-A4AE-F55522;TCGA-J2-A4AE-F70639	3A67D1E9-45FD-41D0-8E79-F27D9B40AE3A;F091573D-78D1-4263-B744-6928E374086D	8;27	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	671;1079	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	1;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2014;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A4AE	Not Available	TUMOR FREE	Not Available	Not Available	NO	0.72	92	Not Applicable	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	Not Available	YES	NO	J2	1	Lung	Alive	2012	2012	Not Available
TCGA-44-7669	59	MALE	574	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1b	N1	MX	Stage IIA	1	390.0			WITH TUMOR				59	R-Upper	Not Applicable	TCGA-44-7669	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	21	-21893	574	0	Not Available	Not Available	Lung Adenocarcinoma	52	TCGA-44-7669-D20477;TCGA-44-7669-D20479;TCGA-44-7669-D20476;TCGA-44-7669-D20478	8187bd18-8f5a-4de2-9aa1-fc17056a991c;600924bb-9e59-41f0-9493-647a4c8d40e8;c6e5598b-8c2a-45db-9833-9ca073f0c347;96593f12-a433-4978-8449-36f7fb287d10	Not Available;Not Available;Not Available;Not Available	13;13;13;13	180;539;180;539	117;539;117;539	Alimta;Carboplatin;Cisplatin;Gemzar	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;1;4;1	975;460;145;1900	mg;mg;mg;mg	ADJUVANT;PALLIATIVE;ADJUVANT;PALLIATIVE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;2	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3900;460;580;1900	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;NO;YES	NO;YES;YES	NO;Not Available;NO	YES;NO;NO	TCGA-44-7669-F20203;TCGA-44-7669-F20504;TCGA-44-7669-F20505	acda688e-dc06-46a1-b242-5151d5db16d9;669a7ac9-cbe5-43c2-950e-2fb09904248f;2f13835e-7692-473a-8e9c-204fc08242a0	6;16;16	Not Available;Not Available;Not Available	390;Not Available;Not Available	574;574;574	Not Available;Not Available;Not Available	390;418;525	4;Not Available;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	1;1;1	Not Available;Not Available;Not Available	YES;YES;YES	Post-Adjuvant Therapy;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;Not Available;Not Available	Complete Remission/Response;Not Available;Not Available	Not Available;Not Available;Not Available	NO;Not Available;Not Available	Dead;Dead;Dead	2012;2012;2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	7669	Not Available	WITH TUMOR	84	80	Not Available	80	73	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available	Distant site;Distant Recurrence	TCGA-44-7669-R20489;TCGA-44-7669-R20506	1c8ca0de-06fc-4cc4-8e81-0b2c8f09778a;8fad2a3d-2f24-4766-9878-9a7767a87e16	1;2	16;16	474;532	474;526	Not Available;Not Available	1;1	1;5	2000;2000	NO;NO	OTHER;EXTERNAL BEAM	Cyberknife;Not Applicable	PROGRESSION;PALLIATIVE	Not Available;Not Available	cGy;cGy	2012;2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b	Not Available	YES	NO	44	2	Lung	Dead	2011	2010	1970
TCGA-44-8119	73	MALE	285	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	M0	Stage IIB	0	285			TUMOR FREE				73	R-Upper	Not Applicable	TCGA-44-8119	230dc42d-681c-4e31-9d2e-c724e61829fb	31	-27003	Not Applicable	0	99	Not Available	Lung Adenocarcinoma	40																								0	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	NO	Not Available	TCGA-44-8119-F38976	B83A8367-B557-44BB-9319-F428D59570DE	8	Not Applicable	Not Applicable	Not Applicable	285	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	1	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Unknown	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	50	Yes, History of Prior Malignancy	8119	Preoperative	TUMOR FREE	74	59	NO	73	55	Complete Remission/Response	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	44	2	Lung	Alive	2012	2012	1961
TCGA-50-5941	55	FEMALE	1474	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N2	M0	Stage IIIA	0	1474			Not Available				55	R-Upper	Not Applicable	TCGA-50-5941	f3f024c2-52f1-400e-946c-398f5b72e6dc	2	-20350	Not Applicable	0	285	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5941-D32131;TCGA-50-5941-D32132	c30f3b22-ea7d-4ef7-8735-85a743e37de2;1d4ba45d-7254-42be-a255-644f5af80b46	Not Available;Not Available	17;17	Not Available;Not Available	Not Available;Not Available	Cisplatin;Docetaxel	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-50-5941-F32129;TCGA-50-5941-F70451	f165ea21-c724-4532-8246-fa21fc059d3e;0895F08D-E71D-4197-896D-5BE29B632798	17;16	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	567;1474	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	5;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	5941	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2a	Not Available	NO	YES	50	2	Lung	Alive	2011	2010	Not Available
TCGA-64-5781	55	FEMALE	1559	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	1	96.0		Distant Metastasis	TUMOR FREE				55	R-Upper	Not Applicable	TCGA-64-5781	41c4c704-825e-49f5-9d54-dbd7d30725e0	3	-20219	Not Applicable	0	1202	Not Available	Lung Adenocarcinoma	73	TCGA-64-5781-D11407;TCGA-64-5781-D11405;TCGA-64-5781-D11406;TCGA-64-5781-D31491;TCGA-64-5781-D31492;TCGA-64-5781-D31493	92010938-ac4a-4ab1-b25e-dba6632b92ba;4ffd6d8f-3ded-49b0-a532-d0fb97ef1033;83cf163f-43dc-4a75-9ed6-a433a2226488;04bd06de-39e1-47d6-bdb4-de3aeccf9f63;86ff15d3-47d0-47e5-ad61-cded2ed6345d;acadc104-cf2b-4ac0-8598-f4e35edbb3d1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	187;215;215;215;215;187	159;101;101;131;131;159	Bevacizumab;Cisplatin;Gemcitabine;Cisplatin;Gemcitabine;Bevacizumab	Not Available;Not Available;Not Available;Complete Response;Complete Response;Complete Response	5;5;5;5;5;5	3;4;4;Not Available;Not Available;Not Available	15;75;1250;Not Available;Not Available;Not Available	mg/kg;mg/m2;mg/m2;Not Available;Not Available;Not Available	PROGRESSION;ADJUVANT;PROGRESSION;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;Not Available;Not Available;Not Available	IV;IV;IV;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;NO;NO;NO	2011;2011;2011;2012;2012;2012	0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES;NO	NO;NO	NO;NO	YES;YES	TCGA-64-5781-F11404;TCGA-64-5781-F31490	2d57acf6-f8b7-4de5-bc21-d804fc3b145d;295e781b-ad5c-445b-8dbc-9d12b2b6495d	3;3	Not Available;Not Available	112;112	Not Applicable;Not Applicable	1202;1559	96;96	0;0	Not Available;Additional New Tumor Event	Complete Remission/Response;Complete Remission/Response	Not Available;Unknown	Not Available;Not Available	5;5	Not Available;Distant Metastasis	YES;YES	Post-Adjuvant Therapy;Unknown	TUMOR FREE;TUMOR FREE	NO;NO	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	Alive;Alive	2011;2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	5781	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	61	77	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2007	NO	YES	64	4	Lung	Alive	2011	2007	1982
TCGA-73-4666	52	FEMALE	800	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M1	Stage IV	1				TUMOR FREE				52	R-Upper	Not Applicable	TCGA-73-4666	4c31127e-d095-4978-9dac-35153c27f6ed	6	-19074	Not Applicable	0	618	Not Available	Lung Adenocarcinoma	Not Available	TCGA-73-4666-D13246;TCGA-73-4666-D13245	6e0afbee-c9ca-4103-850d-1c7e07b03d56;d23a0b04-32a9-428b-b725-89722eeb2d40	Not Available;Not Available	6;6	119;119	56;56	carboplatin;taxol	Not Available;Not Available	12;12	4;4	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	mg;mg	Not Available;Not Available	2010;2010	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	YES	TCGA-73-4666-F12865	66debbbc-3fbd-4209-a23b-eb3076bc6ed8	10	Not Available	-43	Not Applicable	800	Not Available	1	Not Available	Complete Remission/Response	80	Not Available	6	Not Available	YES	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	YES	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	NO	Not Available	Not Available	Central Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	No	4666	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-73-4666-R12866	daf9b0b5-1a62-4a76-afa0-77726b8a1718	1	10	70	70	Not Available	6	1	1800	NO	OTHER	Gamma Knife	ADJUVANT	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M1	N0	T1	2002	NO	YES	73	4	Lung	Alive	2011	2009	1982
TCGA-L9-A8F4	64	FEMALE	476	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	476			TUMOR FREE				64	L-Upper	Not Applicable	TCGA-L9-A8F4	927FC5E0-2C14-4C20-A49B-F10D8A1175C3	14	-23617	Not Applicable	0	102	Not Available	Lung Adenocarcinoma	35																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-L9-A8F4-F64972	230AAB9B-F943-4A2F-BB3D-A975974BAD7D	16	Not Applicable	Not Applicable	Not Applicable	476	Not Applicable	0	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	9	Not Available	NO	Preoperative	Unknown	NO	Not Applicable	Not Available	YES	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	14	No	A8F4	Preoperative	TUMOR FREE	48	54	NO	45	53	Not Applicable	YES	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-L9-A8F4-R56626	2B7AD134-01C1-4492-A078-579A3A274609	Not Available	14	Not Available	64	Not Applicable	2	Not Available	82	YES	Internal	Not Applicable	Not Available	Not Available	Gy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	L9	2	Lung	Alive	2014	2013	1973
TCGA-69-8253	59	FEMALE	426	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1a	N1	MX	Stage IIA	0	426			Unknown				59	R-Lower	Not Applicable	TCGA-69-8253	44d8c859-4b7a-4e9d-bffc-0de0e6afdcc4	1	-21771	Not Applicable	0	100	Not Available	Lung Adenocarcinoma	Not Available	TCGA-69-8253-D32564;TCGA-69-8253-D32565	E2D64977-0DCC-4BF6-A66E-7D40AF9263AF;3AF5EEC9-47EC-4D16-8427-FE85149B06A5	Not Available;Not Available	1;1	Not Available;Not Available	55;55	Cisplatin;Pemetrexed	Not Applicable;Not Applicable	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-8253-F41949	909F53FB-3A49-456C-9593-B6B043711B7B	5	Not Applicable	Not Applicable	Not Applicable	426	Not Applicable	1	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	4	Not Available	NO	Preoperative	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	7.8	No	8253	Pre-Adjuvant Therapy	Unknown	Not Available	Not Available	YES	Not Available	87	Unknown	YES	BLACK OR AFRICAN AMERICAN	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1a	2011	YES	NO	69	4	Lung	Alive	2012	2012	1972
TCGA-97-8552	55	FEMALE	626	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T1a	N0	MX	Stage I	0	626			TUMOR FREE				55	L-Lower	Not Applicable	TCGA-97-8552	9ca1a26c-82e0-48b3-b3bb-2ed57086eeb1	26	-20331	Not Applicable	0	115	Not Available	Lung Adenocarcinoma	75																								0	Not Available	YES	Exon 19 Deletion	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-8552-F49557	D1BF3872-D42B-4E2D-8D18-D1AE4F0E4BDF	3	Not Applicable	Not Applicable	Not Applicable	626	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	Not Available	YES	NO	Not Available	Unknown	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8552	Preoperative	TUMOR FREE	Not Available	Not Available	NO	77	95	Complete Remission/Response	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	Not Available	YES	NO	97	1	Lung	Alive	2012	2012	Not Available
TCGA-44-6776	60	FEMALE	2616	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	MX	Stage IA	0	2616			TUMOR FREE				60	R-Upper	Not Applicable	TCGA-44-6776	c2a1de2e-6451-4c95-8ce6-263f2b7e6eff	25	-22150	Not Applicable	0	1938	Not Available	Lung Adenocarcinoma	80																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;Not Available	TCGA-44-6776-F15756;TCGA-44-6776-F39378	452c565f-f54c-4dcb-b781-4c6940df5e67;323859A8-8025-4125-B8C2-A96C40DB24D1	31;21	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	1938;2616	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	8;1	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	45	Yes	6776	Not Available	TUMOR FREE	85	82	Not Available	95	74	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	2005	NO	YES	44	4	Lung	Alive	2011	2005	1960
TCGA-L9-A5IP	40	FEMALE	58	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N2	M1b	Stage IV	1	49.0		Locoregional Recurrence	WITH TUMOR				40	R-Upper	Not Applicable	TCGA-L9-A5IP	2A43E61E-2151-4C5A-B062-74CE9DFD8D4A	14	-14681	58	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Unknown	5	NO	NO	49	NO	Not Available	NO	Not Available	Locoregional Recurrence;Distant Metastasis	Convincing Imaging	YES	Not Available	No	A5IP	Not Evaluated	WITH TUMOR	Not Available	Not Available	NO	Not Available	Not Available	Progressive Disease	NO	BLACK OR AFRICAN AMERICAN	NO																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1b	N2	T3	2012	YES	NO	L9	4	Lung	Dead	2013	2012	Not Available
TCGA-44-6148	60	MALE	704	Lung Mucinous Adenocarcinoma	Lung	Alive	T1b	N0	M0	Stage IA	0	704			TUMOR FREE				60	L-Lower	Not Applicable	TCGA-44-6148	8994c8c4-9ea0-46cb-b4a5-0055d7da5bfa	31	-22138	Not Applicable	0	96	96	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;Not Available	TCGA-44-6148-F20979;TCGA-44-6148-F38967	0588d138-a508-4c15-80e2-1703a91ce323;6B732B61-446B-4800-B3A3-D7A74FBAB87E	25;7	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	362;704	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	1;1	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	MALE	Lung Mucinous Adenocarcinoma	No	C34.30	8480/3	C34.3	YES	Not Available	NO	NO	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	No	6148	Preoperative	TUMOR FREE	110	77	Not Available	98	74	Not Available	YES	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	1994	YES	NO	44	3	Lung	Alive	2011	2011	1963
TCGA-38-4630	75	FEMALE	1073	Lung Papillary Adenocarcinoma	Lung	Dead	T2	N0	M0	Stage IB	1	524.0			WITH TUMOR				75	R-Upper	Not Applicable	TCGA-38-4630	f1985735-a188-4567-a88a-530f9b80291b	14	-27667	1073	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO;NO;NO	YES;YES;YES	NO;NO;NO	NO;Not Available;NO	TCGA-38-4630-F4890;TCGA-38-4630-F4943;TCGA-38-4630-F4972	de9bcf35-aaab-4e5d-815f-d1568b93d2ce;46bd4471-369f-4e60-b754-b39b142348bf;9687a1c3-6c11-4d6b-9130-26b74c79e736	14;16;16	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	1073;1073;1073	Not Available;Not Available;Not Available	524;746;836	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Stable Disease;Stable Disease;Stable Disease	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	12;12;12	Not Available;Not Available;Not Available	YES;YES;YES	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;NO;NO	Not Available;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Not Available	NO;YES;NO	Dead;Dead;Dead	2010;2010;2010	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	4630	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Distant site;Local Recurrence;Distant Recurrence	TCGA-38-4630-R4944;TCGA-38-4630-R4942;TCGA-38-4630-R4973	3e17d3f4-0106-465e-8130-6031c5d2e239;17380ae4-f888-43ff-8c25-bd48f811558e;21b69307-a2ec-4d9e-bbe6-3ba5d6b5db41	2;1;3	16;16;16	772;573;869	754;554;848	Not Available;Not Available;Not Available	12;12;12	10;14;15	2250;3500;3000	NO;NO;NO	EXTERNAL BEAM;EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable;Not Applicable	PALLIATIVE;PALLIATIVE;PALLIATIVE	Not Available;Not Available;Not Available	cGy;cGy;cGy	2010;2010;2010	R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	38	1	Lung	Dead	2010	2000	Not Available
TCGA-95-7947	67	MALE	477	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1a	N0	M0	Stage IA	0	477			TUMOR FREE				67	L-Upper	Not Applicable	TCGA-95-7947	e0acafdd-06d0-48a6-bd68-577ef666a419	21	-24752	Not Applicable	0	40	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-95-7947-F29538;TCGA-95-7947-F40940	B3F9AD18-04AD-45A3-8BF2-D7B6E98FFF80;D77E598A-8BC0-454B-A226-D9BB32070504	22;7	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	40;477	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	3;3	Not Available;Not Available	NO;NO	Not Available;Not Available	Not Available;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	100	Yes	7947	Not Available	TUMOR FREE	Not Available	37	Not Available	Not Available	37	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	2006	YES	NO	95	4	Lung	Alive	2012	2011	1956
TCGA-4B-A93V	52	FEMALE	300	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1b	N0	M0	Stage IA	1	251.0		Distant Metastasis	WITH TUMOR				52	R-Lower	Not Applicable	TCGA-4B-A93V	F1F80DD2-891D-46DD-A3E0-F007628CB515	11	-19035	Not Applicable	0	254	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;NO	YES;YES	NO;NO	NO;NO	TCGA-4B-A93V-F67799;TCGA-4B-A93V-F67919	A3A0DE3B-6050-4CEB-9F60-77C7AC386672;36B3E382-04CE-480A-BA97-2A3D1877B59A	11;12	Not Available;Not Available	Not Available;Not Available	Not Applicable;300	254;Not Available	251;251	2;Not Evaluated	Scheduled Follow-up Submission;Additional New Tumor Event	Progressive Disease;Progressive Disease	60;0	NO;YES	11;11	Distant Metastasis;Distant Metastasis	YES;YES	Pre-Adjuvant Therapy;Post-Adjuvant Therapy	WITH TUMOR;WITH TUMOR	NO;NO	Progressive Disease;Progressive Disease	Convincing Imaging;Convincing Imaging	YES;YES	Alive;Dead	2014;2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8140/3	C34.3	YES	100	Not Available	Not Available	Not Available	Peripheral Lung	11	NO	YES	251	NO	Not Available	NO	Not Available	Distant Metastasis	Convincing Imaging	YES	30	No	A93V	Preoperative	WITH TUMOR	Not Available	Not Available	NO	Not Available	Not Available	Progressive Disease	NO	BLACK OR AFRICAN AMERICAN	YES	Distant site	TCGA-4B-A93V-R67898	AA1EAA14-5EC7-47BC-8073-6F27DB7718CB	Not Available	12	267	252	Radiographic Progressive Disease	11	10	2500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	2013	YES	NO	4B	4	Lung	Alive	2014	2013	1984
TCGA-86-8076	42	MALE	993	Lung Papillary Adenocarcinoma	Lung	Alive	T1	N0	M0	Stage IA	0	993			TUMOR FREE				42	R-Upper	Not Applicable	TCGA-86-8076	8609edfc-119d-4d63-9188-c86aabd5ca52	9	-15605	Not Applicable	0	26	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8076-D41684;TCGA-86-8076-D41685	50F44FAB-0ED8-4107-BFA7-F1D90752FECF;6DF79C11-EF79-4AF7-90DA-26FB54BB5161	Not Available;Not Available	25;25	193;193	40;40	Etoposide;Cisplatin	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-86-8076-F41683;TCGA-86-8076-F63522	A93C981E-4BCD-444A-889C-3F75CF9D1642;F06BE3BF-4A95-4C31-A00E-C6DA89CC89B6	25;12	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	489;993	Not Applicable;Not Applicable	2;0	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	80;100	NO;NO	3;8	Not Available;Not Available	NO;NO	Preoperative;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	80	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	8076	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	YES	NO	86	1	Lung	Alive	2012	2011	Not Available
TCGA-05-4410	62	MALE	0	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	0			Not Available				62	L-Upper	Not Applicable	TCGA-05-4410	d28e465c-e553-4c53-8bb7-3d8199b9a8a5	22	-22888	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	98	Yes	4410	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2007	NO	YES	05	4	Lung	Alive	2010	2007	1958
TCGA-62-A472	70	MALE	910	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	M0	Stage IIB	1	290.0		Locoregional Recurrence	WITH TUMOR				70	R-Lower	Not Applicable	TCGA-62-A472	E499069B-A16A-49E9-941A-E3E9EA62AF25	30	-25893	Not Applicable	0	540	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	Not Available	TCGA-62-A472-F51442	1082EB06-8D5B-4D85-8A83-B2125E571F3E	19	Not Available	Not Available	Not Applicable	910	290	1	Scheduled Follow-up Submission	Partial Remission/Response	80	NO	11	Locoregional Recurrence	YES	Preoperative	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	80	NO	Not Available	Not Available	Central Lung	10	NO	YES	290	NO	Not Available	Not Available	Not Available	Locoregional Recurrence	Biopsy with Histologic Confirmation;Convincing Imaging	YES	60	No	A472	Preoperative	WITH TUMOR	Not Available	Not Available	NO	70	87	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	NO	YES	62	2	Lung	Alive	2012	2011	Not Available
TCGA-55-6968	61	MALE	1293	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M1	Stage IV	1				WITH TUMOR				61	R-Lower	Not Applicable	TCGA-55-6968	83a6ed20-b3cf-48b9-8ed3-a080cd4951fa	28	-22344	1293	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-6968-D56252	FA5390E8-6281-46F2-891D-82EAF29D6654	Not Available	30	Not Available	13	Not Available	Stable Disease	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-6968-F56247	78B86F68-8C53-4B9F-8321-02FDEB8CB702	30	Not Applicable	Not Applicable	1293	Not Available	Not Applicable	Unknown	Scheduled Follow-up Submission	Stable Disease	Unknown	NO	1	Not Available	NO	Not Available	WITH TUMOR	YES	Stable Disease	Not Available	YES	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6968	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-55-6968-R56251	2FDE65C3-7B12-4A5E-9DEF-E8CAFBDAD8D6	Not Available	30	57	13	Stable Disease	1	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T1	Not Available	NO	YES	55	2	Lung	Dead	2011	2004	Not Available
TCGA-55-8514	70	FEMALE	520	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	520			TUMOR FREE				70	R-Upper	Not Applicable	TCGA-55-8514	6845099a-b2c9-48d8-b856-9903d39bb92e	11	-25608	Not Applicable	0	202	Not Available	Lung Adenocarcinoma	90																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8514-F57917	6DD813FA-5CF4-4E9F-AA13-F9EA9CC8391B	28	Not Applicable	Not Applicable	Not Applicable	520	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	3	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	No	8514	Not Available	TUMOR FREE	Not Available	Not Available	NO	114	85	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	2011	YES	NO	55	4	Lung	Alive	2013	2012	1971
TCGA-75-7031	Not Available	FEMALE		Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung		T2	N0	M0	Stage IB	0				TUMOR FREE				Not Available	R-Upper	Not Applicable	TCGA-75-7031	4efc2dac-6330-4b7a-a529-a27285f5fc23	16	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	NO	NO	TCGA-75-7031-F15880	2281f87d-086d-493d-9bbe-8a41dc1a216f	16	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	0	Not Available	Not Available	Not Available	Not Available	8	Not Available	NO	Not Available	Not Available	NO	Not Available	Not Available	NO	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	No	7031	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1975	NO	YES	75	3	Lung	Alive	2011	2008	1965
TCGA-62-8397	70	FEMALE	1289	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T3	N0	M0	Stage IIB	0	1289			TUMOR FREE				70	R-Lower	Not Applicable	TCGA-62-8397	9240d5fc-de23-4436-8099-da9bd3054860	4	-25728	Not Applicable	0	940	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-62-8397-F42100	FF6E4644-94D8-4449-857F-11AF95093868	15	Not Applicable	Not Applicable	Not Applicable	1289	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	90	NO	5	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	90	NO	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8397	Preoperative	TUMOR FREE	Not Available	Not Available	NO	64	86	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	NO	YES	62	1	Lung	Alive	2012	2008	Not Available
TCGA-86-7953	69	FEMALE	997	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	997			TUMOR FREE				69	L-Upper	Not Applicable	TCGA-86-7953	54775a66-08cc-4f38-98f2-e7b2b5cec994	14	-25315	Not Applicable	0	34	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-86-7953-F41095;TCGA-86-7953-F66262	F62E2EA8-719A-48F5-8571-DB4C59F3A166;5ACE5873-EB42-4FFE-84C9-1DA5D2DD3D9B	12;7	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	591;997	Not Applicable;Not Applicable	1;1	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	90;90	NO;NO	3;10	Not Available;Not Available	NO;NO	Preoperative;Preoperative	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8250/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7953	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	86	1	Lung	Alive	2012	2011	Not Available
TCGA-75-5146	Not Available	MALE	2368	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	1	1773.0		New Primary Tumor	TUMOR FREE				Not Available	R-Lower	Not Applicable	TCGA-75-5146	1d276b62-5e64-48fb-b2ce-5192b511fe37	6	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;YES	Not Available;NO	Not Available;Not Available	Not Available;Not Available	TCGA-75-5146-F11744;TCGA-75-5146-F72030	d54f5d79-f71c-4fc5-8a86-be0e098fae39;A034F00F-B0BD-4792-8085-A036CD719983	6;2	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	Not Available;2368	Not Applicable;1773	Not Available;Not Evaluated	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Unknown	Not Available;Not Evaluated	Not Available;NO	4;4	Not Available;New Primary Tumor	NO;YES	Adjuvant therapy;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8252/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5146	Other	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1987	NO	YES	75	3	Lung	Alive	2011	Not Available	Not Available
TCGA-44-A47G	73	FEMALE	351	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	351			TUMOR FREE				73	R-Upper	Not Applicable	TCGA-44-A47G	DA345947-498B-4272-A231-A987ED4FE151	27	-26800	Not Applicable	0	135	Not Available	Lung Adenocarcinoma	85																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-44-A47G-F49023	B45EC546-C7BD-426B-B7AE-16F5FF6A1559	25	Not Applicable	Not Applicable	Not Applicable	351	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	9	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	28	No	A47G	Preoperative	TUMOR FREE	Not Available	Not Available	NO	113	100	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2012	YES	NO	44	4	Lung	Alive	2012	2012	1956
TCGA-86-8671	72	FEMALE	839	Lung Papillary Adenocarcinoma	Lung	Alive	T2b	N1	M0	Stage IIB	0	839			WITH TUMOR				72	R-Upper	Not Applicable	TCGA-86-8671	c4cfa3cc-e305-42dd-be57-97efbb891659	30	-26448	Not Applicable	0	18	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8671-D66090;TCGA-86-8671-D66091	151A219B-0DB6-4158-A30B-35B97CC9A1A9;36EB3446-D9DC-4620-830A-8CE6A214F2DB	Not Available;Not Available	2;2	104;104	18;18	Cisplatin;Etoposide	Complete Response;Complete Response	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8671-F66089	97BC43F2-A652-4731-B5BD-37770F5ADB10	2	Not Applicable	Not Applicable	Not Applicable	839	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	10	Not Available	NO	Other	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	90	Not Available	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	8671	Preoperative	WITH TUMOR	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2b	Not Available	YES	NO	86	1	Lung	Alive	2012	2012	Not Available
TCGA-86-8358	44	MALE	653	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	653			TUMOR FREE				44	R-Upper	Not Applicable	TCGA-86-8358	467d96d7-4a42-4116-8c32-0e4b34f96d8a	6	-16409	Not Applicable	0	19	Not Available	Lung Adenocarcinoma	Not Available																								2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8358-F58410	AE9316FF-560B-4692-AC3C-90AC5D7895B2	9	Not Applicable	Not Applicable	Not Applicable	653	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	4	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	NO	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	No	8358	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	Not Available	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	86	2	Lung	Alive	2012	2012	1992
TCGA-93-A4JN	71	MALE	718	Lung Acinar Adenocarcinoma	Lung	Alive	T2a	N0	M1a	Stage IV	1				WITH TUMOR				71	L-Upper	Not Applicable	TCGA-93-A4JN	9DDA72EC-1698-44E2-B35C-11E9A2704380	27	-26273	Not Applicable	0	382	Not Available	Lung Adenocarcinoma	Not Available	TCGA-93-A4JN-D64292;TCGA-93-A4JN-D64293	45BA034F-50ED-4FD8-ADE2-AE234CC3F945;7A4ADFCB-3BF9-433A-8A71-9BF156B3E93A	Not Available;Not Available	28;28	399;697	340;410	Belinostat;Carboplatin	Unknown;Stable Disease	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;NO	2014;2014	1	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-93-A4JN-F56980	014DBA19-FC98-48AD-8BE7-F9F6FC3E6375	27	Not Applicable	Not Applicable	Not Applicable	718	Not Applicable	1	Scheduled Follow-up Submission	Stable Disease	Not Evaluated	NO	2	Not Available	NO	Not Available	WITH TUMOR	YES	Stable Disease	Not Available	NO	Alive	2014	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	90	YES	NO	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	A4JN	Preoperative	WITH TUMOR	Not Available	Not Available	NO	Not Available	Not Available	Stable Disease	NO	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1a	N0	T2a	1991	YES	NO	93	3	Lung	Alive	2014	2012	1971
TCGA-05-4432	66	MALE	761	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N1	M0	Stage IIB	0	761			TUMOR FREE				66	R-Upper	Not Applicable	TCGA-05-4432	e737f650-b72d-44e7-b750-558a56716803	22	-24350	Not Applicable	0	761	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-4432-D36425;TCGA-05-4432-D36426	50774761-63F6-4356-AFF1-6CB33BC143F8;7CDBF312-289A-49AD-989C-52221C8B04E8	Not Available;Not Available	5;5	61;61	31;31	Cisplatin;Vinorelbine	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4432-F36424	2D609D44-E554-4B5E-AB4C-FA32A56E80D9	30	Not Applicable	Not Applicable	Not Applicable	761	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	58	No	4432	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	05	2	Lung	Alive	2010	2008	Not Available
TCGA-86-8669	64	MALE	938	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	1	849.0		Distant Metastasis	TUMOR FREE				64	R-Upper	Not Applicable	TCGA-86-8669	7b89166e-c5b8-481b-aa70-495141499b91	30	-23443	Not Applicable	0	34	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8669-D66086;TCGA-86-8669-D66087	E18E7469-7056-41A2-8BB1-43EE190292AC;336C3649-8213-4895-8F57-85A6FEE79492	Not Available;Not Available	2;2	938;938	854;854	Cisplatin;Etoposide	Complete Response;Complete Response	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	NO	TCGA-86-8669-F66085	60AC3AE9-E893-49D1-A1C0-47BEAE953467	15	Not Available	Not Available	Not Applicable	938	849	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	10	Distant Metastasis	YES	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Convincing Imaging	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	NO	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	47	No	8669	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	86	2	Lung	Alive	2012	2012	1965
TCGA-95-A4VK	74	FEMALE	651	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2b	N2	M0	Stage IIIA	1	496.0		Distant Metastasis	TUMOR FREE				74	R-Upper	Not Applicable	TCGA-95-A4VK	D344DAE0-ADF4-4697-B703-7690C13D8331	21	-27040	Not Applicable	0	121	Not Available	Lung Adenocarcinoma	81	TCGA-95-A4VK-D40500;TCGA-95-A4VK-D40512	676EB575-B085-4F0A-AAD2-CD3F2A17544E;F28DCD0F-6819-45FB-9F86-5FACA3E69090	Not Available;Not Available	21;21	121;121	76;76	Cisplatin;Alimta	Stable Disease;Stable Disease	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	NO	TCGA-95-A4VK-F58477	7505B09D-6FAB-4A2B-9EA8-7146661CF8D2	10	Not Available	Not Available	Not Applicable	651	496	1	Scheduled Follow-up Submission	Stable Disease	Not Evaluated	NO	4	Distant Metastasis	YES	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	Convincing Imaging	YES	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	45	Yes, History of Prior Malignancy	A4VK	Not Available	TUMOR FREE	72	99	YES	67	99	Stable Disease	YES	WHITE	YES	Regional site	TCGA-95-A4VK-R40497	9E26A096-8F54-4594-B63A-E5754FBBD9DD	Not Available	21	202	202	Stable Disease	2	28	50.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2b	1986	YES	NO	95	3	Lung	Alive	2013	2012	1956
TCGA-44-7670	47	FEMALE	882	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N1	M0	Stage IIA	0	882			TUMOR FREE				47	L-Upper	Not Applicable	TCGA-44-7670	9b38eded-3f46-4aaa-9991-68008d97bdbe	18	-17392	Not Applicable	0	531	Not Available	Lung Adenocarcinoma	50	TCGA-44-7670-D20715;TCGA-44-7670-D20716	cd9d0292-629c-4b64-976d-92921bc73acf;98b04e0c-0fb1-4f87-97fc-97aed384b749	Not Available;Not Available	19;19	165;165	88;88	Docetaxel;Cisplatin	Not Available;Not Available	1;1	4;4	100-120;98-125	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	420;419	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;Not Available	TCGA-44-7670-F20714;TCGA-44-7670-F39052	58360ec4-71c7-4e83-bec3-c8948c4dcff4;AC8BF10A-8F00-4860-B41E-5D9CCAA18829	19;9	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	531;882	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	1;1	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	Yes	7670	Not Available	TUMOR FREE	90	82	Not Available	86	80	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	Not Available	YES	NO	44	2	Lung	Alive	2012	2010	1980
TCGA-73-7499	81	FEMALE	1531	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2a	N0	M0	Stage IB	1	1447.0		Distant Metastasis	TUMOR FREE				81	R-Upper	Not Applicable	TCGA-73-7499	7782ceaa-da49-4232-8b3f-534971adaad8	31	-29683	Not Applicable	0	519	Not Available	Lung Adenocarcinoma	54																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;NO	Not Available;NO	Not Available;Not Available	Not Available;YES	TCGA-73-7499-F48754;TCGA-73-7499-F69827	B21C6B2B-AE23-49B9-B9FE-0F1511785AA0;4A31205D-4A32-435E-8909-40A109975FC6	20;21	Not Applicable;Not Available	Not Applicable;1451	Not Applicable;1531	715;Not Available	Not Applicable;1447	1;3	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	80;40	NO;NO	9;1	Not Available;Distant Metastasis	NO;YES	Preoperative;Other	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Dead	2013;2015	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	90	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	7499	Other	TUMOR FREE	Not Available	Not Available	NO	103.7	91.5	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	NO	YES	73	1	Lung	Alive	2012	2010	Not Available
TCGA-62-A46U	71	FEMALE	2067	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N1	M0	Stage IIB	0	2067			TUMOR FREE				71	R-Lower	Not Applicable	TCGA-62-A46U	793649E5-F479-4D64-8723-2EF488FE0FD9	30	-25998	Not Applicable	0	1708	Not Available	Lung Adenocarcinoma	Not Available	TCGA-62-A46U-D36362;TCGA-62-A46U-D40575	7D7C9C05-6714-45E1-BFA5-C1EC33D20EBF;A6950970-9BFA-42C0-99E7-E2B841A95279	Not Available;Not Available	30;25	161;161	71;71	Carboplatin;Navelbine	Complete Response;Complete Response	10;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2013	Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-62-A46U-F51441	60C0A334-F34C-4404-A2C3-1005E8EC0C17	19	Not Applicable	Not Applicable	Not Applicable	2067	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	11	Not Available	NO	Preoperative	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	100	NO	Not Available	Not Available	Central Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A46U	Preoperative	TUMOR FREE	Not Available	Not Available	YES	81	131	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	62	1	Lung	Alive	2012	2007	Not Available
TCGA-55-8508	60	FEMALE	617	Mucinous (Colloid) Carcinoma	Lung	Alive	T2a	N1	MX	Stage IIA	0	617			Unknown				60	R-Upper	Not Applicable	TCGA-55-8508	bab335f9-b241-41a7-b107-79b9676b37b8	28	-22159	Not Applicable	0	15	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-8508-D66138;TCGA-55-8508-D66139	09E9C95E-CD77-45FB-AF89-25C96E794AB8;E05A3BB7-4A18-439D-BDD9-4DBBA8128428	Not Available;Not Available	3;3	120;120	57;57	Cisplatin;Pemetrexed	Complete Response;Complete Response	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	2	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8508-F66137	58A4C50E-35F0-439A-B28A-732F1048D6C4	3	Not Applicable	Not Applicable	Not Applicable	617	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES	60	Unknown	Not Available	Not Available	Central Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8508	Preoperative	Unknown	Not Available	Not Available	YES	Not Available	Not Available	Complete Remission/Response	Not Available	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a	Not Available	YES	NO	55	2	Lung	Alive	2012	2012	Not Available
TCGA-44-2657	74	FEMALE	1351	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	NX	M0	Stage IB	0	1351			TUMOR FREE				74	L-Upper	Not Applicable	TCGA-44-2657	f40301ba-831e-4afd-9ce8-5f3c1a05ff7e	8	-27298	Not Applicable	0	400	Not Available	Lung Adenocarcinoma	96																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-44-2657-F5295;TCGA-44-2657-F39296	c8b44a22-7cab-4d8d-a222-c557b242790d;AF57BA2D-C882-45E5-B422-31170E8D4F3C	8;16	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	400;1351	Not Applicable;Not Applicable	0;Not Available	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	10;1	Not Available;Not Available	NO;NO	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2010;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	2657	Pre-Adjuvant Therapy	TUMOR FREE	87	147	Not Available	78	120	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	2006	YES	NO	44	4	Lung	Alive	2010	2009	1959
TCGA-97-8171	81	MALE	568	Lung Papillary Adenocarcinoma	Lung	Alive	T2a	N2	M1a	Stage IV	1	441.0		Distant Metastasis	WITH TUMOR				81	Other (please specify)	RUL and RML	TCGA-97-8171	397d3f69-1453-4057-b177-8723eec923d1	13	-29627	Not Applicable	0	107	Not Available	Lung Adenocarcinoma	110	TCGA-97-8171-D44343	26978718-D8A3-4747-A8BE-D3C96E87A6A3	Not Available	19	Not Available	16	Tarceva	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Targeted Molecular therapy	Not Available	Not Available	Not Available	NO	2013	1	Not Available	YES	Exon 19 Deletion	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	NO	Not Available	YES	TCGA-97-8171-F44232	98AD8302-28ED-452F-8867-B5A52BF7A2EE	19	Not Available	441	Not Applicable	568	441	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	6	Distant Metastasis	YES	Not Evaluated	WITH TUMOR	YES	Progressive Disease	Biopsy with Histologic Confirmation	NO	Alive	2013	MALE	Lung Papillary Adenocarcinoma	No	C34.8	8260/3	C34.8	YES	Not Available	YES	NO	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	65	No	8171	Preoperative	WITH TUMOR	55	104	Unknown	55	99	Progressive Disease	YES	ASIAN	Unknown																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1a	N2	T2a	Not Available	YES	NO	97	2	Lung	Alive	2012	2011	1946
TCGA-50-5944	69	FEMALE	1750	Lung Acinar Adenocarcinoma	Lung	Alive	T1	N0	M0	Stage IA	0	1750			TUMOR FREE				69	R-Upper	Not Applicable	TCGA-50-5944	1c339545-c08a-4a77-b8e9-a7e49e53853f	2	-25440	Not Applicable	0	373	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-50-5944-F32136;TCGA-50-5944-F70454	974a8262-421f-448c-805e-b4553844dc24;6CEEF46B-0ED2-4D96-BB16-9FB2A5D44BF9	17;16	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	764;1750	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	5;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2015	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5944	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	50	Not Available	Lung	Alive	2011	2010	Not Available
TCGA-78-7633	67	MALE	1528	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N0	M0	Stage IB	1	1450.0		Locoregional Recurrence	Not Available				67	L-Upper	Not Applicable	TCGA-78-7633	44218b35-219c-4ad9-a01e-fde14067c4c0	31	-24713	Not Applicable	0	994	Not Available	Lung Adenocarcinoma	57																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Unknown	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	TCGA-78-7633-F21095;TCGA-78-7633-F46157	f9269731-0d0b-4785-9c9b-6b9766317d29;8A95CDC5-FB75-4B7D-AE3F-923D2FF527B2	31;29	Not Available;Not Available	Not Available;Not Available	Not Applicable;1528	994;Not Available	Not Available;1450	Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Progressive Disease	Not Available;Not Available	Not Available;NO	1;8	Not Available;Locoregional Recurrence	Not Available;YES	Not Available;Not Available	Not Available;WITH TUMOR	Not Available;Unknown	Not Available;Complete Remission/Response	Not Available;Biopsy with Histologic Confirmation	Not Available;Unknown	Alive;Dead	2012;2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	94	Yes	7633	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	100	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2002	NO	YES	78	4	Lung	Alive	2012	2009	1955
TCGA-64-5775	71	MALE	62	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T4	N0	M0	Stage IIIA	1				WITH TUMOR				71	L-Upper	Not Applicable	TCGA-64-5775	c8544fb3-b26e-4672-bb81-a271db724b04	2	-26058	62	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-64-5775-D11419;TCGA-64-5775-D11422	4d9280cc-1045-45ad-9f20-9ea5dc1ea652;7c68848c-8750-490a-811a-2d79abb12d7a	Not Available;Not Available	3;3	28;34	0;0	Carboplatin;Taxol	Not Available;Not Available	5;5	02;05	5;80	AUC;mg/m2	OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Neo-Adjuvant;Neo-Adjuvant	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-64-5775-F11418	ef8d69d0-68e9-401f-a2c7-795dffabb80f	2	Not Applicable	Not Applicable	62	Not Available	Not Applicable	Not Available	Not Available	Progressive Disease	0	Not Available	5	Not Available	NO	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Yes	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	110	No	5775	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	Not Available	NO	YES	64	2	Lung	Dead	2011	2005	1950
TCGA-J2-8194	69	FEMALE	724	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T3	N0	MX	Stage IIB	1	470.0		Distant Metastasis	Unknown				69	R-Lower	Not Applicable	TCGA-J2-8194	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	6	-25441	Not Applicable	0	114	Not Available	Lung Adenocarcinoma	59	TCGA-J2-8194-D32562;TCGA-J2-8194-D32566;TCGA-J2-8194-D55424;TCGA-J2-8194-D55426;TCGA-J2-8194-D55427;TCGA-J2-8194-D55428	2FAE07DB-7F3D-45D6-BA62-5C795B46A511;04888E00-4D3A-44D4-9C38-BB9DA5B386B7;4C297630-A1FD-4811-899D-AA652ACB4F3D;726C1CA1-1718-4EA7-9CAC-8701FA927C14;7AE778AB-433A-4D39-AB87-A4A38B5EF832;F21DD793-5C47-438B-9CBC-8E3B6B4DE464	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;7;7;7;7	Not Available;Not Available;584;584;640;Not Available	72;72;546;546;597;663	carboplatin;alimta;Carboplatin;Gemcitabine;Doxetaxol;Erlotinib	Not Available;Not Available;Clinical Progressive Disease;Clinical Progressive Disease;Stable Disease;Not Applicable	6;6;1;1;1;1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2014;2014;2014;2014	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	YES	TCGA-J2-8194-F55317	CCFB27C8-26F9-4711-BDF0-683C72901DE8	3	Not Available	518	Not Applicable	724	470	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	1	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Biopsy with Histologic Confirmation;Convincing Imaging	YES	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Unknown	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	Yes, History of Prior Malignancy	8194	Not Available	Unknown	2.04	83	YES	2.04	83	Unknown	YES	WHITE	NO	Unknown	TCGA-J2-8194-R55430	39FF1C80-F11B-4726-A0BD-CF3836CB2627	Not Available	7	271	240	Unknown	1	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2014	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	1982	YES	NO	J2	3	Lung	Alive	2012	2011	1956
TCGA-78-7539	75	FEMALE	791	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2b	N0	M0	Stage IIA	1	688.0		Distant Metastasis	Not Available				75	R-Upper	Not Applicable	TCGA-78-7539	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	19	-27445	Not Applicable	0	327	Not Available	Lung Adenocarcinoma	Not Available	TCGA-78-7539-D20644;TCGA-78-7539-D20647;TCGA-78-7539-D20645;TCGA-78-7539-D20646	ee4766b1-b93f-47b2-8296-193336607673;ef32890a-c5fc-4abf-915c-3c0394c365a4;55910d2b-0159-402a-a7c3-dc40c6dd4fcd;0a178b02-54e3-4690-8a6b-a18c85384aa2	Not Available;Not Available;Not Available;Not Available	19;19;19;19	42;133;49;133	36;70;36;70	Cisplatin;Paclitaxel;Vinorelbine;Carboplatin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	1;4;1;4	75;262;37.5;284	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;2	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	150;1048;112.5;1167	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Unknown	Not Available;YES	Not Available;Not Available	Not Available;YES	TCGA-78-7539-F20643;TCGA-78-7539-F46143	e53bcc72-3116-4b4d-a4d9-712dab94cf72;73006682-67D7-4FC9-9CFE-3C60E6B3B825	19;4	Not Available;Not Available	Not Available;688	Not Applicable;Not Applicable	327;791	Not Available;688	Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Not Available	Not Available;NO	1;8	Not Available;Distant Metastasis	Not Available;YES	Not Available;Not Available	Not Available;Unknown	YES;YES	Not Available;Complete Remission/Response	Not Available;Biopsy with Histologic Confirmation	NO;NO	Alive;Alive	2012;2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2.2	No	7539	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	1981	NO	YES	78	3	Lung	Alive	2012	2011	1953
TCGA-91-6829	78	MALE	1258	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Dead	T2	N0	MX	Stage IB	0	1258			TUMOR FREE				78	R-Lower	Not Applicable	TCGA-91-6829	1427cd18-5ad3-491a-9981-908e31ae49db	19	-28841	1258	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-6829-F32591	3d7c1967-95c7-4bfe-ac6c-b8e1de1816c8	4	Not Applicable	Not Applicable	1258	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Progressive Disease	0	NO	6	Not Available	NO	Not Available	Unknown	NO	Progressive Disease	Not Available	NO	Dead	2012	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	94.5	No	6829	Other	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	2003	NO	YES	91	4	Lung	Dead	2011	2001	1940
TCGA-99-8028	50	FEMALE	1118	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	1118			TUMOR FREE				50	L-Upper	Not Applicable	TCGA-99-8028	9759bf3a-74ff-433f-99bb-f9406f222ed2	15	-18542	Not Applicable	0	459	Not Available	Lung Adenocarcinoma	71																								0	Not Available	YES	Not Available	Not Available	RT-PCR	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-99-8028-F57699	ADD85632-529E-47C6-BEDA-7857D1A5C780	17	Not Applicable	Not Applicable	Not Applicable	1118	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	4	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	YES	YES	G12C	Unknown	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	No	8028	Preoperative	TUMOR FREE	91	98	NO	91	94	Not Available	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	2011	NO	YES	99	4	Lung	Alive	2012	2011	1981
TCGA-78-7153	65	FEMALE	3635	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	3635			Not Available				65	R-Upper	Not Applicable	TCGA-78-7153	c353f949-5f66-4a2c-b8f0-17be8bf19e0a	29	-23922	Not Applicable	0	760	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-78-7153-F16980;TCGA-78-7153-F46077	932b04a8-46cd-464a-97f5-682b9dbe77de;C9C20E98-3841-44E5-B29C-946EDFFABBAF	29;23	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	760;3635	Not Available;Not Available	Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Not Available	Not Available;NO	9;8	Not Available;Not Available	Not Available;Unknown	Not Available;Unknown	Not Available;Unknown	NO;NO	Not Available;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.8	8255/3	C34.8	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	7153	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1988	NO	YES	78	4	Lung	Alive	2011	2003	1948
TCGA-L9-A50W	75	MALE	442	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1b	N1	MX	Stage IIA	1	389.0		Distant Metastasis	TUMOR FREE				75	L-Lower	Not Applicable	TCGA-L9-A50W	A815619F-DBBA-469F-A1F7-DFBD51CD86C5	8	-27414	Not Applicable	0	266	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	YES	T790M	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-L9-A50W-F50396	F09EA740-220C-4B79-BDA9-418554DFD3D0	23	Not Available	Not Available	442	Not Available	389	0	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Distant Metastasis	YES	Preoperative	WITH TUMOR	NO	Stable Disease	Biopsy with Histologic Confirmation;Convincing Imaging	NO	Dead	2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	19	No	A50W	Preoperative	TUMOR FREE	Not Available	Not Available	NO	103	81	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b	1986	YES	NO	L9	3	Lung	Alive	2013	2012	1967
TCGA-50-6594	79	FEMALE	370	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N2	M0	Stage IIIA	1	285.0		Distant Metastasis	WITH TUMOR				79	L-Upper	Not Applicable	TCGA-50-6594	8504fd86-a70a-4cba-9ec8-25c9e60ca549	25	-28924	370	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	NO	YES	Not Available	NO	TCGA-50-6594-F44032	08A5B385-FE6B-4B2C-8BAF-CB57CE32AA51	13	Not Available	Not Available	370	Not Available	285	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	6	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Convincing Imaging	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	NO	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6594	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Distant Recurrence	TCGA-50-6594-R44126	FCD116A9-2F06-48CA-ACE7-2D26AD148F79	Not Available	13	318	317	Radiographic Progressive Disease	6	1	24	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	1998	NO	YES	50	4	Lung	Dead	2011	2009	Not Available
TCGA-50-5936	58	MALE	257	Mucinous (Colloid) Carcinoma	Lung	Dead	T2	N2	M0	Stage IIIA	1	150.0			Not Available				58	R-Lower	Not Applicable	TCGA-50-5936	ef42ae4c-a108-468e-beed-437cf3cf2962	2	-21238	257	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5936-D41910	26C486FA-3DCE-4BA5-A30E-544DBBDDEE25	Not Available	3	257	188	TAXOL	Clinical Progressive Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	YES	NO	TCGA-50-5936-F32110	a515c2f5-9d6e-4d08-a136-8480b38b7e6b	17	177	Not Available	257	Not Available	150	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Not Available	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Biopsy with Histologic Confirmation;Convincing Imaging	NO	Dead	2012	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES	Not Available	YES	YES	G12C	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5936	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	50	Not Available	Lung	Dead	2011	2007	Not Available
TCGA-05-5428	57	MALE	670	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1b	N1	M0	Stage IIA	0	670			TUMOR FREE				57	R-Upper	Not Applicable	TCGA-05-5428	3fe8f8e4-5396-4362-82f5-366e2fb69db2	22	-21061	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-5428-D36413;TCGA-05-5428-D36412	871796B4-AAF5-4244-9638-B330F655C4AF;6CA3C122-D3BF-44D7-A79B-A496388F0C6E	Not Available;Not Available	30;5	153;153	62;62	Cisplatin;Vinorelbine	Complete Response;Complete Response	10;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-5428-F36401	A9413EB4-15FC-4952-A58C-DEF0CFDC8CB1	30	Not Applicable	Not Applicable	Not Applicable	670	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	YES	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.9	8255/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	5428	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-05-5428-R36414	5E20E156-0C33-4B57-819A-266FF7C951BC	Not Available	30	274	215	Complete Response	10	Not Available	64	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	1993	NO	YES	05	3	Lung	Alive	2011	2010	1969
TCGA-55-5899	58	MALE	930	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N1	M0		0	930			Not Available				58	R-Upper	Not Applicable	TCGA-55-5899	996a0070-e9bf-4601-8ef7-60212108258d	20	Not Available	Not Applicable	0	87	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-5899-D43195;TCGA-55-5899-D43196	C4183530-28BE-42D7-AD22-5C1C476E2388;314FCD94-F0EA-4781-95F8-659D257724EB	Not Available;Not Available	15;15	208;208	146;146	Carboplatin;Taxol	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-5899-F43194	2C5BA987-9730-46DB-B69A-829E5803E4EF	15	Not Applicable	Not Applicable	Not Applicable	930	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	5	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5899	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1a	Not Available	NO	YES	55	2	Lung	Alive	2010	2010	1985
TCGA-44-7659	70	MALE	691	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	MX	Stage IA	0	691			TUMOR FREE				70	L-Upper	Not Applicable	TCGA-44-7659	b86b1616-20a2-4300-8daa-03dcc9938215	30	-25730	Not Applicable	0	299	Not Available	Lung Adenocarcinoma	43																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;Not Available	TCGA-44-7659-F30936;TCGA-44-7659-F39654	2f3b8b99-565e-4ad3-a8f0-edc89b22bd70;AD1BC6F4-A6B6-45BF-B2A2-C2EE5E33B07B	19;29	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	444;691	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	4;1	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	Not Available;NO	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;NO	Alive;Alive	2012;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	7659	Not Available	TUMOR FREE	60	47	Not Available	55	42	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	YES	NO	44	2	Lung	Alive	2011	2010	1989
TCGA-55-7816	49	FEMALE	468	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	TX	NX	MX	Stage IV	1				WITH TUMOR				49	R-Upper	Not Applicable	TCGA-55-7816	548b0b68-ff45-4d45-adbe-984259e4a68b	9	-18170	Not Applicable	0	44	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7816-F60131	6AFEC225-5C90-4B90-8F48-FB7786DF92B3	29	Not Applicable	Not Applicable	468	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	5	Not Available	NO	Not Evaluated	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7816	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	YES	NO	55	1	Lung	Alive	2012	2011	Not Available
TCGA-05-4425	70	FEMALE	669	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M1	Stage IV	0	669			Not Available				70	R-Middle	Not Applicable	TCGA-05-4425	69b23036-add9-42c9-941f-02fb74d9b08c	22	-25902	Not Applicable	0	669	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-4425-D36541;TCGA-05-4425-D36542	9F72525F-2709-42EF-831A-25435428F054;E3F50215-27BD-43FC-BD2F-C7C06D44035E	Not Available;Not Available	5;5	153;153	31;31	Cisplatin;Vinorelbine	Unknown;Unknown	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	28	No	4425	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	Not Available	NO	YES	05	3	Lung	Alive	2010	2008	Not Available
TCGA-44-2665	55	FEMALE	1301	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N1	M0	Stage IIB	0	1301			TUMOR FREE		FPPP	TCGA	55	R-Upper	Not Applicable	TCGA-44-2665	fb79c491-7b01-42ae-8369-8364e442e31b	13	-20349	Not Applicable	0	400	Not Available	Lung Adenocarcinoma	71	TCGA-44-2665-D5300;TCGA-44-2665-D5303;TCGA-44-2665-D5301	166a00a1-1d11-4315-85ec-f0ff6b2c184b;180ce2c6-d1aa-416d-bcd6-2ecd63c5793d;b9858076-20a0-4a78-b334-9965e070182e	Not Available;Not Available;Not Available	13;13;13	308;140;140	77;77;77	Bevacizumab;Pemetrexed disodium;Cisplatin	Not Available;Not Available;Not Available	10;10;10	12;4;4	1139;910;137	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	12988;3625;545	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-44-2665-F5298;TCGA-44-2665-F15326;TCGA-44-2665-F40281	9ee191ec-e1cb-48f8-a661-441671526c98;628830b0-7076-423a-a197-1167e6b16fe7;3AD91BAD-E04E-4CDB-A793-F338823FC89E	13;18;15	Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	400;706;1301	Not Applicable;Not Applicable;Not Applicable	0;0;0	Not Available;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease;Complete Remission/Response	Not Available;Not Available;Not Available	Not Available;Not Available;NO	10;8;2	Not Available;Not Available;Not Available	NO;NO;NO	Post-Adjuvant Therapy;Post-Adjuvant Therapy;Other	TUMOR FREE;TUMOR FREE;TUMOR FREE	YES;Not Available;YES	Stable Disease;Not Available;Stable Disease	Not Available;Not Available;Not Available	NO;Not Available;NO	Alive;Alive;Alive	2010;2011;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	2665	Pre-Adjuvant Therapy	TUMOR FREE	79	105	Not Available	79	114	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	YES	NO	44	1	Lung	Alive	2010	2009	Not Available
TCGA-05-4424	70	MALE	913	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T3	N0	M0	Stage IIB	1	153.0		Distant Metastasis	WITH TUMOR				70	R-Upper	Not Applicable	TCGA-05-4424	66763a0c-6cda-4832-a0cc-e7b496d78eaa	22	-25689	Not Applicable	0	913	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-4424-D36537	65585949-E6ED-42E6-B1D5-002FBB849BB1	Not Available	5	Not Available	699	Erlotinib	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Immunotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	Not Available	TCGA-05-4424-F36536	97188E69-9925-4A74-B986-E22FD997CD52	1	Not Available	Not Available	Not Applicable	913	153	Not Available	Scheduled Follow-up Submission	Partial Remission/Response	Not Available	NO	11	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Not Available	YES	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	4424	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field;Distant Recurrence;Distant Recurrence	TCGA-05-4424-R36538;TCGA-05-4424-R36539;TCGA-05-4424-R36540	2FB387B1-1AE0-442B-BB82-D85638F7A0E0;D458480E-E0FB-4E6B-85DC-CBB28101BE78;A5534445-62B5-4F9F-983B-F42DCE652083	Not Available;Not Available;Not Available	1;1;1	30;Not Available;Not Available	30;153;699	Partial Response;Partial Response;Partial Response	11;11;11	Not Available;Not Available;Not Available	60;3;30	NO;YES;YES	External;Unknown;Unknown	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Gy;Gy;Gy	2012;2012;2012	R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	2007	NO	YES	05	4	Lung	Alive	2010	2008	1957
TCGA-78-7156	62	MALE	976	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T4	N1	M1	Stage IV	0	976			Not Available				62	Not Available	Not Applicable	TCGA-78-7156	7b0622ab-63ea-483f-ae40-d3ea587bdbba	29	-22720	976	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-78-7156-F16982	03cedf57-e893-47ff-a0d8-d67a938ec858	29	Not Available	Not Available	976	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	Dead	2011	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.9	8255/3	C34.9	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	84	No	7156	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T4	1989	NO	YES	78	3	Lung	Dead	2011	2006	1961
TCGA-49-4512	69	FEMALE	905	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	MX	Stage IIIA	1				WITH TUMOR				69	R-Middle	Not Applicable	TCGA-49-4512	a1e65587-24c1-4b41-92a7-4e1f15fffd78	9	-25502	905	0	157	Not Available	Lung Adenocarcinoma	Not Available	TCGA-49-4512-D14718	11659d14-75e7-4990-bcf1-fd6d91969685	Not Available	9	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-49-4512-F14815	5d052835-b26a-42e0-aa2d-fb53c06891f4	10	Not Applicable	Not Applicable	905	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	8	Not Available	NO	Not Available	WITH TUMOR	YES	Progressive Disease	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4512	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T2	Not Available	NO	YES	49	1	Lung	Dead	2011	2007	Not Available
TCGA-78-7536	69	MALE	244	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	1	231.0			WITH TUMOR				69	R-Upper	Not Applicable	TCGA-78-7536	daf0e08e-1738-43f8-874a-b37d79cbe3a7	19	-25558	244	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	NO	NO	TCGA-78-7536-F20631	01b8e373-4376-4322-8924-06beb651d367	19	Not Available	Not Available	244	Not Available	231	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	1	Not Available	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	YES	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	44	No	7536	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-78-7536-R20632	6428d89d-10a1-4a35-b613-ae1a428fa8ce	1	19	90	55	Not Available	1	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1993	NO	YES	78	4	Lung	Dead	2012	2001	1949
TCGA-97-8175	55	FEMALE	551	Lung Solid Pattern Predominant Adenocarcinoma	Lung	Alive	T2a	N0	M0	Stage IB	1	294.0		Locoregional Recurrence	TUMOR FREE				55	L-Upper	Not Applicable	TCGA-97-8175	f4350d9c-3f40-4829-bbc4-8acb2f3ff512	13	-20206	Not Applicable	0	87	Not Available	Lung Adenocarcinoma	Not Available	TCGA-97-8175-D44236;TCGA-97-8175-D44238	9EF4D129-7435-454B-B14A-430A7F80A624;8165798D-0A35-4166-92DD-22748F0BB7A0	Not Available;Not Available	19;19	Not Available;Not Available	472;472	Alimta;Cisplatin	Not Available;Not Available	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	YES	YES	YES	Not Available	TCGA-97-8175-F44234	891298DD-4123-4570-8D90-B7AF4B6AF406	19	294	Not Available	Not Applicable	551	294	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	6	Locoregional Recurrence	YES	Not Available	TUMOR FREE	NO	Complete Remission/Response	Biopsy with Histologic Confirmation	NO	Alive	2013	FEMALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.1	8230/3	C34.1	YES	Not Available	YES	NO	Not Available	Peripheral Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8175	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	NO	WHITE	NO	Local Recurrence	TCGA-97-8175-R44237	54EAF59D-B6E1-49F1-BE58-190269254416	Not Available	19	441	427	Complete Response	6	5	5000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1981	YES	NO	97	3	Lung	Alive	2012	2011	Not Available
TCGA-49-4501	67	FEMALE	1421	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	545.0			WITH TUMOR				67	R-Upper	Not Applicable	TCGA-49-4501	0780eb43-d5b5-4c3d-9825-beacba5cc723	2	-24817	1421	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-49-4501-D17258	741831e9-9044-4e74-a539-7165b5914a80	Not Available	6	694	664	Gemzar	Not Available	10	2	Not Available	Not Available	RECURRENCE	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	Not Available	TCGA-49-4501-F7014	0d45623b-abf3-45d1-bcd6-319ebd5a50de	2	Not Available	Not Available	1421	Not Available	545	1	Not Available	Progressive Disease	Not Available	Not Available	2	Not Available	YES	Other	WITH TUMOR	NO	Complete Remission/Response	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	4501	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	49	1	Lung	Dead	2011	1996	Not Available
TCGA-53-7626	76	FEMALE	929	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N1	M0	Stage IIA	1	865.0		Locoregional Recurrence	WITH TUMOR				76	R-Upper	Not Applicable	TCGA-53-7626	d3ff328c-2488-47bd-8663-366b6812c7b5	13	-28024	929	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-53-7626-D39213;TCGA-53-7626-D39214	0BEFAE89-775A-44A5-8352-ECB58FBCA0B3;61FB2C2D-04A9-420C-881B-821008C23CCA	Not Available;Not Available	15;15	Not Available;Not Available	Not Available;Not Available	Cisplatin;Taxotere	Clinical Progressive Disease;Clinical Progressive Disease	1;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	Not Available	TCGA-53-7626-F38969	8B9047BD-EFD5-41E5-863C-04D4F982B422	15	Not Available	Not Available	929	Not Available	865	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	1	Locoregional Recurrence	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Biopsy with Histologic Confirmation	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	35	No	7626	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1	2006	NO	YES	53	4	Lung	Dead	2011	2008	1971
TCGA-55-6984	71	FEMALE	760	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	724.0			WITH TUMOR				71	L-Lower	Not Applicable	TCGA-55-6984	f063ddbb-1668-40df-9ec2-b0a23ca2c389	27	Not Available	760	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-6984-D45633;TCGA-55-6984-D45634	2EEFA4BA-8311-4923-9CC0-43AEDFF385C4;0D8E1A7A-9075-4584-B85F-489D6DAB16F2	Not Available;Not Available	17;17	Not Available;747	65;724	Chemo, Multi-Agent, NOS;Chemo, NOS	Complete Response;Clinical Progressive Disease	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	NO	TCGA-55-6984-F45632	DB66DE4C-0099-4F8A-8ABA-4D7D43922A68	17	Not Available	Not Available	760	Not Available	724	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	7	Not Available	YES	Not Evaluated	WITH TUMOR	YES	Complete Remission/Response	Not Available	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6984	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	55	Not Available	Lung	Dead	2011	2006	Not Available
TCGA-44-2659	65	FEMALE	1367	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N1	M0	Stage IIB	1	1146.0		Locoregional Recurrence	TUMOR FREE				65	Discrepancy	Not Available	TCGA-44-2659	bf15f7ad-9d92-473b-91d1-f24aa373ab97	11	-23808	Not Applicable	0	529	Not Available	Lung Adenocarcinoma	67	TCGA-44-2659-D5025;TCGA-44-2659-D5026	110a7cbc-d353-458a-93f3-10c16adcb893;cc1ab570-e73a-425d-9314-fcd5bcd1998e	Not Available;Not Available	20;20	101;101	39;39	Alimta;Cisplatin	Not Available;Not Available	10;10	4;4	1100;160	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	4400;640	mg;mg	Not Available;Not Available	2010;2010	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available;YES;Not Available	Not Available;Not Available;NO;Not Available	Not Available;Not Available;NO;Not Available	Not Available;Not Available;Not Available;Not Available	TCGA-44-2659-F5024;TCGA-44-2659-F10479;TCGA-44-2659-F32677;TCGA-44-2659-F40300	075c8c08-1113-488d-9a27-0bfe68135696;cf63a898-7c03-4b02-8491-13b75918bc4b;280f4a45-10dc-4ed2-943f-73782c35f16f;2386C68E-B1CA-41B8-A7E5-129D0CE2E2CA	20;27;7;15	Not Applicable;Not Available;Not Available;Not Applicable	Not Applicable;Not Available;Not Available;Not Applicable	Not Applicable;Not Applicable;Not Applicable;Not Applicable	529;701;1147;1367	Not Applicable;Not Available;1146;Not Applicable	1;1;Not Available;Not Available	Not Available;Not Available;Additional New Tumor Event;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;NO;NO	10;4;6;2	Not Available;Not Available;Locoregional Recurrence;Not Available	NO;Not Available;YES;NO	Adjuvant therapy;Adjuvant therapy;Not Available;Not Available	TUMOR FREE;TUMOR FREE;WITH TUMOR;TUMOR FREE	YES;Not Available;YES;YES	Complete Remission/Response;Not Available;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Biopsy with Histologic Confirmation;Convincing Imaging;Not Available	NO;Not Available;NO;NO	Alive;Alive;Alive;Alive	2010;2011;2012;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	57	No	2659	Other	TUMOR FREE	87	73	Not Available	77	64	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1	2003	YES	NO	44	4	Lung	Alive	2010	2009	1965
TCGA-MP-A4SW	53	MALE	1778	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	0	1778			Unknown				53	L-Upper	Not Applicable	TCGA-MP-A4SW	15F12D2C-B834-4BFC-B526-F03BF85BFE96	2	-19640	1778	0	Not Available	Not Available	Lung Adenocarcinoma	102																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Unknown																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	15	No	A4SW	Not Evaluated	Unknown	Not Available	101	NO	Not Available	90	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	1982	NO	YES	MP	3	Lung	Dead	2013	2002	1967
TCGA-55-A48X	63	FEMALE	689	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N1	M0	Stage IIA	1	615.0		New Primary Tumor	TUMOR FREE				63	L-Lower	Not Applicable	TCGA-55-A48X	32D9935A-F5CD-43B3-88BD-09E6E2B9090D	21	-23341	Not Applicable	0	33	Not Available	Lung Adenocarcinoma	79	TCGA-55-A48X-D61502;TCGA-55-A48X-D61503	D62B9942-18BB-46BB-9CD2-27E149A14B9D;119EF573-924B-4764-935E-8156AEC3B7B8	Not Available;Not Available	30;30	160;150	66;66	Carboplatin;Alimta	Complete Response;Complete Response	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	YES	NO	YES	Not Available	TCGA-55-A48X-F61500	9BD03D83-FD93-44FB-AFAF-230675A93AAA	30	615	Not Available	Not Applicable	689	615	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	6	New Primary Tumor	YES	Not Available	TUMOR FREE	YES	Complete Remission/Response	Biopsy with Histologic Confirmation	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	36	Yes, History of Prior Malignancy	A48X	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	57	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	1999	YES	NO	55	4	Lung	Alive	2013	2012	1963
TCGA-55-1592	65	MALE	701	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IA	1	452.0			WITH TUMOR				65	L-Upper	Not Applicable	TCGA-55-1592	a41c46da-7ed4-4192-bd16-b3cbb94a5133	15	Not Available	701	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-55-1592-F9167	d1fe03fa-cf81-4ff3-beb4-aaeb15b9e6ae	15	Not Available	Not Available	701	Not Available	452	Not Available	Not Available	Progressive Disease	Not Available	Not Available	3	Not Available	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Not Available	NO	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	1592	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1997	NO	YES	55	4	Lung	Dead	2011	2005	1957
TCGA-86-8673	61	MALE	862	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T2	N0	M0	Stage IB	1	636.0		Locoregional Recurrence	TUMOR FREE				61	L-Upper	Not Applicable	TCGA-86-8673	bc4c4079-b449-485d-84e4-a40496e563e8	30	-22571	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available;NO	Not Available;NO	Not Available;YES	Not Available;Not Available	TCGA-86-8673-F41842;TCGA-86-8673-F59092	4D099A3E-8646-424C-AEF4-394D2DDC653A;7D5C34E4-E4BC-41BC-9704-35161E33F1E6	1;30	Not Applicable;639	Not Applicable;Not Available	Not Applicable;Not Applicable	455;862	Not Applicable;636	Not Evaluated;Not Evaluated	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Evaluated;Not Evaluated	NO;NO	4;4	Not Available;Locoregional Recurrence	NO;YES	Not Evaluated;Not Evaluated	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES	Unknown	Unknown	Not Available	Not Available	Unknown	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	54	No	8673	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	86	2	Lung	Alive	2012	2011	1968
TCGA-35-4123	38	MALE	182	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	182			TUMOR FREE				38	R-Upper	Not Applicable	TCGA-35-4123	6cf49cf0-de4c-4c90-8358-eae19c6206b0	20	-14064	Not Applicable	0	182	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-35-4123-F68918	EC7AA234-A6E0-4907-8754-531418756764	23	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	12	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	4123	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2010	NO	YES	35	4	Lung	Alive	2010	2010	1990
TCGA-78-8640	59	MALE	7062	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N1	M0	Stage IIA	0	7062			TUMOR FREE				59	L-Upper	Not Applicable	TCGA-78-8640	18478121-f1d1-4bdd-9511-8ab22f4a0660	23	-21832	Not Applicable	0	6346	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-78-8640-F46106;TCGA-78-8640-F70500	E3777749-8064-4049-A825-BB96779AEAD3;D76CC938-737A-46E4-BA56-1A16F671F442	4;25	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	6528;7062	Not Applicable;Not Available	Unknown;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Unknown	Not Available;Not Available	NO;NO	8;3	Not Available;Not Available	NO;Unknown	Unknown;Not Available	Unknown;Unknown	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	45	No	8640	Preoperative	TUMOR FREE	Not Available	Not Available	NO	73	66	Complete Remission/Response	YES	Not Evaluated	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1	Not Available	NO	YES	78	2	Lung	Alive	2012	1994	1949
TCGA-75-7027	Not Available	MALE	3059	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	1	2949.0		Locoregional Recurrence	TUMOR FREE				Not Available	L-Lower	Not Applicable	TCGA-75-7027	488646a1-0bdb-45f8-8c30-bef006924511	12	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;YES	Not Available;YES	Not Available;NO	Not Available;Not Available	TCGA-75-7027-F15876;TCGA-75-7027-F72040	65d0b206-5ccc-4f50-97a2-027970e57dc5;EED8BCA9-FFEB-4DC8-97A8-84C471919B0A	12;2	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	Not Available;3059	Not Applicable;2949	0;Unknown	Not Available;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Unknown	Not Available;NO	8;4	Not Available;Locoregional Recurrence	NO;YES	Not Available;Unknown	Not Available;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	7027	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	75	2	Lung	Alive	2011	Not Available	1956
TCGA-99-8032	61	MALE	44	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	44			TUMOR FREE				61	R-Upper	Not Applicable	TCGA-99-8032	7e83f9dd-b038-497b-a113-a55605398b7b	15	-22635	Not Applicable	0	44	Not Available	Lung Adenocarcinoma	54																								0	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	YES	YES	G12C	Unknown	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	90	No	8032	Preoperative	TUMOR FREE	Not Available	Not Available	NO	55	59	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	99	2	Lung	Alive	2012	2011	1966
TCGA-49-6761	68	FEMALE	354	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N2	MX	Stage IIIA	0	354			TUMOR FREE				68	R-Upper	Not Applicable	TCGA-49-6761	4cd3d483-2283-4c6a-a57a-444216119d34	2	-24849	Not Applicable	0	1	Not Available	Lung Adenocarcinoma	1																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	Not Available	TCGA-49-6761-F22056	8ad6b3d6-48a1-4f9e-8ea6-cf0d7394cdf6	23	Not Applicable	Not Applicable	Not Applicable	354	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	2	Not Available	NO	Not Available	Not Available	NO	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	Yes	6761	Not Available	TUMOR FREE	64	56	Not Available	64	52	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T1	Not Available	NO	YES	49	4	Lung	Alive	2012	2009	Not Available
TCGA-MP-A4SY	61	MALE	1501	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	489.0		Locoregional Recurrence	TUMOR FREE				61	R-Lower	Not Applicable	TCGA-MP-A4SY	8CC6BCEC-65DF-46A9-A88C-09762A132857	2	-22448	1501	0	Not Available	Not Available	Lung Adenocarcinoma	73																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Central Lung	4	YES	NO	489	YES	489	Not Available	Not Available	Locoregional Recurrence	Biopsy with Histologic Confirmation	YES	40	No	A4SY	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	74	NO	Not Available	54	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	2002	NO	YES	MP	4	Lung	Dead	2013	2002	Not Available
TCGA-55-A490	78	MALE	99	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2b	N0	MX	Stage IIA	0	99			TUMOR FREE				78	R-Upper	Not Applicable	TCGA-55-A490	B89DE053-D253-447F-952E-9A2EDCF6BCA5	21	-28728	Not Applicable	0	48	Not Available	Lung Adenocarcinoma	40	TCGA-55-A490-D59079;TCGA-55-A490-D59080	A6D28342-BD3F-4814-B710-BFBA6B19D0B3;2A35CBA5-76D7-4EAC-AF33-941BD871E623	Not Available;Not Available	30;30	89;89	89;89	Carboplatin;Alimta	Unknown;Unknown	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	1	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-A490-F59076	813389EA-D9E4-47C0-B21A-5FA647E9EEB8	30	Not Applicable	Not Applicable	99	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Not Applicable	Not Evaluated	NO	4	Not Available	NO	Not Available	TUMOR FREE	YES	Not Applicable	Not Available	NO	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	YES	YES	G12C	Peripheral Lung	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	34	No	A490	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	60	56	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	1985	YES	NO	55	3	Lung	Alive	2013	2012	1951
TCGA-93-7348	75	FEMALE	531	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	MX	Stage IA	0	531			TUMOR FREE				75	R-Upper	Not Applicable	TCGA-93-7348	e739b4f7-ae46-45c6-9013-9571cbadaf99	14	-27456	Not Applicable	0	127	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-93-7348-F18347;TCGA-93-7348-F43154	9b7a6ba2-fb2c-4500-8854-b49be293dec9;D4ACD5E1-FB96-40B5-85BB-8997E1454195	14;14	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	127;531	Not Applicable;Not Applicable	0;Not Evaluated	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Not Applicable	100;Not Evaluated	Not Available;NO	11;5	Not Available;Not Available	NO;NO	Other;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	NO	Not Available	Not Available	Central Lung	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	42	No	7348	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	1999	YES	NO	93	4	Lung	Alive	2011	2011	1957
TCGA-49-AAR0	57	MALE	4765	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	MX	Stage IA	0	4765			TUMOR FREE				57	R-Upper	Not Applicable	TCGA-49-AAR0	3AFA5045-A1EE-4A07-8AAD-2E252B2F7D7A	18	-20932	Not Applicable	0	4415	Not Available	Lung Adenocarcinoma	107																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-49-AAR0-F70568;TCGA-49-AAR0-F71576	F9F535E5-5CBE-4B1A-AA4E-859DCDC99180;B48FD5B1-3409-4981-9800-700ADA31B79E	25;10	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	4655;4765	Not Applicable;Not Applicable	1;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	80;Not Available	NO;NO	2;4	Not Available;Not Available	NO;NO	Preoperative;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2015;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	37	Yes, History of Prior Malignancy	AAR0	Preoperative	TUMOR FREE	80	62.5	NO	58.6	85.4	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	Not Available	NO	YES	49	2	Lung	Alive	2014	2002	Not Available
TCGA-93-A4JP	64	MALE	578	Lung Papillary Adenocarcinoma	Lung	Alive	TX	NX	M1b	Stage IV	1	497.0		Distant Metastasis	WITH TUMOR				64	R-Lower	Not Applicable	TCGA-93-A4JP	30F276A8-3A4B-4DE8-AEA0-7F605D100401	27	-23620	Not Applicable	0	269	Not Available	Lung Adenocarcinoma	Not Available	TCGA-93-A4JP-D65104	6D848A43-59A3-46FE-9574-9F37B0059EC8	Not Available	18	101	17	Carboplatin	Partial Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	YES	L861Q	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	YES	Not Available	NO	TCGA-93-A4JP-F56970	ED886C70-F6A0-43DD-8B8D-D9182B3D1DC2	28	Not Available	Not Available	Not Applicable	578	497	1	Scheduled Follow-up Submission	Progressive Disease	Unknown	NO	2	Distant Metastasis	YES	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Convincing Imaging	NO	Alive	2014	MALE	Lung Papillary Adenocarcinoma	No	C34.3	8260/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A4JP	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available	Partial Remission/Response	NO	ASIAN	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1b	NX	TX	Not Available	YES	NO	93	1	Lung	Alive	2014	2012	Not Available
TCGA-55-6979	59	FEMALE	237	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	195.0		Distant Metastasis	WITH TUMOR				59	L-Upper	Not Applicable	TCGA-55-6979	5af499be-d2b9-4eaf-9a9f-435dccb51917	26	-21780	237	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-6979-D40547;TCGA-55-6979-D40548	F521F7CC-4443-4315-B2C2-B486B17D0DC5;7F10EFEE-013A-4927-8BAD-1683AED5FA99	Not Available;Not Available	22;22	149;149	57;57	Carboplatin;Taxol	Clinical Progressive Disease;Clinical Progressive Disease	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	YES	YES	Not Available	NO	TCGA-55-6979-F37057	7DAF16E2-34A6-40ED-99FB-8C3F3205DA98	22	Not Available	Not Available	237	Not Available	195	Unknown	Scheduled Follow-up Submission	Progressive Disease	Unknown	NO	2	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Convincing Imaging	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	6979	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	55	3	Lung	Dead	2011	2006	Not Available
TCGA-73-7498	58	FEMALE	1189	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T1b	N0	M0	Stage IA	0	1189			TUMOR FREE				58	R-Lower	Not Applicable	TCGA-73-7498	ad74c0e8-8878-4efc-997d-981cd547bc5b	31	-21527	Not Applicable	0	621	Not Available	Lung Adenocarcinoma	74.0	TCGA-73-7498-D32539;TCGA-73-7498-D32540;TCGA-73-7498-D32543;TCGA-73-7498-D48756;TCGA-73-7498-D48757	0809DF70-4919-4CE8-926D-7348AC6DC9B7;DE51B406-96D0-467C-9B21-E48C69E073BA;554C1877-3CCE-449E-9CA4-5FF8E51826CE;5FD1CDCF-3998-4DC4-A725-FE3A445BE552;C2185383-54C4-42AD-B2BF-402648CCF841	Not Available;Not Available;Not Available;Not Available;Not Available	31;31;31;20;20	110;68;110;131;131	47;47;68;47;47	Pemetrexed;Cisplatin;Carboplatin;pemetrexed;cisplatin	Complete Response;Unknown;Complete Response;Complete Response;Complete Response	5;5;5;9;9	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2013;2013	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-73-7498-F48755	E191A2F8-AD1C-44A4-97DF-59279AC7A789	20	Not Applicable	Not Applicable	Not Applicable	1189	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	9	Not Available	NO	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	80	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	28	Yes, History of Synchronous/Bilateral Malignancy	7498	Preoperative	TUMOR FREE	89.6	60.1	YES	91.9	61.2	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	1997	NO	YES	73	4	Lung	Alive	2012	2010	1969
TCGA-MP-A4T8	68	MALE	161	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	0	161			Unknown				68	L-Upper	Not Applicable	TCGA-MP-A4T8	7C4ED533-EE66-48BE-A84B-FF8607742818	2	-25069	161	0	Not Available	Not Available	Lung Adenocarcinoma	102	TCGA-MP-A4T8-D41347;TCGA-MP-A4T8-D41348	5847897E-0C0F-4333-98FC-46101B12E294;254AEB4C-E848-471D-90B6-75DC48A1F902	Not Available;Not Available	15;15	72;72	42;42	Navelbine;Cisplatin	Unknown;Unknown	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Unknown																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	25	Yes, History of Prior Malignancy	A4T8	Pre-Adjuvant Therapy	Unknown	Not Available	72	YES	Not Available	60	Unknown	YES	Unknown	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1972	NO	YES	MP	3	Lung	Dead	2013	2006	1957
TCGA-50-6590	72	FEMALE	1288	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	0	1288			TUMOR FREE				72	R-Upper	Not Applicable	TCGA-50-6590	114a34c0-983b-4d90-9181-1823c9637a63	25	-26444	1288	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-6590-D43830;TCGA-50-6590-D43831	A075B030-D2CD-4488-9FD9-D0BFD2A087A7;A3CB9C93-4673-49EE-AB53-9823D496F039	Not Available;Not Available	4;4	189;189	92;92	Paclitaxel;Carboplatin	Complete Response;Complete Response	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-50-6590-F43827	47ED4445-67EF-44BD-AC55-2C3E733F62CF	4	Not Applicable	Not Applicable	1288	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	6	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	6590	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2002	NO	YES	50	4	Lung	Dead	2011	2005	Not Available
TCGA-64-5815	74	MALE	866	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N1	M0	Stage IIB	0	866			TUMOR FREE				74	R-Upper	Not Applicable	TCGA-64-5815	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	2	-27280	Not Applicable	0	224	Not Available	Lung Adenocarcinoma	87	TCGA-64-5815-D11426;TCGA-64-5815-D11429;TCGA-64-5815-D11431;TCGA-64-5815-D11434;TCGA-64-5815-D31481;TCGA-64-5815-D31482;TCGA-64-5815-D31483;TCGA-64-5815-D31484	c5c5b4f0-2f37-4d6a-b486-29c7638c00e5;96ec4fe4-fb5e-4fd3-903d-aef8816562c7;0750d485-4281-41ea-a62c-7860f4e50db9;35b6dcb0-3140-4e22-8857-a5adcc1bd27f;65568c73-1054-4a71-bb8c-ecdd22eaf03e;f1173777-7ce0-422c-8f6f-e4216233f93e;20c7f73f-0afe-4e4a-b887-93338bfd9df6;4878b403-b86b-448f-a98c-f33fb9f7ea01	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;3;3;3;3	103;103;188;188;132;132;195;195	93;93;146;146;83;83;146;146	Carboplatin;Gemzar;Alimta;Carboplatin;Gemcitabine;Carboplatin;Carboplatin;Almita	Not Available;Not Available;Not Available;Not Available;Complete Response;Complete Response;Complete Response;Complete Response	5;5;5;5;5;5;5;5	3;3;3;3;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;NO;NO;NO;NO	2011;2011;2011;2011;2012;2012;2012;2012	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-64-5815-F11425;TCGA-64-5815-F31480	a63ab9cf-8d93-4b05-b5e0-1134350e3251;986ba4af-3586-4aca-af09-a3aded054b3c	2;3	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	224;866	Not Applicable;Not Available	Not Available;1	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Unknown	Not Available;Unknown	Not Available;Not Available	5;5	Not Available;Not Available	NO;Unknown	Not Available;Post-Adjuvant Therapy	TUMOR FREE;Unknown	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	YES	Not Available	Not Available	Central Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	5815	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	76	89	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	1985	NO	YES	64	3	Lung	Alive	2011	2009	Not Available
TCGA-78-7540	66	FEMALE	1197	Lung Bronchioloalveolar Carcinoma Mucinous	Lung	Dead	T2	N0	M0	Stage IB	0	1197			Not Available				66	L-Lower	Not Applicable	TCGA-78-7540	05534064-8b43-4c82-95da-70fd83bd6560	18	-24440	Not Applicable	0	881	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-78-7540-F20484;TCGA-78-7540-F46104	ff5b85d0-1d1f-4e04-865e-c2f897aa5866;AEF11AFE-F0B6-41CA-A7A9-527C1A1BC8F0	19;2	Not Available;Not Available	Not Available;Not Available	Not Applicable;1197	881;Not Available	Not Available;Not Available	Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Unknown	Not Available;Not Available	Not Available;NO	1;8	Not Available;Not Available	Not Available;Unknown	Not Available;Unknown	Not Available;Unknown	NO;Unknown	Not Available;Complete Remission/Response	Not Available;Not Available	NO;Unknown	Alive;Dead	2012;2013	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.3	8253/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7540	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	78	1	Lung	Alive	2012	1999	Not Available
TCGA-55-8510	55	FEMALE	539	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	539			TUMOR FREE				55	R-Lower	Not Applicable	TCGA-55-8510	962fd4e7-9199-43d9-abce-e3dfa46da62c	11	-20410	Not Applicable	0	228	Not Available	Lung Adenocarcinoma	54																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8510-F57923	DA25CA2A-4E7D-4A2E-83C3-00BD003968B2	28	Not Applicable	Not Applicable	Not Applicable	539	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	3	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8510	Not Available	TUMOR FREE	90	70	NO	98	70	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	55	2	Lung	Alive	2013	2012	Not Available
TCGA-44-7671	64	MALE	889	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N0	M0	Stage IB	1	883.0		Locoregional Recurrence	TUMOR FREE				64	Not Available	Not Applicable	TCGA-44-7671	ebb33753-9d38-4368-9033-3e55f129d00d	17	-23538	Not Applicable	0	535	Not Available	Lung Adenocarcinoma	65																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;NO	Not Available;Unknown	Not Available;NO	Not Available;Not Available	TCGA-44-7671-F20565;TCGA-44-7671-F38982	ca842d9f-9ec6-407c-85fa-3d6557381f6b;9F7BD92F-14C8-42FF-BA9E-7FBBA4D0A447	17;8	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	535;889	Not Applicable;883	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Unknown	Not Available;Not Available	Not Available;NO	1;1	Not Available;Locoregional Recurrence	NO;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Convincing Imaging	NO;NO	Alive;Alive	2012;2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	7671	Not Available	TUMOR FREE	103	82	Not Available	97	76	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1995	YES	NO	44	3	Lung	Alive	2012	2010	Not Available
TCGA-91-8496	63	FEMALE	505	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T2a	NX	MX	Stage IB	0	505			Unknown				63	L-Lower	Not Applicable	TCGA-91-8496	656a5eb4-e4a5-4d21-a800-3586f4d6588b	23	-23358	Not Applicable	0	197	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-8496-F45467	7004F428-D84D-4816-B359-2D998F95C44B	15	Not Applicable	Not Applicable	Not Applicable	505	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	7	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8496	Preoperative	Unknown	Not Available	Not Available	NO	Not Available	Not Available	Unknown	NO	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2a	Not Available	YES	NO	91	1	Lung	Alive	2012	2011	Not Available
TCGA-55-8089	56	MALE	702	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1a	N0	M0	Stage IA	0	702			TUMOR FREE				56	R-Upper	Not Applicable	TCGA-55-8089	1070ff27-17c9-43dd-a4f6-daa643eb9123	17	-20576	Not Applicable	0	100	Not Available	Lung Adenocarcinoma	90																								0	Not Available	YES	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8089-F59075	C8B09023-1E19-4E25-83B5-FB60003D08F0	30	Not Applicable	Not Applicable	702	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	4	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	YES	NO	Not Available	Peripheral Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	97	No	8089	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	85	70	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	1973
TCGA-99-AA5R	70	FEMALE	658	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	658			TUMOR FREE				70	L-Lower	Not Applicable	TCGA-99-AA5R	D3E23815-7F9D-48AA-9AEF-3A1DD9D464D7	14	-25778	Not Applicable	0	189	Not Available	Lung Adenocarcinoma	47																								1	Not Available	YES	Not Available	Not Available	IHC	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-99-AA5R-F69298	BF89B2AB-9B58-4E72-9EAC-7E5FA90BA49B	31	Not Applicable	Not Applicable	Not Applicable	658	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Unknown	Not Evaluated	NO	12	Not Available	NO	Not Evaluated	Unknown	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Unknown	YES	YES	G12C	Unknown	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	46	No	AA5R	Preoperative	TUMOR FREE	Not Available	Not Available	NO	65	64	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	99	2	Lung	Alive	2014	2013	1967
TCGA-55-8505	62	MALE	440	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N2	MX	Stage IIIA	0	440			TUMOR FREE				62	R-Lower	Not Applicable	TCGA-55-8505	f59e5a76-f803-470b-910c-a897a149d939	28	-22676	Not Applicable	0	29	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-8505-D47799;TCGA-55-8505-D47801	E1832AA8-C7E7-4BF8-BF54-E7BC3EEF3619;57354507-5DEF-495C-8B74-0E7773AC1C4B	Not Available;Not Available	28;28	159;159	96;96	Cisplatin;Alimta	Complete Response;Complete Response	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8505-F47798	20147D1C-C4BA-40AF-9FF7-4122FAA97854	28	Not Applicable	Not Applicable	Not Applicable	440	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8505	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	Not Available	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T1a	Not Available	YES	NO	55	1	Lung	Alive	2012	2012	Not Available
TCGA-05-5423	65	MALE	151	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N1	M0	Stage IIB	0	151			TUMOR FREE				65	L-Upper	Not Applicable	TCGA-05-5423	33e3f736-7990-4f7a-ac35-863247566541	22	-23863	Not Applicable	0	151	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.9	8255/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	72	No	5423	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	1980	NO	YES	05	3	Lung	Alive	2011	2006	1956
TCGA-55-8614	76	MALE	536	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	536			TUMOR FREE				76	L-Upper	Not Applicable	TCGA-55-8614	a8de1beb-6296-44eb-bd63-c603f70faaf3	11	-27924	Not Applicable	0	41	Not Available	Lung Adenocarcinoma	113																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8614-F47843	FC34AC51-73E6-4D1F-9BBE-658B99CDD4D5	29	Not Applicable	Not Applicable	Not Applicable	536	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	8614	Not Evaluated	TUMOR FREE	Not Available	Not Available	NO	Not Available	94	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	1995	YES	NO	55	3	Lung	Alive	2013	2011	Not Available
TCGA-50-5946	62	MALE	1617	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1	N0	MX	Stage IA	1	221.0		Distant Metastasis	WITH TUMOR				62	R-Upper	Not Applicable	TCGA-50-5946	c95957a7-1a1a-4c8d-bb61-7c99b500f224	2	-22852	Not Applicable	0	349	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES;NO	YES;NO	NO;Not Available	YES;NO	TCGA-50-5946-F32143;TCGA-50-5946-F70455	28fbb9d8-ddc3-44a6-9f34-2ee25dbe35c3;27EC65A2-6B63-4A0F-A8E3-7C0C7905CF5F	17;16	Not Available;Not Available	221;Not Available	Not Applicable;Not Applicable	686;1617	221;811	Not Available;Not Available	Scheduled Follow-up Submission;Not Available	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	5;2	Distant Metastasis;Distant Metastasis	YES;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Progressive Disease;Progressive Disease	Biopsy with Histologic Confirmation;Convincing Imaging;Convincing Imaging	NO;NO	Alive;Alive	2012;2015	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5946	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	2009	NO	YES	50	4	Lung	Alive	2011	2010	Not Available
TCGA-05-4245	81	MALE	730	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N2	M0	Stage IIIA	1	334.0			TUMOR FREE				81	L-Upper	Not Applicable	TCGA-05-4245	03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2	22	-29647	Not Applicable	0	395	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	Not Available	Not Available	TCGA-05-4245-F36308	8B6363A9-C846-48D4-8051-2A0B97BAD585	29	Not Available	Not Available	Not Applicable	730	334	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	YES	Not Available	TUMOR FREE	NO	Not Applicable	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	32	Yes	4245	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	05	4	Lung	Alive	2010	2009	Not Available
TCGA-91-A4BD	78	MALE	603	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N1	MX	Stage IIA	0	603			TUMOR FREE				78	L-Lower	Not Applicable	TCGA-91-A4BD	0D980584-4484-4063-8243-C3CD67F6F588	5	-28544	Not Applicable	0	218	Not Available	Lung Adenocarcinoma	94																								1	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-A4BD-F58335	13A3B033-52C9-4C1F-B2FB-196BBE0A75D9	7	Not Applicable	Not Applicable	Not Applicable	603	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	4	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Unknown	NO	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A4BD	Other	TUMOR FREE	70	92	NO	Not Available	Not Available	Complete Remission/Response	YES	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b	1981	YES	NO	91	3	Lung	Alive	2013	2012	Not Available
TCGA-55-8512	41	MALE	607	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Dead	T1a	N1	M1b	Stage IV	1				WITH TUMOR				41	R-Lower	Not Applicable	TCGA-55-8512	202e5df9-69f2-432c-a59d-cc5aa176e973	11	-15266	Not Applicable	0	3	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8512-F64286	C86A17B3-ACBB-498F-8D5F-5A2A4EE2A07A	28	Not Applicable	Not Applicable	607	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	8	Not Available	NO	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Dead	2014	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES	90	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	19	No	8512	Preoperative	WITH TUMOR	Not Available	Not Available	Unknown	Not Available	Not Available	Not Applicable	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1b	N1	T1a	Not Available	YES	NO	55	2	Lung	Alive	2013	2012	1989
TCGA-NJ-A55A	76	FEMALE	15	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	15			TUMOR FREE				76	R-Lower	Not Applicable	TCGA-NJ-A55A	B8B5ED35-B299-4C1E-9226-5CA055DC7A43	27	-28022	Not Applicable	0	3	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-NJ-A55A-F50896;TCGA-NJ-A55A-F70649	C6E65920-A007-4160-A4CD-196B5F996C14;24A27E33-8F11-4A44-BDB0-D081C9BBFBE0	1;27	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	8;15	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Stable Disease;Stable Disease	Not Available;Not Available	NO;YES	11;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2013;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8550/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	25	No	A55A	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Stable Disease	NO	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1983	Not Available	Not Available	NJ	3	Lung	Alive	2013	2009	Not Available
TCGA-05-4434	67	FEMALE	457	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T4	N1	M1	Stage IV	0	457			Not Available				67	R-Lower	Not Applicable	TCGA-05-4434	d94fe32f-bedd-4f4c-9feb-fcb60d40f4bb	22	-24472	457	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	Yes	4434	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T4	Not Available	NO	YES	05	2	Lung	Dead	2010	2008	Not Available
TCGA-97-A4M6	45	FEMALE	568	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1a	N0	M0	Stage IA	0	568			Unknown				45	R-Lower	Not Applicable	TCGA-97-A4M6	31FF69B5-9E58-44DA-8326-BDFC7EE495C4	7	-16764	Not Applicable	0	185	Not Available	Lung Adenocarcinoma	92																								0	Not Available	YES	Exon 19 Deletion	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-A4M6-F57434	5B7F6A58-58A0-4D88-A6E1-339DD38CBEC4	11	Not Applicable	Not Applicable	Not Applicable	568	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	3	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Evaluated	YES	NO	Not Available	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A4M6	Preoperative	Unknown	95	116	NO	95	110	Complete Remission/Response	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	97	1	Lung	Alive	2013	2012	Not Available
TCGA-86-7954	68	FEMALE	605	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T2	N0	M0	Stage IB	0	605			TUMOR FREE				68	R-Lower	Not Applicable	TCGA-86-7954	079ae0b3-b64b-4b8e-ab7d-225b8046568c	30	-25062	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-7954-D57949;TCGA-86-7954-D57950	D1519FCC-3805-4E15-B46C-49EA3BCEEC7D;3D5B9CB0-F3CF-411C-8AFB-E3271BA29B8C	Not Available;Not Available	28;28	81;81	55;55	Carboplatin;Taxol	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-7954-F57948	F5479210-0898-47AC-989D-AD4BEE57AA48	28	Not Applicable	Not Applicable	Not Applicable	605	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	3	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8250/3	C34.3	YES	100	NO	Not Available	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	No	7954	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1971	YES	NO	86	3	Lung	Alive	2012	2011	1963
TCGA-78-7150	59	MALE	666	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	139.0			WITH TUMOR				59	L-Lower	Not Applicable	TCGA-78-7150	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	28	-21891	666	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-78-7150-D16967;TCGA-78-7150-D16965;TCGA-78-7150-D16966	c90077f8-6d30-4eaa-b791-2d8a389fdfbd;071743ff-ba4b-4208-8816-a453c02c436e;a4b1e4fb-299c-4c6f-9057-96dc3d724a7c	Not Available;Not Available;Not Available	28;28;28	642;397;397	607;285;285	Paclitaxel;Carboplatin;Gemcitabine	Not Available;Not Available;Not Available	9;9;9	2;5;5	140;615;1800	mg/m2;AUC;mg	RECURRENCE;PALLIATIVE;PALLIATIVE	Not Applicable;Not Applicable;Not Applicable	3;1;2	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	700;2475;14180	mg/m2;mg;mg/m2	Not Available;Not Available;Not Available	2011;2011;2011	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	YES	YES	NO	YES	TCGA-78-7150-F16962	09ad8f79-3e06-43f3-9c00-cd8c7e87bdcc	28	Not Available	164	666	Not Available	139	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	9	Not Available	YES	Not Available	WITH TUMOR	NO	Not Available	Not Available	NO	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	37	No	7150	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant Recurrence;Distant Recurrence	TCGA-78-7150-R16964;TCGA-78-7150-R16963	969f1a71-c4c4-48e8-8589-faa544fa5515;65e0a687-005d-4fb1-aa3b-fb9f84bb7dc5	2;1	28;28	546;189	531;185	Not Available;Not Available	9;9	10;5	2500;2000	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	RECURRENCE;PALLIATIVE	Not Available;Not Available	cGy;cGy	2011;2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	2000	NO	YES	78	4	Lung	Dead	2011	2002	1963
TCGA-62-A470	84	MALE	1194	Lung Acinar Adenocarcinoma	Lung	Dead	T2	N0	M0	Stage IB	1	539.0		Locoregional Recurrence	WITH TUMOR				84	R-Upper	Not Applicable	TCGA-62-A470	E60A8F8A-0FE6-40E5-9F30-BCFF48AC73F4	30	-30689	1194	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	100	NO	Not Available	Not Available	Central Lung	10	NO	YES	539	NO	Not Available	Not Available	Not Available	Locoregional Recurrence	Convincing Imaging	YES	30	No	A470	Preoperative	WITH TUMOR	Not Available	Not Available	NO	74	111	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	62	3	Lung	Dead	2012	2009	Not Available
TCGA-69-8255	71	MALE	129	Lung Solid Pattern Predominant Adenocarcinoma	Lung	Alive	T1a	N0	M0	Stage IA	0	129			Unknown				71	R-Upper	Not Applicable	TCGA-69-8255	552712d3-da16-441e-ba93-11810793d598	4	-26289	Not Applicable	0	129	Not Available	Lung Adenocarcinoma	60																								Not Available	Not Available	YES	Other	Not Available	Not Available	NO	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-8255-F32611	C4D99C65-5914-401C-9071-C2ED9877F39C	4	Not Applicable	Not Applicable	Not Applicable	129	Not Applicable	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	6	Not Available	NO	Not Available	Not Available	NO	Unknown	Not Available	NO	Alive	2012	MALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.1	8230/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	8255	Not Available	Unknown	Not Available	60	NO	Not Available	57	Unknown	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	69	2	Lung	Alive	2012	2011	1971
TCGA-55-8208	73	FEMALE	674	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	1	511.0		Distant Metastasis	TUMOR FREE				73	R-Upper	Not Applicable	TCGA-55-8208	77f8c850-b4e6-46a1-ab12-a50e0044a0c8	13	-26716	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	50																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Unknown	YES	Not Available	YES	TCGA-55-8208-F59045	6F292E9C-8A64-4D70-B169-8AE2D8E32EB1	30	Not Available	536	Not Applicable	674	511	Unknown	Scheduled Follow-up Submission	Stable Disease	Unknown	YES	4	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Biopsy with Histologic Confirmation;Convincing Imaging	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	Not Available	Not Available	Not Available	Peripheral Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	50	No	8208	Preoperative	TUMOR FREE	68	151	Unknown	72	156	Complete Remission/Response	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	55	2	Lung	Alive	2012	2012	Not Available
TCGA-50-5051	42	FEMALE	478	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	1	184.0		Distant Metastasis	TUMOR FREE				42	L-Upper	Not Applicable	TCGA-50-5051	e1c55bac-bb41-4964-add5-ecd6ba04b58d	25	-15585	Not Applicable	0	455	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5051-D32021;TCGA-50-5051-D32022	487b2e04-b00a-4221-b759-d6496965c6d9;f3f3dcc2-08bc-4d5d-9293-f608b65f06e9	Not Available;Not Available	15;15	123;123	62;62	Carboplatin;Taxol	Partial Response;Partial Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-50-5051-F32019	c0485b95-039c-4102-9293-f2829790b4f3	15	Not Available	Not Available	478	Not Available	184	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Distant Metastasis	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Convincing Imaging	YES	Dead	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	YES	Other	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	5051	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-50-5051-R32020	47ffdbd3-4e1b-4e78-b229-1e3cf0b787d6	01	15	124	71	Not Available	5	33	5490	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	2006	NO	YES	50	4	Lung	Alive	2011	2007	Not Available
TCGA-55-7910	50	FEMALE	1040	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N0	M0	Stage IIA	1	1018.0			WITH TUMOR				50	L-Lower	Not Applicable	TCGA-55-7910	b2bc53d6-ef78-4ae9-a6b5-1c7cad9a43eb	10	-18289	Not Applicable	0	203	Not Available	Lung Adenocarcinoma	44	TCGA-55-7910-D66141	76D8449C-257D-474B-A830-EDE15DAE2DDD	Not Available	3	Not Available	253	Cisplatin	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	YES	Unknown	Unknown	TCGA-55-7910-F66140	50A3A722-AEC7-4FBC-AFDA-7B45FEA1263A	3	Not Available	Not Available	Not Applicable	1040	1018	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	10	Not Available	YES	Not Available	WITH TUMOR	YES	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	80	Not Available	Not Available	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	No	7910	Preoperative	WITH TUMOR	91	91	Not Available	97	86	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available	Unknown	TCGA-55-7910-R66142	ACCCBE41-BDFD-4BDF-9192-6EF3399B09D5	Not Available	3	Not Available	1040	Not Applicable	10	Not Available	Not Available	YES	External	Not Applicable	Not Available	Not Available	Not Available	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	2011	YES	NO	55	4	Lung	Alive	2012	2011	1996
TCGA-38-7271	72	FEMALE	800	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	1	304.0			WITH TUMOR				72	R-Upper	Not Applicable	TCGA-38-7271	8214a0d1-5e2d-4a7a-acb1-e5580755db83	10	-26440	800	0	Not Available	Not Available	Lung Adenocarcinoma	76	TCGA-38-7271-D18306;TCGA-38-7271-D18311;TCGA-38-7271-D18310	39b80d4f-cb2c-42f3-9e88-32dadd933c17;be281462-f8ee-4c19-95d2-3a8f7295265f;fac1fe79-b59c-4d7b-b36a-89b3c8e29166	Not Available;Not Available;Not Available	10;10;10	371;623;574	329;574;574	Cisplatin;Alimta;Carboplatin	Not Available;Not Available;Not Available	11;11;11	3;2;1	30;500;Not Available	mg/m2;mg/m2;AUC	RECURRENCE;PALLIATIVE;PALLIATIVE	Not Applicable;Not Applicable;Not Applicable	1;2;2	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	324;1760;798	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;YES;NO	YES;YES;YES	NO;NO;NO	Not Available;NO;NO	TCGA-38-7271-F18305;TCGA-38-7271-F18308;TCGA-38-7271-F18312	f7734211-9e7c-43ca-90e7-5c8de6e7bfee;24d3b53b-221b-4620-9d62-d627741e2a70;620bde19-e077-43c4-b7e0-f3b00df96316	10;10;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	800;800;800	Not Available;Not Available;Not Available	304;561;633	Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Stable Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	11;11;11	Not Available;Not Available;Not Available	YES;YES;YES	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;Not Available;Not Available	Complete Remission/Response;Not Available;Not Available	Not Available;Not Available;Not Available	NO;Not Available;Not Available	Dead;Dead;Dead	2011;2011;2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	Yes	7271	Not Available	WITH TUMOR	46	45	Not Available	43	40	Not Available	YES	WHITE	Not Available	Distant site;Distant site;Local Recurrence	TCGA-38-7271-R18309;TCGA-38-7271-R18313;TCGA-38-7271-R18307	06943636-0118-4a9a-80ad-eda14819da97;a027a42b-2d51-47e7-9dcf-60f81b2d234d;a8e5e91e-4df7-465e-88b0-eb30765f0f30	2;3;1	10;10;10	564;665;379	564;633;329	Not Available;Not Available;Not Available	11;11;11	1;14;23	2000;2500;7000	NO;NO;NO	OTHER;EXTERNAL BEAM;EXTERNAL BEAM	Cyber Knife Stereotactic Radiosurgery;Not Applicable;Not Applicable	PALLIATIVE;PALLIATIVE;RECURRENCE	Not Available;Not Available;Not Available	cGy;cGy;cGy	2011;2011;2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1999	NO	YES	38	4	Lung	Dead	2011	2006	1971
TCGA-86-8585	57	MALE	353	Lung Solid Pattern Predominant Adenocarcinoma	Lung	Alive	T2a	N0	M0	Stage IB	0	353			TUMOR FREE				57	L-Upper	Not Applicable	TCGA-86-8585	2f1a4b16-104c-40eb-8114-8245847bb716	30	-20918	Not Applicable	0	35	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	NO	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8585-F46400	FCD3444C-82E2-4973-B06F-3F0471930298	19	Not Applicable	Not Applicable	Not Applicable	353	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	YES	9	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.1	8230/3	C34.1	YES	Unknown	NO	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	8585	Unknown	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	86	1	Lung	Alive	2012	2012	Not Available
TCGA-86-8075	66	FEMALE	694	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	199.0		Locoregional Recurrence	TUMOR FREE				66	L-Upper	Not Applicable	TCGA-86-8075	8869000d-09d7-465a-ac32-54d1935c43e7	16	-24402	Not Applicable	0	43	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-8075-D41680;TCGA-86-8075-D41681;TCGA-86-8075-D41682	3C971D88-EA87-4F2F-893C-B7BB558C402E;7E6A245F-8FC9-4F05-BA87-C6FC12A202EB;9C62E82D-EABF-452D-9CE1-6F3146D45E6C	Not Available;Not Available;Not Available	25;25;25	364;364;Not Available	201;201;388	Etoposide;Cisplatin;Gefitinib	Complete Response;Complete Response;Not Applicable	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;Not Available	NO;Not Available	NO;Not Available	NO;Not Available	TCGA-86-8075-F41679;TCGA-86-8075-F63521	686D13D9-B93A-4157-9E8D-B441EA26F6D0;B67D4CCB-D243-4337-B31E-BE40BFD0ED38	25;12	Not Available;Not Applicable	Not Available;Not Applicable	Not Applicable;694	479;Not Available	199;Not Applicable	1;1	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Applicable;Complete Remission/Response	90;90	NO;NO	3;8	Locoregional Recurrence;Not Available	YES;NO	Pre-Adjuvant Therapy;Preoperative	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Biopsy with Histologic Confirmation;Not Available	NO;NO	Alive;Dead	2013;2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	8075	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	86	1	Lung	Alive	2012	2011	Not Available
TCGA-73-4676	45	MALE	281	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N1	M0	Stage IIA	1				TUMOR FREE				45	R-Upper	Not Applicable	TCGA-73-4676	195a5afb-b79f-44d2-9d12-884487630c2b	18	-16746	Not Applicable	0	122	Not Available	Lung Adenocarcinoma	86	TCGA-73-4676-D12586;TCGA-73-4676-D12585;TCGA-73-4676-D12587;TCGA-73-4676-D12556	48957710-70e7-4615-9717-fb2a9174b210;0989c0d2-81e6-4f78-93b4-3a7f35ba221b;1eba36d1-01f8-4cd4-b90d-98cc949417f0;da213998-af4a-4a37-967e-419359cab836	Not Available;Not Available;Not Available;Not Available	2;2;2;2	66;-40;66;-40	45;-74;45;-74	Docetaxel;Cisplatin;Cisplatin;Docetaxel	Not Available;Not Available;Not Available;Not Available	6;6;6;6	2;3;2;3	Not Available;75;Not Available;75	mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;neo-adjuvant;Not Applicable;neo-adjuvant	2;1;2;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;225;Not Available;225	mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-73-4676-F12553;TCGA-73-4676-F71022	f8c9076a-23b2-4792-bcbc-c88d250d1ff3;B89F1AE8-D8B3-4B9D-9B4F-D3F9F887FFF9	18;18	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;281	164;Not Available	Not Applicable;Not Available	0;Unknown	Not Available;Scheduled Follow-up Submission	Not Available;Unknown	90;Unknown	Not Available;NO	5;3	Not Available;Not Available	NO;Unknown	Adjuvant therapy;Unknown	Not Available;WITH TUMOR	YES;YES	Not Available;Unknown	Not Available;Not Available	YES;YES	Alive;Dead	2011;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Yes	C34.1	8140/3	C34.1	YES	70	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	48	No	4676	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	67	78	Not Available	YES	WHITE	Not Available	Primary Tumor Field	TCGA-73-4676-R12555	04a28cdd-15da-414f-8481-8b42047187f6	1	2	125	Not Available	Not Available	6	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	2009	NO	YES	73	4	Lung	Alive	2011	2010	1977
TCGA-50-5933	72	MALE	2393	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T4	N2	M0	Stage IIIB	0	2393			TUMOR FREE				72	L-Lower	Not Applicable	TCGA-50-5933	7a0ea814-f0de-4bc4-a81a-daa000559369	2	-26377	2393	0	2370	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5933-D32106;TCGA-50-5933-D32107	668c16ce-1cba-4ca4-bccf-1a6e757231c0;69084794-9ae1-4394-bad1-f449c2205282	Not Available;Not Available	17;17	210;210	189;189	Carboplatin;Taxol	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-50-5933-F32104	ceeea662-3e16-4daf-bcf0-50f8d50e75ea	17	Not Applicable	Not Applicable	2393	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	YES	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5933	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-50-5933-R32105	e36e75c7-b427-4319-b831-13118a2a146a	1	17	215	171	Not Available	5	30	5400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T4	Not Available	NO	YES	50	Not Available	Lung	Dead	2011	2001	Not Available
TCGA-73-4675	59	MALE	922	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N1	M0	Stage IIIA	1	361.0		Locoregional Recurrence	TUMOR FREE				59	L-Lower	Not Applicable	TCGA-73-4675	ae39e358-08d7-4367-ae68-82b469e791e4	7	-21614	Not Applicable	0	40	Not Available	Lung Adenocarcinoma	69	TCGA-73-4675-D71056;TCGA-73-4675-D71057;TCGA-73-4675-D71058;TCGA-73-4675-D71059;TCGA-73-4675-D71060;TCGA-73-4675-D71061;TCGA-73-4675-D71062	13B8CCE4-8461-4A03-A567-E5922A9A11A4;3C9951FA-7567-4A17-8ED5-031F790060D7;25DC92F4-A154-4196-9D5F-4BE559E42ABA;1C265224-D738-4F25-8103-9B037F9C9447;DC1FC3CB-3680-4D2A-86C2-B9DBC184D6BC;08130C1E-5BB6-4080-939E-11D5E4215EEF;3BF6C8DC-1CB9-4686-987C-7DA51220B8A3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17;17;17	482;117;104;483;483;483;676	110;27;27;459;459;459;592	Carboplatin;Alimta;Cisplatin;Carboplatin;Taxotere;Avastin;Tarceva	Complete Response;Complete Response;Complete Response;Stable Disease;Stable Disease;Stable Disease;Clinical Progressive Disease	3;3;3;3;3;3;3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO	2015;2015;2015;2015;2015;2015;2015	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;YES	Not Available;NO	Not Available;NO	Not Available;Not Available	TCGA-73-4675-F8551;TCGA-73-4675-F71055	05da2e27-6b81-4a1f-887c-1a42d8bc1786;AC8B9FDB-A4DE-4944-94BF-6BB1CAF80003	7;17	Not Available;Not Available	Not Available;Not Available	Not Applicable;922	40;Not Available	Not Available;361	0;Unknown	Not Available;Scheduled Follow-up Submission	Not Available;Progressive Disease	Not Available;Unknown	Not Available;NO	1;3	Not Available;Locoregional Recurrence	Not Available;YES	Pre-Adjuvant Therapy;Unknown	TUMOR FREE;Unknown	Not Available;YES	Not Available;Progressive Disease	Not Available;Convincing Imaging	Not Available;NO	Alive;Dead	2011;2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	41	No	4675	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	55	66	Not Available	YES	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	2010	NO	YES	73	4	Lung	Alive	2011	2010	1969
TCGA-55-6987	77	MALE	2137	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	2137			TUMOR FREE				77	L-Lower	Not Applicable	TCGA-55-6987	2efc156c-464a-4c2f-a854-39fefe32081c	27	-28382	Not Applicable	0	1170	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-6987-F47803	18F46E93-2092-4031-B41F-BDDD78B2223D	28	Not Applicable	Not Applicable	Not Applicable	2137	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6987	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2006	NO	YES	55	4	Lung	Alive	2011	2006	Not Available
TCGA-50-5055	79	FEMALE	1830	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1	N1	M0	Stage IIA	1	771.0		Locoregional Recurrence	WITH TUMOR				79	L-Lower	Not Applicable	TCGA-50-5055	cc3d9750-7ce0-489f-86d4-8017b7ebed29	2	-28988	Not Applicable	0	785	Not Available	Lung Adenocarcinoma	Not Available	TCGA-50-5055-D40457;TCGA-50-5055-D41755;TCGA-50-5055-D41761;TCGA-50-5055-D41762;TCGA-50-5055-D41763;TCGA-50-5055-D41764	851C0D83-B6C9-427B-A391-46ED77BABB58;7404E87B-2128-4132-AB47-14402C1130F0;9AAF3C36-BC75-459E-9B70-00E485E07138;53DEAEDA-8DF5-4023-9F27-12DD16A6A2C1;C6E4C339-ED92-49E9-BE3C-37BFC3B9D570;3B8F2796-A1BC-4B2A-AC33-8108523F87C6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27	153;1284;1284;1522;1649;Not Available	31;1135;1135;1284;1522;1649	Not specified;CARBOPLATIN;PACLITAXEL;ALIMTA;TARCEVA;TAXOTERE	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	3;3;3;3;3;3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Not Available;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES	YES	YES	NO	TCGA-50-5055-F32023	b971489c-681a-4176-861a-5190efe60761	15	792	Not Available	1830	Not Available	771	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	5	Locoregional Recurrence;Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Stable Disease	Biopsy with Histologic Confirmation;Convincing Imaging	NO	Dead	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	YES	NO	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5055	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1	Not Available	NO	YES	50	Not Available	Lung	Alive	2011	2008	Not Available
TCGA-MN-A4N5	63	MALE	84	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1a	N0	M0	Stage IA	0	84			Unknown				63	L-Upper	Not Applicable	TCGA-MN-A4N5	17E09B0D-EAB2-40EC-AE3C-BE9AB63FCEF0	4	-23257	Not Applicable	0	84	Not Available	Lung Adenocarcinoma	82																								0	Not Available	YES	Not Available	Not Available	IHC	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-MN-A4N5-F56665	7484D5CB-5D52-4177-9FF8-CC427340FC45	17	Not Applicable	Not Applicable	Not Applicable	84	Not Applicable	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	2	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	NO	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	A4N5	Preoperative	Unknown	Not Available	Not Available	NO	77	105	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	2011	NO	YES	MN	4	Lung	Alive	2012	2011	1971
TCGA-38-A44F	80	MALE	133	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N0	M0	Stage IB	0	133			TUMOR FREE				80	R-Upper	Not Applicable	TCGA-38-A44F	258A3A41-211B-4C66-BD3B-EF03014A6967	31	-29534	Not Applicable	0	133	Not Available	Lung Adenocarcinoma	35																								Not Evaluated	Not Available	NO	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-38-A44F-F47557	25815E78-A0C8-4308-9087-3C032BCFED78	26	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	8	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Alive	2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8550/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	12	No	A44F	Not Available	TUMOR FREE	71	Not Available	NO	72	52	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1977	YES	NO	38	3	Lung	Alive	2012	2012	1965
TCGA-55-6971	59	FEMALE	1400	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	0	1400			TUMOR FREE				59	L-Lower	Not Applicable	TCGA-55-6971	8d0736fe-261c-445c-bfd2-a3ea3ceaf367	28	-21734	Not Applicable	0	25	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-55-6971-F56190	12A8DE46-0514-47CB-A544-77296F337007	29	Not Applicable	Not Applicable	Not Applicable	1400	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	1	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	No	6971	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	2010	NO	YES	55	4	Lung	Alive	2011	2010	1970
TCGA-69-7974	54	FEMALE	184	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N2	MX	Stage IIIA	1				WITH TUMOR				54	L-Upper	Not Applicable	TCGA-69-7974	3e1df30f-744a-41e9-a169-7dbbff66622e	9	-20021	Not Applicable	0	184	Not Available	Lung Adenocarcinoma	Not Available	TCGA-69-7974-D30366;TCGA-69-7974-D30368;TCGA-69-7974-D30370	FF1F92D3-3742-477D-8C65-C4AC2811A0C2;E368B4BF-E5C5-4E85-BDA5-8A7A50246BA7;D76675FA-0F02-4B08-91C1-D014BBC62EF2	Not Available;Not Available;Not Available	9;9;9	54;96;96	33;33;75	Cisplatin;Pemetrexed;Carboplatin	Unknown;Clinical Progressive Disease;Clinical Progressive Disease	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	YES	Other	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-69-7974-F30365	21EB1C00-AEF8-466D-B783-A523818D00B2	9	Not Applicable	Not Applicable	Not Applicable	184	Not Applicable	Not Available	Scheduled Follow-up Submission	Progressive Disease	80	Not Available	4	Not Available	NO	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Not Available	YES	Alive	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	80	Not Available	Not Available	Not Available	Peripheral Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	7974	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	58	47	Not Available	YES	WHITE	Not Available	Regional site	TCGA-69-7974-R30373	5051D4B2-CA36-4831-B8B9-975261929A95	1	9	Not Available	141	Not Available	4	30	6000	YES	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T2a	2011	NO	YES	69	4	Lung	Alive	2012	2011	1981
TCGA-44-6779	50	FEMALE	500	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	MX	Stage IIB	1	232.0			WITH TUMOR				50	Discrepancy	Not Available	TCGA-44-6779	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	31	-18469	500	0	Not Available	Not Available	Lung Adenocarcinoma	44	TCGA-44-6779-D16019;TCGA-44-6779-D16027;TCGA-44-6779-D16021;TCGA-44-6779-D16023	cf85260a-95a7-40dd-85dc-fe3146f7e584;53ef5ace-fd50-4f47-a1ff-3a77d45be688;4d765560-c992-4deb-be5c-3f95e52efc0a;ea0269ad-e8e3-4fa6-a6fd-adc142fc13a0	Not Available;Not Available;Not Available;Not Available	12;12;12;12	141;435;141;303	77;391;77;257	Taxol;Gemcitabine;Carboplatin;Taxotere	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;5;4;3	340;1600;650;130	mg;mg;mg;mg	ADJUVANT;PROGRESSION;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;1;2	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1360;8000;2600;390	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	NO	NO	Not Available	TCGA-44-6779-F15758	8f506af0-e7ee-46c3-b57c-ab3eace80f10	12	Not Available	Not Available	500	Not Available	232	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	9	Not Available	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	No	6779	Not Available	WITH TUMOR	83	48	Not Available	83	49	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2	2008	NO	YES	44	4	Lung	Dead	2011	2008	1978
TCGA-MP-A4TC	77	MALE	74	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N2	M0	Stage IIIA	0	74			TUMOR FREE				77	R-Middle	Not Applicable	TCGA-MP-A4TC	99C35245-E1C8-4805-B7A5-F703BB506030	2	-28471	74	0	Not Available	Not Available	Lung Adenocarcinoma	68	TCGA-MP-A4TC-D41397;TCGA-MP-A4TC-D41398	2D936FD6-139F-4EBD-9EAB-D843254E987A;ED1C314A-2C4D-4A19-A6A2-0FB17145C3E5	Not Available;Not Available	18;18	25;25	25;25	Cisplatin;Navelbine	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	125	Yes, History of Prior Malignancy	A4TC	Not Evaluated	TUMOR FREE	Not Available	76	YES	Not Available	83	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T1	1976	NO	YES	MP	3	Lung	Dead	2013	2008	1944
TCGA-55-8302	54	MALE	478	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	0	478			TUMOR FREE				54	R-Lower	Not Applicable	TCGA-55-8302	807cc7d2-6e3b-4f2d-9531-0da994eeeada	3	-20011	Not Applicable	0	23	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	TCGA-55-8302-F56188	D21EFBC3-C259-4902-A3EB-2E4DD065185A	29	Not Applicable	Not Applicable	Not Applicable	478	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	1	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Unknown	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	59	No	8302	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	Not Available	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	Not Available	YES	NO	55	2	Lung	Alive	2012	2012	1965
TCGA-67-3774	73	FEMALE	385	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	385			TUMOR FREE				73	L-Lower	Not Applicable	TCGA-67-3774	36ad7fc7-0cc1-4f01-aef1-f89b3cb4feac	3	-26704	Not Applicable	0	385	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	3774	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	YES	NO	67	3	Lung	Alive	2011	2009	Not Available
TCGA-55-A493	54	FEMALE	28	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	28			TUMOR FREE				54	R-Upper	Not Applicable	TCGA-55-A493	E43A2B72-35C6-4466-9007-CE96CAF77EA8	21	-20027	Not Applicable	0	28	Not Available	Lung Adenocarcinoma	102																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	53	No	A493	Not Evaluated	TUMOR FREE	71	2	Unknown	65	2	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	55	2	Lung	Alive	2013	2012	1977
TCGA-50-7109	60	MALE	308	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	1	15.0		Distant Metastasis	Not Available				60	R-Lower	Not Applicable	TCGA-50-7109	7eb540b4-8dd3-4382-a488-e48b1c7213b3	9	-21979	Not Applicable	0	255	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-50-7109-F44136	DE5C9A3D-232A-4614-AA6C-B1156B85E208	13	Not Available	Not Available	308	Not Available	15	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	6	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Convincing Imaging	NO	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	120	No	7109	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	NO	YES	50	2	Lung	Alive	2012	2011	Not Available
TCGA-55-6982	79	FEMALE	995	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	1	183.0		Distant Metastasis	WITH TUMOR				79	R-Lower	Not Applicable	TCGA-55-6982	35cb7841-9b09-465a-90c5-e3b8a9faad49	26	Not Available	995	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-6982-D46628;TCGA-55-6982-D46629;TCGA-55-6982-D46637	51A05329-99B3-4DE3-BEEC-F7B7584AEE8C;F2442589-3EA6-4F5B-AA58-D61A68517EBF;8D09A550-760E-4CF9-8FC7-95C7C2613527	Not Available;Not Available;Not Available	13;13;13	Not Available;Not Available;939	397;397;698	Gemzar;Navelbine;Tarceva	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	YES	YES	NO	YES	TCGA-55-6982-F46626	482B5DF1-D91C-483A-ACE3-C2C65F5FA3DD	13	Not Available	183	995	Not Available	183	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	8	Distant Metastasis	YES	Not Evaluated	WITH TUMOR	NO	Progressive Disease	Convincing Imaging	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6982	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-55-6982-R46627	BC037851-C729-42AC-B820-0FCC9D22FA88	Not Available	13	687	642	Radiographic Progressive Disease	8	25	03500	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	55	1	Lung	Dead	2011	2004	Not Available
TCGA-86-8074	62	FEMALE	24	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N1	M0	Stage IIA	0	24			TUMOR FREE				62	L-Lower	Not Applicable	TCGA-86-8074	482eb2a7-6fed-4e4c-b1b6-14d6d869f855	9	-22862	Not Applicable	0	24	Not Available	Lung Adenocarcinoma	Not Available																								2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-8074-F41667	69D69C1B-6691-4BAA-A3F5-3E34CBD24E19	26	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	YES	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8260/3	C34.3	YES	80	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	40	No	8074	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	Not Available	YES	NO	86	2	Lung	Alive	2012	2011	1970
TCGA-69-A59K	60	FEMALE	591	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T3	N0	M0	Stage IIB	0	591			TUMOR FREE				60	R-Upper	Not Applicable	TCGA-69-A59K	67FA3E41-C7C6-44C5-9E67-6BCB2715AACC	18	-22093	Not Applicable	0	214	Not Available	Lung Adenocarcinoma	75	TCGA-69-A59K-D40359;TCGA-69-A59K-D40360	095F50E9-408C-4353-B7D6-339A2BBC1895;EE6D5CA4-FDD0-45B6-A767-D5B34DE311ED	Not Available;Not Available	18;18	135;135	72;72	cisplatin;pemetrexed	Stable Disease;Stable Disease	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	2	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-69-A59K-F56712;TCGA-69-A59K-F57660	5E0B884C-C335-4788-8FFF-1F4CF6565627;6D298071-0FB0-40B6-A0D9-43F6B40F136C	19;19	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	591;522	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Applicable;Not Applicable	Not Available;Not Available	NO;NO	2;3	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Stable Disease;Stable Disease	Not Available;Not Available	NO;NO	Alive;Alive	2014;2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Unknown	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	25	No	A59K	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	120	YES	Not Available	118	Stable Disease	YES	BLACK OR AFRICAN AMERICAN	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	2012	YES	NO	69	4	Lung	Alive	2013	2012	1999
TCGA-55-8090	80	MALE	598	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1a	N0	M0	Stage IA	1	548.0		Distant Metastasis	WITH TUMOR				80	R-Lower	Not Applicable	TCGA-55-8090	4d51ee44-e6f4-4bcb-be28-e9df54b39a8d	8	-29235	Not Applicable	0	6	Not Available	Lung Adenocarcinoma	58																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	NO	TCGA-55-8090-F56189	05C48DBC-1101-4B07-947B-180BC0D657EE	29	Not Available	Not Available	598	Not Available	548	Unknown	Scheduled Follow-up Submission	Progressive Disease	Unknown	NO	1	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Synchronous/Bilateral Malignancy	8090	Not Available	WITH TUMOR	4	6	Unknown	103	83	Complete Remission/Response	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	Not Available
TCGA-97-A4M2	66	MALE	624	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1a	N0	M0	Stage IA	0	624			TUMOR FREE				66	R-Middle	Not Applicable	TCGA-97-A4M2	345AEF28-D49B-491B-A337-B1AC55C37D35	7	-24313	Not Applicable	0	197	Not Available	Lung Adenocarcinoma	91																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-A4M2-F57453	C19E7A8D-1092-4915-BC25-8935E50F3DA1	12	Not Applicable	Not Applicable	Not Applicable	624	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	3	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES	Not Evaluated	YES	NO	Not Available	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	100	Yes, History of Prior Malignancy	A4M2	Preoperative	TUMOR FREE	89	103	NO	96	102	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	Not Available	YES	NO	97	2	Lung	Alive	2013	2012	1972
TCGA-MP-A4T9	54	FEMALE	1265	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	MX	Stage IIIA	1	341.0		Locoregional Recurrence	WITH TUMOR				54	L-Upper	Not Applicable	TCGA-MP-A4T9	70081320-540F-41D2-8687-EE6D011F8EB0	2	-19767	1265	0	Not Available	Not Available	Lung Adenocarcinoma	106	TCGA-MP-A4T9-D41350;TCGA-MP-A4T9-D41351;TCGA-MP-A4T9-D41352	C9F75A26-D387-48A4-BA06-A9D5C58CA315;758F08E1-B373-4964-9966-691B1D562B6C;ECBC2354-5C73-46FD-94A7-D519D192334F	Not Available;Not Available;Not Available	15;15;15	55;55;62	34;34;62	Vinorelbine;Cisplatin;Gemcitabine	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;YES;NO	YES;YES;NO	Not Available;Not Available;YES	YES;NO;Not Available	TCGA-MP-A4T9-F41355;TCGA-MP-A4T9-F41356;TCGA-MP-A4T9-F41357	714B05C6-BB16-44AD-8A30-BA165B380950;CF943926-D77C-4F79-B844-7E46E5029D58;5FB23630-A7A5-4A7D-9CF1-AFE2A8EBD806	15;15;15	Not Available;Not Available;1255	938;Not Available;Not Available	1265;1265;1265	Not Available;Not Available;Not Available	418;889;1248	Not Evaluated;Not Evaluated;Not Evaluated	Additional New Tumor Event;Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Partial Remission/Response;Progressive Disease	Not Evaluated;Not Evaluated;Not Evaluated	NO;NO;NO	3;3;3	Distant Metastasis;Distant Metastasis;Locoregional Recurrence	YES;YES;YES	Not Evaluated;Not Evaluated;Not Evaluated	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Biopsy with Histologic Confirmation;Convincing Imaging;Biopsy with Histologic Confirmation	YES;YES;YES	Dead;Dead;Dead	2013;2013;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	NO	YES	341	NO	Not Available	NO	Not Available	Locoregional Recurrence;Distant Metastasis	Convincing Imaging	YES	24	No	A4T9	Unknown	WITH TUMOR	Not Available	105	YES	Not Available	99	Complete Remission/Response	YES	WHITE	YES	Primary Tumor Field	TCGA-MP-A4T9-R41353	8CE9F14D-8BF0-438D-94D0-89396D078E74	Not Available	15	166	132	Complete Response	3	25	5000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T2	2004	NO	YES	MP	4	Lung	Dead	2013	2006	1980
TCGA-MP-A4TK	56	FEMALE	582	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	MX	Stage IIB	1	397.0		Distant Metastasis	WITH TUMOR				56	R-Lower	Not Applicable	TCGA-MP-A4TK	F7F9F522-DE88-4F9C-8BA4-7BE3726FAAF8	2	-20581	582	0	Not Available	Not Available	Lung Adenocarcinoma	88																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Unknown	YES	YES	Not Available	NO	TCGA-MP-A4TK-F41426	445D9B7D-F0FC-4879-AC28-B16DC3E929A5	18	Not Available	Not Available	582	Not Available	545	Not Evaluated	Additional New Tumor Event	Progressive Disease	Not Evaluated	NO	3	Distant Metastasis	YES	Not Evaluated	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	NO	YES	397	Not Available	Not Available	NO	Not Available	Distant Metastasis	Biopsy with Histologic Confirmation	YES	28	No	A4TK	Not Evaluated	WITH TUMOR	Not Available	64	NO	Not Available	57	Complete Remission/Response	YES	Unknown	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2	1999	NO	YES	MP	4	Lung	Dead	2013	2002	1971
TCGA-91-6849	75	FEMALE	35	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N2	MX	Stage IIIA	0	35			Not Available				75	L-Upper	Not Applicable	TCGA-91-6849	953a908d-0993-42f6-853b-512611d19a2c	20	-27676	Not Applicable	0	35	Not Available	Lung Adenocarcinoma	66																								Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-6849-F32642	7A852ADD-9BFF-47D8-8ACB-A7FAAB892A7C	5	Not Available	Not Available	Not Applicable	35	Not Available	Unknown	Scheduled Follow-up Submission	Unknown	Unknown	YES	6	Not Available	Unknown	Not Available	Unknown	Unknown	Unknown	Not Available	Unknown	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	6849	Preoperative	Not Available	75	86	Not Available	76	88	Not Available	YES	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T2	1976	NO	YES	91	3	Lung	Alive	2011	2009	1946
TCGA-50-6593	49	FEMALE	336	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1	N2	M0	Stage IIIA	1	266.0		Distant Metastasis	WITH TUMOR				49	R-Upper	Not Applicable	TCGA-50-6593	e10568fe-0436-43f2-9f0f-48f9903868c4	25	-18152	336	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	NO	NO	Not Available	NO	TCGA-50-6593-F43840	BB824133-F8BB-4916-968D-86355FA69BA7	13	Not Available	Not Available	336	Not Available	266	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	6	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Convincing Imaging	YES	Dead	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6593	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Primary Tumor Field	TCGA-50-6593-R44122	CAA51D9B-D706-4474-8194-EC7E82AFBF1E	Not Available	13	210	173	Radiographic Progressive Disease	6	27	5400	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T1	Not Available	NO	YES	50	4	Lung	Dead	2011	2008	Not Available
TCGA-95-7043	63	FEMALE	503	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1a	N0	MX	Stage IA	1				TUMOR FREE				63	R-Upper	Not Applicable	TCGA-95-7043	c650b1ff-8a4c-4ee9-b7c1-268c28c83827	Not Available	-23165	Not Applicable	0	2	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-95-7043-F15630;TCGA-95-7043-F40744;TCGA-95-7043-F67188	436c5e80-a001-43df-9fa0-09e27e2b6b94;F13DCB77-68C2-46E3-9F52-B436E8BEFDEE;6DDC89F9-3685-44FF-A873-4F8A039C96C7	Not Available;15;31	Not Applicable;Not Available;Not Available	Not Applicable;Not Available;Not Available	Not Applicable;Not Applicable;503	2;37;Not Available	Not Applicable;Not Available;Not Available	Not Available;Not Available;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Unknown;Progressive Disease	Not Available;Not Available;Unknown	Not Available;YES;NO	8;3;10	Not Available;Not Available;Not Available	NO;Not Available;Unknown	Not Available;Not Available;Not Available	TUMOR FREE;Not Available;WITH TUMOR	YES;Not Available;YES	Complete Remission/Response;Not Available;Complete Remission/Response	Not Available;Not Available;Not Available	NO;Not Available;Unknown	Alive;Alive;Dead	2011;2013;2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	Yes	7043	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	2003	YES	NO	95	4	Lung	Alive	2011	2011	1964
TCGA-55-7724	76	FEMALE	705	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	705			TUMOR FREE				76	L-Upper	Not Applicable	TCGA-55-7724	294cb595-0907-44c7-bbef-985a27c1e6e2	8	-27891	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	49																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7724-F56186	519BD0D9-C612-41B2-A0ED-177FDA150DFD	29	Not Applicable	Not Applicable	Not Applicable	705	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	1	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	Yes	7724	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	36	33	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	2008	YES	NO	55	4	Lung	Alive	2012	2011	1958
TCGA-53-A4EZ	63	MALE	1071	Lung Acinar Adenocarcinoma	Lung	Alive	T2a	N1	MX	Stage IIA	0	1071			TUMOR FREE				63	L-Upper	Not Applicable	TCGA-53-A4EZ	7CA711EC-9AC0-4FA7-8A60-32AE84B8789A	7	-23201	Not Applicable	0	280	Not Available	Lung Adenocarcinoma	86	TCGA-53-A4EZ-D40957;TCGA-53-A4EZ-D40958	EAB7D354-078B-4978-AD4F-A6B8C3C68D35;58DBAB3C-5977-4D7B-8AF2-07D3D6AC5F27	Not Available;Not Available	7;7	226;226	132;132	Cisplatin;Navelbine	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	0	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-53-A4EZ-F61081	F04EA78A-0FDE-41CC-8D26-94D7E06CF8A2	19	Not Applicable	Not Applicable	Not Applicable	1071	Not Applicable	1	Scheduled Follow-up Submission	Complete Remission/Response	80	NO	3	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Stable Disease	Not Available	YES	Alive	2015	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	100	YES	NO	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	A4EZ	Preoperative	TUMOR FREE	73	75	YES	73	76	Not Applicable	YES	WHITE	NO	Primary Tumor Field	TCGA-53-A4EZ-R71153	8A1064A2-9B4F-4B7B-A6E4-5A95F83F36B1	Not Available	20	428	Not Available	Not Available	3	30	2	NO	Systemic	Not Applicable	Not Available	Not Available	Gy	2015	RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a	1996	YES	NO	53	3	Lung	Alive	2013	2012	1956
TCGA-44-7667	49	FEMALE	1097	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	MX	Stage IIB	0	1097			TUMOR FREE				49	R-Lower	Not Applicable	TCGA-44-7667	7f6455e8-fa3d-4452-acb2-8c9995073072	21	-18062	Not Applicable	0	557	Not Available	Lung Adenocarcinoma	50																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-44-7667-F19718;TCGA-44-7667-F39968	c40ab53b-c1c0-402e-aedc-d93158731d75;3218051E-D4B6-489A-B881-073C5B57FBEA	21;7	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	557;1097	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	Not Available;NO	12;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	7667	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	104	74	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	YES	NO	44	2	Lung	Alive	2011	2009	1974
TCGA-44-8117	54	FEMALE	385	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	385			TUMOR FREE				54	R-Upper	Not Applicable	TCGA-44-8117	6d96a298-be5a-4e14-afe8-ca4b6ca298d6	11	-19855	Not Applicable	0	259	Not Available	Lung Adenocarcinoma	86	TCGA-44-8117-D32726;TCGA-44-8117-D32727	19D36EEB-480F-4671-BCA8-86F6494EA205;EEB0D889-2452-4652-AD4C-81CCD822D2CE	Not Available;Not Available	13;13	176;133	113;113	Cisplatin;Docetaxel	Complete Response;Complete Response	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	1	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-44-8117-F36070	E5A2A932-540F-4F64-8A4B-0357E1C9C18B	18	Not Applicable	Not Applicable	Not Applicable	385	Not Applicable	1	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Unknown	Not Available	Not Available	Unknown	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	54	No	8117	Pre-Adjuvant Therapy	TUMOR FREE	88	65	YES	83	60	Complete Remission/Response	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	2011	YES	NO	44	4	Lung	Alive	2012	2011	1975
TCGA-55-6983	81	MALE	2823	Mucinous (Colloid) Carcinoma	Lung	Alive	T2	N1	M0	Stage IIB	0	2823			TUMOR FREE				81	L-Lower	Not Applicable	TCGA-55-6983	54a0e4d7-c274-4569-9c25-45bbe26d7f21	27	Not Available	Not Applicable	0	1826	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-6983-D47806	A9AB2D29-B945-4946-B6F7-5EEB91B352A4	Not Available	28	365	142	Chemo, NOS	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-6983-F47805	1E012012-FC2E-4B87-A8A8-30017E10F92D	28	Not Applicable	Not Applicable	Not Applicable	2823	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60	No	6983	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	55	4	Lung	Alive	2011	2005	Not Available
TCGA-44-6146	64	MALE	728	Lung Mucinous Adenocarcinoma	Lung	Alive	T3	N0	M0	Stage IIB	1	631.0		Locoregional Recurrence	TUMOR FREE		FPPP	TCGA	64	L-Lower	Not Applicable	TCGA-44-6146	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	7	-23378	Not Applicable	0	302	Not Available	Lung Adenocarcinoma	76	TCGA-44-6146-D12761;TCGA-44-6146-D12762;TCGA-44-6146-D12759	e3862c58-05db-4b2a-8c54-fc72bee3ce23;b7252803-5a38-42ce-8246-c0298c823279;e1605149-0bd0-4889-8db8-71f1eeacda90	Not Available;Not Available;Not Available	7;7;7	107;107;44	44;66;44	Alimta;Carboplatin;Cisplatin	Not Available;Not Available;Not Available	6;6;6	4;3;1	1100;456-570;165	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	4400;1600;165	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;YES	Not Available;NO	Not Available;NO	Not Available;Not Available	TCGA-44-6146-F12758;TCGA-44-6146-F34551	37ef67dc-0389-44bd-9265-02d220a94c2f;0DE929CF-9DF4-4EB5-9E02-DDF823FD3413	7;22	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	302;728	Not Available;631	1;0	Not Available;Additional New Tumor Event	Not Available;Unknown	Not Available;Not Available	Not Available;NO	6;8	Not Available;Locoregional Recurrence	Not Available;YES	Adjuvant therapy;Other	TUMOR FREE;Unknown	YES;Not Available	Complete Remission/Response;Not Available	Not Available;Convincing Imaging	NO;Not Available	Alive;Alive	2011;2012	MALE	Lung Mucinous Adenocarcinoma	No	C34.30	8480/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	Yes	6146	Other	TUMOR FREE	95	94	Not Available	88	87	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	1980	YES	NO	44	3	Lung	Alive	2011	2010	Not Available
TCGA-55-8513	77	FEMALE	791	Mucinous (Colloid) Carcinoma	Lung	Alive	T3	N0	MX	Stage IIB	1	317.0		Distant Metastasis	TUMOR FREE				77	L-Lower	Not Applicable	TCGA-55-8513	a3fd20b2-e001-44ab-9716-754e5ae70808	11	-28284	Not Applicable	0	146	Not Available	Lung Adenocarcinoma	65	TCGA-55-8513-D64284;TCGA-55-8513-D64285	2FEFA276-5D66-46D2-B73C-6138E1E304B9;3D2150F8-FBEF-4037-83F8-E9BB0CD7746E	Not Available;Not Available	28;28	460;Not Available	352;561	Tarceva;Alimta	Clinical Progressive Disease;Not Applicable	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Evaluated	Not Available	YES	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	NO	TCGA-55-8513-F64283	BED3B17C-69EA-4302-B3E2-D8C6371B867F	28	Not Available	Not Available	Not Applicable	791	317	2	Scheduled Follow-up Submission	Stable Disease	60	NO	8	Distant Metastasis	YES	Other	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Alive	2014	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES	Not Evaluated	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8513	Not Evaluated	TUMOR FREE	Not Available	Not Available	NO	108	87	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	YES	NO	55	1	Lung	Alive	2013	2012	Not Available
TCGA-MP-A5C7	76	FEMALE	2248	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	2248			TUMOR FREE				76	L-Upper	Not Applicable	TCGA-MP-A5C7	8F04660A-2EFB-4947-9EAB-375066B9EB33	10	-28015	Not Applicable	0	1490	Not Available	Lung Adenocarcinoma	105																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-MP-A5C7-F54544;TCGA-MP-A5C7-F67079	2777977A-E3E5-4AFD-AE85-CCC79DF0E736;A86ED60C-DDCE-4E9A-9B2D-9888E9F12C9F	19;30	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	1862;2248	Not Applicable;Not Applicable	Not Evaluated;1	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Evaluated;Not Evaluated	NO;NO	12;10	Not Available;Not Available	NO;NO	Not Available;Other	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2013;2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Central Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	15	No	A5C7	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	93	NO	Not Available	89	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1968	NO	YES	MP	3	Lung	Alive	2013	2008	1953
TCGA-75-6214	Not Available	FEMALE	1115	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N2	M0	Stage IIIA	1	419.0		Distant Metastasis	WITH TUMOR				Not Available	R-Upper	Not Applicable	TCGA-75-6214	32592562-11fa-435a-b40b-2b242bae53aa	12	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;NO	Not Available;YES	Not Available;Not Available	Not Available;YES	TCGA-75-6214-F15860;TCGA-75-6214-F72038	17e757bc-f78c-4be4-8ece-1109e163916d;8103EC55-5AAD-42CC-988D-A617888D510B	12;2	Not Available;Not Available	Not Available;524	Not Applicable;1115	Not Available;Not Available	Not Available;419	0;0	Not Available;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	Not Available;Not Evaluated	Not Available;NO	8;4	Not Available;Distant Metastasis	YES;YES	Adjuvant therapy;Post-Adjuvant Therapy	Not Available;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Dead	2011;2015	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	6214	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	Not Available	NO	YES	75	2	Lung	Alive	2011	Not Available	1970
TCGA-86-7713	70	MALE	1157	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N0	M0	Stage IIA	0	1157			TUMOR FREE				70	R-Middle	Not Applicable	TCGA-86-7713	cc68632c-b1e3-491b-b562-9468e2d1c101	2	-25791	Not Applicable	0	7	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-7713-D35429;TCGA-86-7713-D35430	505DA070-940F-431E-B3D0-0DEC1E27D175;20185B1B-9AFC-48FB-A72A-4E830C7CB786	Not Available;Not Available	27;27	182;182	29;29	Etoposide;Cisplatin	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-86-7713-F35420;TCGA-86-7713-F63513	B1E72965-1FBD-4BC1-8B24-56DDA7973B73;EB9FA841-4000-4DE3-B4DB-8714AB0669CD	27;12	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	422;1157	Not Applicable;Not Applicable	0;0	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	100;100	NO;NO	9;8	Not Available;Not Available	NO;NO	Post-Adjuvant Therapy;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2012;2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	80	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	7713	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	YES	NO	86	1	Lung	Alive	2011	2011	Not Available
TCGA-75-6212	Not Available	FEMALE	1516	Lung Micropapillary Adenocarcinoma	Lung	Dead	T2	N1	M0	Stage IIB	1	1340.0		New Primary Tumor	TUMOR FREE				Not Available	L-Lower	Not Applicable	TCGA-75-6212	23069f19-eba5-4ea5-ae7d-1ee4399ce7c1	21	Not Available	Not Applicable	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-75-6212-D15103;TCGA-75-6212-D15104;TCGA-75-6212-D15105	29ddd4fa-0d94-4bd7-9ce4-ba2c453d721d;ae10c460-9eda-43b3-a9de-ffc66804c8ba;6ea72d6c-a27f-4f01-ba06-912e368af3ea	Not Available;Not Available;Not Available	21;21;21	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Cisplatin;Vinorelbine Tartrate;Carboplatin	Not Available;Not Available;Not Available	7;7;7	3;4;1	70;42;437	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;2	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	210;572;437	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;YES	Not Available;NO	Not Available;Not Available	Not Available;Not Available	TCGA-75-6212-F15102;TCGA-75-6212-F72037	3befd11c-b526-47a9-8f68-01705132520b;9280DD0B-754D-4122-BB45-B9C44CF31270	21;2	Not Available;Not Available	Not Available;Not Available	Not Applicable;1516	Not Available;Not Available	Not Available;1340	0;0	Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Progressive Disease	Not Available;Not Evaluated	Not Available;NO	7;4	Not Available;New Primary Tumor	YES;YES	Post-Adjuvant Therapy;Post-Adjuvant Therapy	TUMOR FREE;WITH TUMOR	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Dead	2011;2015	FEMALE	Lung Micropapillary Adenocarcinoma	No	C34.3	8507/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6212	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	75	1	Lung	Alive	2011	Not Available	Not Available
TCGA-62-8394	65	FEMALE	139	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T4	N2	M0	Stage IIIB	0	139			TUMOR FREE				65	L-Lower	Not Applicable	TCGA-62-8394	742e0e32-25b5-4d41-8bf5-364b571cfd93	5	-23758	139	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-62-8394-D33506;TCGA-62-8394-D40459	66473842-A8EB-488E-BDE4-81A6B15B53B9;16DB8141-F66A-4A03-ABB6-CF51C96CC392	Not Available;Not Available	5;21	124;124	54;54	Carboplatin;Gemcitabine	Unknown;Unknown	7;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2013	Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	100	NO	Not Available	Not Available	Central Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8394	Preoperative	TUMOR FREE	Not Available	Not Available	YES	74	115	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T4	Not Available	NO	YES	62	1	Lung	Dead	2012	2008	Not Available
TCGA-64-5778	60	MALE	1305	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Alive	T2	N0	M0	Stage IB	1	962.0		Distant Metastasis	TUMOR FREE				60	R-Upper	Not Applicable	TCGA-64-5778	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	2	-21927	Not Applicable	0	926	Not Available	Lung Adenocarcinoma	Not Available	TCGA-64-5778-D31472	fc448027-ade7-47c9-8323-907f35fc2702	Not Available	3	Not Available	1174	Tarceva	Clinical Progressive Disease	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;NO;YES	Not Available;YES;NO	Not Available;Not Available;NO	Not Available;YES;NO	TCGA-64-5778-F11415;TCGA-64-5778-F31469;TCGA-64-5778-F31471	842094a7-5a39-4da3-827b-ee53549be95d;f7a90387-29d8-4956-93db-8347c2b623a8;cca86d2f-f557-4d7d-8128-137f7a6a6c3a	2;3;3	Not Applicable;Not Available;Not Available	Not Applicable;975;Not Available	Not Applicable;Not Applicable;Not Applicable	926;1305;1305	Not Applicable;962;1168	Not Available;1;1	Not Available;Additional New Tumor Event;Additional New Tumor Event	Complete Remission/Response;Progressive Disease;Progressive Disease	Not Available;Unknown;Unknown	Not Available;NO;NO	5;5;5	Not Available;Distant Metastasis;Not Available	NO;YES;YES	Not Available;Unknown;Unknown	TUMOR FREE;WITH TUMOR;WITH TUMOR	NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Not Available	NO;NO;NO	Alive;Alive;Alive	2011;2012;2012	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES	Discrepancy	Not Available	Not Available	Not Available	Central Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	68	No	5778	Other	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	WHITE	Not Available	Distant site	TCGA-64-5778-R31470	a16a4831-91fc-43b0-83ac-f24a068b3b7c	1	16	1022	994	Not Available	4	20	Not Available	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2000	NO	YES	64	4	Lung	Alive	2011	2008	1966
TCGA-97-8174	67	MALE	164	Lung Papillary Adenocarcinoma	Lung	Dead	T2b	N0	M0	Stage IIA	0	164			Not Available				67	R-Upper	Not Applicable	TCGA-97-8174	8c695c24-e7f9-449a-9258-a1bc8a33bf9a	13	-24725	164	0	Not Available	Not Available	Lung Adenocarcinoma	90	TCGA-97-8174-D32911;TCGA-97-8174-D32912	78B19468-4913-4164-B4EF-AF0FD08CB063;093ACF14-8C3A-40FC-9089-FB1AE39C6278	Not Available;Not Available	15;15	102;102	53;53	Vinorelbine;CISplatinum	Unknown;Unknown	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	0	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	Not Available	YES	NO	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	8174	Preoperative	Not Available	86	99	YES	81	91	Not Available	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	1985	YES	NO	97	3	Lung	Dead	2012	2011	1965
TCGA-50-8459	68	MALE	1119	Mucinous (Colloid) Carcinoma	Lung	Alive	T3	N0	M0	Stage IIB	1	432.0		Locoregional Recurrence	WITH TUMOR				68	R-Lower	Not Applicable	TCGA-50-8459	9cfc1519-33e7-4145-a4ad-78b5c449853a	16	-24859	Not Applicable	0	231	Not Available	Lung Adenocarcinoma	70	TCGA-50-8459-D42678;TCGA-50-8459-D42680;TCGA-50-8459-D42681	F90C20E9-5A78-4BD2-8814-AEFA21BA329D;4E2BDC04-BC96-442A-A92E-F5E7E00A1E90;C21CFFFF-014E-482A-B414-AFF5106E530C	Not Available;Not Available;Not Available	26;26;26	147;147;147	76;76;76	ALIMTA;Cisplatin;Avastin	Complete Response;Complete Response;Complete Response	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;YES	2013;2013;2013	Not Available	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;Not Available	NO;Not Available	YES;Not Available	Not Available;Not Available	TCGA-50-8459-F69334;TCGA-50-8459-F70410	9A74D1CF-D426-4C2E-AF2F-25F0C20A6705;63A0899A-AF36-4E80-A590-B5EF20006A8C	5;11	432;Not Applicable	Not Available;Not Applicable	Not Applicable;Not Applicable	589;1119	432;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Progressive Disease	Not Available;Not Available	NO;NO	1;2	Locoregional Recurrence;Not Available	YES;NO	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	Biopsy with Histologic Confirmation;Not Available	NO;NO	Alive;Alive	2015;2015	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES	Not Available	YES	YES	G12C	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	10	No	8459	Not Available	WITH TUMOR	Not Available	Not Available	YES	70	72	Progressive Disease	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	YES	NO	50	2	Lung	Alive	2012	2012	Not Available
TCGA-50-8457	63	FEMALE	1125	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1a	N0	M0	Stage IA	0	1125			TUMOR FREE				63	R-Upper	Not Applicable	TCGA-50-8457	d45aee46-838e-44af-8422-46710b3240a8	16	-23055	Not Applicable	0	44	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-50-8457-F69333;TCGA-50-8457-F70409	C2D58752-6A3C-46E7-9BF4-34591B2C0C16;367955C7-74FB-4A08-A87A-9719A41AAF35	5;11	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	779;1125	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	1;2	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2015;2015	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	YES	YES	G12A	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	No	8457	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	NO	BLACK OR AFRICAN AMERICAN	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	1997	YES	NO	50	4	Lung	Alive	2012	2011	Not Available
TCGA-97-A4M1	52	FEMALE	601	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1a	N0	M0	Stage IA	0	601			Unknown				52	R-Upper	Not Applicable	TCGA-97-A4M1	C0C879F7-C332-4D31-9F7E-A3BF361B36EE	7	-19272	Not Applicable	0	209	Not Available	Lung Adenocarcinoma	111																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-A4M1-F57386	4503E4C1-A9BE-4125-9311-A8140E6486AF	10	Not Applicable	Not Applicable	Not Applicable	601	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	3	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	No	A4M1	Preoperative	Unknown	92	105	NO	87	100	Complete Remission/Response	YES	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1a	1975	YES	NO	97	3	Lung	Alive	2013	2012	1972
TCGA-78-7166	84	MALE	258	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	0	258			Not Available				84	L-Lower	Not Applicable	TCGA-78-7166	b40d0849-f4ef-4a14-9732-9beb708cb46b	28	-30869	258	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	Not Available	Not Available	TCGA-78-7166-F16954	91193834-639f-45c9-9c1b-79a5c5c33f76	28	Not Applicable	Not Applicable	258	Not Available	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	9	Not Available	NO	Not Available	Not Available	NO	Not Available	Not Available	YES	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	38	Yes	7166	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-78-7166-R16955	cd485d3f-a20d-4299-8f2f-2dd37177e390	1	28	Not Available	Not Available	Not Available	9	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	1972	NO	YES	78	3	Lung	Dead	2011	2002	1934
TCGA-83-5908	59	FEMALE	824	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	824			TUMOR FREE				59	L-Upper	Not Applicable	TCGA-83-5908	25d4ea9e-f773-4f11-bac9-64efdad73211	25	-21760	Not Applicable	0	420	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-83-5908-F12196	144eec6d-ffea-424d-be87-9284d029b02c	25	Not Applicable	Not Applicable	Not Applicable	824	Not Applicable	1	Not Available	Stable Disease	90	Not Available	5	Not Available	NO	Other	TUMOR FREE	NO	Stable Disease	Not Available	NO	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90	NO	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	69	No	5908	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	2007	YES	NO	83	4	Lung	Alive	2011	2009	1962
TCGA-05-4426	71	MALE	791	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	1	457.0			TUMOR FREE				71	L-Lower	Not Applicable	TCGA-05-4426	36bf02f8-c1c8-49f9-a417-adf88a205c70	22	-26084	Not Applicable	0	791	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	Not Available	TCGA-05-4426-F36562	76BC7F31-DA6E-448B-8B2D-68A57B4B9805	2	Not Available	Not Available	Not Applicable	791	457	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	YES	Not Available	TUMOR FREE	Unknown	Complete Remission/Response	Not Available	Unknown	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	4426	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	05	3	Lung	Alive	2010	2008	Not Available
TCGA-55-7995	73	FEMALE	889	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	1	468.0		Locoregional Recurrence	TUMOR FREE				73	L-Upper	Not Applicable	TCGA-55-7995	abd6647b-d2eb-404d-8283-443e92addf55	7	-26837	Not Applicable	0	5	Not Available	Lung Adenocarcinoma	51	TCGA-55-7995-D65702;TCGA-55-7995-D65703	39A1C7F0-0574-41C9-98D5-D0D7AF66D866;386B9E74-6618-451B-8F90-9F3BFDE51CD1	Not Available;Not Available	26;26	525;525	483;483	Carboplatin;Paclitaxel	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	YES	NO	Not Available	TCGA-55-7995-F65700	FD821C68-D4E0-4555-BAD0-65DC0C3F3FD0	26	Not Available	Not Available	Not Applicable	889	468	1	Scheduled Follow-up Submission	Complete Remission/Response	80	NO	9	Locoregional Recurrence	YES	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response	Convincing Imaging	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Unknown	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	60	No	7995	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	71	77	Unknown	YES	WHITE	Unknown	Regional site	TCGA-55-7995-R65701	FB0F9AE8-CC60-4A32-80BE-77F43A903343	Not Available	26	525	483	Complete Response	9	Not Available	6500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	2002	YES	NO	55	4	Lung	Alive	2012	2012	Not Available
TCGA-93-8067	77	MALE	186	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	0	186			TUMOR FREE				77	L-Lower	Not Applicable	TCGA-93-8067	bbe88801-34f3-46d2-bbfd-b46c3901ed71	18	-28453	Not Applicable	0	186	Not Available	Lung Adenocarcinoma	47																								2	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-93-8067-F32193	88DF8B42-F107-47B4-84A7-2E62FE30E870	18	Not Applicable	Not Applicable	Not Applicable	186	Not Applicable	2	Scheduled Follow-up Submission	Complete Remission/Response	80	NO	5	Not Available	NO	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	80	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	Yes, History of Prior Malignancy	8067	Preoperative	TUMOR FREE	94	103	NO	89	94	Complete Remission/Response	YES	ASIAN	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	2001	YES	NO	93	4	Lung	Alive	2012	2011	1961
TCGA-55-7284	74	MALE	243	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Dead	T3	N0	MX	Stage IIB	1	231.0		Distant Metastasis	TUMOR FREE				74	R-Lower	Not Applicable	TCGA-55-7284	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	13	-27087	Not Applicable	0	121	Not Available	Lung Adenocarcinoma	89																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	NO	TCGA-55-7284-F61486	411282A6-43D3-468C-8DD9-47C991653F13	30	Not Available	Not Available	243	Not Available	231	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	6	Distant Metastasis	YES	Not Available	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2014	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.8	8252/3	C34.8	YES	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Synchronous/Bilateral Malignancy	7284	Not Available	TUMOR FREE	102	70	Unknown	108	74	Unknown	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	YES	NO	55	3	Lung	Alive	2012	2011	Not Available
TCGA-55-1595	74	FEMALE	1479	Lung Clear Cell Adenocarcinoma	Lung	Alive	T1	N0	M0	Stage IA	0	1479			TUMOR FREE				74	L-Lower	Not Applicable	TCGA-55-1595	d31aeefc-b59b-42e9-9919-750b17a70a3d	14	Not Available	Not Applicable	0	1479	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-1595-F9159	f19c76be-c9be-4437-a591-dad05ade0132	15	Not Applicable	Not Applicable	Not Applicable	1479	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2011	FEMALE	Lung Clear Cell Adenocarcinoma	No	C34.3	8310/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	1595	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1993	Not Available	Not Available	55	4	Lung	Alive	2011	2004	1964
TCGA-44-2655	65	FEMALE	1324	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	1	1009.0		New Primary Tumor	TUMOR FREE				65	R-Upper	Not Applicable	TCGA-44-2655	07b5663f-9a54-4462-b6c1-6fc8116b8714	9	-23854	Not Applicable	0	575	575	Lung Adenocarcinoma	73																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;Not Available;NO	NO;Not Available;NO	NO;Not Available;NO	NO;Not Available;NO	TCGA-44-2655-F5293;TCGA-44-2655-F5096;TCGA-44-2655-F39289	42f22d9e-2d8f-4b1f-81e7-29eca0f4fed2;9cfda329-c1e1-43cb-9157-daa5aee723ef;08096B08-FEB1-4550-830D-4BEE7FD6E37F	8;20;16	Not Applicable;Not Applicable;Not Available	Not Applicable;Not Applicable;Not Available	Not Applicable;Not Applicable;Not Applicable	575;667;1324	Not Applicable;Not Applicable;1009	Not Available;Not Available;Not Available	Not Available;Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Not Available;Complete Remission/Response	Not Available;Not Available;Not Available	Not Available;Not Available;NO	10;12;1	Not Available;Not Available;New Primary Tumor	NO;NO;YES	Not Available;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Not Available	NO;NO;NO	Alive;Alive;Alive	2010;2010;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	Yes	2655	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	100	91	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1988	YES	NO	44	3	Lung	Alive	2010	2009	1958
TCGA-69-8453	77	MALE	813	Mucinous (Colloid) Carcinoma	Lung	Alive	T3	N0	MX	Stage IIB	1	344.0		Locoregional Recurrence	WITH TUMOR				77	R-Lower	Not Applicable	TCGA-69-8453	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	21	-28413	Not Applicable	0	171	Not Available	Lung Adenocarcinoma	52	TCGA-69-8453-D38749;TCGA-69-8453-D52053;TCGA-69-8453-D52058;TCGA-69-8453-D38750	ADF240B0-E64F-4B67-B0D0-67705AEA4763;668F81DB-46F6-4AF3-AA38-ECC71EC50D0A;D34529C7-817F-493F-9304-FFD96B855AFE;E78C20DE-6F02-4FAE-9948-42E954BBFACB	Not Available;Not Available;Not Available;Not Available	28;27;27;19	157;571;571;157	45;505;505;45	carboplatinum;Carboplatin;Alimta;paclitaxel	Unknown;Unknown;Unknown;Unknown	2;11;11;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2014	1	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	YES;Not Available;Not Available	YES;Not Available;Not Available	NO;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-69-8453-F52051;TCGA-69-8453-F58885;TCGA-69-8453-F58874	70276434-5352-4885-B9F5-681F889F8DA0;366AD6FB-38AA-4D12-9AAD-C4322679F1B1;D19A5525-7925-47D0-BD4A-5E3949C724C6	27;25;5	Not Available;Not Applicable;Not Applicable	Not Available;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	550;813;788	344;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission;Scheduled Follow-up Submission	Unknown;Unknown;Unknown	Not Available;Not Available;Not Available	NO;NO;NO	11;4;8	Locoregional Recurrence;Not Available;Not Available	YES;NO;NO	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Stable Disease;Stable Disease;Stable Disease	Biopsy with Histologic Confirmation;Not Available;Not Available	NO;NO;NO	Alive;Alive;Alive	2013;2014;2014	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES	Not Available	Unknown	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	12	No	8453	Preoperative	WITH TUMOR	87	85	YES	86	85	Unknown	YES	WHITE	NO	Local Recurrence	TCGA-69-8453-R52059	4D8BD4E2-6E35-485C-BDE0-3924285ACA73	Not Available	27	417	413	Unknown	11	5	5000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	1974	YES	NO	69	3	Lung	Alive	2012	2012	Not Available
TCGA-91-6835	81	FEMALE	79	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	79			Not Available				81	R-Lower	Not Applicable	TCGA-91-6835	2f09479f-87fc-4c34-8e2c-333e970a3681	20	-29887	Not Applicable	0	35	Not Available	Lung Adenocarcinoma	78																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-6835-F32643	169e8cda-2406-4085-97e2-7287e1bd2e41	5	Not Applicable	Not Applicable	Not Applicable	79	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	YES	6	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	6835	Not Available	Not Available	Not Available	91	Not Available	Not Available	75	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	1976	NO	YES	91	3	Lung	Alive	2011	2010	Not Available
TCGA-95-8039	72	MALE	830	Lung Acinar Adenocarcinoma	Lung	Alive	T1	N0	MX	Stage IA	1	228.0		Locoregional Recurrence	TUMOR FREE				72	R-Upper	Not Applicable	TCGA-95-8039	87f1b3df-4bc7-4336-b658-f30ac1c5c796	20	-26317	Not Applicable	0	27	Not Available	Lung Adenocarcinoma	98																								Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;YES	Not Available;YES	Not Available;NO	Not Available;Not Available	TCGA-95-8039-F33080;TCGA-95-8039-F61691	748F6706-9CBF-4D1F-A596-95427E569680;CB3116B9-ED5E-4C0D-AA9B-65B6C91F0939	20;3	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	27;830	Not Applicable;228	Not Evaluated;0	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Applicable;Complete Remission/Response	Not Evaluated;Not Evaluated	NO;NO	6;7	Not Available;Locoregional Recurrence	NO;YES	Not Evaluated;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Biopsy with Histologic Confirmation;Convincing Imaging	NO;NO	Alive;Alive	2012;2014	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Evaluated	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	8039	Not Evaluated	TUMOR FREE	70	2.54	NO	67	2.40	Complete Remission/Response	YES	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	Not Available	YES	NO	95	1	Lung	Alive	2012	2012	Not Available
TCGA-97-7938	76	FEMALE	18	Lung Bronchioloalveolar Carcinoma Nonmucinous	Lung	Dead	T1a	N0	MX	Stage IA	0	18			TUMOR FREE				76	R-Upper	Not Applicable	TCGA-97-7938	e6e75590-9520-4b1c-8a28-4a1d2b2218fc	13	-27980	18	0	Not Available	Not Available	Lung Adenocarcinoma	53																								Not Available	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-7938-F57460	0EB1C458-4194-49CB-8BC9-D806490FF5E5	11	Not Applicable	Not Applicable	18	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	3	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Dead	2014	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES	Not Available	YES	YES	G12C	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	7938	Not Available	TUMOR FREE	59	54	Not Available	58	50	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	1996	YES	NO	97	3	Lung	Dead	2012	2011	Not Available
TCGA-69-7978	59	MALE	134	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2b	N1	MX	Stage IIB	0	134			WITH TUMOR				59	R-Upper	Not Applicable	TCGA-69-7978	f462cfef-f60a-4d3e-b92d-b8d8f50b6bb3	9	-21785	Not Applicable	0	70	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	YES	Other	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	NO	Not Available	TCGA-69-7978-F39911	66B2ED66-C09F-466B-8570-8D90725A6E44	11	Not Applicable	Not Applicable	Not Applicable	134	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Stable Disease	Not Evaluated	NO	2	Not Available	NO	Not Evaluated	Discrepancy	NO	Unknown	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80	No	7978	Not Available	WITH TUMOR	91	75	Not Available	88	67	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2b	Not Available	NO	YES	69	2	Lung	Alive	2012	2011	Not Available
TCGA-55-7994	81	MALE	603	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N0	MX	Stage IIB	0	603			TUMOR FREE				81	R-Upper	Not Applicable	TCGA-55-7994	67dbe286-edb3-4d07-8f74-9e5254f01945	7	-29858	Not Applicable	0	31	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-7994-D47824;TCGA-55-7994-D47825	711DE5E8-64BE-4AE2-9B48-BE206A7960AC;C4E8D500-182E-4A75-9E3A-5EC4E60DD487	Not Available;Not Available	28;28	121;121	56;56	Carboplatin;Taxol	Complete Response;Complete Response	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7994-F47823	F1F645DE-9236-459D-A930-61A18E1E6F22	28	Not Applicable	Not Applicable	Not Applicable	603	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	28	No	7994	Not Available	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	Not Available	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	Not Available
TCGA-55-8619	72	FEMALE	416	Mucinous (Colloid) Carcinoma	Lung	Alive	T3	N0	MX	Stage IIB	0	416			TUMOR FREE				72	R-Lower	Not Applicable	TCGA-55-8619	772324a5-5513-454d-ad6b-605798f69b73	11	-26616	Not Applicable	0	49	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8619-F57919	127448B8-A332-41F4-BDDF-9AAC9647E785	28	Not Applicable	Not Applicable	Not Applicable	416	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	3	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES	90	Unknown	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Prior Malignancy	8619	Preoperative	TUMOR FREE	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	Not Available	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	Not Available	YES	NO	55	1	Lung	Alive	2013	2012	Not Available
TCGA-78-7149	71	MALE	3940	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T4	N0	M0	Stage IIIB	0	3940			Not Available				71	R-Lower	Not Applicable	TCGA-78-7149	2de1ba51-eae1-4a54-b7cd-d6d739fdc39d	3	-26285	Not Applicable	0	1093	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-78-7149-F17123;TCGA-78-7149-F46148	95813dc5-e402-4f0b-a425-2578fff0d0c2;20D89F59-36DA-4A8A-A462-4A3DA7D3CF50	3;23	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	1093;3940	Not Available;Not Available	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Not Available	Not Available;Not Available	Not Available;NO	10;8	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	115	No	7149	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	Not Available	NO	YES	78	2	Lung	Alive	2011	2002	1950
TCGA-38-4631	72	FEMALE	354	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1				WITH TUMOR				72	L-Upper	Not Applicable	TCGA-38-4631	2483621a-4db3-41ab-aa33-b9427ea8a0af	14	-26538	354	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	NO	YES	NO	NO	TCGA-38-4631-F4892	48e7462e-19a5-4897-9104-e131fa220329	14	Not Available	Not Available	354	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Dead	2010	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	Yes	4631	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Distant site	TCGA-38-4631-R4893	adf6e9ab-7efe-43bf-83e4-ae864d19e186	1	14	115	87	Not Available	12	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	Not Available	2010	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	38	4	Lung	Dead	2010	1997	Not Available
TCGA-44-2662	65	MALE	1280	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	1	245.0			Discrepancy		FPPP	TCGA	65	R-Upper	Not Applicable	TCGA-44-2662	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	12	-24014	Not Applicable	0	480	Not Available	Lung Adenocarcinoma	78	TCGA-44-2662-D5033;TCGA-44-2662-D5035;TCGA-44-2662-D5034	49760024-30c8-4540-a1fc-44ee2672a837;ada4d1fb-41a4-4448-8509-1d01a0c093c1;11737323-43bd-4c4f-9c44-43683d677c92	Not Available;Not Available;Not Available	21;21;21	162;362;362	76;277;277	rec MAGE 3-AS + AS15 ACS1 / Placebo Vaccine;Taxol;Carboplatin	Not Available;Not Available;Not Available	10;10;10	5;8;8	0.5;480;935	mL;mg;mg	ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	1;2;2	IM;IV;IV	NO;NO;NO	Other, specify in notes;Chemotherapy;Chemotherapy	GSK Mage Vaccine Study;Not Available;Not Available	2.5;1608;3817	mL;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	YES;Not Available;Not Available	YES;Not Available;Not Available	NO;Not Available;NO	NO;Not Available;Not Available	TCGA-44-2662-F5032;TCGA-44-2662-F12836;TCGA-44-2662-F39415	b2f9a164-783a-4a61-ba4e-eab35f83bab7;8e0b739c-e99b-4cc0-863d-b56cc7271eb2;529CB643-2E54-48E0-8587-7ABEE3A9830E	21;9;22	Not Available;Not Applicable;Not Applicable	Not Available;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	480;673;1280	245;Not Applicable;Not Applicable	1;0;Not Available	Not Available;Not Available;Scheduled Follow-up Submission	Partial Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Not Available	Not Available;Not Available;NO	10;6;1	Not Available;Not Available;Not Available	YES;NO;NO	Post-Adjuvant Therapy;Post-Adjuvant Therapy;Not Available	Discrepancy;TUMOR FREE;TUMOR FREE	YES;YES;YES	Progressive Disease;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available	NO;NO;NO	Alive;Alive;Alive	2010;2011;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	56	Yes	2662	Not Available	Discrepancy	94	73	Not Available	88	67	Not Available	YES	WHITE	Not Available	Local Recurrence	TCGA-44-2662-R5036	1a2f8bdd-81c3-426c-ba0b-6b486d266c9a	1	21	316	277	Not Available	10	30	6000	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2010	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1984	YES	NO	44	3	Lung	Alive	2010	2009	1956
TCGA-MP-A4SV	67	MALE	2620	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	0	2620			Unknown				67	L-Lower	Not Applicable	TCGA-MP-A4SV	706420C4-8820-4B41-80D9-F3EFD1D2A4F0	2	-24516	2620	0	Not Available	Not Available	Lung Adenocarcinoma	48																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Unknown																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	110	No	A4SV	Not Evaluated	Unknown	Not Available	78	NO	Not Available	62	Complete Remission/Response	YES	Unknown	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	MP	2	Lung	Dead	2013	2001	1946
TCGA-L9-A7SV	69	MALE	565	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N1	M0	Stage IIA	0	565			TUMOR FREE				69	L-Lower	Not Applicable	TCGA-L9-A7SV	54E90433-5218-4D83-848F-F995ECBA2A63	7	-25298	Not Applicable	0	111	Not Available	Lung Adenocarcinoma	55	TCGA-L9-A7SV-D55465;TCGA-L9-A7SV-D55466	01FFB728-9015-4A08-9273-307A5FFCA9C7;AF22DDC1-B76C-49AC-AAC4-32359ACDB718	Not Available;Not Available	7;7	104;104	41;41	cisplatin;pemetrexed disodium	Complete Response;Complete Response	1;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-L9-A7SV-F65116	4AC0A1A6-41A9-4E59-B676-A750306905C7	18	Not Applicable	Not Applicable	Not Applicable	565	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Preoperative	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	93	No	A7SV	Preoperative	TUMOR FREE	40	45	YES	38	40	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	1990	YES	NO	L9	3	Lung	Alive	2014	2013	1959
TCGA-93-A4JQ	49	MALE	526	Lung Acinar Adenocarcinoma	Lung	Alive	T1b	N0	MX	Stage IA	0	526			TUMOR FREE				49	R-Upper	Not Applicable	TCGA-93-A4JQ	7093024B-CF56-4783-B973-B72573ED7F2B	27	-17951	Not Applicable	0	100	Not Available	Lung Adenocarcinoma	83																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-93-A4JQ-F57022	7F31161F-621B-476D-A8D8-D67E63CED9D9	28	Not Applicable	Not Applicable	Not Applicable	526	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	2	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Prior Malignancy	A4JQ	Preoperative	TUMOR FREE	97	100	NO	94	93	Complete Remission/Response	YES	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	1993	YES	NO	93	3	Lung	Alive	2014	2012	1973
TCGA-35-3615	57	MALE	14	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	14			TUMOR FREE				57	R-Upper	Not Applicable	TCGA-35-3615	e8b7a103-644f-4865-92f8-80b053bd5e17	20	-21076	Not Applicable	0	14	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-35-3615-F68919	DEA1DE43-7C05-44A1-ABEF-9C495D3A8150	24	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	YES	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2015	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	3615	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	35	1	Lung	Alive	2010	2007	Not Available
TCGA-05-4418	69	MALE	274	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T3	N2	M0	Stage IIIA	0	274			Not Available				69	L-Lower	Not Applicable	TCGA-05-4418	d2c1e896-6886-4122-bb48-5fbcd3f641f4	22	-25417	274	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	Yes	4418	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	Not Available	NO	YES	05	2	Lung	Dead	2010	2008	Not Available
TCGA-05-4249	67	MALE	1523	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	1523			TUMOR FREE				67	R-Lower	Not Applicable	TCGA-05-4249	4addf05f-3668-4b3f-a17f-c0227329ca52	22	-24532	Not Applicable	0	1158	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4249-F36327	485963A2-753D-4E86-B3DF-E3F66189ABEE	29	Not Applicable	Not Applicable	Not Applicable	1523	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	NO	Not Applicable	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Peripheral Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	52	No	4249	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	05	3	Lung	Alive	2010	2007	Not Available
TCGA-MN-A4N4	57	MALE	1175	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	1175			Unknown				57	L-Upper	Not Applicable	TCGA-MN-A4N4	CEEAD734-1CE0-4385-B65A-A9C853B7308E	4	-20888	Not Applicable	0	622	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-MN-A4N4-F56667	6E245328-C4AD-4FC6-BC4E-0967868C7228	17	Not Applicable	Not Applicable	Not Applicable	1175	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	2	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	NO	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A4N4	Preoperative	Unknown	75	82	NO	70	77	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	NO	YES	MN	2	Lung	Alive	2012	2010	1980
TCGA-73-4658	80	FEMALE	1600	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	0	1600			TUMOR FREE				80	L-Lower	Not Applicable	TCGA-73-4658	afb91740-2668-46d7-ba01-bb26153ad1c7	15	-29508	1600	0	1600	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-73-4658-F12975	54126ff4-4956-4563-97f0-8103fd637634	15	Not Applicable	Not Applicable	1600	1600	Not Applicable	Not Available	Not Available	Complete Remission/Response	Not Available	Not Available	6	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	Yes	4658	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	73	3	Lung	Dead	2011	2004	Not Available
TCGA-44-A4SS	73	MALE	415	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	415			TUMOR FREE				73	L-Upper	Not Applicable	TCGA-44-A4SS	F934ED41-090E-4313-BBC5-D1A4A9ED9AD7	28	-26991	Not Applicable	0	114	Not Available	Lung Adenocarcinoma	54																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-44-A4SS-F49165	7E3B2EA0-2129-451F-A502-B57F589DC4F8	26	Not Applicable	Not Applicable	Not Applicable	415	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	9	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	90	No	A4SS	Preoperative	TUMOR FREE	88	71	NO	86	69	Complete Remission/Response	YES	WHITE	NO																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	2012	YES	NO	44	4	Lung	Alive	2013	2012	1952
TCGA-95-A4VP	66	FEMALE	605	Lung Acinar Adenocarcinoma	Lung	Alive	T2b	N2	M0	Stage IIIA	1	216.0		Distant Metastasis	TUMOR FREE				66	L-Lower	Not Applicable	TCGA-95-A4VP	9E22A3AF-7F28-4757-8684-ED64A2A27AD1	22	-24130	Not Applicable	0	168	Not Available	Lung Adenocarcinoma	Not Available	TCGA-95-A4VP-D40540;TCGA-95-A4VP-D40543	EEC4E284-83E6-48D8-9E22-87A68963B598;B3A1D470-D0D9-4ABF-A3AF-1447CD0096B4	Not Available;Not Available	22;22	126;126	63;63	Carboplatin;Taxol	Stable Disease;Stable Disease	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Evaluated	NO	YES	Not Available	NO	TCGA-95-A4VP-F58502	29D06D6D-2BAB-4F87-85B2-F4B369A1C6C4	11	Not Available	Not Available	Not Applicable	605	216	1	Scheduled Follow-up Submission	Stable Disease	Not Evaluated	NO	4	Distant Metastasis	YES	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	Biopsy with Histologic Confirmation;Convincing Imaging	NO	Alive	2014	FEMALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	No	A4VP	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	Not Available	Stable Disease	NO	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2b	2012	YES	NO	95	4	Lung	Alive	2013	2012	1972
TCGA-55-7914	71	FEMALE	187	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1b	N1	MX	Stage IIA	1				WITH TUMOR				71	R-Upper	Not Applicable	TCGA-55-7914	69dba721-a168-47a4-b7ff-80a448bad654	10	-26105	Not Applicable	0	3	Not Available	Lung Adenocarcinoma	56	TCGA-55-7914-D59093;TCGA-55-7914-D59094;TCGA-55-7914-D59095	6C2F2B61-58BA-4970-BC91-DF0902E87C39;5EEF9195-2694-425E-9C08-5C82278C9C16;6A7819DA-BFA9-4BCF-BA27-3DC196B9EF70	Not Available;Not Available;Not Available	30;30;30	132;132;132	27;27;27	Carboplatin;Alimta;Avastin	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	1	Not Available	YES	Not Available	Not Available	FISH	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-7914-F59091	F480A7D2-81F1-4436-93FA-C86100C335C8	30	Not Applicable	Not Applicable	187	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	4	Not Available	NO	Not Evaluated	WITH TUMOR	YES	Progressive Disease	Not Available	NO	Dead	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	YES	YES	G12C	Central Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Yes	7914	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	88	73	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	1990
TCGA-78-7145	52	FEMALE	826	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T4	N1	M1	Stage IV	1	422.0			WITH TUMOR				52	R-Middle	Not Applicable	TCGA-78-7145	4ef872e1-82c9-4939-9248-41ed9d3085b2	23	-19080	826	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-78-7145-D16675;TCGA-78-7145-D16672;TCGA-78-7145-D16674;TCGA-78-7145-D16673;TCGA-78-7145-D17203	93f81bc9-f22b-4e9f-85b9-da28d41a7569;b3966e3e-c4e0-4a0f-875b-5a2b599ef98d;8798a8c5-378c-44b9-b21b-f09302daab77;12b1de25-cb72-4778-a205-ad6d7f68c4e4;703cc226-f1a6-4c2e-bdc6-dcf30f5b8c11	Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;5	Not Available;161;685;547;161	716;28;605;440;28	Not Available;Cisplatin;Gefitinib;Docetaxel;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;10	Not Available;6;Not Available;6;6	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;1;3;2;1	IM;IV;PO;IV;IV	NO;NO;NO;NO;NO	Other, specify in notes;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Phase II clinical trial KRW2170;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	YES	YES	NO	NO	TCGA-78-7145-F16671	faa937a2-b75e-4764-89e0-8a9d3698ecda	23	Not Available	Not Available	826	Not Available	422	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	9	Not Available	YES	Not Available	WITH TUMOR	YES	Not Available	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	7145	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-78-7145-R17204	aade3c8c-dc1c-4127-b685-c52607c1406e	1	5	644	644	Not Available	10	1	800	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	cGy	2011	R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N1	T4	1998	NO	YES	78	4	Lung	Dead	2011	2000	1973
TCGA-55-8092	75	MALE	154	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T3	N0	MX	Stage IIB	1	127.0		Locoregional Recurrence	TUMOR FREE				75	R-Upper	Not Applicable	TCGA-55-8092	4b92fce2-3772-40eb-ab34-a27937b58590	8	-27597	Not Applicable	0	26	Not Available	Lung Adenocarcinoma	19																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	Not Available	TCGA-55-8092-F46643	08F57135-8BDA-492F-9F56-7D5C9BEF9DDE	13	Not Available	Not Available	154	Not Available	127	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	8	Locoregional Recurrence	YES	Not Evaluated	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	40	No	8092	Not Available	TUMOR FREE	2	19	Unknown	66	68	Complete Remission/Response	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	2012	YES	NO	55	4	Lung	Alive	2012	2012	1972
TCGA-MP-A4TE	56	MALE	896	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2b	N0	MX	Stage IIA	1	226.0		Locoregional Recurrence	WITH TUMOR				56	L-Lower	Not Applicable	TCGA-MP-A4TE	BEBD0025-74E2-451B-93B3-86F82DF43573	2	-20627	896	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;Unknown	NO;Unknown	NO;Not Available	Not Available;NO	TCGA-MP-A4TE-F41404;TCGA-MP-A4TE-F41405	1239E6E6-49B6-494D-B3DC-33A65B8F4058;DCD8612E-0ACE-4A8A-AD8A-FDBC2CC58B58	18;18	Not Available;Not Available	Not Available;Not Available	896;896	Not Available;Not Available	411;845	Not Evaluated;Not Evaluated	Additional New Tumor Event;Additional New Tumor Event	Progressive Disease;Unknown	Not Evaluated;Not Evaluated	NO;NO	3;3	Locoregional Recurrence;Distant Metastasis	YES;YES	Not Evaluated;Not Evaluated	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response	Convincing Imaging;Convincing Imaging	NO;NO	Dead;Dead	2013;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	YES	YES	G12C	Peripheral Lung	4	NO	NO	226	YES	226	Not Available	Not Available	Locoregional Recurrence	Biopsy with Histologic Confirmation	YES	40	No	A4TE	Not Evaluated	WITH TUMOR	Not Available	Not Available	NO	Not Available	Not Available	Complete Remission/Response	NO	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	2010	NO	YES	MP	4	Lung	Dead	2013	2010	1970
TCGA-MP-A4T4	68	FEMALE	2617	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N1	M0	Stage IIB	0	2617			Unknown				68	R-Lower	Not Applicable	TCGA-MP-A4T4	301CA6E8-7981-4264-B4AE-38F56F7F9225	2	-25052	2617	0	Not Available	Not Available	Lung Adenocarcinoma	53																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Unknown																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	50	No	A4T4	Preoperative	Unknown	Not Available	110	NO	Not Available	113	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	NO	YES	MP	2	Lung	Dead	2013	2004	1954
TCGA-55-8203	69	FEMALE	547	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	547			TUMOR FREE				69	R-Lower	Not Applicable	TCGA-55-8203	9a9bd705-1ef1-4a6c-bb1e-bdd346dc01c0	16	-25477	Not Applicable	0	4	Not Available	Lung Adenocarcinoma	39																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8203-F47819	C9045FA4-F6A7-401C-8BB1-2A97C88D9330	28	Not Applicable	Not Applicable	Not Applicable	547	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	NO	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	50	Yes, History of Prior Malignancy	8203	Not Available	TUMOR FREE	50	48	Unknown	52	49	Complete Remission/Response	YES	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	55	2	Lung	Alive	2012	2011	Not Available
TCGA-55-6712	71	MALE	171	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N1	MX	Stage IIA	1				WITH TUMOR				71	L-Upper	Not Applicable	TCGA-55-6712	f17d3463-af6c-42c2-a8e9-fae45f69286f	19	Not Available	Not Applicable	0	24	Not Available	Lung Adenocarcinoma	Not Available	TCGA-55-6712-D46640;TCGA-55-6712-D46641	54BFE572-6DCC-4E84-884A-ED9F30AA3A5E;E61C6649-A6C8-4399-BC96-CE8A7ADA6686	Not Available;Not Available	13;13	164;164	55;55	Carboplatin;Taxol	Clinical Progressive Disease;Clinical Progressive Disease	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-55-6712-F46639	635BF546-710A-4C39-9D56-E3D0FCFBC9F6	13	Not Applicable	Not Applicable	171	Not Available	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Progressive Disease	Not Evaluated	NO	8	Not Available	NO	Not Evaluated	WITH TUMOR	YES	Progressive Disease	Not Available	NO	Dead	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6712	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a	2003	NO	YES	55	4	Lung	Alive	2011	2010	1970
TCGA-49-6743	81	FEMALE	1621	Lung Clear Cell Adenocarcinoma	Lung	Alive	T1	N2	MX	Stage IIIA	0	1621			TUMOR FREE				81	R-Upper	Not Applicable	TCGA-49-6743	a391d49f-a822-460b-981c-6fbe1868ee38	10	-29807	Not Applicable	0	369	Not Available	Lung Adenocarcinoma	Not Available	TCGA-49-6743-D14859;TCGA-49-6743-D16685;TCGA-49-6743-D16684	77afb595-62de-41ce-bbd0-3e811685cfcf;faeee125-10d2-46c8-81cc-75ade012acdb;586c3a98-5004-43da-832f-73b1ec351173	Not Available;Not Available;Not Available	10;23;23	140;140;140	18;48;48	Cisplatin;Bevacizumab;Pemetrexed	Not Available;Not Available;Not Available	8;9;9	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	TCGA-49-6743-F14858;TCGA-49-6743-F71136	cd1e65ca-466c-495d-b733-aac17946d06a;74E45F53-1B39-45A5-A07E-4B3BB42BC37E	10;18	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Applicable;Not Applicable	369;1621	Not Applicable;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Complete Remission/Response	Not Available;100	Not Available;NO	8;3	Not Available;Not Available	NO;NO	Not Available;Not Available	TUMOR FREE;Not Available	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;NO	Alive;Alive	2011;2015	FEMALE	Lung Clear Cell Adenocarcinoma	No	C34.1	8310/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	6743	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T1	Not Available	NO	YES	49	4	Lung	Alive	2011	2010	Not Available
TCGA-73-4668	66	FEMALE	467	Lung Micropapillary Adenocarcinoma	Lung	Alive	T2	N1	M0	Stage IIB	1	236.0			WITH TUMOR				66	L-Upper	Not Applicable	TCGA-73-4668	b2285924-9813-4f46-bb8f-91a0efd8a9b6	6	-24255	Not Applicable	0	467	Not Available	Lung Adenocarcinoma	Not Available	TCGA-73-4668-D7959;TCGA-73-4668-D7956;TCGA-73-4668-D7960;TCGA-73-4668-D7957	b2535da4-0fa6-43d0-92c1-05717101d861;0a6f15d0-842e-4da6-8de0-8374e694987a;cca6912e-8a06-4270-8717-86cfd00d2ec7;9eb9db2a-643c-49ca-ab5b-7dd90adcbbc5	Not Available;Not Available;Not Available;Not Available	6;6;6;6	Not Available;110;Not Available;110	369;43;369;43	Gemcitabine;Pemetrexed;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	5;4;5;4	1000;500;5;6	mg/m2;mg/m2;AUC;AUC	PALLIATIVE;ADJUVANT;PALLIATIVE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;2;1	IV;IV;IV;IV	YES;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;4320;Not Available;2184	Not Available;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES;YES	NO;YES	NO;NO	NO;NO	TCGA-73-4668-F7955;TCGA-73-4668-F7958	c82cb3f9-fb87-4f7f-80c0-9ec28a8368c0;32244464-38fc-4145-a984-d23cc7196130	6;6	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	467;467	236;282	0;Not Available	Not Available;Not Available	Not Available;Stable Disease	90;80	Not Available;Not Available	1;1	Not Available;Not Available	YES;YES	Post-Adjuvant Therapy;Post-Adjuvant Therapy	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	Not Available;Not Available	NO;NO	Alive;Alive	2011;2011	FEMALE	Lung Micropapillary Adenocarcinoma	No	C34.1	8507/3	C34.1	YES	100	NO	Not Available	Not Available	Peripheral Lung	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	55	No	4668	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	AMERICAN INDIAN OR ALASKA NATIVE	Not Available	Distant site	TCGA-73-4668-R7962	2be59a25-2f78-497d-a99d-68364ee85d2f	1	6	299	299	Not Available	1	1	4000	NO	OTHER	Gamma Knife	PROGRESSION	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	2005	NO	YES	73	4	Lung	Alive	2011	2009	1968
TCGA-67-3770	70	FEMALE	610	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1	N0	M0	Stage IA	0	610			TUMOR FREE				70	R-Upper	Not Applicable	TCGA-67-3770	eeab558b-8d1e-4843-861d-dbfb06061758	Not Available	-25658	Not Applicable	0	610	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Central Lung	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	3770	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	YES	NO	67	3	Lung	Alive	2010	2009	Not Available
TCGA-64-1680	63	MALE	1126	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N2	M1	Stage IV	0	1126			TUMOR FREE				63	R-Middle	Not Applicable	TCGA-64-1680	1ab7ad70-0f80-41d8-8efa-3baebc8223cc	16	-23267	Not Applicable	0	1126	Not Available	Lung Adenocarcinoma	Not Available	TCGA-64-1680-D4377	16e53760-5ca6-4a73-b332-a900418c84d6	Not Available	16	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	Not Available	Not Available	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-64-1680-F4387	509d68b7-f334-42a9-962b-b7ff425bab81	16	Not Applicable	Not Applicable	Not Applicable	1126	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	YES	Alive	2010	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.8	8255/3	C34.8	YES	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	1680	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-64-1680-R4378	d4ad9989-199c-4734-be42-ec485b3ea9eb	1	16	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N2	T2a	1982	NO	YES	64	3	Lung	Alive	2010	2007	1962
TCGA-05-4398	47	FEMALE	1431	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T4	N3	M0	Stage IIIB	0	1431			TUMOR FREE				47	R-Upper	Not Applicable	TCGA-05-4398	31c96e35-5e2f-429c-b12a-7bc5a497a300	22	-17471	Not Applicable	0	1431	Not Available	Lung Adenocarcinoma	Not Available	TCGA-05-4398-D36463;TCGA-05-4398-D36465	9DC1C815-EC00-4CDE-BB84-3F8EB3DD9B4F;48CF8515-16A9-4E33-B2F5-AC6157DC8C51	Not Available;Not Available	5;5	92;92	0;0	Carboplatin;Etoposide	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4398-F36462	F7EFBD0A-009C-48EE-B6F6-B67D4F976432	31	Not Applicable	Not Applicable	Not Applicable	1431	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	10	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	72	No	4398	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N3	T4	Not Available	NO	YES	05	2	Lung	Alive	2010	2006	Not Available
TCGA-78-7155	68	MALE	1171	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	209.0			Not Available				68	L-Upper	Not Applicable	TCGA-78-7155	fc79086c-af9a-4c27-b074-f7050b6f3381	28	-24863	1171	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-78-7155-D16959;TCGA-78-7155-D17202	b699c307-543d-4e31-9adf-19275a9cb2ff;6db2eeea-88ce-495f-b14b-214400fff219	Not Available;Not Available	21;5	Not Available;253	253;253	Carboplatin;Gemcitabine	Not Available;Not Available	9;10	2;2	Not Available;Not Available	Not Available;Not Available	OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	new primary;New Primary	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2011;2011	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	YES	YES	NO	NO	TCGA-78-7155-F16958	8ede53b4-10e1-4371-b89d-c4f2423cda1b	28	Not Available	Not Available	1171	Not Available	209	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	9	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	48	No	7155	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-78-7155-R16960	d46f3ed7-d9f7-4800-9aff-2d7226581603	1	28	314	Not Available	Not Available	9	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	OTHER, SPECIFY IN NOTES	New Primary	Not Available	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2005	NO	YES	78	4	Lung	Dead	2011	2005	1957
TCGA-78-7152	65	MALE	1215	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N0	M0	Stage IB	1	1202.0		Distant Metastasis	WITH TUMOR				65	R-Upper	Not Applicable	TCGA-78-7152	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	29	-23782	Not Applicable	0	1202	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available;NO	YES;YES	NO;Not Available	NO;NO	TCGA-78-7152-F16986;TCGA-78-7152-F46144	37c9fd67-631d-4341-998d-1c995eaa7999;D9E98591-BA37-4BE6-9F12-3E9E4DBED53B	29;4	Not Available;Not Available	Not Available;Not Available	Not Applicable;1215	1202;Not Available	1202;1202	3;Unknown	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Progressive Disease	Not Available;Not Available	Not Available;NO	9;8	Not Available;Distant Metastasis	YES;YES	Other;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Not Available;Complete Remission/Response	Not Available;Biopsy with Histologic Confirmation;Convincing Imaging	NO;NO	Alive;Dead	2011;2013	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Peripheral Lung	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40	No	7152	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available	Distant site	TCGA-78-7152-R16987	b75b20df-f44d-4dad-b13a-6212725b3643	1	29	Not Available	1154	Not Available	9	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	Not Available	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1999	NO	YES	78	4	Lung	Alive	2011	2003	1959
TCGA-75-6211	Not Available	FEMALE		Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung		T2	N0	M0	Stage IB	1				WITH TUMOR				Not Available	Discrepancy	Not Available	TCGA-75-6211	2db08267-d346-4d42-aac0-b76831903253	21	Not Available	Not Available	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	NO	TCGA-75-6211-F15095	3b3000b8-4b0f-4a15-bdbc-0565868daa27	21	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	7	Not Available	YES	Adjuvant therapy	WITH TUMOR	NO	Complete Remission/Response	Not Available	NO	Dead	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	34	No	6211	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Distant site	TCGA-75-6211-R15097	faa5218b-def1-499d-aa96-930ae142d62c	1	21	Not Available	Not Available	Not Available	7	5	2000	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	cGy	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	75	2	Lung	Dead	2011	2009	Not Available
TCGA-MP-A4T6	76	FEMALE	1790	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N2	MX	Stage IIIA	0	1790			TUMOR FREE				76	L-Lower	Not Applicable	TCGA-MP-A4T6	5F4934BE-EEE3-40E1-8838-38103BADC898	2	-27993	1790	0	Not Available	Not Available	Lung Adenocarcinoma	63																								Not Evaluated	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Peripheral Lung	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	50	No	A4T6	Not Evaluated	TUMOR FREE	Not Available	79	NO	Not Available	77	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N2	T1	1989	NO	YES	MP	3	Lung	Dead	2013	2005	Not Available
TCGA-55-A57B	80	FEMALE	546	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1b	N0	M0	Stage IA	0	546			TUMOR FREE				80	L-Upper	Not Applicable	TCGA-55-A57B	3B21B982-DBA2-45F4-AD8D-21DC86FCAAA7	31	-29452	Not Applicable	0	21	Not Available	Lung Adenocarcinoma	77																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-A57B-F60133	828E9149-B556-4073-8F6B-55F1F065F37C	29	Not Applicable	Not Applicable	Not Applicable	546	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	NO	5	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	90	NO	Not Available	Not Available	Peripheral Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	A57B	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	99	114	Not Applicable	YES	BLACK OR AFRICAN AMERICAN	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	YES	NO	55	1	Lung	Alive	2013	2012	Not Available
TCGA-44-2656	59	MALE	1429	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	1	568.0		New Primary Tumor	TUMOR FREE		FPPP	TCGA	59	R-Upper	Not Applicable	TCGA-44-2656	42ca54fc-c1ae-41cd-bca1-7fe9810db460	8	-21766	Not Applicable	0	582	Not Available	Lung Adenocarcinoma	72																								0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;Not Available;YES	Not Available;Not Available;YES	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-44-2656-F5294;TCGA-44-2656-F9736;TCGA-44-2656-F39934	ca338d6c-2526-45f1-9b0d-c0a045d0ac8c;f823f92c-9e8e-4393-9381-62cfc40ff094;01F40F24-6888-4940-8620-3E5F531523DD	8;14;6	Not Applicable;Not Available;Not Available	Not Applicable;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	582;749;1429	Not Applicable;Not Available;568	Not Available;Not Available;Not Available	Not Available;Not Available;Scheduled Follow-up Submission	Complete Remission/Response;Not Available;Complete Remission/Response	Not Available;Not Available;Not Available	Not Available;Not Available;NO	10;4;2	Not Available;Not Available;New Primary Tumor	NO;Not Available;YES	Not Available;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Not Available;Biopsy with Histologic Confirmation	NO;NO;NO	Alive;Alive;Alive	2010;2011;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	23	No	2656	Pre-Adjuvant Therapy	TUMOR FREE	86	84	Not Available	86	79	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2009	YES	NO	44	4	Lung	Alive	2010	2009	1994
TCGA-93-A4JO	70	MALE	33	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T1a	N0	MX	Stage IA	0	33			TUMOR FREE				70	R-Lower	Not Applicable	TCGA-93-A4JO	3DAEBE75-C6DF-478E-8A4C-11186FD5EAD9	27	-25898	33	0	Not Available	Not Available	Lung Adenocarcinoma	81																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	90	NO	Not Available	Not Available	Unknown	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	50	No	A4JO	Preoperative	TUMOR FREE	126	97	NO	125	98	Not Applicable	YES	WHITE	NO																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1a	2006	YES	NO	93	4	Lung	Dead	2014	2012	1956
TCGA-78-7535	45	MALE	949	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	809.0			WITH TUMOR				45	L-Upper	Not Applicable	TCGA-78-7535	46592b7b-6968-42a6-83af-0917c9f4a9a5	19	-16571	949	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-78-7535-D20641;TCGA-78-7535-D20640	81a1889c-bbcb-408b-8c95-1a0acf920311;b445a5a2-5b5c-47d3-962d-04da28489e68	Not Available;Not Available	19;19	124;130	60;60	Vinblastine;Cisplatin	Not Available;Not Available	1;1	3;4	8;160	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	56;640	mg;mg	Not Available;Not Available	2012;2012	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	NO	YES	TCGA-78-7535-F20633	63e1af54-b78a-4f59-9871-30d86f0546f6	19	Not Available	809	949	Not Available	809	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	1	Not Available	YES	Not Available	WITH TUMOR	YES	Stable Disease	Not Available	NO	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	35	No	7535	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	78	2	Lung	Dead	2012	2000	1972
TCGA-62-8398	55	MALE	444	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T2	N2	M0	Stage IIIA	0	444			TUMOR FREE				55	R-Lower	Not Applicable	TCGA-62-8398	2fabeb98-05e3-4f55-97f5-fbc675e25a3d	4	-20197	444	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available	TCGA-62-8398-D33507;TCGA-62-8398-D40458	316E364F-9824-4D22-AB44-6C9181EF3AAA;BB70829B-5995-4D0D-ABEF-22D1AD108527	Not Available;Not Available	5;21	113;113	41;41	Carboplatin;Vinorelbin	Complete Response;Complete Response	7;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2013	Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	100	NO	Not Available	Not Available	Central Lung	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	No	8398	Preoperative	TUMOR FREE	Not Available	Not Available	YES	72	64	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2	1999	NO	YES	62	4	Lung	Dead	2012	2007	1970
TCGA-91-6840	59	FEMALE	372	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T1b	N0	M0	Stage IA	0	372			TUMOR FREE				59	R-Upper	Not Applicable	TCGA-91-6840	d5326429-9805-47f9-97b0-fbda658e3f01	15	-21854	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-6840-F21664	733715F8-948C-4764-9C90-5A5A19666BC2	8	Not Applicable	Not Applicable	Not Applicable	372	Not Applicable	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	5	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50	No	6840	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	1996	YES	NO	91	3	Lung	Alive	2011	2011	1971
TCGA-75-5122	Not Available	MALE		Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung		T2	N0	M0	Stage IB	1				WITH TUMOR				Not Available	L-Upper	Not Applicable	TCGA-75-5122	78ae716b-0ca5-4c01-a053-d41288385fcd	28	Not Available	Not Available	Not Available	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available	NO	NO	Not Available	NO	TCGA-75-5122-F11750	ded07f2c-1693-4ffa-b33d-e4c0e47bc2f2	31	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Progressive Disease	0	Not Available	3	Not Available	YES	Adjuvant therapy	WITH TUMOR	NO	Complete Remission/Response	Not Available	NO	Dead	2011	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	0	NO	Not Available	Not Available	Peripheral Lung	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20	No	5122	Other	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	1985	NO	YES	75	3	Lung	Dead	2011	2005	Not Available
TCGA-99-8025	72	FEMALE	1060	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T3	N2	M0	Stage IIIA	0	1060			TUMOR FREE				72	R-Upper	Not Applicable	TCGA-99-8025	84c3ba70-afa7-4b69-be69-7ec8d6022c56	25	-26634	Not Applicable	0	427	Not Available	Lung Adenocarcinoma	87	TCGA-99-8025-D33590	E437156A-F538-4BCB-9CC6-2B6DC295AA6D	Not Available	9	286	213	Gemzar	Unknown	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	1	Not Available	YES	Not Available	Not Available	Not Available	YES	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-99-8025-F57698	13030256-EACD-4E4B-B19C-592CBBE0A543	23	Not Applicable	Not Applicable	Not Applicable	1060	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	5	Not Available	NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Unknown	YES	NO	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	No	8025	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	111	Unknown	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T3	1998	NO	YES	99	4	Lung	Alive	2012	2010	1958
TCGA-55-8207	73	MALE	977	Lung Acinar Adenocarcinoma	Lung	Alive	T2a	N0	MX	Stage IB	0	977			TUMOR FREE				73	L-Lower	Not Applicable	TCGA-55-8207	b256e065-c681-4f82-8b68-a8ef7c413791	8	-26897	Not Applicable	0	66	Not Available	Lung Adenocarcinoma	48																								Unknown	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-55-8207-F65849	29690F66-8E25-4910-9609-41662B16E775	30	Not Applicable	Not Applicable	Not Applicable	977	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	9	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES	Unknown	Unknown	Not Available	Not Available	Unknown	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Yes, History of Synchronous/Bilateral Malignancy	8207	Unknown	TUMOR FREE	84	83	NO	86	84	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	Not Available	YES	NO	55	3	Lung	Alive	2012	2011	Not Available
TCGA-55-6969	52	MALE	1239	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	0	1239			TUMOR FREE				52	L-Upper	Not Applicable	TCGA-55-6969	d6e274a0-6425-437b-bc07-1225be7808d5	25	-19270	Not Applicable	0	1239	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	Not Available																													MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6969	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2004	NO	YES	55	4	Lung	Alive	2011	2004	Not Available
TCGA-64-5774	60	MALE	2676	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	M0	Stage IB	1	246.0			TUMOR FREE				60	Discrepancy	Not Available	TCGA-64-5774	fd3fc273-c035-40ea-a459-ff4806f5d592	2	-22059	Not Applicable	0	2550	Not Available	Lung Adenocarcinoma	95																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;NO	YES;NO	Not Available;Not Available	YES;YES	TCGA-64-5774-F11400;TCGA-64-5774-F31478	4fe330f5-c1e9-4079-93ae-28cc03a377c3;950e7225-f00b-441c-ba1a-5873e13fa6db	2;3	Not Available;Not Available	277;Not Available	Not Applicable;Not Applicable	2550;2676	246;277	Not Available;Unknown	Not Available;Additional New Tumor Event	Complete Remission/Response;Unknown	Not Available;Unknown	Not Available;Not Available	5;5	Not Available;Distant Metastasis	YES;YES	Not Available;Unknown	TUMOR FREE;Unknown	NO;NO	Complete Remission/Response;Unknown	Not Available;Not Available	NO;NO	Alive;Alive	2011;2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.0	8140/3	C34.0	YES	Not Available	Not Available	Not Available	Not Available	Central Lung	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	45	No	5774	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	71	72	Not Available	YES	WHITE	Not Available	Distant site	TCGA-64-5774-R11401	c6f6101e-4029-49d5-a1ad-424e7d6211dd	1	2	Not Available	Not Available	Not Available	5	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	Not Available	2011	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	2004	NO	YES	64	4	Lung	Alive	2011	2004	1959
TCGA-O1-A52J	74	FEMALE	1798	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	MX	Stage IA	1	898.0		Locoregional Recurrence	WITH TUMOR				74	L-Lower	Not Applicable	TCGA-O1-A52J	42432463-8E92-4F25-B72A-F03953527AA5	11	-27223	1798	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								1	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Evaluated	NO	Not Available	Not Available	Unknown	4	NO	NO	898	NO	Not Available	Not Available	Not Available	Locoregional Recurrence	Not Available	YES	45	No	A52J	Unknown	WITH TUMOR	Not Available	Not Available	NO	Not Available	Not Available	Unknown	NO	WHITE	NO																			Not Evaluated	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	1980	NO	YES	O1	3	Lung	Dead	2013	2007	1950
TCGA-86-6851	73	FEMALE	179	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T1b	N1	M0	Stage IIA	0	179			TUMOR FREE				73	L-Upper	Not Applicable	TCGA-86-6851	035c0b2b-c722-443b-8962-db4ee92c7532	7	-26808	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-6851-F53594	40FE93C5-B9C4-47D2-B194-C15151EBC3CF	12	Not Applicable	Not Applicable	Not Applicable	179	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	YES	12	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	52	No	6851	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	Not Available	YES	NO	86	2	Lung	Alive	2011	2011	1959
TCGA-62-8395	80	FEMALE	1216	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T3	N0	M0	Stage IIB	1	395.0		Locoregional Recurrence	WITH TUMOR				80	R-Upper	Not Applicable	TCGA-62-8395	5c266025-e590-457c-af86-4c2dc9797267	4	-29311	Not Applicable	0	705	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	YES	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	YES	NO	NO	Not Available	TCGA-62-8395-F42099	2705FAEA-A87F-4437-8A72-3CD9216FC451	15	Not Available	Not Available	Not Applicable	1216	395	0	Scheduled Follow-up Submission	Progressive Disease	100	NO	5	Locoregional Recurrence	YES	Preoperative	WITH TUMOR	NO	Complete Remission/Response	Convincing Imaging	NO	Alive	2013	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	100	NO	Not Available	Not Available	Central Lung	7	YES	NO	500	NO	Not Available	NO	Not Available	Locoregional Recurrence;Distant Metastasis	Convincing Imaging	YES	Not Available	No	8395	Preoperative	WITH TUMOR	Not Available	Not Available	NO	86	130	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	NO	YES	62	1	Lung	Alive	2012	2009	Not Available
TCGA-86-A4P7	63	FEMALE	415	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	M0	Stage IB	0	415			TUMOR FREE				63	L-Lower	Not Applicable	TCGA-86-A4P7	9E640FF7-996E-427B-B56C-519A1E23BAAB	7	-23330	Not Applicable	0	14	Not Available	Lung Adenocarcinoma	Not Available																								0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-86-A4P7-F66092	575B0BCF-4A4C-489E-9FD7-5CF28FBD3A68	2	Not Applicable	Not Applicable	Not Applicable	415	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	10	Not Available	NO	Other	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2014	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	100	NO	Not Available	Not Available	Peripheral Lung	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	No	A4P7	Preoperative	TUMOR FREE	Not Available	Not Available	Unknown	Not Available	Not Available	Complete Remission/Response	NO	WHITE	Unknown																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	YES	NO	86	1	Lung	Alive	2013	2012	Not Available
TCGA-91-6831	66	MALE	310	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	0	310			TUMOR FREE				66	R-Middle	Not Applicable	TCGA-91-6831	db0b9e63-4272-4f29-bf0e-1ec0fe79a9d7	19	-24436	Not Applicable	0	39	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-91-6831-F32636	05ae61a2-c054-4273-b50c-4760cbb08a73	5	Not Applicable	Not Applicable	Not Applicable	310	Not Applicable	Unknown	Scheduled Follow-up Submission	Complete Remission/Response	Unknown	YES	6	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	Not Available	NO	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6831	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	Not Available	NO	YES	91	2	Lung	Alive	2011	2001	Not Available
TCGA-05-4420	41	MALE	912	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2	N0	M0	Stage IB	0	912			TUMOR FREE				41	R-Lower	Not Applicable	TCGA-05-4420	3d2aa654-1b5f-4eb4-a1c2-af31f5760069	22	-15159	Not Applicable	0	912	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-05-4420-F36531	F35DE973-C732-4FC5-9C26-51A06531E0A2	1	Not Applicable	Not Applicable	Not Applicable	912	Not Applicable	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11	Not Available	NO	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2012	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	38	No	4420	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	05	2	Lung	Alive	2010	2008	Not Available
TCGA-05-4395	76	MALE	0	Lung Adenocarcinoma Mixed Subtype	Lung	Dead	T4	N2	M0	Stage IIIB	0	0			TUMOR FREE				76	L-Upper	Not Applicable	TCGA-05-4395	762dea8a-5b41-4058-979a-b7876ed13d7e	22	-27971	0	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	4395	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T4	1983	NO	YES	05	3	Lung	Dead	2010	2006	Not Available
TCGA-67-6217	73	FEMALE	422	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N1	M0	Stage IIA	1	296.0			WITH TUMOR				73	L-Upper	Not Applicable	TCGA-67-6217	108a71cf-b9db-47cd-aa74-c03ec989b41b	6	-26920	Not Applicable	0	422	Not Available	Lung Adenocarcinoma	Not Available	TCGA-67-6217-D13740	912f0718-4f53-4ab2-9972-8bbadf753d8d	Not Available	11	443	399	Tarceva	Not Available	7	1	100	mg	PROGRESSION	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	YES	L858R	Not Available	RT-PCR	YES	Not Available	NOT HISPANIC OR LATINO	YES	Not Available	NO	NO	TCGA-67-6217-F13566	b1095ed9-280b-4211-9fa7-7013f6da1d5d	5	Not Available	Not Available	Not Applicable	422	296	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	Not Available	7	Not Available	YES	Not Available	WITH TUMOR	NO	Progressive Disease	Not Available	NO	Alive	2011	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	YES	NO	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Yes	6217	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	1965	YES	NO	67	3	Lung	Alive	2011	2010	Not Available
TCGA-44-4112	60	FEMALE	808	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N0	M0	Stage IB	1	619.0			Not Available		FPPP	TCGA	60	R-Upper	Not Applicable	TCGA-44-4112	68b86559-38b2-41f2-b66e-c3c2b628b14d	12	-22106	Not Applicable	0	141	141	Lung Adenocarcinoma	Not Available	TCGA-44-4112-D13710;TCGA-44-4112-D13711	75c42d72-040a-42d2-953d-8a4a9c467011;1c60b058-9bc5-4159-996a-57177380956d	Not Available;Not Available	11;11	142;142	78;78	Cisplatin;Alimta	Not Available;Not Available	7;7	4;4	165;1100	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	660;4400	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;NO;Not Available	Not Available;YES;Not Available	Not Available;NO;NO	Not Available;YES;Not Available	TCGA-44-4112-F13709;TCGA-44-4112-F30573;TCGA-44-4112-F32266	84d22f7a-401b-4420-92c0-d5bd3374c131;646d47cb-6adc-4cae-966a-f63c8ac3c781;dfbce6d3-9f66-439a-8c79-9b18418af662	11;12;22	Not Available;Not Available;Not Applicable	Not Available;619;Not Applicable	Not Applicable;Not Applicable;808	370;722;Not Available	Not Available;619;Not Applicable	0;Not Available;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event;Not Available	Complete Remission/Response;Stable Disease;Not Evaluated	Not Available;70;Not Available	Not Available;Not Available;Not Available	7;4;5	Not Available;Not Available;Not Available	Not Available;YES;NO	Adjuvant therapy;Other;Not Available	TUMOR FREE;WITH TUMOR;WITH TUMOR	YES;Not Available;Not Available	Complete Remission/Response;Not Available;Not Available	Not Available;Not Available;Not Available	NO;Not Available;Not Available	Alive;Alive;Dead	2011;2012;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	4112	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	WHITE	Not Available	Distant Recurrence	TCGA-44-4112-R30706	a33297b6-1b28-4a0e-af21-09030850c6b7	1	16	675	654	Not Available	4	14	3500	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2012	R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	1992	YES	NO	44	3	Lung	Alive	2010	2010	1972
TCGA-49-AAR2	64	MALE	2224	Lung Acinar Adenocarcinoma	Lung	Alive	T2	N0	MX	Stage IB	0	2224			TUMOR FREE				64	R-Lower	Not Applicable	TCGA-49-AAR2	F809E7D9-A75E-41C9-AC2C-5BEC6FFCB4A2	18	-23479	Not Applicable	0	1945	Not Available	Lung Adenocarcinoma	105.8	TCGA-49-AAR2-D72096	5FF030BD-A154-4ACD-B9B3-057B31650269	Not Available	10	123	85	TAXOL	Complete Response	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2015	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-49-AAR2-F72094	BC671272-CB8C-48B0-9CA4-7408D1BE13D6	10	Not Applicable	Not Applicable	Not Applicable	2224	Not Applicable	1	Scheduled Follow-up Submission	Complete Remission/Response	90	NO	4	Not Available	NO	Preoperative	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2015	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES	90	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	No	AAR2	Preoperative	TUMOR FREE	78.2	79.5	NO	78.6	80	Complete Remission/Response	YES	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	2006	NO	YES	49	4	Lung	Alive	2014	2009	Not Available
TCGA-62-A46O	65	FEMALE	1454	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2	N0	M0	Stage IB	1	943.0		Locoregional Recurrence	WITH TUMOR				65	R-Lower	Not Applicable	TCGA-62-A46O	D7AE8EFB-AA4D-4807-9772-55B0A28CCD5C	29	-24050	1454	0	Not Available	Not Available	Lung Adenocarcinoma	Not Available																								Unknown	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO																													FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	100	NO	Not Available	Not Available	Central Lung	10	NO	NO	943	NO	Not Available	NO	Not Available	Locoregional Recurrence;Distant Metastasis	Convincing Imaging	YES	48	No	A46O	Preoperative	WITH TUMOR	Not Available	Not Available	NO	65	106	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	NO	YES	62	2	Lung	Dead	2012	2006	Not Available
TCGA-44-7660	72	MALE	592	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	1	253.0		Locoregional Recurrence	TUMOR FREE				72	R-Upper	Not Applicable	TCGA-44-7660	a534b96b-1665-444a-9308-e610f2f0e510	22	-26594	Not Applicable	0	162	Not Available	Lung Adenocarcinoma	80	TCGA-44-7660-D32371	452ec58f-55a9-4b79-9095-1800bc34f9a8	ASCI	24	141	78	recPRAME+AS15 ASCI	Clinical Progressive Disease	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Vaccine	Not Available	Not Available	Not Available	YES	2012	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO;Not Available	NO;Not Available	NO;NO	Not Available;Not Available	TCGA-44-7660-F32361;TCGA-44-7660-F40409	57f9b0eb-17e0-4b6b-92a0-407511f014d9;4B16E925-6686-4721-B792-96761A62E44C	24;19	Not Available;Not Applicable	Not Available;Not Applicable	Not Applicable;Not Applicable	325;592	253;Not Applicable	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Progressive Disease;Stable Disease	Not Available;70	NO;NO	5;2	Locoregional Recurrence;Not Available	YES;NO	Not Available;Other	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	Convincing Imaging;Not Available	NO;NO	Alive;Alive	2012;2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	124	No	7660	Pre-Adjuvant Therapy	TUMOR FREE	95	94	Not Available	92	83	Not Available	YES	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	Not Available	YES	NO	44	2	Lung	Alive	2011	2011	1949
TCGA-44-3919	71	FEMALE	1026	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T1	N0	M0	Stage IA	1	921.0		Locoregional Recurrence	TUMOR FREE				71	R-Upper	Not Applicable	TCGA-44-3919	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	7	-26081	Not Applicable	0	190	Not Available	Lung Adenocarcinoma	103																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available;NO;NO	Not Available;YES;YES	Not Available;NO;NO	Not Available;NO;NO	TCGA-44-3919-F5232;TCGA-44-3919-F38529;TCGA-44-3919-F38530	5d1a6aba-a69b-4767-b109-8ae19be0770f;E807118D-E91B-41E2-A96D-69FFF71A8E0F;9EC1AE84-0030-4A21-8ECF-F1E537C866C4	8;19;19	Not Applicable;Not Available;Not Available	Not Applicable;Not Available;Not Available	Not Applicable;1026;1026	190;Not Available;Not Available	Not Applicable;921;984	Not Available;2;2	Not Available;Additional New Tumor Event;Additional New Tumor Event	Complete Remission/Response;Progressive Disease;Not Applicable	Not Available;Not Available;Not Available	Not Available;NO;NO	10;12;12	Not Available;Locoregional Recurrence;Distant Metastasis	NO;YES;YES	Not Available;Other;Other	TUMOR FREE;WITH TUMOR;WITH TUMOR	NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	Not Available;Convincing Imaging;Convincing Imaging	NO;NO;NO	Alive;Dead;Dead	2010;2012;2012	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	3919	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	99	100	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	Not Available	YES	NO	44	1	Lung	Alive	2010	2010	Not Available
TCGA-44-6775	72	FEMALE	705	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2a	N0	MX	Stage IB	1	684.0		Locoregional Recurrence	Not Available		FPPP	TCGA	72	R-Upper	Not Applicable	TCGA-44-6775	3c4ff061-d214-4d1c-8d2e-3034f207c252	24	-26415	Not Applicable	0	83	Not Available	Lung Adenocarcinoma	66																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	HISPANIC OR LATINO	Not Available;NO	Not Available;NO	Not Available;NO	Not Available;Not Available	TCGA-44-6775-F30930;TCGA-44-6775-F40408	b3652245-e7e8-4b5a-b946-07b14256210b;5A214384-F238-4FFD-A355-8617658950AD	19;19	Not Applicable;Not Available	Not Applicable;Not Available	Not Applicable;Not Applicable	370;705	Not Applicable;684	Not Available;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Complete Remission/Response;Progressive Disease	Not Available;100	Not Available;NO	4;2	Not Available;Locoregional Recurrence	NO;YES	Not Available;Other	TUMOR FREE;WITH TUMOR	Not Available;NO	Not Available;Complete Remission/Response	Not Available;Convincing Imaging	Not Available;NO	Alive;Alive	2012;2013	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	No	6775	Not Available	Not Available	89	72	Not Available	84	68	Not Available	YES	WHITE	Not Available																			RX	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a	2005	YES	NO	44	4	Lung	Alive	2011	2011	1955
TCGA-97-7554	83	FEMALE	775	Lung Papillary Adenocarcinoma	Lung	Alive	T2a	N2	M0	Stage IIIA	0	775			TUMOR FREE				83	L-Lower	Not Applicable	TCGA-97-7554	a9644274-13bb-4228-9b4f-14260ccc26eb	17	-30327	Not Applicable	0	264	Not Available	Lung Adenocarcinoma	53	TCGA-97-7554-D18639;TCGA-97-7554-D18627	779af18b-5c23-4e62-ae9c-b6288f15b3da;c7851da9-c4f2-4a19-b48c-a90e5b4d9cba	Not Available;Not Available	21;21	111;111	49;49	Alimta;Carboplatin	Not Available;Not Available	11;11	4;4	817;350	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3268;1400	mg;mg	Not Available;Not Available	2011;2011	0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-97-7554-F20552	C53D0705-AD5B-47B9-8D49-C786D4466CC7	17	Not Applicable	Not Applicable	Not Applicable	775	Not Applicable	1	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	1	Not Available	NO	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2012	FEMALE	Lung Papillary Adenocarcinoma	No	C34.3	8260/3	C34.3	YES	Not Available	YES	YES	G12V	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30	No	7554	Preoperative	TUMOR FREE	75	75	Not Available	76	68	Not Available	YES	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N2	T2a	1983	NO	YES	97	3	Lung	Alive	2011	2010	1945
TCGA-86-6562	52	MALE	376	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Dead	T2a	N1	M0	Stage IIA	1	274.0			TUMOR FREE				52	R-Upper	Not Applicable	TCGA-86-6562	dcd066ba-5894-453e-b1da-82092858c3db	21	-19301	Not Applicable	0	0	Not Available	Lung Adenocarcinoma	Not Available	TCGA-86-6562-D29769;TCGA-86-6562-D29767	f359ca59-3a44-488c-bfc2-7aea795f3d57;02372dd0-f7cc-47c8-a3d0-0c6031d75cda	Not Available;Not Available	28;28	253;253	27;27	Vinblastine;Cisplatin	Not Available;Not Available	3;3	4;4	6;150	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	120;600	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NOT HISPANIC OR LATINO	NO	NO	NO	Not Available	TCGA-86-6562-F29765	a47bbc7f-a0b3-4a1f-bf61-b6fd5f425572	28	Not Available	Not Available	376	Not Available	274	Not Available	Scheduled Follow-up Submission	Progressive Disease	0	Not Available	3	Not Available	YES	Not Available	WITH TUMOR	YES	Progressive Disease	Not Available	NO	Dead	2012	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	Not Available	NO	Not Available	Not Available	Central Lung	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6562	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	YES	NO	86	1	Lung	Alive	2011	2011	Not Available
TCGA-55-6642	63	MALE	2449	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2	N0	MX	Stage IB	0	2449			TUMOR FREE				63	R-Lower	Not Applicable	TCGA-55-6642	474b86d9-d897-467d-85d4-51dfa26ea107	19	-23107	Not Applicable	0	993	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-55-6642-F45614	A3AE45C0-A9BD-4E60-93D7-9017BF3411E0	17	Not Applicable	Not Applicable	Not Applicable	2449	Not Applicable	Not Evaluated	Scheduled Follow-up Submission	Complete Remission/Response	Not Evaluated	NO	7	Not Available	NO	Not Evaluated	TUMOR FREE	NO	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	6642	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	Not Available	NO	YES	55	2	Lung	Alive	2011	2006	1961
TCGA-62-A471	64	MALE	1246	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Lung	Alive	T2b	N1	M0	Stage IIB	0	1246			TUMOR FREE				64	L-Upper	Not Applicable	TCGA-62-A471	0075437E-BA1A-46BE-86D6-9773209A2B5E	30	-23689	Not Applicable	0	883	Not Available	Lung Adenocarcinoma	Not Available	TCGA-62-A471-D36369;TCGA-62-A471-D40576;TCGA-62-A471-D40577	0B09C8A2-1EDD-4523-9B04-7C6DCA69D4CE;AB370E23-6CB3-4C2D-AAEE-F18B9832C078;8E2B3458-E311-41FF-BA45-78E93803E232	Not Available;Not Available;Not Available	30;25;25	115;115;115	41;41;41	Cisplatin;Vinorelbine;Gemcitabine	Complete Response;Complete Response;Complete Response	10;2;2	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2013;2013	0	Not Available	NO	Not Available	Not Available	Not Available	NO	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-62-A471-F51439	9BA3092F-235D-4C9D-943F-BD40B1D24721	19	Not Applicable	Not Applicable	Not Applicable	1246	Not Applicable	0	Scheduled Follow-up Submission	Complete Remission/Response	100	NO	11	Not Available	NO	Preoperative	TUMOR FREE	YES	Complete Remission/Response	Not Available	NO	Alive	2013	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	100	NO	Not Available	Not Available	Peripheral Lung	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	30	No	A471	Preoperative	TUMOR FREE	Not Available	Not Available	YES	75	104	Complete Remission/Response	YES	WHITE	NO																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2b	2006	NO	YES	62	4	Lung	Alive	2012	2010	Not Available
TCGA-05-5715	69	FEMALE	62	Lung Adenocarcinoma Mixed Subtype	Lung	Alive	T2a	N0	M0	Stage IB	0	62			TUMOR FREE				69	L-Upper	Not Applicable	TCGA-05-5715	e0a19099-5d25-40df-ad73-6260df3a1b32	22	-25383	Not Applicable	0	62	Not Available	Lung Adenocarcinoma	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																													FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	5715	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	NO	YES	05	1	Lung	Alive	2011	2010	Not Available
